
<html lang="en"     class="pb-page"  data-request-id="7df6dd9a-b5b6-47ef-bd37-5b9f1aedc3a4"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2010.53.issue-7;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm901443h;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Through the “Gatekeeper Door”: Exploiting the Active Kinase Conformation" /></meta><meta name="dc.Creator" content="Fabio  Zuccotto" /></meta><meta name="dc.Creator" content="Elena  Ardini" /></meta><meta name="dc.Creator" content="Elena  Casale" /></meta><meta name="dc.Creator" content="Mauro  Angiolini" /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 14, 2009" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm901443h" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm901443h" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm901443h" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm901443h" /></link>
        
    
    

<title>Through the “Gatekeeper Door”: Exploiting the Active Kinase Conformation | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm901443h" /></meta><meta property="og:title" content="Through the “Gatekeeper Door”: Exploiting the Active Kinase Conformation" /></meta><meta property="og:image" content="https://pubs.acs.org/pb-assets/images/CoverImages_2by1Scaled/jmcmar-1595795902140.png" /></meta><meta property="og:description" content="" /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm901443h"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm901443h">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm901443h&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm901443h&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm901443h&amp;href=/doi/10.1021/jm901443h" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 2681-2694</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm100264u" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm901294u" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Through the “Gatekeeper Door”: Exploiting the Active Kinase Conformation</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fabio++Zuccotto">Fabio Zuccotto</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elena++Ardini">Elena Ardini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elena++Casale">Elena Casale</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mauro++Angiolini">Mauro Angiolini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="affa"><span class="aff-symbol">†</span> <span class="aff-text">Department of Chemical Core Technologies</span></div><div class="aff-info" id="affb"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Cell Biology Signal Transduction</span></div><div class="aff-info" id="affc"><span class="aff-symbol">§</span> <span class="aff-text">Department of Medicinal Chemistry</span></div><div class="aff-info" id="nms"><span class="aff-text">Nerviano Medical Sciences, Oncology, Viale Pasteur 10, Nerviano 20014, Italy</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: +39-0331-581103. Fax: +39-0331-581106. E-mail: <a href="/cdn-cgi/l/email-protection#c583a4a7acaaeb9fb0a6a6aab1b1aa858ba0b7b3aca4abaaa8b6eba6aaa8"><span class="__cf_email__" data-cfemail="0d4b6c6f64622357786e6e627979624d43687f7b646c6362607e236e6260">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm901443h&amp;href=/doi/10.1021%2Fjm901443h" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 2681–2694</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 14, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>29 September 2009</li><li><span class="item_label"><b>Published</b> online</span>14 December 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 April 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm901443h" title="DOI URL">https://doi.org/10.1021/jm901443h</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2681%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DFabio%2BZuccotto%252C%2BElena%2BArdini%252C%2BElena%2BCasale%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D7%26contentID%3Djm901443h%26title%3DThrough%2Bthe%2B%25E2%2580%259CGatekeeper%2BDoor%25E2%2580%259D%253A%2BExploiting%2Bthe%2BActive%2BKinase%2BConformation%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2694%26publicationDate%3DApril%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm901443h"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">12989</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">322</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm901443h" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Through the “Gatekeeper Door”: Exploiting the Active Kinase Conformation&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Fabio&quot;,&quot;last_name&quot;:&quot;Zuccotto&quot;},{&quot;first_name&quot;:&quot;Elena&quot;,&quot;last_name&quot;:&quot;Ardini&quot;},{&quot;first_name&quot;:&quot;Elena&quot;,&quot;last_name&quot;:&quot;Casale&quot;},{&quot;first_name&quot;:&quot;Mauro&quot;,&quot;last_name&quot;:&quot;Angiolini&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;2681-2694&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm901443h&quot;},&quot;abstract&quot;:&quot;&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901443h&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901443h" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901443h&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901443h" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm901443h&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901443h" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm901443h&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm901443h&amp;href=/doi/10.1021/jm901443h" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm901443h" /></input><a href="/doi/pdf/10.1021/jm901443h" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm901443h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm901443h%26sid%3Dliteratum%253Aachs%26pmid%3D20000735%26genre%3Darticle%26aulast%3DZuccotto%26date%3D2010%26atitle%3DThrough%2Bthe%2B%25E2%2580%259CGatekeeper%2BDoor%25E2%2580%259D%253A%2BExploiting%2Bthe%2BActive%2BKinase%2BConformation%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D7%26spage%3D2681%26epage%3D2694%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290663" title="Pharmacophores">Pharmacophores</a>,</li><li><a href="/action/doSearch?ConceptID=291264" title="Kinase inhibitors">Kinase inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292541" title="Cavities">Cavities</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72643" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72643" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The human genome comprises more than 500 protein kinases including serine/threonine, tyrosine and dual specificity kinases.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Because of the important physiological and pathological role of kinases, the human kinome represents one of the most important drug discovery opportunities in oncology and other therapeutic areas such as inflammation, autoimmune diseases, and metabolic disorders.<a onclick="showRef(event, 'ref3 ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6 ref7">(3-7)</a></div><div class="NLM_p">Protein kinases phosphorylate their substrate proteins by catalyzing the transfer of the terminal γ-phosphate of the cosubstrate ATP<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a><div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: ATP, adenosine 5′-triphosphate; FDA, Food and Drug Administration; IP, intellectual property; PDB, Protein Data Bank; SAR, structure−activity relationship; DFG, aspartate−phenylalanine−glycine.</p></div> to the hydroxyl acceptor group on the side chains of serine, threonine, or tyrosine residues of the substrate proteins. Kinase structures present a highly conserved catalytic domain that consists of a bilobed structure with the ATP molecule and a Mg ion binding in a deep cleft located between the N- and C-terminal lobes.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a></div><div class="NLM_p">Since protein phosphorylation represents a key step in many crucial cellular processes like proliferation, differentiation, and apoptosis, the discovery of small molecule kinase inhibitors has attracted growing interest for novel drugs research and development as well as the identification of experimental tools for the understanding of the biological roles of this class of proteins.</div><div class="NLM_p">The possibility of controlling cell proliferation and death by inhibition of a specific target kinase offers the opportunity to introduce the concept of targeted therapies in the treatment of cancer, providing a valid alternative to conventional chemotherapy. In the past, the main effort in kinase inhibitors development was aimed at the identification of highly potent and specific compounds inhibiting a single kinase. The initial strategy was to develop compounds that could mimic ATP binding to the kinase. This led to a first generation of small molecules kinase inhibitors (defined as type I inhibitors) normally targeting the ATP binding site of the enzyme in the active form, which is characterized by an open conformation of the activation loop. This open conformation is normally referred to as DFG “in” based on the position of the conserved triad aspartate−phenylalanine−glycine (DFG) at the beginning of the activation loop. The common feature of the type I compounds is their ability to bind to the ATP site mimicking the adenine ring in its interactions with the “hinge” residues of the protein.</div><div class="NLM_p">However, the first kinase small molecule inhibitor to reach the market was imatinib <b>1</b> (Gleevec, Novartis) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), a compound that recognizes a different form of the kinase.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Structural studies have demonstrated that imatinib <b>1</b>, a cKIT, Abl, and PDGFR inhibitor approved for chronic myeloid leukemia treatment, binds an inactive form of the target kinases characterized by a closed conformation of the activation loop (DFG “out”) which prevents binding of both nucleotide and protein substrates. The flip of the DFG motif in the inactive form considerably changes the morphology of the ATP site and exposes an additional hydrophobic site. The discovery of the novel mode of binding of imatinib <b>1</b> was serendipitous, but following its success a new generation of kinase inhibitors, specifically targeting the DFG “out” form, emerged. This class of compounds, defined as type II inhibitors, binds to the same area occupied by the type I compounds but also extends to the additional hydrophobic site available in the inactive form.</div><div class="NLM_p">Despite numerous drug discovery projects targeting kinases and considerable investments during the past few decades, only a few compounds have reached the market, leaving many potential cancer targets still undrugged. To date, eight kinase small molecules inhibitors have been approved by the FDA for cancer treatment. All these compounds are ATP competitors and follow either a type I (sunitinib <b>2</b>, erlotinib <b>3</b>, getifinib <b>4</b>, dasatinib <b>5</b>, and lapatinib <b>6</b>) or a type II design (imatinib <b>1</b>, sorafenib <b>7</b>, nilotinib <b>8</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Compounds in the late phase of development as kinase inhibitors also fall within the same design paradigms with the exception of a few compounds, defined as allosteric inhibitors, which bind outside the ATP binding site.</div><div class="NLM_p">The development of new kinase inhibitors is still a slow and problematic process. Generally, type I compounds suffer from widespread cross-reactivity among other members of the kinase target family, and intense medicinal chemistry optimization programs are required to modulate their activity. Also, fierce competition in the development of scaffolds that could mimic ATP has led to a crowded IP space.</div><div class="NLM_p">The new opportunities opened by the type II compounds created great expectations, as targeting the allosteric site of the ATP pocket offered additional opportunities to control selectivity and introduce IP novelty. However, clinical evaluation of these compounds has highlighted how the acquisition of resistance-causing mutations of the kinase target limits their efficacy in cancer treatment.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Of late, the targeted therapies paradigm is also changing.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> There is now a general agreement that given the complexity of cancer, in the absence of an “oncogene addiction” mechanism, a multitarget approach might be more effective than the one based on the inhibition of a single target.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13-15)</a> In the discovery of novel kinase inhibitors, however, an uncontrolled promiscuous activity might pose considerable risks due to unforeseeable side effects and toxicity due to broad inhibition of cellular processes. To reduce these risks, a controlled multitarget therapy, based on the selective inhibition on a specific set of kinase targets, is required.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> To achieve this, the rational design of kinase inhibitors with a controlled specificity may be one of the major challenges.</div><div class="NLM_p">The wealth of structural information available on kinases has greatly promoted the rational design of kinase inhibitors and at the same time has provided a clear picture of the level of complexity of the kinase catalytic regulation and the several structural elements that are playing part in the process.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20">(17-20)</a>As a part of a study aimed at understanding how it is possible to take advantage of kinase structural elements to rationally guide compounds selectivity and improve type I and type II designs, an analysis of some recently published kinase inhibitors highlighted an additional kinase inhibitor design strategy. These compounds, which we classified as type I<sup>1</sup>/<sub>2</sub> inhibitors, recognize the target kinases in the DFG “in” form. Type I<sup>1</sup>/<sub>2</sub> compounds bind to the ATP site like type I compounds and extend to target the back cavity, establishing a defined set of conserved interactions with those residues characteristic of the type II design which is based on the DFG “out” form. Type I<sup>1</sup>/<sub>2</sub> design could provide an additional tool in the rational design of compounds with the desired activity profile.</div><figure id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/medium/jm-2009-01443h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Kinase inhibitors currently on the market.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901443h&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Type I Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01251" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01251" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Many of the small molecule kinase inhibitors developed so far are compounds that adhere to the type I design. This may be the result of an initial bias introduced by the use of active phosphorylated kinases in the biochemical assays used for hit identification screening and lead optimization.</div><div class="NLM_p">Type I inhibitors bind to the ATP site and are ATP-competitive. They typically recognize the enzyme in a catalytically active DFG “in” conformation. These molecules mimic the interactions of the adenine moiety (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A) and bind to the kinase through the formation of one to three hydrogen bonds with the backbone residues of the hinge region connecting the kinase N- and C-terminal lobes and establishing hydrophobic interactions in the adenine ring region. These interactions are described by the commonly accepted type I kinase pharmacophore (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B) which comprises a hydrogen bond acceptor, two hydrogen bond donors, and a hydrophobic moiety.<a onclick="showRef(event, 'ref4 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref4 ref21 ref22">(4, 21, 22)</a></div><div class="NLM_p">A representative example of compounds belonging to the type I class of kinase inhibitors is sunitinib <b>2</b> (Sutent, SU11248, Pfizer, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), an oral multikinase inhibitor approved by the FDA in 2006 for the treatment of gastrointestinal tumors and advanced renal-cell carcinoma.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> This indolinone derivative is a promiscuous inhibitor having a dissociation constant of less than 3 μM for 165 out of a 290 kinases screening panel. Sunitinib <b>2</b> inhibits cellular signaling by targeting with remarkable affinity several kinases like PDGFR, VEGFR, c-KIT, RET, CSF-1R, IRK, FLT3, FGFR, CHK1, JAK1, and MPS1.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a></div><div class="NLM_p">Because of the high degree of sequence and structural similarity in the ATP binding site, cross-activity within the kinase target family is a common feature of type I compounds. However, such promiscuous activity is often related to undesirable side effects and toxicity.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> To improve potency and modulate selectivity of the initial lead compounds, differences in ATP binding site residues among various kinases are usually targeted. This is normally carried out by introducing several modifications on the chemical scaffolds and substituents, often leading to extensive medicinal chemistry optimization programs.</div><div class="NLM_p">Although reducing off-target activity in type I inhibitors may be challenging and resource intensive, clean selectivity profiles for type I inhibitors have been achieved. An example is the marketed drug erlotinib <b>3</b> (Tarceva , Roche-Genentech-Osi, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), a potent inhibitor of the tyrosine kinase EGFR effective in a subpopulation of non-small-cell lung cancer (NSCLC) patients harboring a somatic mutation in the catalytic domain of EGFR.<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27-29)</a></div><div class="NLM_p">Given the relative simplicity of the pharmacophore and the intense activity in the development of kinase inhibitors, it is becoming difficult to identify novel type I inhibitors, restricting the possibility for new intellectual property claims.</div><figure id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/medium/jm-2009-01443h_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) ATP binding site regions and ATP interactions with the hinge residues. Hydrogen bonds are represented by orange dashed lines. (B) Type I kinase inhibitor pharmacophore representing the potential hydrogen bonds with the hinge region. (C) Type II kinase inhibitor pharmacophore representing interactions with the hinge region and the allosteric site present in the DFG “out” conformation. (D) Type I<sup>1</sup>/<sub>2</sub> pharmacophore representing the potential interactions at the hinge and in the back cavity. Hydrogen bond donors are represented by circles labeled D, hydrogen bond acceptors by circles labeled A. The larger circles labeled HYD indicate the moieties, hydrophobic in nature, that occupy the adenine ring region (green) and the allosteric site (orange).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901443h&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Type II Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88360" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88360" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Different structural elements of protein kinases could be exploited to introduce potency and selectivity enhancing features in the early phases of design and development of novel chemical classes. An excellent example of the extent that structural elements can be used to guide compound design and contribute to the development of inhibitors with a specific activity/selectivity profile is represented by the DFG motif and the recent development of a second class of kinase inhibitors named type II.<a onclick="showRef(event, 'ref21 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref21 ref30 ref31">(21, 30, 31)</a></div><div class="NLM_p">Type II inhibitors bind to and stabilize an inactive kinase form that is characterized by the DFG motif being in an “out” conformation. The different position of the DFG residues in the “out” form results in the opening of an additional cavity, the allosteric site, which is hydrophobic in nature and is specifically targeted by type II compounds. These inhibitors not only bind to the ATP region through a set of hydrogen bonds to the hinge, like type I compounds, but also exploit hydrogen bonding and hydrophobic interactions within the allosteric site.</div><div class="NLM_p">An analysis of the way type II compounds bind to the protein stabilizing the DFG “out” inactive conformation recently led to the formulation of a type II kinase pharmacophore (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C). The type II pharmacophore can be viewed as an extension of the type I pharmacophore where the elements describing the interactions in the allosteric site are connected through a linker to the hinge-binding type I pharmacophore. In particular, the interactions taking place in the allosteric site of the DFG “out” inactive kinase involve a pair of hydrogen bonds between the ligand and the protein, one with the conserved glutamic acid present on αC-helix and the other with the backbone nitrogen of the DFG aspartic acid. The first interaction requires a hydrogen bond donor on the ligand; the latter requires a hydrogen bond acceptor. Immediately adjacent to the hydrogen bond donor−acceptor pair a hydrophobic moiety is required to form van der Waals interactions with residues of the allosteric site (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p">Imatinib <b>1</b> is a successful example of type II small molecules with global sales of 3.6 billion dollars in 2008. This molecule, however, was initially developed as type I inhibitor within a SAR-guided medicinal chemistry optimization program. Only subsequently, structural studies did highlight its novel mode of binding targeting the DFG “out” form of the kinase. Most of the other known type II inhibitors have also been developed by starting from their type I equivalent compounds following a chemistry-based approach rather than from de novo identified hits. This is probably due to the fact that, for type II compounds, the hit identification phase is particularly challenging. The lack of suitable biochemical assays and the limited availability of relevant structural information, in fact, limit both high-throughput screening (HTS) and structure-based in silico screening methods.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_p">The relation between the type I and type II inhibitors is clear, as the type I pharmacophore is a subset of the type II pharmacophore and they both display the same interactions in the adenine region of the ATP binding site. However, by specifically targeting the allosteric site, the type II design might offer some advantages compared to the type I design. The conformational variability of the DFG motif in the DFG “out” inactive state and the lower level of sequence conservation in the allosteric sites provide interesting opportunities for the development of selective kinase inhibitors.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> Type II inhibitors very often are much more selective compounds than type I inhibitors.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Also, from an IP standpoint, the possibility of targeting the allosteric site can be used to introduce novelty in the design of kinase inhibitors.</div><div class="NLM_p">Types I and II compounds normally show differences in their kinetics of binding and pharmacokinetics profiles. As a result of their more extensive interactions and generally higher potency, type II compounds typically display a lower dissociation rate (<i>K</i><sub>off</sub>) with extended residence time, which has a favorable impact on kinase inhibition.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> Targeting the DFG “out” state of the kinase, which is normally characterized by a <i>K</i><sub>M,ATP</sub> value higher than the corresponding value for the DFG “in” active state, also means that type II inhibitors face weaker competition from cellular ATP resulting in enhanced in vivo activity.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> On the other hand type II compounds are characterized by higher molecular weight, which normally has a negative impact on cellular penetration and results in a lower ligand efficiency.<a onclick="showRef(event, 'ref35 ref43'); return false;" href="javascript:void(0);" class="ref ref35 ref43">(35, 43)</a></div><div class="NLM_p">However, the main problem in targeting the DFG “out” form of the kinases is that type II compounds are more vulnerable to the insurgence of resistance due to mutations in the kinase domain that result in the loss of activity of the inhibitor. A mutation preventing the binding of a type I inhibitor most likely would also result in the disruption of ATP binding leading to a dysfunctional kinase which would not be tolerated by the cell. On the contrary, mutations of residues not involved in ATP recognition or catalytic regulation (e.g., the gatekeeper residue) might still result in a functional enzyme but would prevent inhibitor binding. This is, for instance, the case of the imatinib <b>1</b> resistance inducing T315I mutation of the gatekeeper in Abl.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><div class="NLM_p">Interestingly, the DFG “out” state required for the development of the type II inhibitors does not seem to be accessible to every kinase. It was first reported for the inactive conformation of the insulin receptor kinase (IRK) and was later experimentally observed also for Abl, p38α MAPK, bRAF, FLT3, KIT, LCK, HCK, KDR, TIE2, AUR-A, FMS/CSFR, MET, Src, Pyk2, and CDK6. The vast majority of the kinases for which the DFG “out” state was determined are part of the tyrosine kinase (TK) subfamily, but CMGC (p38α MAPK and CDK6), TKL (bRAF), and AGC (AUR-A) families are also represented. Hence, to date, only a very small portion of the structural data related to the kinome (>1700 structures for 162 different kinase domains) refers to the inactive DFG “out” state (15 different kinase domains, <10%).</div><div class="NLM_p last">As previously discussed, type II inhibitors (hence, the type II pharmacophore) are clearly related to the catalytically inactive DFG “out” form of the protein. This unique relation between pharmacophore, DFG state, and active/inactive form of the protein observed for the type II compounds does not hold true for type I compounds. This class of inhibitors normally binds to a catalytically active DFG “in” protein, but they can also bind to catalytically inactive DFG “in”/αC-helix “out” kinases (e.g., lapatinib <b>6</b> in EGFR kinase, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1xkk">1xkk</a>). A type I inhibitor could even bind to an inactive DFG “out” kinase if its scaffold could satisfy the type I pharmacophore at the hinge without occupying the sugar/phosphate region where the DFG “out” Phe side chain is located. We hence suggest classification of kinase inhibitors as type I or type II based on the kinase pharmacophore that they recognize rather than DFG “in/out” or active/inactive state of the protein they bind to (e.g., sunitinib <b>2</b> binds to a DFG “out” cKIT but matches a type I pharmacophore, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3g0e">3g0e</a>). A detailed comparison of the binding features of the different kinase inhibitors classes can be found in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</div></div><div id="sec1_3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Gatekeeper Residue and Type I<sup>1</sup>/<sub>2</sub> Kinase Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31363" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31363" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Type II design offers the opportunity to address some of the problems intrinsically related to a type I design (i.e., promiscuous activity and IP novelty). However, it is becoming apparent that targeting the inactive conformation poses a new range of problems. In light of this, it was of interest to reassess the opportunities offered by the DFG “in” form of the kinase in the design of inhibitors with a controlled selectivity profile and a favorable IP position.</div><div class="NLM_p">From the structural analysis of recently published kinase inhibitors a class of novel kinase inhibitors that follow a new design paradigm emerged. These compounds specifically target the back cavity of the ATP in either catalytically active (DFG “in” and αC-helix “in”) or inactive (DFG “in” and αC-helix “out”) kinases and conform to a common pharmacophore. Because it can be viewed as a hybrid of the existing types I and II pharmacophores, we defined this novel pharmacophore as type I<sup>1</sup>/<sub>2</sub> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>D). Type I<sup>1</sup>/<sub>2</sub> inhibitors bind to the adenine ring region like type I compounds establishing hydrogen bonds with the hinge region and then extend into the back cavity of the ATP site to give specific interactions with those residues that are involved in the type II pharmacophore. Thus, following this design, it is possible to target a DFG “in” kinase with type II interactions that are typical of a DFG “out” form.</div><div class="NLM_p">The back cavity is mainly hydrophobic and is not occupied by the natural cosubstrate ATP. Its shape and size are primarily controlled by the nature of the gatekeeper residue which is the first residue of the hinge connecting the C- and N-terminal lobes. When the gatekeeper residue has a bulky side chain (like Phe in CDK2, for example; Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A), the back cavity is small and delimited by β-sheets 4 and 6 and by the gatekeeper side chain itself. When the gatekeeper is small (like Thr in bRAF, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B), its side chain no longer limits the size of the cavity which expands toward β sheet 5 and the αC-helix.</div><div class="NLM_p">It is clear that targeting a kinase with a small gatekeeper by placing a substituent in the large back cavity may have the dual effect of increasing potency and increasing selectivity over those kinases that have a large gatekeeper and hence a small back cavity. In particular, it is interesting to note that in a DFG “in” kinase, not only does the presence of a small gatekeeper residue result in a larger cavity but the backbone atoms of the DFG triad and the conserved αC-helix glutamic acid also become exposed to the binding cavity and could interact with a putative ligand. These are the same conserved residues related to the type II pharmacophore observed in the DFG “out” inactive conformation.</div><div class="NLM_p">The novel type I<sup>1</sup>/<sub>2</sub> pharmacophore we propose contains all the elements of the type I pharmacophore describing the interactions at the hinge and the adenine ring region plus three elements of the type II pharmacophore: (i) the linker moiety, (ii) the hydrogen bond donor interacting with the Glu carboxylate, and (iii) the hydrogen bond acceptor interacting with the Asp backbone NH of the back cavity (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>D).</div><div class="NLM_p">The back cavity was first recognized as a druggable ATP subsite by Tong and co-workers who solved the structure of the mitogen-activated protein kinase 14 (MAPK14, also known as p38) in complex with an analogue of the highly specific <i>p</i>-fluorophenylpyridinylimidazole SB203580 inhibitor <b>9</b> (IC<sub>50</sub>(MAPK14) = 48nM; Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) showing that the compound occupies the back cavity.<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37, 38)</a> Other kinase inhibitors developed in the past, such as dasatinib <b>5</b> or lapatinib <b>6</b>, target this area obtaining different levels of specificity.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_p">The back cavity is a poorly conserved area of the ATP binding site and, as a result of the different relative orientations of the C- and N-terminus lobes and the conformational flexibility of the DFG motif which can adopt several “in” like conformations, is characterized by a high level of plasticity among kinases.</div><div class="NLM_p">The possibility of targeting the back cavity following the specific type I<sup>1</sup>/<sub>2</sub> pharmacophore, coupled with the intrinsic high level of plasticity and the lower sequence conservation, might offer the opportunity to rationally develop a new class of inhibitors either de novo or by conversion of type I scaffolds and provide an additional tool in the highly needed modulation of kinase inhibitors specificity.</div><figure id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/medium/jm-2009-01443h_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of the hydrophobic back pockets of a kinase proteins with a large (CDK2) and a small (bRAF) gatekeeper residue. (A) Molecular surface of ATP binding cavity in the ATP-CDK2 complex (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1b39">1b39</a>). The large gatekeeper residue Phe 80 limits the dimensions of the back pocket. (B) Molecular surface of the ATP binding cavity in the SB590885-bRAF complex (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2fb8">2fb8</a>). The small gatekeeper residue Thr 529 allows a large back pocket. To facilitate comparison, the SB590885 ligand was removed and replaced by the ATP molecule after superimposition of the two structures. For clarity, only the gatekeeper residue and the hinge region of the protein are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901443h&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Comparison of the General Properties of Type I, Type II, and Type I<sup>1</sup>/<sub>2</sub> Kinase Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top"><td align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/medium/jm-2009-01443h_0001.gif" alt="" id="fx1" /></img></td></tr></tbody></table></div></div><figure id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/medium/jm-2009-01443h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Chemical structure of the p38 inhibitor <b>9</b> and its mode of binding in the ATP binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901443h&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Type I<sup>1</sup>/<sub>2</sub> Kinase Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15768" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15768" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec1_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Src Tyrosine Kinase. Gatekeeper Thr</h3><div class="NLM_p">An interesting example of type I<sup>1</sup>/<sub>2</sub> compounds is the purine-based compound <b>10</b> (AP23464) developed by ARIAD (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) which targets Src tyrosine kinase with picomolar affinity.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><figure id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/medium/jm-2009-01443h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Chemical structure of the Src inhibitor <b>10</b> and its mode of binding in the ATP binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901443h&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the Src−<b>10</b> complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2bdj">2bdj</a>, Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) it is possible to observe how the compound sits in the ATP pocket of the kinase in a DFG “in” state. The presence of the small gatekeeper residue Thr338 results in the opening of a large back cavity that exposes the conserved Glu310 and the backbone atoms of the DFG motif (Asp404, Phe405, and Gly406) offering the possibility of a type I<sup>1</sup>/<sub>2</sub> ligand design.</div><div class="NLM_p">The structural data clearly show how the binding mode of compound <b>10</b> satisfies the type I<sup>1</sup>/<sub>2</sub> pharmacophore. Like a type I inhibitor, the compound interacts with the protein through two hydrogen bonds at the hinge: one between the acceptor N7 of the purine and the donor backbone NH of Met341, the other one between the aniline donor NH in position 6 of the purine and the carbonyl oxygen of Met341 that acts as acceptor. In addition to interactions at the hinge, the (3-hydroxyphenethyl)-N9 purine substituent penetrates deeply in the back cavity where the pharmacophore elements are present. The aromatic ring of the phenethyl moiety acts as linker unit and is surrounded by the hydrophobic side chains of Met314, Ile336, Thr338, and the hydrophobic part of Lys295. The hydroxyl group in meta position on the phenyl ring matches both the hydrogen bond acceptor and hydrogen bond donor type I<sup>1</sup>/<sub>2</sub> pharmacophore elements of the back cavity, as it establishes hydrogen bonds with both Asp404 backbone NH (as acceptor) and Glu310 carboxylate (as donor). It is interesting to note that compound <b>10</b> was initially developed from purvalanol A, a 2,6,9-trisubstituted purine derivative optimized for CDK2 inhibition (IC<sub>50</sub> = 70 nM for CDK2 and IC<sub>50</sub> = 240 nM for Src), carrying on N9 an isopropyl group instead of the hydroxyphenethyl moiety. The kinase CDK2 is characterized by a phenylalanine as gatekeeper residue (Phe80). The bulky side chain of the gatekeeper severely limits the size of the back pocket in CDK2 which is just large enough to accommodate the isopropyl group. When the isopropyl group in purvalanol A is replaced by the hydroxyphenethyl moiety in derivative <b>10</b>, the activity on CDK2 drastically decreases (IC<sub>50</sub> = 20.9 μM), as the phenethyl group can no longer be accommodated in the back cavity because of steric hindrance with the gatekeeper Phe80 side chain. When assessed against a panel of kinases, compound <b>10</b> showed very potent activity against Src (0.45 nM) and notable activity against Abl, FYN, YES, Lck, LYN, EGFR, HER2, PDGFR, FGFR, cKIT, and bRAF, all kinases characterized by a small gatekeeper residue.</div><div class="NLM_p last">Compound <b>10</b> is a good example of how a type I<sup>1</sup>/<sub>2</sub> design may completely alter the kinase selectivity profile of a known scaffold, opening new opportunities for scaffold rescue, scaffold hopping, and the creation of intellectual property.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Moreover, the reduced incidence of resistant mutations observed for the compound <b>10</b> highlights the importance of targeting the kinase active conformation by design of new small molecule inhibitors aiming to have more efficient cancer treatments.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div></div><div id="sec1_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Vascular Endothelial Growth Factor Receptor 2 (KDR). Gatekeeper Val</h3><div class="NLM_p">Recent work carried out by Amgen researchers on the KDR inhibitors <i>N</i>-alkyl(aryl)naphthamides provides another example of how a type I<sup>1</sup>/<sub>2</sub> design could result in an improved selectivity profile.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Initial work on this scaffold provided access to low nanomolar KDR inhibitors and led to the identification of compound <b>11</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3b8q">3b8q</a>, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) which demonstrated robust KDR activity (IC<sub>50</sub> = 0.48 nM) and in vivo efficacy but also retained an undesired inhibitory activity against Aurora B, a serine−threonine kinase strongly involved in mitotic cellular process, and also against the nonreceptor tyrosine kinase Lck, involved in T cell receptor signal transduction. During medicinal chemistry activity the close analogue compound <b>12</b> (PDB code 3b8r, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) emerged displaying again a favorable activity against KDR (IC<sub>50</sub> = 0.60 nM) but also a more restrictive selectivity profile in a small panel of kinases including Aurora A, Aurora B, Lck, KDR, TIE2, and MET.</div><div class="NLM_p">Structural data provided insight into the origin of the different selectivity profile. From an analysis of the crystallographic structure it emerged that compound <b>11</b> is a type II inhibitor that binds to the KDR catalytic domain in a DFG “out” inactive state. The sp<sup>2</sup> nitrogen (acceptor) of the dimethoxyquinoline ring is involved in a hydrogen bond with the backbone amide NH of Cys919 of the hinge region (donor). The naphthyl moiety occupies the hydrophobic pocket facing the small gatekeeper (Val916 mutated to Thr in this structure) and projects the amide deeply into the back cavity. The carbonyl oxygen (acceptor) and the NH group (donor) of the amide are engaged in two hydrogen bonding interactions with the type II pharmacophore elements of the back cavity: the backbone NH of Asp1046 of the conserved DFG (donor) and the carboxylate on the side chain of the conserved Glu885 (acceptor). The <i>p</i>-chlorophenyl ring penetrates into the allosteric site of the DFG “out” state matching the terminal hydrophobic pharmacophore element of the type II model. On the contrary, compound <b>12</b>, in which the <i>p</i>-chlorophenyl group on the amide is replaced by a smaller and less hydrophobic cyclopropyl group, albeit adopting a very similar mode of binding, binds to the DFG “in” state of the protein following a typical type I<sup>1</sup>/<sub>2</sub> design. The quinoline system establishes the same interaction with the hinge, and the naphthyl moiety accesses the back cavity occupying the same area as in compound <b>11</b>. The small gatekeeper provides full access to the back cavity, allowing access to the type II pharmacophore elements even from the DFG “in” state, and the amide establishes the same interactions with Asp1046 and Glu885. It is very interesting to note that the <i>N</i>-alkyl(aryl)naphthamides scaffold occupies the adenine ring region of the ATP site and then develops into the back cavity without occupying the sugar and phosphate region. This allows this scaffold to bind to both DFG states of the kinase even when, in the presence of a DFG out, the ATP site is partially occupied by the DFG Phe side chain. The equilibrium between the DFG “in” and DFG “out” forms seems to be controlled by the nature of the alkyl(aryl) substituent.</div><div class="NLM_p">These KDR inhibitors also provide evidence that the presence of a large hydrophobic moiety (like the <i>p</i>-chlorophenyl group in compound <b>11</b>) plays a crucial role in the type II inhibitors stabilization of the DFG “out” state in which the hydrophobic spine of the kinase is dismantled. In the DFG “in” form, the DFG Phe side chain is part of the hydrophobic spine, a structural element that stabilizes the active form of the kinase despite the unfavorable DFG Asp torsional angles adopted in this conformation. When the DFG flips in a “out” conformation, the Phe side chain moves away from its position and occupies the ATP pocket, introducing an element of instability by disrupting the hydrophobic spine. In the presence of compound <b>11</b>, a type II ligand, the terminal hydrophobic moiety <i>p</i>-chlorophenyl in the allosteric site partially re-establishes the hydrophobic spine, thus stabilizing the inactive kinase conformation.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> On the contrary, in compound <b>12</b>, the smaller cyclopropyl ring does not provide enough stabilization to the hydrophobic spine and the DFG flips into the “in” state so that the Phe side chain can provide the required hydrophobic interaction.</div><div class="NLM_p">When tested on a larger panel of 43 kinases, compound <b>12</b> displayed a nanomolar range potency for structurally related proteins like PDGFR, KIT, and FMS but not FLT3, which displays a large gatekeeper (Phe), and good selectivity versus EGFR, Src, p38, Abl, FGR, SYK, ZAP70, JAK2, IRK, and TIE2. Interestingly, in this case, the type II inhibitor compound <b>11</b> is less selective than the type I<sup>1</sup>/<sub>2</sub> analogue compound <b>12</b>, showing that conformational variability associated with the DFG motif in the “in” state and the variability in the back cavity sequence coupled with a type I<sup>1</sup>/<sub>2</sub> design can be exploited to produce selective and still potent compounds targeting the DFG “in” state of the kinase. A similar example, where the equilibrium between the DFG states of the protein can be modulated by the presence or absence of a large hydrophobic moiety in the back cavity, can be found in work carried out by GSK on biphenylamides targeting the p38α MAP kinase and in Amgen’s work on Lck inhibitors.<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> Thus, by selection of the proper back cavity substitution, it is possible to induce or trap a preferred DFG state.</div><figure id="fig6" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/medium/jm-2009-01443h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Chemical structure of the KDR inhibitors <b>11</b> and <b>12</b> and their mode of binding in the ATP binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901443h&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Polo-like Kinase 1. Gatekeeper Leu</h3><div class="NLM_p">An additional example of type I<sup>1</sup>/<sub>2</sub> pharmacophore matching molecule is represented by the compound <b>13</b> disclosed by Sunesis (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>), identified as a polo-like kinase 1 inhibitor (IC<sub>50</sub> = 720 nM) during the screening of an Aurora A targeted library.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Structural data (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3db6">3db6</a>, Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>) show that the compound binds to the hinge of PLK1 through two hydrogen bonds: a strong one between the N1 pyrimidine nitrogen (acceptor) and the Cys119 backbone NH (donor), and a weaker one between the anilino NH on the pyrimidine and the carbonyl oxygen of Glu117.</div><figure id="fig7" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/medium/jm-2009-01443h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Chemical structure of the Sunesis PLK1 inhibitor <b>13</b> and its mode of binding in the ATP binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901443h&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The triazole substituent is placed in the sugar region, while the rest of the molecule extends from the 4-NH<sub>2</sub> group of the pyrimidine ring to occupy the large back cavity made available by the presence of the midsized gatekeeper residue Leu116. In this case the linker element of the pharmacophore is the aminoethyl group connecting the pyrimidine ring with the thiazole ring. The sp<sup>2</sup> nitrogen atom of the thiazole matches the type I<sup>1</sup>/<sub>2</sub> acceptor pharmacophore feature in the back cavity, establishing a hydrogen bond with the backbone NH of the DFG Asp180. The type I<sup>1</sup>/<sub>2</sub> donor pharmacophore feature in the same area is satisfied by one of the urea nitrogens which is hydrogen-bonded to the conserved Glu87. Interestingly, by comparison of the PLK1−<b>13</b> complex with the structure of PLK1 complexed with compounds that do not occupy the back cavity (such as the complex with BI6727, PDB 3fc2, for example), it is possible to observe that β-sheet 4 and the glycine rich loop move slightly upward to accommodate the trifluoromethylfuran part of the ligand. In particular the Lys68 side chain extends underneath the glycine rich loop and establishes a hydrogen bond to the urea carbonyl oxygen of the ligand. The trifluoromethylfuran moiety forces its way into the binding site, disrupting the Lys68−Glu87 salt bridge, and occupies the area made available by side chain rearrangement that follows the breaking up of the charged interaction. This ligand-induced effect seems to be made possible by the fact that PLK1 is characterized by a weaker Lys−Glu interaction (>4.0 Å). Other kinases, like cSrc, BTK, JNK3, or MPS1, present a similar feature that could be targeted, within a type I<sup>1</sup>/<sub>2</sub> design.</div><div class="NLM_p last">In the three examples just described the functional group of the ligand matching the hydrogen bond acceptor feature of the type I<sup>1</sup>/<sub>2</sub> pharmacophore in the back cavity area (i.e., the 3-hydroxyl group on the phenethyl moiety in the case of compound <b>10</b> bound to Src, the amide carbonyl in the case of compound <b>12</b>, and the sp<sup>2</sup> nitrogen of the thiazole in the case of compound <b>13</b> bound to PLK1) interacts with the backbone NH of DFG Asp (Asp180 in PLK1 and Asp404 in Src). In most cases the DFG Phe NH is engaged in an interaction with the conserved Glu residue (i.e., Glu310 in Src and Glu87 in PLK1) either directly or through a water molecule. There are instances however, where the same hydrogen bonding acceptor feature of the ligand interacts with the DFG Phe backbone NH instead, either replacing the water molecule that mediates the interaction or interposing itself between the interacting residues.</div></div><div id="sec1_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Checkpoint Kinase 1. Gatekeeper Leu</h3><div class="NLM_p">A specific example where the ligand interacts with the DFG Phe backbone NH is the novel checkpoint kinase 1 (CHK1) inhibitor compound <b>14</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>, IC<sub>50</sub> = 6.2 nM), developed by Abbott from a class of tricyclic pyrazoles initially identified during an HTS campaign.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><figure id="fig8" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/medium/jm-2009-01443h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Chemical structure of the CHK1 inhibitor <b>14</b> and its mode of binding in the ATP binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901443h&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The crystal structure of the complex between CHK1 and compound <b>14</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2e9n">2e9n</a>, Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>) showed that the pyrazole nitrogen atoms of the scaffold make two hydrogen bonding interactions with the hinge residues: one between the sp<sup>2</sup> N1 nitrogen (acting as hydrogen bond acceptor) and the backbone NH of Cys87 (donor), and one between the N2 NH which donates to the carbonyl oxygen of Glu85. The midsized side chain of the gatekeeper residue Leu84 results in a large back cavity that is occupied by the biphenylhydroxyl moiety. Similar to compound <b>10</b> in Src, the biphenyl system provides the linker of the type I<sup>1</sup>/<sub>2</sub> pharmacophore, which delivers the hydroxyl group matching both the hydrogen bonding donor and acceptor pharmacophore features present in the back cavity. The hydroxyl group replaces the water molecule that normally mediates the interaction between the conserved Glu55 and DFG Phe149 backbone NH. A new hydrogen bond network is then established where the hydroxyl group of the ligand interacts as hydrogen bond acceptor with DFG Phe149 backbone NH and as hydrogen bond donor with Glu55. An additional hydrogen bonding interaction is also established with Asn59.</div><div class="NLM_p">When tested on a panel of 13 serine/threonine kinases, compound <b>14</b> showed a good selectivity profile (at least 200-fold more active against CHK1 than the other kinases with only three kinases hit in the micromolar range). Interestingly, compound <b>14</b> showed a limited activity against only one of the nine kinases with a large/long gatekeeper residue (AKT, IC<sub>50</sub> = 4.43 μM, Met as gatekeeper), whereas of the four kinases with a small/medium sized gatekeeper, two were inhibited at low micromolar levels (AUR1, IC<sub>5</sub>0 = 8.09 μM; SGK, IC<sub>50</sub> = 1.32 μM both with Leu as gatekeeper) and two were not inhibited (CHK2 and Src with Leu and Thr as gatekeeper residue). In these cases, differences in binding residues in the ATP region (e.g., Asn59, Tyr86, and Ser147 become Leu227, Leu303, and Thr367 in CHK2) rather than the interactions in the back cavity may be considered responsible for the selectivity.</div><div class="NLM_p">The last two examples clearly show how a type I<sup>1</sup>/<sub>2</sub> design can be applied not just when the gatekeeper residue is small, but with an appropriate chemistry strategy, it is possible to extend it to kinases with medium sized gatekeeper residues such as Leu, Ile, and Met. This could provide an interesting opportunity to develop more effective kinase inhibitors and a successful strategy for dealing with gatekeeper mutations responsible for many resistance mechanisms in oncology. Additional examples of type I<sup>1</sup>/<sub>2</sub> inhibitors identified in the literature include inhibitor <b>15</b> developed by Ariad,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> inhibitors <b>16</b>, <b>17</b>, <b>18</b>, <b>19</b> by GSK,<a onclick="showRef(event, 'ref48 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref48 ref49 ref50">(48-50)</a> inhibitor <b>20</b> by BMS,<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> inhibitor <b>21</b> by Amgen,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> inhibitors <b>22</b> and <b>23</b> by Bayer,<a onclick="showRef(event, 'ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref53 ref54">(53, 54)</a> inhibitor <b>24</b> by Pfizer,<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> inhibitor <b>25</b> by Vertex,<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> inhibitor <b>26</b> by Wyeth,<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> and inhibitor <b>27</b> by Zurich University<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> targeting kinases like Src, Abl, Lck, p38, Ret, EphB4, VEGFR-2, Jak2, and bRAF (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>).</div><figure id="fig9" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/medium/jm-2009-01443h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Additional structures of type I<sup>1</sup>/<sub>2</sub> kinase inhibitors. All compounds target kinases with a small/medium gatekeeper residue. The region interacting with back cavity portion of the type I<sup>1</sup>/<sub>2</sub> pharmacophore is indicated in blue. In parentheses is the kinase target for which the compound has been developed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901443h&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec1_5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Type I<sup>1</sup>/<sub>2</sub> Pharmacophore: Relevance and Selectivity</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44413" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44413" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The possibility of developing kinase inhibitors following a type I<sup>1</sup>/<sub>2</sub> design should be evaluated target by target. Because a large and accessible back cavity is required, kinases with a small or medium sized gatekeeper will probably offer better opportunities for a successful type I<sup>1</sup>/<sub>2</sub> inhibitors development whereas kinases characterized by a large gatekeeper might be more problematic. Despite this limitation, the relevance of the type I<sup>1</sup>/<sub>2</sub> design can be extended to a considerable portion of the human kinome. An in-house analysis of 420 closely related kinase sequences highlighted that about 23% have a small gatekeeper with threonine being the most and alanine the least common residues (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Very bulky gatekeepers like Phe and Tyr account for about 16% of the analyzed kinase sequences, whereas the majority, about 61% of the total, is characterized by midsized gatekeepers that are branched, like Leu and Ile, or characterized by a long but yet flexible side chain like Met (the most frequent gatekeeper residue of the analyzed set with 40% of the occurrences).<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Clearly, small-sized gatekeeper residues (Gly, Ala, Ser, Cys, Val, and Thr) result in the larger back cavities. In this case several different chemical scaffolds are well suited to place substituent groups inside the back cavity providing easy access to the type I<sup>1</sup>/<sub>2</sub> pharmacophore. On the contrary, gatekeeper residues with a large side chain (Phe, Tyr) considerably limit the size of the back cavity, virtually blocking the access to the type I<sup>1</sup>/<sub>2</sub> pharmacophore. A different scenario occurs when a medium-size or flexible side chain gatekeeper is present. In this case, the possibility of placing a substituent in the back cavity and interacting with the type I<sup>1</sup>/<sub>2</sub> pharmacophore is a fine balance between the type of gatekeeper residue and the core chemical scaffold of the ATP mimicking ligand. In particular, the chemical nature and the directional vector of the substituent projected toward the back pocket play a crucial role in a successful design aimed at occupying the back cavity and interacting with the type I<sup>1</sup>/<sub>2</sub> pharmacophore. In the previously discussed PLK1−<b>13</b> complex, for instance, starting from an aminopyrimidine moiety binding at the hinge, access to the back cavity and interaction with the type I<sup>1</sup>/<sub>2</sub> pharmacophore were achieved by introducing the flexible ethyl spacer which avoided clashes with the Leu gatekeeper. Methionine, which is characterized by a fairly bulky but yet flexible side chain, is another example. Even in the presence of a Met as gatekeeper, compounds can sometimes still access and occupy the back pocket by shifting the Met side chain with an induced-fit type of mechanism. One reported example is the 3 Å movement observed for the gatekeeper Met146 side chain in JNK3, when an imidazolopyrimidine-based inhibitor is bound.The gatekeeper movement allows the opening of the back cavity and the positioning of the dichlorophenyl moiety of the ligand.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Another recent example has been presented by Peifer and co-workers, where diarylisoxazoles or -imidazoles revealed potent and dual inhibitors of p38 (Thr as gatekeeper) and CK1 (Met as gatekeeper).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Gatekeeper Residues Distribution in Kinome (420 Closely Related Kinase Sequences)<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="center">gatekeeper</th><th align="center" char=".">no. of kinases</th><th align="center" char=".">%</th><th align="center">size</th></tr></thead><tbody><tr valign="top"><td align="left">Gly</td><td align="char" char=".">1</td><td align="char" char=".">0.24</td><td align="left">S</td></tr><tr valign="top"><td align="left">Ala</td><td align="char" char=".">1</td><td align="char" char=".">0.24</td><td align="left">S</td></tr><tr valign="top"><td align="left">Ser</td><td align="char" char=".">3</td><td align="char" char=".">0.71</td><td align="left">S</td></tr><tr valign="top"><td align="left">Cys</td><td align="char" char=".">2</td><td align="char" char=".">0.48</td><td align="left">S</td></tr><tr valign="top"><td align="left">Thr</td><td align="char" char=".">76</td><td align="char" char=".">18.10</td><td align="left">S</td></tr><tr valign="top"><td align="left">Val</td><td align="char" char=".">13</td><td align="char" char=".">3.10</td><td align="left">S</td></tr><tr valign="top"><td align="left">Ile</td><td align="char" char=".">9</td><td align="char" char=".">2.14</td><td align="left">M</td></tr><tr valign="top"><td align="left">Leu</td><td align="char" char=".">72</td><td align="char" char=".">17.14</td><td align="left">M</td></tr><tr valign="top"><td align="left">Met</td><td align="char" char=".">169</td><td align="char" char=".">40.24</td><td align="left">M</td></tr><tr valign="top"><td align="left">Gln</td><td align="char" char=".">8</td><td align="char" char=".">1.90</td><td align="left">M</td></tr><tr valign="top"><td align="left">Phe</td><td align="char" char=".">63</td><td align="char" char=".">15.00</td><td align="left">L</td></tr><tr valign="top"><td align="left">Tyr</td><td align="char" char=".">3</td><td align="char" char=".">0.71</td><td align="left">L</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Residues have been grouped in three sets according to size. Met has a long but flexible side chain and was classified as medium-sized.</p></div></div></div><div class="NLM_p">The gatekeeper residues in protein kinases regulate the different sizes and the different levels of accessibility to the back cavity and type I<sup>1</sup>/<sub>2</sub> interactions in the ATP pocket in a DFG “in” conformation kinase. This, together with the lower level of sequence conservation and a considerable plasticity of the back cavity, offers interesting opportunities for selective drug design aimed at achieving the desired activity profile for a given chemical class. In addition, a further control on the activity profile within the type I<sup>1</sup>/<sub>2</sub> ligand design can be achieved considering the different distances between the pharmacophore elements, in particular, the distances between the ones shared with the hinge (type I pharmacophore) and the pharmacophore elements in the back cavity specific to type I<sup>1</sup>/<sub>2</sub>. For instance, the distance between the backbone NH of the hinge (the one responsible for the hydrogen bond acceptor feature in the adenine area of the type I) and the donor NH of the DFG Phe is 14.0 Å in CHK1, similar to 13.5 Å in bRAF, but it is 17.2 Å in JNK3. These different distances imply that starting from the same scaffold that interacts at the hinge level, a different linker, hence a different chemistry design, will be required to access the type I<sup>1</sup>/<sub>2</sub> pharmacophore in CHK1 or bRAF and JNK3.</div><div class="NLM_p last">The gatekeeper residue might also play a relevant role in type II inhibition, as it might control which kinases can access the DFG “out” conformation. In fact most of the kinases for which type II inhibitors have been so far discovered display a small gatekeeper residue and in particular the threonine residue. As such, the nature of the gatekeeper residue can deeply affect the strategy underlying a kinase inhibitor development program, offering several opportunities to achieve potency and modulate the selectivity profile of the compounds.</div></div><div id="sec1_6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Future Directions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71566" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71566" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As discussed, a totally clean selectivity profile is not necessarily the main goal in kinase inhibitors development. At the same time, a general promiscuity is highly undesirable because of unexpected off-target effects that might result in severe toxicity. It is now emerging that developing compounds that are characterized by a selective but not specific activity profile could provide a successful strategy in providing an effective answer to cancer therapeutic needs. The possibility of controlling compound selectivity is still a pressing need in the development of new generations of kinase inhibitors with the desired activity profile.</div><div class="NLM_p">The growing number of type II kinase inhibitors that have been successfully marketed for the therapeutic treatment of several cancer forms is a step in the right direction, as they are often characterized by a cleaner selectivity profile. However, the future success of this kinase inhibitor design is hindered by a number of issues that might limit its availability. One of the major drawbacks is that type II compounds, targeting the DFG “out” form, may suffer from mutations of the molecular target that confer resistance often by stabilizing the kinase active conformation. Another problem associated with type II inhibitors is that, at present, it is not possible to assess how many and especially which kinases might adopt the DFG “out” conformation. Hence, the relevance of the type II inhibitors design could be limited to an uncertain portion of the kinome. Not knowing whether the DFG “out” might be available as a drug target and the limitations imposed by the lack of a type II specific screening assay technology platform could limit the further development of other type II inhibitors.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> As the initially perceived advantages offered by targeting the DFG “out” binding mode are becoming increasingly questionable, the possibility of developing inhibitors with a controlled selectivity by targeting the active DFG “in” form of the kinase might offer considerable advantages.</div><div class="NLM_p">The type I<sup>1</sup>/<sub>2</sub> pharmacophore model described in this work targets the hinge, the adenine ring area, and the back cavity of the ATP binding site and acts on the DFG “in” active state of the kinase. In principle, the same design could be applied to DFG “in” inactive kinases (i.e., DFG “in” but αC-helix “out”). Targeting the back cavity by establishing hydrophobic and specific hydrogen bonding interactions (with the conserved Glu and DFG Asp NH) offers interesting opportunities to achieve potency and selectivity maintaining a good level of ligand efficiency. The intrinsic plasticity of the DFG motif and the conformational flexibility of its side chains could represent an additional opportunity to achieve the desired modulation. In the future, type I<sup>1</sup>/<sub>2</sub> design could provide an additional tool and a different strategy in the successful design of a new generation of potent kinase inhibitors with a controlled activity profile, also targeting the growing number of resistant mutations emerging in patients. The type I<sup>1</sup>/<sub>2</sub> design is also relevant for kinases with medium-sized gatekeepers that are often involved in such mutations (e.g., T315I in Abl).</div><div class="NLM_p last">It is also becoming apparent that in targeting kinases, it is not possible to identify a universal strategy that can be applied to achieve a successful and efficacious treatment. For each type of tumor, with its particular genetic makeup, and for each kinase target the most appropriate inhibition strategy, controlled selectivity vs multitarget, and the most appropriate inhibitor design (type I, type I<sup>1</sup>/<sub>2</sub>, or type II) should be specifically evaluated.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm901443h" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40614" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40614" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fabio Zuccotto</span> - <span class="hlFld-Affiliation affiliation">Department of Chemical Core Technologies</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3f795e5d565011654a5c5c504b4b507f715a4d49565e5150524c115c5052"><span class="__cf_email__" data-cfemail="b0f6d1d2d9df9eeac5d3d3dfc4c4dff0fed5c2c6d9d1dedfddc39ed3dfdd">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elena Ardini</span> - <span class="hlFld-Affiliation affiliation">Department of Cell Biology Signal Transduction</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elena Casale</span> - <span class="hlFld-Affiliation affiliation">Department of Chemical Core Technologies</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mauro Angiolini</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="bio"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47145" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47145" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901443h&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Fabio Zuccotto</b> obtained a Laurea degree in Chemistry from Università degli Studi, Milan, Italy, and in 1998 a Ph.D. in Medicinal Chemistry from the Welsh School of Pharmacy in Cardiff, U.K., under the supervision of Prof. I. H. Gilbert. He was a postdoctoral researcher in Prof. G. Roberts' group at the Centre for Mechanisms of Human Toxicity of Leicester University, U.K., and at GlaxoWellcome, Stevenage, U.K., with Dr. A. Leach. In 2001 he joined Inpharmatica, London, U.K., working in the Molecular Design Group as Senior Scientist. In 2006 he moved to Nerviano Medical Sciences, Nerviano, Italy, where he is currently Principal Scientist. His main responsibilities lie in the Computational Chemistry and Fragment Based Drug Discovery areas, working in kinase and non-kinase oncology-related targets.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901443h&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Elena Ardini</b> received her Laurea degree in Biology from Università degli Studi, Milano, Italy, in 1993. From 1993 to 2000 she was a postdoctoral fellow working with Dr. Sylvie Ménard at the Department of Experimental Oncology of the National Cancer Institute of Milan where she was involved in oncology projects mainly focused on investigating the role of tyrosine kinase receptors in breast cancer progression. In 1997, she spent 1 year as a Visiting Research Scientist in Prof. Joseph Schlessinger’s laboratory at the Department of Pharmacology of New York University. In 2000 she joined Pharmacia & Upjohn in Nerviano, Italy (later Nerviano Medical Sciences), where she is currently Project Leader working in the Department of Biology.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901443h&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Elena Casale</b> received her Laurea degree in Pharmaceutical Chemistry from Università degli Studi, Milano, Italy, in 1989. She was a postdoctoral fellow at the Marshall Space Flight Center, NASA, Huntsville, AL, working in the Crystallography group under the supervision of Dr. D. Carter. She did further postdoctoral training with Prof. M. Bolognesi at the Department of Genetic Microbiology of the University of Pavia, Italy. In 1992 she joined Farmitalia Carlo Erba (later Pharmacia & Upjohn and currently Nerviano Medical Sciences), working in the Structural Chemistry Group. She is currently a Principal Research Scientist contributing to several research projects in the oncology area.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901443h&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Mauro Angiolini</b> received in 1995 a Laurea degree in Chemistry and a Ph.D. in Medicinal Chemistry in 1998, working under the supervision of Prof. Carlo Scolastico at the Università degli Studi, Milano, Italy. He joined Pharmacia & Upjohn in Nerviano (later Nerviano Medical Sciences) where he has been involved in many projects related to the discovery of new drugs in the oncology therapeutic area, with considerable focus on kinases inhibitors. In 2000 he spent 1 year as postdoctoral fellow in Prof. S. Hanessian group at Université de Montréal, Canada, focusing on application of the ring closing metathesis reaction. He is currently a Principal Research Scientist working in the Department of Medicinal Chemistry of the Oncology Division.</p></figure></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43133" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43133" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Francesco Colotta, Eduard Felder, Anna Migliazza, Daniele Donati, Roberto Bossi, Paola Bandiera, Barbarba Forte, and Charlotte Waterworth for critical reading of this manuscript and all our colleagues at Nerviano Medical Sciences for valuable discussions.</p></div><div class="postAsapNotesSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="postAsapNotesSection">Note Added After ASAP Publication</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28501" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28501" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This paper was released ASAP on December 14, 2009 with an error in Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>. The revised version was published on January 11, 2010.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62242" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62242" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 62 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_contrib-group">Mannig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whyte, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudarsanam, S.</span><span> </span><span class="NLM_article-title">The protein kinase complement of the human genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1912</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1912-1934&author=G.+Mannigauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sudarsanam&title=The+protein+kinase+complement+of+the+human+genome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMannig%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSudarsanam%26aufirst%3DS.%26atitle%3DThe%2520protein%2520kinase%2520complement%2520of%2520the%2520human%2520genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1912%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Hanks, S. K.</span><span> </span><span class="NLM_article-title">Genomic analysis of the eukaryotic protein kinase superfamily: a perspective</span> <span class="citation_source-journal">GenomeBiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=111&author=S.+K.+Hanks&title=Genomic+analysis+of+the+eukaryotic+protein+kinase+superfamily%3A+a+perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanks%26aufirst%3DS.%2BK.%26atitle%3DGenomic%2520analysis%2520of%2520the%2520eukaryotic%2520protein%2520kinase%2520superfamily%253A%2520a%2520perspective%26jtitle%3DGenomeBiology%26date%3D2003%26volume%3D4%26spage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Johnson, N. L.</span><span> </span><span class="NLM_article-title">Protein Kinase Inhibitors: Contributions from Structure to Clinical Compounds</span>.  <span class="citation_source-book">Quarterly Reviews of Biophysics</span>; <span class="NLM_publisher-name">Cambridge University Press</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1</span>− <span class="NLM_lpage">40</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=1-40&author=N.+L.+Johnson&title=Quarterly+Reviews+of+Biophysics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DN.%2BL.%26atitle%3DProtein%2520Kinase%2520Inhibitors%253A%2520Contributions%2520from%2520Structure%2520to%2520Clinical%2520Compounds%26btitle%3DQuarterly%2520Reviews%2520of%2520Biophysics%26pub%3DCambridge%2520University%2520Press%26date%3D2009%26spage%3D1%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Targeting cancer with small molecule kinase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1038%2Fnrc2559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=19104514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1yg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=28-39&author=J.+Zhangauthor=P.+L.+Yangauthor=N.+S.+Gray&title=Targeting+cancer+with+small+molecule+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer with small molecule kinase inhibitors</span></div><div class="casAuthors">Zhang, Jianming; Yang, Priscilla L.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiol. constraints on growth and survival.  To date, 11 kinase inhibitors have received US Food and Drug Administration approval as cancer treatments, and there are considerable efforts to develop selective small mol. inhibitors for a host of other kinases that are implicated in cancer and other diseases.  Herein we discuss the current challenges in the field, such as designing selective inhibitors and developing strategies to overcome resistance mutations.  This Review provides a broad overview of some of the approaches currently used to discover and characterize new kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriSM3BN_uEz7Vg90H21EOLACvtfcHk0lhPQlRy0Slzag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1yg&md5=35bc38f414cd21eef5e61ce181b580fb</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrc2559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2559%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DP.%2BL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520cancer%2520with%2520small%2520molecule%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D28%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Smith, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, C. A.</span><span> </span><span class="NLM_article-title">Kinase activity of mutant LRRK2 mediates neuronal toxicity</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1231</span><span class="NLM_x">–</span> <span class="NLM_lpage">1233</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1038%2Fnn1776" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=16980962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVSgu7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=1231-1233&author=W.+W.+Smithauthor=Z.+Peiauthor=H.+Jiangauthor=V.+L.+Dawsonauthor=T.+M.+Dawsonauthor=C.+A.+Ross&title=Kinase+activity+of+mutant+LRRK2+mediates+neuronal+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase activity of mutant LRRK2 mediates neuronal toxicity</span></div><div class="casAuthors">Smith, Wanli W.; Pei, Zhong; Jiang, Haibing; Dawson, Valina L.; Dawson, Ted M.; Ross, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1231-1233</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations in the leucine-rich repeat kinase-2 (LRRK2) gene cause autosomal-dominant Parkinson disease and some cases of sporadic Parkinson disease.  Here we found that LRRK2 kinase activity was regulated by GTP via the intrinsic GTPase Roc domain, and alterations of LRRK2 protein that reduced kinase activity of mutant LRRK2 correspondingly reduced neuronal toxicity.  These data elucidate the pathogenesis of LRRK2-linked Parkinson disease, potentially illuminate mechanisms of sporadic Parkinson disease and suggest therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS61-FFqaSfLVg90H21EOLACvtfcHk0lhPQlRy0Slzag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVSgu7fJ&md5=353c92fdf5be0efb00e23b6d0b8141d6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnn1776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn1776%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DPei%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DRoss%26aufirst%3DC.%2BA.%26atitle%3DKinase%2520activity%2520of%2520mutant%2520LRRK2%2520mediates%2520neuronal%2520toxicity%26jtitle%3DNat.%2520Neurosci.%26date%3D2006%26volume%3D9%26spage%3D1231%26epage%3D1233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Whartenby, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabresi, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCadden, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kardian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosse, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardoll, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, D.</span><span> </span><span class="NLM_article-title">Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">16741</span><span class="NLM_x">–</span> <span class="NLM_lpage">16746</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=16741-16746&author=K.+A.+Whartenbyauthor=P.+A.+Calabresiauthor=E.+McCaddenauthor=B.+Nguyenauthor=D.+Kardianauthor=T.+Wangauthor=C.+Mosseauthor=D.+M.+Pardollauthor=D.+Small&title=Inhibition+of+FLT3+signaling+targets+DCs+to+ameliorate+autoimmune+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWhartenby%26aufirst%3DK.%2BA.%26aulast%3DCalabresi%26aufirst%3DP.%2BA.%26aulast%3DMcCadden%26aufirst%3DE.%26aulast%3DNguyen%26aufirst%3DB.%26aulast%3DKardian%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DMosse%26aufirst%3DC.%26aulast%3DPardoll%26aufirst%3DD.%2BM.%26aulast%3DSmall%26aufirst%3DD.%26atitle%3DInhibition%2520of%2520FLT3%2520signaling%2520targets%2520DCs%2520to%2520ameliorate%2520autoimmune%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D16741%26epage%3D16746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Solinas, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilcu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neels, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandyopadhyay, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naugler, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grivennikov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynshaw-Boris, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scadeng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olefsky, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karin, M.</span><span> </span><span class="NLM_article-title">JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">386</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1016%2Fj.cmet.2007.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=17983584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlemsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=386-397&author=G.+Solinasauthor=C.+Vilcuauthor=J.+G.+Neelsauthor=G.+K.+Bandyopadhyayauthor=J.+L.+Luoauthor=W.+Nauglerauthor=S.+Grivennikovauthor=A.+Wynshaw-Borisauthor=M.+Scadengauthor=J.+M.+Olefskyauthor=M.+Karin&title=JNK1+in+hematopoietically+derived+cells+contributes+to+diet-induced+inflammation+and+insulin+resistance+without+affecting+obesity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity</span></div><div class="casAuthors">Solinas, Giovanni; Vilcu, Cristian; Neels, Jaap G.; Bandyopadhyay, Gautam K.; Luo, Jun-Li; Naugler, Willscott; Grivennikov, Sergei; Wynshaw-Boris, Anthony; Scadeng, Miriam; Olefsky, Jerrold M.; Karin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">386-397</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Obesity-induced insulin resistance is a major factor in the etiol. of type 2 diabetes, and Jun kinases (JNKs) are key neg. regulators of insulin sensitivity in the obese state.  Activation of JNKs (mainly JNK1) in insulin target cells results in phosphorylation of insulin receptor substrates (IRSs) at serine and threonine residues that inhibit insulin signaling.  JNK1 activation is also required for accumulation of visceral fat.  Here the authors used reciprocal adoptive transfer expts. to det. whether JNK1 in myeloid cells, such as macrophages, also contributes to insulin resistance and central adiposity.  The authors' results show that deletion of Jnk1 in the nonhematopoietic compartment protects mice from high-fat diet (HFD)-induced insulin resistance, in part through decreased adiposity.  By contrast, Jnk1 removal from hematopoietic cells has no effect on adiposity but confers protection against HFD-induced insulin resistance by decreasing obesity-induced inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzkPr_p6vAZLVg90H21EOLACvtfcHk0lhKJO4lQ7e0lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlemsr%252FL&md5=d700af389f61db82aa6e6837617394ef</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2007.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2007.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DSolinas%26aufirst%3DG.%26aulast%3DVilcu%26aufirst%3DC.%26aulast%3DNeels%26aufirst%3DJ.%2BG.%26aulast%3DBandyopadhyay%26aufirst%3DG.%2BK.%26aulast%3DLuo%26aufirst%3DJ.%2BL.%26aulast%3DNaugler%26aufirst%3DW.%26aulast%3DGrivennikov%26aufirst%3DS.%26aulast%3DWynshaw-Boris%26aufirst%3DA.%26aulast%3DScadeng%26aufirst%3DM.%26aulast%3DOlefsky%26aufirst%3DJ.%2BM.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DJNK1%2520in%2520hematopoietically%2520derived%2520cells%2520contributes%2520to%2520diet-induced%2520inflammation%2520and%2520insulin%2520resistance%2520without%2520affecting%2520obesity%26jtitle%3DCell%2520Metab.%26date%3D2007%26volume%3D6%26spage%3D386%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Johnson, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D.</span><span> </span><span class="NLM_article-title">The eleventh Datta lecture. The structural basis for substrate recognition and control by protein kinases</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">430</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=1998&pages=1-11&author=L.+N.+Johnsonauthor=E.+D.+Loweauthor=M.+E.+Nobleauthor=D.+Owen&title=The+eleventh+Datta+lecture.+The+structural+basis+for+substrate+recognition+and+control+by+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DL.%2BN.%26aulast%3DLowe%26aufirst%3DE.%2BD.%26aulast%3DNoble%26aufirst%3DM.%2BE.%26aulast%3DOwen%26aufirst%3DD.%26atitle%3DThe%2520eleventh%2520Datta%2520lecture.%2520The%2520structural%2520basis%2520for%2520substrate%2520recognition%2520and%2520control%2520by%2520protein%2520kinases%26jtitle%3DFEBS%2520Lett.%26date%3D1998%26volume%3D430%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Huse, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span> </span><span class="NLM_article-title">The conformational plasticity of protein kinases</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1016%2FS0092-8674%2802%2900741-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=12015977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvV2lsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=275-282&author=M.+Huseauthor=J.+Kuriyan&title=The+conformational+plasticity+of+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The conformational plasticity of protein kinases</span></div><div class="casAuthors">Huse, Morgan; Kuriyan, John</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">275-282</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review with 48 refs.  Protein kinases operate in a large no. of distinct signaling pathways, where the tight regulation of their catalytic activity is crucial to the development and maintenance of eukaryotic organisms.  The catalytic domains of different kinases adopt strikingly similar structures when they are active.  By contrast, crystal structures of inactive kinases have revealed a marked plasticity in the kinase domain that allows the adoption of distinct conformations in response to interactions with specific regulatory domains or proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJrn7F3h4ej7Vg90H21EOLACvtfcHk0lhKJO4lQ7e0lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvV2lsLw%253D&md5=cd56edae94ad239f2ce7a5d6c8930cbb</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2802%2900741-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252802%252900741-9%26sid%3Dliteratum%253Aachs%26aulast%3DHuse%26aufirst%3DM.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DThe%2520conformational%2520plasticity%2520of%2520protein%2520kinases%26jtitle%3DCell%26date%3D2002%26volume%3D109%26spage%3D275%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Schindler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornmann, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicena, P</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarkson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span> </span><span class="NLM_article-title">Structural mechanism for STI-571 inhibition of abelson tyrosine kinase</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">1938</span><span class="NLM_x">–</span> <span class="NLM_lpage">1942</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1126%2Fscience.289.5486.1938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=10988075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD3cXms1altLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2000&pages=1938-1942&author=T.+Schindlerauthor=W.+Bornmannauthor=P+Pellicenaauthor=W.+T.+Millerauthor=B.+Clarksonauthor=J.+Kuriyan&title=Structural+mechanism+for+STI-571+inhibition+of+abelson+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase</span></div><div class="casAuthors">Schindler, Thomas; Bornmann, William; Pellicena, Patricia; Miller, W. Todd; Clarkson, Bayard; Kuriyan, John</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">5486</span>),
    <span class="NLM_cas:pages">1938-1942</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The inadvertent activation of the Abelson tyrosine kinase (Abl) causes chronic myelogenous leukemia (CML).  A small-mol. inhibitor of Abl (STI-571) is effective in the treatment of CML.  We report the crystal structure of the catalytic domain of Abl, complexed to a variant of STI-571.  Crit. to the binding of STI-571 is the adoption by the kinase of an inactive conformation, in which a centrally located "activation loop" is not phosphorylated.  The conformation of this loop is distinct from that in active protein kinases, as well as in the inactive form of the closely related Src kinases.  These results suggest that compds. that exploit the distinctive inactivation mechanisms of individual protein kinases can achieve both high affinity and high specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9eAZqIQ1aebVg90H21EOLACvtfcHk0lgjy1QBgnUgLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXms1altLc%253D&md5=56bb233f010f099d0073020ac6b9db59</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1126%2Fscience.289.5486.1938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.289.5486.1938%26sid%3Dliteratum%253Aachs%26aulast%3DSchindler%26aufirst%3DT.%26aulast%3DBornmann%26aufirst%3DW.%26aulast%3DPellicena%26aufirst%3DP%26aulast%3DMiller%26aufirst%3DW.%2BT.%26aulast%3DClarkson%26aufirst%3DB.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DStructural%2520mechanism%2520for%2520STI-571%2520inhibition%2520of%2520abelson%2520tyrosine%2520kinase%26jtitle%3DScience%26date%3D2000%26volume%3D289%26spage%3D1938%26epage%3D1942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Bikker, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span> </span><span class="NLM_article-title">Kinase domain mutations in cancer: implications for small molecule drug design strategies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1493</span><span class="NLM_x">–</span> <span class="NLM_lpage">1509</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8010542" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisVCisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1493-1509&author=J.+A.+Bikkerauthor=N.+Brooijmansauthor=A.+Wisserauthor=T.+S.+Mansour&title=Kinase+domain+mutations+in+cancer%3A+implications+for+small+molecule+drug+design+strategies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase Domain Mutations in Cancer: Implications for Small Molecule Drug Design Strategies</span></div><div class="casAuthors">Bikker, Jack A.; Brooijmans, Natasja; Wissner, Allan; Mansour, Tarek S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1493-1509</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review will provide a brief overview of kinase structure and function as it pertains to drug discovery, describe the location and importance of clin. mutations, and review the emerging understanding of their impact based on sequence homol., protein crystal complexes, and biochem./biophys. information.  Underlying this discussion is our appreciation that the current clin. arsenal of small mol. kinase inhibitors only contains the first weapons to be deployed in a long war against drug resistance mutations occurring in multiple kinases that target multiple cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBBjVt8P6JI7Vg90H21EOLACvtfcHk0lgjy1QBgnUgLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisVCisr0%253D&md5=fa09d8a6e553ccd1bb1f093176ecb366</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm8010542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8010542%26sid%3Dliteratum%253Aachs%26aulast%3DBikker%26aufirst%3DJ.%2BA.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DWisser%26aufirst%3DA.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26atitle%3DKinase%2520domain%2520mutations%2520in%2520cancer%253A%2520implications%2520for%2520small%2520molecule%2520drug%2520design%2520strategies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1493%26epage%3D1509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Jänne, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settleman, J.</span><span> </span><span class="NLM_article-title">Factors underlying sensitivity of cancers to small-molecule kinase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">709</span><span class="NLM_x">–</span> <span class="NLM_lpage">723</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=709-723&issue=9&author=P.+A.+J%C3%A4nneauthor=N.+Grayauthor=J.+Settleman&title=Factors+underlying+sensitivity+of+cancers+to+small-molecule+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJ%25C3%25A4nne%26aufirst%3DP.%2BA.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DSettleman%26aufirst%3DJ.%26atitle%3DFactors%2520underlying%2520sensitivity%2520of%2520cancers%2520to%2520small-molecule%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26issue%3D9%26spage%3D709%26epage%3D723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Fernandez, A.</span><span> </span><span class="NLM_article-title">Is there a case for selectively promiscuous anticancer drugs?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=1-5&author=A.+Fernandez&title=Is+there+a+case+for+selectively+promiscuous+anticancer+drugs%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez%26aufirst%3DA.%26atitle%3DIs%2520there%2520a%2520case%2520for%2520selectively%2520promiscuous%2520anticancer%2520drugs%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D1%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Petrelli, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, S.</span><span> </span><span class="NLM_article-title">From single- to multi-target drugs in cancer therapy: when aspecificity becomes an advantage</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">422</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.2174%2F092986708783503212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=18288997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVyisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=422-432&author=A+Petrelliauthor=S.+Giordano&title=From+single-+to+multi-target+drugs+in+cancer+therapy%3A+when+aspecificity+becomes+an+advantage"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">From single- to multi-target drugs in cancer therapy: when a specificity becomes an advantage</span></div><div class="casAuthors">Petrelli, A.; Giordano, S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">422-432</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Targeted therapies by means of compds. that inhibit a specific target mol. represent a new perspective in the treatment of cancer.  In contrast to conventional chemotherapy which acts on all dividing cells generating toxic effects and damage of normal tissues, targeted drugs allow to hit, in a more specific manner, subpopulations of cells directly involved in tumor progression.  Mols. controlling cell proliferation and death, such as Tyrosine Kinase Receptors (RTKs) for growth factors, are among the best targets for this type of therapeutic approach.  Two classes of compds. targeting RTKs are currently used in clin. practice: monoclonal antibodies and tyrosine kinase inhibitors.  The era of targeted therapy began with the approval of Trastuzumab, a monoclonal antibody against HER2, for treatment of metastatic breast cancer, and Imatinib, a small tyrosine kinase inhibitor targeting BCR-Abl, in Chronic Myeloid Leukemia.  Despite the initial enthusiasm for the efficacy of these treatments, clinicians had to face soon the problem of relapse, as almost invariably cancer patients developed drug resistance, often due to the activation of alternative RTKs pathways.  In this view, the rationale at the basis of targeting drugs is radically shifting.  In the past, the main effort was aimed at developing highly specific inhibitors acting on single RTKs.  Now, there is a general agreement that mols. interfering simultaneously with multiple RTKs might be more effective than single target agents.  With the recent approval by FDA of Sorafenib and Sunitinib - targeting VEGFR, PDGFR, FLT-3 and c-Kit - a different scenario has been emerging, where a new generation of anti-cancer drugs, able to inhibit more than one pathway, would probably play a major role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8AXb2ROTStLVg90H21EOLACvtfcHk0ljE-yvbSwZtiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVyisL0%253D&md5=d90df6a670921b6fad58caa46db01fa5</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F092986708783503212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708783503212%26sid%3Dliteratum%253Aachs%26aulast%3DPetrelli%26aufirst%3DA%26aulast%3DGiordano%26aufirst%3DS.%26atitle%3DFrom%2520single-%2520to%2520multi-target%2520drugs%2520in%2520cancer%2520therapy%253A%2520when%2520aspecificity%2520becomes%2520an%2520advantage%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26spage%3D422%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Smyth, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span> </span><span class="NLM_article-title">Measuring and interpreting the selectivity of protein kinase inhibitors</span> <span class="citation_source-journal">J. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1007%2Fs12154-009-0023-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A280%3ADC%252BD1MrkslGqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=131-151&issue=3&author=L.+A.+Smythauthor=I.+Collins&title=Measuring+and+interpreting+the+selectivity+of+protein+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Measuring and interpreting the selectivity of protein kinase inhibitors</span></div><div class="casAuthors">Smyth Lynette A; Collins Ian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of chemical biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">131-51</span>
        ISSN:<span class="NLM_cas:issn">1864-6158</span>.
    </div><div class="casAbstract">Protein kinase inhibitors are a well-established class of clinically useful drugs, particularly for the treatment of cancer.  Achieving inhibitor selectivity for particular protein kinases often remains a significant challenge in the development of new small molecules as drugs or as tools for chemical biology research.  This review summarises the methodologies available for measuring kinase inhibitor selectivity, both in vitro and in cells.  The interpretation of kinase inhibitor selectivity data is discussed, particularly with reference to the structural biology of the protein targets.  Measurement and prediction of kinase inhibitor selectivity will be important for the development of new multi-targeted kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQzU9rA5WZcz9FxYDaSSP8XfW6udTcc2ebwS6----EzMbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrkslGqtA%253D%253D&md5=f78ff1202a949a71ffd65e804298c37f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1007%2Fs12154-009-0023-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12154-009-0023-9%26sid%3Dliteratum%253Aachs%26aulast%3DSmyth%26aufirst%3DL.%2BA.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DMeasuring%2520and%2520interpreting%2520the%2520selectivity%2520of%2520protein%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D2%26issue%3D3%26spage%3D131%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Morphy, R.</span><span> </span><span class="NLM_article-title">Selectively nonselective kinase inhibition: striking the right balance</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1021/jm901132v</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm901132v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=R.+Morphy&title=Selectively+nonselective+kinase+inhibition%3A+striking+the+right+balance&doi=10.1021%2Fjm901132v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm901132v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901132v%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26atitle%3DSelectively%2520nonselective%2520kinase%2520inhibition%253A%2520striking%2520the%2520right%2520balance%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26doi%3D10.1021%2Fjm901132v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Cowan-Jacob, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Möbitz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span> </span><span class="NLM_article-title">Structural biology contributions to tyrosine kinase drug discovery</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">280</span><span class="NLM_x">–</span> <span class="NLM_lpage">287</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1016%2Fj.ceb.2009.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=19208462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVCksr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=280-287&issue=2&author=S.+W.+Cowan-Jacobauthor=H.+M%C3%B6bitzauthor=D.+Fabbro&title=Structural+biology+contributions+to+tyrosine+kinase+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Structural biology contributions to tyrosine kinase drug discovery</span></div><div class="casAuthors">Cowan-Jacob, Sandra W.; Moebitz, Henrik; Fabbro, Doriano</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">280-287</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Successful kinase inhibitor drug discovery relies heavily on the structural knowledge of the interaction of inhibitors with the target.  Structural biol. of kinases and in particular of tyrosine kinases has given detailed insights into the intrinsic flexibility of the catalytic domain and has provided a rational basis for obtaining selective inhibitors.  Important progress was made recently, both in academia and in the pharmaceutical industry, with respect to solving structures of inactive, multidomain or protein-protein complexes of kinases, which helps our understanding of the dynamics of regulation of kinase activity.  This leads to a better understanding of how mutations lead to activation of kinases and resistance, in addn. to providing opportunities for novel modes of targeting kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo09-Hgo00-bLVg90H21EOLACvtfcHk0lgR0xKx8l8PSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVCksr8%253D&md5=125e7217308850813cde9dce356bf1a4</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2009.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2009.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DCowan-Jacob%26aufirst%3DS.%2BW.%26aulast%3DM%25C3%25B6bitz%26aufirst%3DH.%26aulast%3DFabbro%26aufirst%3DD.%26atitle%3DStructural%2520biology%2520contributions%2520to%2520tyrosine%2520kinase%2520drug%2520discovery%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2009%26volume%3D21%26issue%3D2%26spage%3D280%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Azam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeliger, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daley, G. Q.</span><span> </span><span class="NLM_article-title">Activation of tyrosine kinases by mutation of the gatekeeper threonine</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1109</span><span class="NLM_x">–</span> <span class="NLM_lpage">1118</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1038%2Fnsmb.1486" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=18794843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Sisb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=1109-1118&issue=10&author=M.+Azamauthor=M.+A.+Seeligerauthor=N.+S.+Grayauthor=J.+Kuriyanauthor=G.+Q.+Daley&title=Activation+of+tyrosine+kinases+by+mutation+of+the+gatekeeper+threonine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of tyrosine kinases by mutation of the gatekeeper threonine</span></div><div class="casAuthors">Azam, Mohammad; Seeliger, Markus A.; Gray, Nathanael S.; Kuriyan, John; Daley, George Q.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1109-1118</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein kinases targeted by small-mol. inhibitors develop resistance through mutation of the 'gatekeeper' threonine residue of the active site.  Here we show that the gatekeeper mutation in the cellular forms of c-ABL, c-SRC, platelet-derived growth factor receptor-α and -β, and epidermal growth factor receptor activates the kinase and promotes malignant transformation of BaF3 cells.  Structural anal. reveals that a network of hydrophobic interactions - the hydrophobic spine - characteristic of the active kinase conformation is stabilized by the gatekeeper substitution.  Substitution of glycine for the residues constituting the spine disrupts the hydrophobic connectivity and inactivates the kinase.  Furthermore, a small-mol. inhibitor (compd. 14) that maximizes complementarity with the dismantled spine inhibits the gatekeeper mutation of BCR-ABL-T315I.  These results demonstrate that mutation of the gatekeeper threonine is a common mechanism of activation for tyrosine kinases and provide structural insights to guide the development of next-generation inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEoZTY5SkbALVg90H21EOLACvtfcHk0lgR0xKx8l8PSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Sisb%252FM&md5=4afc4e5a0850a4510ced3fa5fbda97fa</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1486%26sid%3Dliteratum%253Aachs%26aulast%3DAzam%26aufirst%3DM.%26aulast%3DSeeliger%26aufirst%3DM.%2BA.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DKuriyan%26aufirst%3DJ.%26aulast%3DDaley%26aufirst%3DG.%2BQ.%26atitle%3DActivation%2520of%2520tyrosine%2520kinases%2520by%2520mutation%2520of%2520the%2520gatekeeper%2520threonine%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2008%26volume%3D15%26issue%3D10%26spage%3D1109%26epage%3D1118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Kornev, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haste, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ten Eyck, L. F.</span><span> </span><span class="NLM_article-title">Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">17783</span><span class="NLM_x">–</span> <span class="NLM_lpage">17788</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1073%2Fpnas.0607656103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=17095602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1KnurfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=17783-17788&author=A.+P.+Kornevauthor=N.+M.+Hasteauthor=S.+S.+Taylorauthor=L.+F.+Ten+Eyck&title=Surface+comparison+of+active+and+inactive+protein+kinases+identifies+a+conserved+activation+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism</span></div><div class="casAuthors">Kornev, Alexandr P.; Haste, Nina M.; Taylor, Susan S.; Ten Eyck, Lynn F.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">17783-17788</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The surface comparison of different serine-threonine and tyrosine kinases reveals a set of 30 residues whose spatial positions are highly conserved.  The comparison between active and inactive conformations identified the residues whose positions are the most sensitive to activation.  Based on these results, we propose a model of protein kinase activation.  This model explains how the presence of a phosphate group in the activation loop dets. the position of the catalytically important aspartate in the Asp-Phe-Gly (DFG) motif.  According to the model, the most important feature of the activation is a "spine" formation that is dynamically assembled in all active kinases.  The spine is comprised of four hydrophobic residues that we detected in a set of 23 eukaryotic and prokaryotic kinases.  It spans the mol. and plays a coordinating role in activated kinases.  The spine is disordered in the inactive kinases and can explain how stabilization of the whole mol. is achieved upon phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwv4ByA5owH7Vg90H21EOLACvtfcHk0lg8EmjAnJsF-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1KnurfJ&md5=f474acffd8b17d8352ac9f6fc9bbbf8f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0607656103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0607656103%26sid%3Dliteratum%253Aachs%26aulast%3DKornev%26aufirst%3DA.%2BP.%26aulast%3DHaste%26aufirst%3DN.%2BM.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26aulast%3DTen%2BEyck%26aufirst%3DL.%2BF.%26atitle%3DSurface%2520comparison%2520of%2520active%2520and%2520inactive%2520protein%2520kinases%2520identifies%2520a%2520conserved%2520activation%2520mechanism%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D17783%26epage%3D17788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Kornev, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ten Eyck, L. F.</span><span> </span><span class="NLM_article-title">A helix scaffold for the assembly of active protein kinases</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">14377</span><span class="NLM_x">–</span> <span class="NLM_lpage">14382</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=14377-14382&author=A.+P.+Kornevauthor=S.+S.+Taylorauthor=L.+F.+Ten+Eyck&title=A+helix+scaffold+for+the+assembly+of+active+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKornev%26aufirst%3DA.%2BP.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26aulast%3DTen%2BEyck%26aufirst%3DL.%2BF.%26atitle%3DA%2520helix%2520scaffold%2520for%2520the%2520assembly%2520of%2520active%2520protein%2520kinases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D14377%26epage%3D14382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Rational design of inhibitors that bind to inactive kinase conformations</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1038%2Fnchembio799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=16783341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFGjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=358-364&issue=7&author=Y.+Liuauthor=N.+S.+Gray&title=Rational+design+of+inhibitors+that+bind+to+inactive+kinase+conformations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of inhibitors that bind to inactive kinase conformations</span></div><div class="casAuthors">Liu, Yi; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">358-364</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The majority of kinase inhibitors, known as type I inhibitors that have been developed so far target the ATP binding site of the kinase in its active conformation, in which the activation loop is phosphorylated.  Recently, crystal structures of inhibitors such as imatinib, BIRB796, and sorafenib (BAY43-9006), known as type II inhibitors, have revealed a new binding mode that exploits an addnl. binding site immediately adjacent to the region occupied by ATP.  This pocket is made accessible by an activation-loop rearrangement that is characteristic of kinases in an inactive conformation.  The examn. of binding features of known type II inhibitors is discussed and a pharmacophore model currently used in the design of a new generation of structurally diverse type II inhibitors is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxahsMPlhgDbVg90H21EOLACvtfcHk0ljFA_QZWHReIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFGjs7g%253D&md5=4a9347a44a2cf4a412c9741fdcc5696b</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnchembio799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio799%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DRational%2520design%2520of%2520inhibitors%2520that%2520bind%2520to%2520inactive%2520kinase%2520conformations%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26issue%3D7%26spage%3D358%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Backes, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zech, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebl, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, G.</span><span> </span><span class="NLM_article-title">Small-molecule inhibitors binding to protein kinases. Part I: exceptions from the traditional pharmacophore approach of type I inhibition</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1409</span><span class="NLM_x">–</span> <span class="NLM_lpage">1425</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1409-1425&issue=12&author=A.+C.+Backesauthor=B.+Zechauthor=B.+Felberauthor=B.+Kleblauthor=G.+M%C3%BCller&title=Small-molecule+inhibitors+binding+to+protein+kinases.+Part+I%3A+exceptions+from+the+traditional+pharmacophore+approach+of+type+I+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBackes%26aufirst%3DA.%2BC.%26aulast%3DZech%26aufirst%3DB.%26aulast%3DFelber%26aufirst%3DB.%26aulast%3DKlebl%26aufirst%3DB.%26aulast%3DM%25C3%25BCller%26aufirst%3DG.%26atitle%3DSmall-molecule%2520inhibitors%2520binding%2520to%2520protein%2520kinases.%2520Part%2520I%253A%2520exceptions%2520from%2520the%2520traditional%2520pharmacophore%2520approach%2520of%2520type%2520I%2520inhibition%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2008%26volume%3D3%26issue%3D12%26spage%3D1409%26epage%3D1425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirazian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuj, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuda, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nematalla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sistla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luu, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span> </span><span class="NLM_article-title">Discovery of 5-[5-fluoro-2-oxo-1,2- dihydroindol-(3<i>Z</i>)-ylidenemethyl]-2,4-dimethyl-1<i>H</i>-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1116</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0204183" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1116-1119&author=L.+Sunauthor=C.+Liangauthor=S.+Shirazianauthor=Y.+Zhouauthor=T.+Millerauthor=J.+Cujauthor=J.+Y.+Fukudaauthor=J.+Y.+Chuauthor=A.+Nematallaauthor=X.+Wangauthor=H.+Chenauthor=A.+Sistlaauthor=T.+C.+Luuauthor=F.+Tangauthor=J.+Weiauthor=C.+Tang&title=Discovery+of+5-%5B5-fluoro-2-oxo-1%2C2-+dihydroindol-%283Z%29-ylidenemethyl%5D-2%2C4-dimethyl-1H-pyrrole-3-carboxylic+acid+%282-diethylaminoethyl%29amide%2C+a+novel+tyrosine+kinase+inhibitor+targeting+vascular+endothelial+and+platelet-derived+growth+factor+receptor+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm0204183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0204183%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DShirazian%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DCuj%26aufirst%3DJ.%26aulast%3DFukuda%26aufirst%3DJ.%2BY.%26aulast%3DChu%26aufirst%3DJ.%2BY.%26aulast%3DNematalla%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DSistla%26aufirst%3DA.%26aulast%3DLuu%26aufirst%3DT.%2BC.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DC.%26atitle%3DDiscovery%2520of%25205-%255B5-fluoro-2-oxo-1%252C2-%2520dihydroindol-%25283Z%2529-ylidenemethyl%255D-2%252C4-dimethyl-1H-pyrrole-3-carboxylic%2520acid%2520%25282-diethylaminoethyl%2529amide%252C%2520a%2520novel%2520tyrosine%2520kinase%2520inhibitor%2520targeting%2520vascular%2520endothelial%2520and%2520platelet-derived%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1116%26epage%3D1119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Karaman, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">A quantitative analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1038%2Fnbt1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=18183025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=127-132&author=M.+W.+Karamanauthor=S.+Herrgardauthor=D.+K.+Treiberauthor=P.+Gallantauthor=C.+E.+Atteridgeauthor=B.+T.+Campbellauthor=K.+W.+Chanauthor=P.+Ciceriauthor=M.+I.+Davisauthor=P.+T.+Edeenauthor=R.+Faraoniauthor=M.+Floydauthor=J.+P.+Huntauthor=D.+J.+Lockhartauthor=Z.+V.+Milanovauthor=M.+J.+Morrisonauthor=G.+Pallaresauthor=H.+K.+Patelauthor=S.+Pritchardauthor=L.+M.+Wodickaauthor=P.+P.+Zarrinkar&title=A+quantitative+analysis+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.  The biol. consequences of multikinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome.  The authors present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome.  The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns.  To enable a global anal. of the results, the authors introduce the concept of a selectivity score as a general tool to quantify and differentiate the obsd. interaction patterns.  The authors further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiArJSq2_lPrVg90H21EOLACvtfcHk0li2Sgu_agpBfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D&md5=346265d412853ced636ad4128ed8a76f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnbt1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1358%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DM.%2BW.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DCampbell%26aufirst%3DB.%2BT.%26aulast%3DChan%26aufirst%3DK.%2BW.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DPritchard%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DA%2520quantitative%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D127%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><div class="note"><p class="first last">An important feature of sunitinib is that its promiscuous profile is due to the indolinone scaffold ability to bind both DFG “in” and DFG “out” states of the protein, interacting via hydrogen bond with the hinge region and displaying hydrophobic contacts like a type I inhibitor. </p></div><span class="NLM_contrib-group">Gajiwala, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiNitto, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">English, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greig, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacques, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunney, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molina, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quenzer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmett, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demetri, J. D.</span><span> </span><span class="NLM_article-title">KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">1542</span><span class="NLM_x">–</span> <span class="NLM_lpage">1547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1073%2Fpnas.0812413106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=19164557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVOms78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=1542-1547&author=K.+S.+Gajiwalaauthor=J.+C.+Wuauthor=J.+Christensenauthor=G.+D.+Deshmukhauthor=W.+Diehlauthor=J.+P.+DiNittoauthor=J.+M.+Englishauthor=J.+M.+Greigauthor=Y.+A.+Heauthor=S.+L.+Jacquesauthor=E.+A.+Lunneyauthor=M.+McTigueauthor=D.+Molinaauthor=T.+Quenzerauthor=P.+A.+Wellsauthor=X.+Yuauthor=Y.+Zhangauthor=A.+Zouauthor=M.+R.+Emmettauthor=A.+G.+Marshallauthor=H.+M.+Zhangauthor=J.+D.+Demetri&title=KIT+kinase+mutants+show+unique+mechanisms+of+drug+resistance+to+imatinib+and+sunitinib+in+gastrointestinal+stromal+tumor+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients</span></div><div class="casAuthors">Gajiwala, Ketan S.; Wu, Joe C.; Christensen, James; Deshmukh, Gayatri D.; Diehl, Wade; DiNitto, Jonathan P.; English, Jessie M.; Greig, Michael J.; He, You-Ai; Jacques, Suzanne L.; Lunney, Elizabeth A.; McTigue, Michele; Molina, Dave; Quenzer, Terri; Wells, Peter A.; Yu, Xiu; Zhang, Yan; Zou, Aihua; Emmett, Mark R.; Marshall, Alan G.; Zhang, Hui-Min; Demetri, George D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1542-1547</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Most gastrointestinal stromal tumors (GISTs) exhibit aberrant activation of the receptor tyrosine kinase (RTK) KIT.  The efficacy of the inhibitors imatinib mesylate and sunitinib malate in GIST patients has been linked to their inhibition of these mutant KIT proteins.  However, patients on imatinib can acquire secondary KIT mutations that render the protein insensitive to the inhibitor.  Sunitinib has shown efficacy against certain imatinib-resistant mutants, although a subset that resides in the activation loop, including D816H/V, remains resistant.  Biochem. and structural studies were undertaken to det. the mol. basis of sunitinib resistance.  Our results show that sunitinib targets the autoinhibited conformation of WT KIT and that the D816H mutant undergoes a shift in conformational equil. toward the active state.  These findings provide a structural and enzymol. explanation for the resistance profile obsd. with the KIT inhibitors.  Prospectively, they have implications for understanding oncogenic kinase mutants and for circumventing drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkwFxa-p-iWbVg90H21EOLACvtfcHk0lj1QNyVSCO8fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVOms78%253D&md5=dd226c914c6f9a258426c0f4984a5258</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0812413106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0812413106%26sid%3Dliteratum%253Aachs%26aulast%3DGajiwala%26aufirst%3DK.%2BS.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DDeshmukh%26aufirst%3DG.%2BD.%26aulast%3DDiehl%26aufirst%3DW.%26aulast%3DDiNitto%26aufirst%3DJ.%2BP.%26aulast%3DEnglish%26aufirst%3DJ.%2BM.%26aulast%3DGreig%26aufirst%3DJ.%2BM.%26aulast%3DHe%26aufirst%3DY.%2BA.%26aulast%3DJacques%26aufirst%3DS.%2BL.%26aulast%3DLunney%26aufirst%3DE.%2BA.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DMolina%26aufirst%3DD.%26aulast%3DQuenzer%26aufirst%3DT.%26aulast%3DWells%26aufirst%3DP.%2BA.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZou%26aufirst%3DA.%26aulast%3DEmmett%26aufirst%3DM.%2BR.%26aulast%3DMarshall%26aufirst%3DA.%2BG.%26aulast%3DZhang%26aufirst%3DH.%2BM.%26aulast%3DDemetri%26aufirst%3DJ.%2BD.%26atitle%3DKIT%2520kinase%2520mutants%2520show%2520unique%2520mechanisms%2520of%2520drug%2520resistance%2520to%2520imatinib%2520and%2520sunitinib%2520in%2520gastrointestinal%2520stromal%2520tumor%2520patients%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D1542%26epage%3D1547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Features of selective kinase inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">637</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1016%2Fj.chembiol.2005.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=15975507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=621-637&author=Z.+A.+Knightauthor=K.+M.+Shokat&title=Features+of+selective+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Features of Selective Kinase Inhibitors</span></div><div class="casAuthors">Knight, Zachary A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">621-637</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Summary: Small-mol. inhibitors of protein and lipid kinases have emerged as indispensable tools for studying signal transduction.  Despite the widespread use of these reagents, there is little consensus about the biochem. criteria that define their potency and selectivity in cells.  We discuss some of the features that det. the cellular activity of kinase inhibitors and propose a framework for interpreting inhibitor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJWhVxtSrCLVg90H21EOLACvtfcHk0lj4c_GXCgEjLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D&md5=ce5b3505a0326b04479172ec05573152</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DFeatures%2520of%2520selective%2520kinase%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D621%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Sequist, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, T. J.</span><span> </span><span class="NLM_article-title">EGFR tyrosine kinase inhibitors in lung cancer: an evolving story</span> <span class="citation_source-journal">Annu. Rev. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">442</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2008&pages=429-442&author=L.+V.+Sequistauthor=T.+J.+Lynch&title=EGFR+tyrosine+kinase+inhibitors+in+lung+cancer%3A+an+evolving+story"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSequist%26aufirst%3DL.%2BV.%26aulast%3DLynch%26aufirst%3DT.%2BJ.%26atitle%3DEGFR%2520tyrosine%2520kinase%2520inhibitors%2520in%2520lung%2520cancer%253A%2520an%2520evolving%2520story%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2008%26volume%3D59%26spage%3D429%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Lynch, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sordella, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurubhagavatula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okimoto, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brannigan, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haserlat, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supko, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haluska, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiani, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settleman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haber, D. A.</span><span> </span><span class="NLM_article-title">Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">2129</span><span class="NLM_x">–</span> <span class="NLM_lpage">2139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1056%2FNEJMoa040938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=15118073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktF2js7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=2129-2139&issue=21&author=T.+J.+Lynchauthor=D.+W.+Bellauthor=R.+Sordellaauthor=S.+Gurubhagavatulaauthor=R.+A.+Okimotoauthor=B.+W.+Branniganauthor=P.+L.+Harrisauthor=S.+M.+Haserlatauthor=J.+G.+Supkoauthor=F.+G.+Haluskaauthor=D.+N.+Louisauthor=D.+C.+Christianiauthor=J.+Settlemanauthor=D.+A.+Haber&title=Activating+mutations+in+the+epidermal+growth+factor+receptor+underlying+responsiveness+of+non-small-cell+lung+cancer+to+gefitinib"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib</span></div><div class="casAuthors">Lynch, Thomas J.; Bell, Daphne W.; Sordella, Raffaella; Gurubhagavatula, Sarada; Okimoto, Ross A.; Brannigan, Brian W.; Harris, Patricia L.; Haserlat, Sara M.; Supko, Jeffrey G.; Haluska, Frank G.; Louis, David N.; Christiani, David C.; Settleman, Jeff; Haber, Daniel A.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2129-2139</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Most patients with non-small-cell lung cancer have no response to the tyrosine kinase inhibitor gefitinib, which targets the epidermal growth factor receptor (EGFR).  However, about 10% of patients have a rapid and often dramatic clin. response.  The mol. mechanisms underlying sensitivity to gefitinib are unknown.  We searched for mutations in the EGFR gene in primary tumors from patients with non-small-cell lung cancer who had a response to gefitinib, those who did not have a response, and those who had not been exposed to gefitinib.  The functional consequences of identified mutations were evaluated after the mutant proteins were expressed in cultured cells.  Somatic mutations were identified in the tyrosine kinase domain of the EGFR gene in eight of nine patients with gefitinib-responsive lung cancer, as compared with none of the seven patients with no response (P < 0.001).  Mutations were either small, in-frame deletions or amino acid substitutions clustered around the ATP-binding pocket of the tyrosine kinase domain.  Similar mutations were detected in tumors from 2 of 25 patients with primary non-small-cell lung cancer who had not been exposed to gefitinib (8%).  All mutations were heterozygous, and identical mutations were obsd. in multiple patients, suggesting an additive specific gain of function.  In vitro, EGFR mutants demonstrated enhanced tyrosine kinase activity in response to epidermal growth factor and increased sensitivity to inhibition by gefitinib.  A subgroup of patients with non-small-cell lung cancer have specific mutations in the EGFR gene, which correlate with clin. responsiveness to the tyrosine kinase inhibitor gefitinib.  These mutations lead to increased growth factor signaling and confer susceptibility to the inhibitor.  Screening for such mutations in lung cancers may identify patients who will have a response to gefitinib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXwWGeAQrNTLVg90H21EOLACvtfcHk0lg_dTdQwlMAZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktF2js7c%253D&md5=fad70aa0f32ad4105ad6f3db98135bf9</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa040938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa040938%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DT.%2BJ.%26aulast%3DBell%26aufirst%3DD.%2BW.%26aulast%3DSordella%26aufirst%3DR.%26aulast%3DGurubhagavatula%26aufirst%3DS.%26aulast%3DOkimoto%26aufirst%3DR.%2BA.%26aulast%3DBrannigan%26aufirst%3DB.%2BW.%26aulast%3DHarris%26aufirst%3DP.%2BL.%26aulast%3DHaserlat%26aufirst%3DS.%2BM.%26aulast%3DSupko%26aufirst%3DJ.%2BG.%26aulast%3DHaluska%26aufirst%3DF.%2BG.%26aulast%3DLouis%26aufirst%3DD.%2BN.%26aulast%3DChristiani%26aufirst%3DD.%2BC.%26aulast%3DSettleman%26aufirst%3DJ.%26aulast%3DHaber%26aufirst%3DD.%2BA.%26atitle%3DActivating%2520mutations%2520in%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520underlying%2520responsiveness%2520of%2520non-small-cell%2520lung%2520cancer%2520to%2520gefitinib%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26issue%3D21%26spage%3D2129%26epage%3D2139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Paez, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jänne, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greulich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggon, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naoki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span> </span><span class="NLM_article-title">EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">1497</span><span class="NLM_x">–</span> <span class="NLM_lpage">1500</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1126%2Fscience.1099314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=15118125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVGmsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2004&pages=1497-1500&author=J.+G.+Paezauthor=P.+A.+J%C3%A4nneauthor=J.+C.+Leeauthor=S.+Tracyauthor=H.+Greulichauthor=S.+Gabrielauthor=P.+Hermanauthor=F.+J.+Kayeauthor=N.+Lindemanauthor=T.+J.+Boggonauthor=K.+Naokiauthor=H.+Sasakiauthor=Y.+Fujiiauthor=M.+J.+Eckauthor=W.+R.+Sellersauthor=B.+E.+Johnsonauthor=M.+Meyerson&title=EGFR+mutations+in+lung+cancer%3A+correlation+with+clinical+response+to+gefitinib+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy</span></div><div class="casAuthors">Paez, J. Guillermo; Jaenne, Pasi A.; Lee, Jeffrey C.; Tracy, Sean; Greulich, Heidi; Gabriel, Stacey; Herman, Paula; Kaye, Frederic J.; Lindeman, Neal; Boggon, Titus J.; Naoki, Katsuhiko; Sasaki, Hidefumi; Fujii, Yoshitaka; Eck, Michael J.; Sellers, William R.; Johnson, Bruce E.; Meyerson, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">5676</span>),
    <span class="NLM_cas:pages">1497-1500</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Receptor tyrosine kinase genes were sequenced in non-small cell lung cancer (NSCLC) and matched normal tissue.  Somatic mutations of the epidermal growth factor receptor gene EGFR were found in 15 of 58 unselected tumors from Japan and 1 of 61 from the United States.  Treatment with the EGFR kinase inhibitor gefitinib (Iressa) causes tumor regression in some patients with NSCLC, more frequently in Japan.  EGFR mutations were found in addnl. lung cancer samples from U.S. patients who responded to gefitinib therapy and in a lung adenocarcinoma cell line that was hypersensitive to growth inhibition by gefitinib, but not in gefitinib-insensitive tumors or cell lines.  These results suggest that EGFR mutations may predict sensitivity to gefitinib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGxLJH5f3Kb7Vg90H21EOLACvtfcHk0liYzgdDuuDh_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVGmsbs%253D&md5=6df1b11bf9b3c284fbe000e34c61ebac</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1126%2Fscience.1099314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1099314%26sid%3Dliteratum%253Aachs%26aulast%3DPaez%26aufirst%3DJ.%2BG.%26aulast%3DJ%25C3%25A4nne%26aufirst%3DP.%2BA.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DTracy%26aufirst%3DS.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DGabriel%26aufirst%3DS.%26aulast%3DHerman%26aufirst%3DP.%26aulast%3DKaye%26aufirst%3DF.%2BJ.%26aulast%3DLindeman%26aufirst%3DN.%26aulast%3DBoggon%26aufirst%3DT.%2BJ.%26aulast%3DNaoki%26aufirst%3DK.%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DFujii%26aufirst%3DY.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DJohnson%26aufirst%3DB.%2BE.%26aulast%3DMeyerson%26aufirst%3DM.%26atitle%3DEGFR%2520mutations%2520in%2520lung%2520cancer%253A%2520correlation%2520with%2520clinical%2520response%2520to%2520gefitinib%2520therapy%26jtitle%3DScience%26date%3D2004%26volume%3D304%26spage%3D1497%26epage%3D1500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Alton, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunney, E. A.</span><span> </span><span class="NLM_article-title">Targeting the inactivated conformations of protein kinases for small molecule drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">605</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=595-605&issue=6&author=G.+R.+Altonauthor=E.+A.+Lunney&title=Targeting+the+inactivated+conformations+of+protein+kinases+for+small+molecule+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlton%26aufirst%3DG.%2BR.%26aulast%3DLunney%26aufirst%3DE.%2BA.%26atitle%3DTargeting%2520the%2520inactivated%2520conformations%2520of%2520protein%2520kinases%2520for%2520small%2520molecule%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2008%26volume%3D3%26issue%3D6%26spage%3D595%26epage%3D605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Backes, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zech, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebl, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, G.</span><span> </span><span class="NLM_article-title">Small-molecule inhibitors binding to protein kinase. Part II: the novel pharmacophore approach of type II and type III inhibition</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1427</span><span class="NLM_x">–</span> <span class="NLM_lpage">1449</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1427-1449&issue=12&author=A.+C.+Backesauthor=B.+Zechauthor=B.+Felberauthor=B.+Kleblauthor=G.+M%C3%BCller&title=Small-molecule+inhibitors+binding+to+protein+kinase.+Part+II%3A+the+novel+pharmacophore+approach+of+type+II+and+type+III+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBackes%26aufirst%3DA.%2BC.%26aulast%3DZech%26aufirst%3DB.%26aulast%3DFelber%26aufirst%3DB.%26aulast%3DKlebl%26aufirst%3DB.%26aulast%3DM%25C3%25BCller%26aufirst%3DG.%26atitle%3DSmall-molecule%2520inhibitors%2520binding%2520to%2520protein%2520kinase.%2520Part%2520II%253A%2520the%2520novel%2520pharmacophore%2520approach%2520of%2520type%2520II%2520and%2520type%2520III%2520inhibition%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2008%26volume%3D3%26issue%3D12%26spage%3D1427%26epage%3D1449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Chène, P.</span><span> </span><span class="NLM_article-title">Challenges in design of biochemical assays for the identification of small molecules to target multiple conformations of protein kinases</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">522</span><span class="NLM_x">–</span> <span class="NLM_lpage">529</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=522-529&author=P.+Ch%C3%A8ne&title=Challenges+in+design+of+biochemical+assays+for+the+identification+of+small+molecules+to+target+multiple+conformations+of+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCh%25C3%25A8ne%26aufirst%3DP.%26atitle%3DChallenges%2520in%2520design%2520of%2520biochemical%2520assays%2520for%2520the%2520identification%2520of%2520small%2520molecules%2520to%2520target%2520multiple%2520conformations%2520of%2520protein%2520kinases%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2008%26volume%3D13%26spage%3D522%26epage%3D529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Regan, J.</span><span> </span><span class="NLM_article-title">The kinetics of binding to p38 MAP kinase by analogues of BIRB 796</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3101</span><span class="NLM_x">–</span> <span class="NLM_lpage">3104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1016%2FS0960-894X%2803%2900656-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=12941343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1Gmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3101-3104&author=J.+Regan&title=The+kinetics+of+binding+to+p38+MAP+kinase+by+analogues+of+BIRB+796"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The kinetics of binding to p38 MAP kinase of analogues of BIRB 796</span></div><div class="casAuthors">Regan, John; Pargellis, Christopher A.; Cirillo, Pier F.; Gilmore, Thomas; Hickey, Eugene R.; Peet, Gregory W.; Proto, Alfred; Swinamer, Alan; Moss, Neil</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3101-3104</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">BIRB 796, a member of the N-pyrazole-N'-naphthyl urea class of p38 MAPK inhibitors, binds to the kinase with both slow assocn. and dissocn. rates.  Prior to binding, the kinase undergoes a reorganization of the activation loop exposing a crit. binding domain.  We demonstrate that, independent of the loop movement, assocn. rates are governed by low energy conformations of the inhibitor and polar functionality on the tolyl ring.  As anticipated, the dissocn. rates of the inhibitors from the kinase are slowed by lipophilic and hydrogen bond interactions.  The value of structure-kinetic relationships (SKR) in drug design is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr1jPKElIlvrVg90H21EOLACvtfcHk0lhDBdx8Vx2JFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1Gmt7s%253D&md5=1ca2cb661cf037790ec1b0b43a105cf3</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900656-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900656-5%26sid%3Dliteratum%253Aachs%26aulast%3DRegan%26aufirst%3DJ.%26atitle%3DThe%2520kinetics%2520of%2520binding%2520to%2520p38%2520MAP%2520kinase%2520by%2520analogues%2520of%2520BIRB%2520796%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D3101%26epage%3D3104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Pargellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchill, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grob, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, J.</span><span> </span><span class="NLM_article-title">Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1038%2Fnsb770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Kisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=268-272&author=C.+Pargellisauthor=L.+Tongauthor=L.+Churchillauthor=P.+F.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=P.+M.+Grobauthor=E.+R.+Hickeyauthor=N.+Mossauthor=S.+Pavauthor=J.+Regan&title=Inhibition+of+p38+MAP+kinase+by+utilizing+a+novel+allosteric+binding+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site</span></div><div class="casAuthors">Pargellis, Christopher; Tong, Liang; Churchill, Laurie; Cirillo, Pier F.; Gilmore, Thomas; Graham, Anne G.; Grob, Peter M.; Hickey, Eugene R.; Moss, Neil; Pav, Susan; Regan, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">268-272</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">The p38 MAP kinase plays a crucial role in regulating the prodn. of proinflammatory cytokines, such as tumor necrosis factor and interleukin-1.  Blocking this kinase may offer an effective therapy for treating many inflammatory diseases.  Here we report a new allosteric binding site for a diaryl urea class of highly potent and selective inhibitors against human p38 MAP kinase.  The formation of this binding site requires a large conformational change not obsd. previously for any of the protein Ser/Thr kinases.  This change is in the highly conserved Asp-Phe-Gly motif within the active site of the kinase.  Soln. studies demonstrate that this class of compds. has slow binding kinetics, consistent with the requirement for conformational change.  Improving interactions in this allosteric pocket, as well as establishing binding interactions in the ATP pocket, enhanced the affinity of the inhibitors by 12,000-fold.  One of the most potent compds. in this series, BIRB 796, has picomolar affinity for the kinase and low nanomolar inhibitory activity in cell culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT8_QT7_pbYrVg90H21EOLACvtfcHk0ljIBZV0HF3TvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Kisbk%253D&md5=68850ecdbe08df4285ba38cfa2c93ea4</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnsb770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb770%26sid%3Dliteratum%253Aachs%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DChurchill%26aufirst%3DL.%26aulast%3DCirillo%26aufirst%3DP.%2BF.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DGrob%26aufirst%3DP.%2BM.%26aulast%3DHickey%26aufirst%3DE.%2BR.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DRegan%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520p38%2520MAP%2520kinase%2520by%2520utilizing%2520a%2520novel%2520allosteric%2520binding%2520site%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D268%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polverino, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bready, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choquette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMelfi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doerr, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neervannan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potashman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roveto, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrag, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starnes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teffera, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanon, R.</span><span> </span><span class="NLM_article-title">Evaluation of a series of naphthamides as potent, orally active vascular endothelial growth factor receptor-2 tyrosine kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1668</span><span class="NLM_x">–</span> <span class="NLM_lpage">1680</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701098w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1668-1680&author=M.+M.+Weissauthor=J.+C.+Harmangeauthor=A.+J.+Polverinoauthor=D.+Bauerauthor=L.+Berryauthor=V.+Berryauthor=G.+Borgauthor=J.+Breadyauthor=D.+Chenauthor=D.+Choquetteauthor=A.+Coxonauthor=T.+DeMelfiauthor=N.+Doerrauthor=J.+Estradaauthor=J.+Flynnauthor=R.+F.+Graceffaauthor=S.+P.+Harrimanauthor=S.+Kaufmanauthor=D.+S.+Laauthor=A.+Longauthor=S.+Neervannanauthor=V.+F.+Patelauthor=M.+Potashmanauthor=K.+Regalauthor=P.+M.+Rovetoauthor=M.+L.+Schragauthor=C.+Starnesauthor=A.+Taskerauthor=Y.+Tefferaauthor=D.+A.+Whittingtonauthor=R.+Zanon&title=Evaluation+of+a+series+of+naphthamides+as+potent%2C+orally+active+vascular+endothelial+growth+factor+receptor-2+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm701098w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701098w%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26aulast%3DPolverino%26aufirst%3DA.%2BJ.%26aulast%3DBauer%26aufirst%3DD.%26aulast%3DBerry%26aufirst%3DL.%26aulast%3DBerry%26aufirst%3DV.%26aulast%3DBorg%26aufirst%3DG.%26aulast%3DBready%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DChoquette%26aufirst%3DD.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DDeMelfi%26aufirst%3DT.%26aulast%3DDoerr%26aufirst%3DN.%26aulast%3DEstrada%26aufirst%3DJ.%26aulast%3DFlynn%26aufirst%3DJ.%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26aulast%3DKaufman%26aufirst%3DS.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLong%26aufirst%3DA.%26aulast%3DNeervannan%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DPotashman%26aufirst%3DM.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DRoveto%26aufirst%3DP.%2BM.%26aulast%3DSchrag%26aufirst%3DM.%2BL.%26aulast%3DStarnes%26aufirst%3DC.%26aulast%3DTasker%26aufirst%3DA.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DZanon%26aufirst%3DR.%26atitle%3DEvaluation%2520of%2520a%2520series%2520of%2520naphthamides%2520as%2520potent%252C%2520orally%2520active%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1668%26epage%3D1680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Shah, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagar, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorre, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquette, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span> </span><span class="NLM_article-title">Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=117-125&issue=2&author=N.+P.+Shahauthor=J.+M.+Nicollauthor=B.+Nagarauthor=M.+E.+Gorreauthor=R.+L.+Paquetteauthor=J.+Kuriyanauthor=C.+L.+Sawyers&title=Multiple+BCR-ABL+kinase+domain+mutations+confer+polyclonal+resistance+to+the+tyrosine+kinase+inhibitor+imatinib+%28STI571%29+in+chronic+phase+and+blast+crisis+chronic+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DN.%2BP.%26aulast%3DNicoll%26aufirst%3DJ.%2BM.%26aulast%3DNagar%26aufirst%3DB.%26aulast%3DGorre%26aufirst%3DM.%2BE.%26aulast%3DPaquette%26aufirst%3DR.%2BL.%26aulast%3DKuriyan%26aufirst%3DJ.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DMultiple%2520BCR-ABL%2520kinase%2520domain%2520mutations%2520confer%2520polyclonal%2520resistance%2520to%2520the%2520tyrosine%2520kinase%2520inhibitor%2520imatinib%2520%2528STI571%2529%2520in%2520chronic%2520phase%2520and%2520blast%2520crisis%2520chronic%2520myeloid%2520leukemia%26jtitle%3DCancer%2520Cell%26date%3D2002%26volume%3D2%26issue%3D2%26spage%3D117%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Cuenda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouse, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doza, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span> </span><span class="NLM_article-title">SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">364</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=1995&pages=229-233&issue=2&author=A.+Cuendaauthor=J.+Rouseauthor=Y.+N.+Dozaauthor=R.+Meierauthor=P.+Cohenauthor=T.+F.+Gallagherauthor=P.+R.+Youngauthor=J.+C.+Lee&title=SB+203580+is+a+specific+inhibitor+of+a+MAP+kinase+homologue+which+is+stimulated+by+cellular+stresses+and+interleukin-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCuenda%26aufirst%3DA.%26aulast%3DRouse%26aufirst%3DJ.%26aulast%3DDoza%26aufirst%3DY.%2BN.%26aulast%3DMeier%26aufirst%3DR.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DGallagher%26aufirst%3DT.%2BF.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26atitle%3DSB%2520203580%2520is%2520a%2520specific%2520inhibitor%2520of%2520a%2520MAP%2520kinase%2520homologue%2520which%2520is%2520stimulated%2520by%2520cellular%2520stresses%2520and%2520interleukin-1%26jtitle%3DFEBS%2520Lett.%26date%3D1995%26volume%3D364%26issue%3D2%26spage%3D229%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cywin, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C. A.</span><span> </span><span class="NLM_article-title">A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">316</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1038%2Fnsb0497-311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADyaK2sXitl2murc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1997&pages=311-316&author=L.+Tongauthor=S.+Pavauthor=D.+M.+Whiteauthor=S+Rogersauthor=K.+M.+Craneauthor=C.+L.+Cywinauthor=M.+L.+Brownauthor=C.+A.+Pargellis&title=A+highly+specific+inhibitor+of+human+p38+MAP+kinase+binds+in+the+ATP+pocket"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket</span></div><div class="casAuthors">Tong, Liang; Pav, Susan; White, Della M.; Rogers, Sheri; Crane, Kathy M.; Cywin, Charles L.; Brown, Maryanne L.; Pargellis, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-316</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">The crystal structure of human p38 mitogen-activated protein (MAP) kinase in complex with a potent and highly specific pyridinyl-imidazole inhibitor was detd. at 2.0 Å resoln.  The structure of the kinase, which is in its unphosphorylated state, is similar to that of the closely-related ERK2.  The inhibitor mol. is bound in the ATP pocket.  A hydrogen bond is made between the pyridyl nitrogen of the inhibitor and the main chain amido nitrogen of residue 109, analogous to the interaction from the N1 atom of ATP.  The crystal structure provides possible explanations for the specificity of this class of inhibitors.  Other protein kinase inhibitors may achieve their specificity through a similar mechanism.  The structure also reveals a possible second binding site for this inhibitor, with currently unknown function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNChzA5qquarVg90H21EOLACvtfcHk0lhsFEwuK8ISRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXitl2murc%253D&md5=3d5f157fdfa876b74dc3881857bc67b3</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnsb0497-311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb0497-311%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DL.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DD.%2BM.%26aulast%3DRogers%26aufirst%3DS%26aulast%3DCrane%26aufirst%3DK.%2BM.%26aulast%3DCywin%26aufirst%3DC.%2BL.%26aulast%3DBrown%26aufirst%3DM.%2BL.%26aulast%3DPargellis%26aufirst%3DC.%2BA.%26atitle%3DA%2520highly%2520specific%2520inhibitor%2520of%2520human%2520p38%2520MAP%2520kinase%2520binds%2520in%2520the%2520ATP%2520pocket%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D4%26spage%3D311%26epage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><div class="note"><p class="first last">Lapatinib is an EGFR inhibitor. Structural evidence (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1xkk">1xkk</a>) shows that it binds to an inactive form of the kinase. However, in this particular case, the kinase inactivity is not the consequence of a DFG “out” state but instead the result of a misplaced αC-helix (probably a ligand induced effect) that leads to the disruption of the salt bridge between the conserved Lys-Glu residues which is essential for catalytic activity. </p></div><span class="NLM_contrib-group">Lackey, K. E.</span><span> </span><span class="NLM_article-title">Lessons from the drug discovery of lapatinib, a dual ErbB1/2 tyrosine kinase inhibitor</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.2174%2F156802606776743156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=16719802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtV2juro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=435-460&author=K.+E.+Lackey&title=Lessons+from+the+drug+discovery+of+lapatinib%2C+a+dual+ErbB1%2F2+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons from the drug discovery of Lapatinib, a dual ErbB1/2 tyrosine Kinase inhibitor</span></div><div class="casAuthors">Lackey, Karen E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">435-460</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein Kinases offer many opportunities for drug intervention points since phosphorylation is the most common post-translational modification.  Phosphorylation regulates activity, location, degrdn., and conformation and the aberrant activity is implicated in many diseases, including cancer, inflammation, cardiovascular, and central nervous system diseases.  The focus of this review will be on the generation of highly effective signaling inhibitors targeting members of the erbB family of receptor tyrosine kinases, EGFR and ErbB-2, also known as transmembrane Type 1 receptor tyrosine kinases of the HER family of receptors.  Ligand binding to the receptor causes a conformational change which activates the tyrosine kinase domain leading to autophosphorylation.  This autophosphorylation activates the RAS/mitogen-activated protein (MAP) kinase and phosphoinositol-3-kinase (PI3K) pathways leading to a myriad of signaling and cellular activities.  Type 1 receptors are overexpressed in a variety of cancers and generally correlate with poor prognosis.  For this reason, scientists at GlaxoSmithKline and many others in the scientific community target the ATP binding site of the intracellular portion of the protein to block the aberrant signaling event.  This review intends to cover the lessons learned in the discovery of Lapatinib (GW572016, GW2016) by pulling together the various different publications that have been generated in distinct disciplines on aspects of the drug discovery program.  Data analyses and correlation of assay data to help with the design of drug-like mols. are included and demonstrate a break from the traditional focus on abs. potency as a guiding factor in lead compd. selection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnKhQE45WWsbVg90H21EOLACvtfcHk0lg26ASXpFV2CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtV2juro%253D&md5=5bb70c03abc1fb8c301cac0f5f713fbe</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.2174%2F156802606776743156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606776743156%26sid%3Dliteratum%253Aachs%26aulast%3DLackey%26aufirst%3DK.%2BE.%26atitle%3DLessons%2520from%2520the%2520drug%2520discovery%2520of%2520lapatinib%252C%2520a%2520dual%2520ErbB1%252F2%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D435%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Dalgarno, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stehle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schelling, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Schravendijk, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keats, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ram, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacNeil, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, C.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakespeare, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaramoorthi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohacek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigele, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, T.</span><span> </span><span class="NLM_article-title">Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1111%2Fj.1747-0285.2005.00316.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=16492148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVSjt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=46-57&author=D.+Dalgarnoauthor=T.+Stehleauthor=S.+Narulaauthor=P.+Schellingauthor=M.+R.+van+Schravendijkauthor=S.+Adamsauthor=L.+Andradeauthor=J.+Keatsauthor=M.+Ramauthor=L.+Jinauthor=T.+Grossmanauthor=I.+MacNeilauthor=C.+Metcalfauthor=W.+Shakespeareauthor=Y.+Wangauthor=T.+Keenanauthor=R.+Sundaramoorthiauthor=R.+Bohacekauthor=M.+Weigeleauthor=T.+Sawyer&title=Structural+basis+of+Src+tyrosine+kinase+inhibition+with+a+new+class+of+potent+and+selective+trisubstituted+purine-based+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds</span></div><div class="casAuthors">Dalgarno, David; Stehle, Thilo; Narula, Surinder; Schelling, Pierre; van Schravendijk, Marie Rose; Adams, Susan; Andrade, Lawrence; Keats, Jeff; Ram, Mary; Jin, Lei; Grossman, Trudy; MacNeil, Ian; Metcalf, Chester, III; Shakespeare, William; Wang, Yihan; Keenan, Terry; Sundaramoorthi, Raji; Bohacek, Regine; Weigele, Manfred; Sawyer, Tomi</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-57</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The tyrosine kinase pp60src (Src) is the prototypical member of a family of proteins that participate in a broad array of cellular signal transduction processes, including cell growth, differentiation, survival, adhesion, and migration.  Abnormal Src family kinase (SFK) signaling has been linked to several disease states, including osteoporosis and cancer metastases.  Src has thus emerged as a mol. target for the discovery of small-mol. inhibitors that regulate Src kinase activity by binding to the ATP pocket within the catalytic domain.  Here, we present crystal structures of the kinase domain of Src in complex with two purine-based inhibitors: AP23451, a small-mol. inhibitor designed to inhibit Src-dependent bone resorption, and AP23464, a small-mol. inhibitor designed to inhibit the Src-dependent metastatic spread of cancer.  In each case, a trisubstituted purine template core was elaborated using structure-based drug design to yield a potent Src kinase inhibitor.  These structures represent early examples of high affinity purine-based Src family kinase-inhibitor complexes, and they provide a detailed view of the specific protein-ligand interactions that lead to potent inhibition of Src.  In particular, the 3-hydroxyphenethyl N9 substituent of AP23464 forms unique interactions with the protein that are crit. to the picomolar affinity of this compd. for Src.  The comparison of these new structures with two relevant kinase-inhibitor complexes provides a structural basis for the obsd. kinase inhibitory selectivity.  Further comparisons reveal a concerted induced-fit movement between the N- and C-terminal lobes of the kinase that correlates with the affinity of the ligand.  Binding of the most potent inhibitor, AP23464, results in the largest induced-fit movement, which can be directly linked to interactions of the hydrophenethyl N9 substituent with a region at the interface between the two lobes.  A less pronounced induced-fit movement is also obsd. in the Src-AP23451 complex.  These new structures illustrate how the combination of structural, computational, and medicinal chem. can be used to rationalize the process of developing high affinity, selective tyrosine kinase inhibitors as potential therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqAcWZyLy8JrVg90H21EOLACvtfcHk0lgnMIXqIQBC6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVSjt7Y%253D&md5=5a89de976e29e65aec0553c84e2e0b92</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2005.00316.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2005.00316.x%26sid%3Dliteratum%253Aachs%26aulast%3DDalgarno%26aufirst%3DD.%26aulast%3DStehle%26aufirst%3DT.%26aulast%3DNarula%26aufirst%3DS.%26aulast%3DSchelling%26aufirst%3DP.%26aulast%3Dvan%2BSchravendijk%26aufirst%3DM.%2BR.%26aulast%3DAdams%26aufirst%3DS.%26aulast%3DAndrade%26aufirst%3DL.%26aulast%3DKeats%26aufirst%3DJ.%26aulast%3DRam%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DGrossman%26aufirst%3DT.%26aulast%3DMacNeil%26aufirst%3DI.%26aulast%3DMetcalf%26aufirst%3DC.%26aulast%3DShakespeare%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DKeenan%26aufirst%3DT.%26aulast%3DSundaramoorthi%26aufirst%3DR.%26aulast%3DBohacek%26aufirst%3DR.%26aulast%3DWeigele%26aufirst%3DM.%26aulast%3DSawyer%26aufirst%3DT.%26atitle%3DStructural%2520basis%2520of%2520Src%2520tyrosine%2520kinase%2520inhibition%2520with%2520a%2520new%2520class%2520of%2520potent%2520and%2520selective%2520trisubstituted%2520purine-based%2520compounds%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2006%26volume%3D67%26spage%3D46%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Mauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guba, W.</span><span> </span><span class="NLM_article-title">Recent developments in de novo design and scaffold hopping</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=18428090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXls1Wkuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=365-374&author=H.+Mauserauthor=W.+Guba&title=Recent+developments+in+de+novo+design+and+scaffold+hopping"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in de novo design and scaffold hopping</span></div><div class="casAuthors">Mauser, Harald; Guba, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">365-374</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  This review covers the developments in the fields of de novo ligand design and scaffold hopping since 2006.  De novo ligand design was introduced in 1991 as a purely structure-based method to suggest ligands for synthesis and was later augmented by ligand-based approaches.  Both structure-based and ligand-based methods identify pharmacophores, as well as shape constraints, and subsequently match these with complementary features embedded into small-mol. topologies.  Recently, significant attention has been paid to de novo ligand design in combination with biophys. fragment screening and x-ray structure elucidation.  Scaffold hopping has evolved from a niche application of de novo design into a rapidly expanding suite of different software tools, which are used extensively in the pharmaceutical industry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3SAbJ0iQ7W7Vg90H21EOLACvtfcHk0lgaNVv1iP9Zbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXls1Wkuro%253D&md5=d09183320c2739c1aef769f4d16b606e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DGuba%26aufirst%3DW.%26atitle%3DRecent%2520developments%2520in%2520de%2520novo%2520design%2520and%2520scaffold%2520hopping%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2008%26volume%3D11%26spage%3D365%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Azam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nardi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakespeare, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, C. A.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohacek, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaramoorthi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sliz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veach, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornmann, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarkson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalgarno, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daley, G. Q.</span><span> </span><span class="NLM_article-title">Activity of dual SRC-ABL inhibitors highlights the role of BCR/ABL kinase dynamics in drug resistance</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">9244</span><span class="NLM_x">–</span> <span class="NLM_lpage">9249</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=9244-9249&author=M.+Azamauthor=V.+Nardiauthor=W.+C.+Shakespeareauthor=C.+A.+Metcalfauthor=R.+S.+Bohacekauthor=Y.+Wangauthor=R.+Sundaramoorthiauthor=P.+Slizauthor=D.+R.+Veachauthor=W.+G.+Bornmannauthor=B.+Clarksonauthor=D.+C.+Dalgarnoauthor=T.+K.+Sawyerauthor=G.+Q.+Daley&title=Activity+of+dual+SRC-ABL+inhibitors+highlights+the+role+of+BCR%2FABL+kinase+dynamics+in+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAzam%26aufirst%3DM.%26aulast%3DNardi%26aufirst%3DV.%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26aulast%3DMetcalf%26aufirst%3DC.%2BA.%26aulast%3DBohacek%26aufirst%3DR.%2BS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSundaramoorthi%26aufirst%3DR.%26aulast%3DSliz%26aufirst%3DP.%26aulast%3DVeach%26aufirst%3DD.%2BR.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DClarkson%26aufirst%3DB.%26aulast%3DDalgarno%26aufirst%3DD.%2BC.%26aulast%3DSawyer%26aufirst%3DT.%2BK.%26aulast%3DDaley%26aufirst%3DG.%2BQ.%26atitle%3DActivity%2520of%2520dual%2520SRC-ABL%2520inhibitors%2520highlights%2520the%2520role%2520of%2520BCR%252FABL%2520kinase%2520dynamics%2520in%2520drug%2520resistance%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D9244%26epage%3D9249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Angell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angell, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bambourough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamford, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flack, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laine, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longstaff, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludbrook, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smee, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somers, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span> </span><span class="NLM_article-title">Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4433</span><span class="NLM_x">–</span> <span class="NLM_lpage">4437</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4433-4437&author=R.+M.+Angellauthor=T.+D.+Angellauthor=P.+Bambouroughauthor=M.+J.+Bamfordauthor=C.+Chungauthor=S.+G.+Cockerillauthor=S.+S.+Flackauthor=K.+L.+Jonesauthor=D.+I.+Laineauthor=T.+Longstaffauthor=S.+Ludbrookauthor=R.+Pearsonauthor=K.+J.+Smithauthor=P.+A.+Smeeauthor=D.+O.+Somersauthor=A.+L.+Walker&title=Biphenyl+amide+p38+kinase+inhibitors+4%3A+DFG-in+and+DFG-out+binding+modes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAngell%26aufirst%3DR.%2BM.%26aulast%3DAngell%26aufirst%3DT.%2BD.%26aulast%3DBambourough%26aufirst%3DP.%26aulast%3DBamford%26aufirst%3DM.%2BJ.%26aulast%3DChung%26aufirst%3DC.%26aulast%3DCockerill%26aufirst%3DS.%2BG.%26aulast%3DFlack%26aufirst%3DS.%2BS.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DLaine%26aufirst%3DD.%2BI.%26aulast%3DLongstaff%26aufirst%3DT.%26aulast%3DLudbrook%26aufirst%3DS.%26aulast%3DPearson%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DSmee%26aufirst%3DP.%2BA.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26atitle%3DBiphenyl%2520amide%2520p38%2520kinase%2520inhibitors%25204%253A%2520DFG-in%2520and%2520DFG-out%2520binding%2520modes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4433%26epage%3D4437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Deak, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMauro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodous, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span> </span><span class="NLM_article-title"><i>N</i>-(3-(Phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: structure, synthesis and SAR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1172</span><span class="NLM_x">–</span> <span class="NLM_lpage">1176</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1172-1176&author=H.+L.+Deakauthor=J.+R.+Newcombauthor=J.+J.+Nunesauthor=C.+Boucherauthor=A.+C.+Chengauthor=E.+F.+DiMauroauthor=L.+F.+Epsteinauthor=P.+Gallantauthor=B.+L.+Hodousauthor=X.+Huangauthor=J.+H.+Leeauthor=V.+F.+Patelauthor=S.+Schneiderauthor=S.+M.+Turciauthor=X.+Zhu&title=N-%283-%28Phenylcarbamoyl%29arylpyrimidine%29-5-carboxamides+as+potent+and+selective+inhibitors+of+Lck%3A+structure%2C+synthesis+and+SAR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeak%26aufirst%3DH.%2BL.%26aulast%3DNewcomb%26aufirst%3DJ.%2BR.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DEpstein%26aufirst%3DL.%2BF.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DHodous%26aufirst%3DB.%2BL.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DN-%25283-%2528Phenylcarbamoyl%2529arylpyrimidine%2529-5-carboxamides%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520Lck%253A%2520structure%252C%2520synthesis%2520and%2520SAR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1172%26epage%3D1176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Elling, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fucini, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanan, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barr, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulvannan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romanowski, M. J.</span><span> </span><span class="NLM_article-title">Structures of the wild-type and activated catalytic domains of <i>Brachydanio rerio</i> polo-like kinase 1 (Plk1): changes in the active-site conformation and interactions with ligands</span> <span class="citation_source-journal">Acta Crystallogr., Sect. F</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">686</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1107%2FS1744309108019623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=18678933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptlOqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=686-691&author=R.+A.+Ellingauthor=R.+V.+Fuciniauthor=E.+J.+Hananauthor=K.+J.+Barrauthor=J.+Zhuauthor=K.+Paulvannanauthor=W.+Yangauthor=M.+J.+Romanowski&title=Structures+of+the+wild-type+and+activated+catalytic+domains+of+Brachydanio+rerio+polo-like+kinase+1+%28Plk1%29%3A+changes+in+the+active-site+conformation+and+interactions+with+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the Brachydanio rerio Polo-like kinase 1 (Plk1) catalytic domain in complex with an extended inhibitor targeting the adaptive pocket of the enzyme</span></div><div class="casAuthors">Elling, Robert A.; Fucini, Raymond V.; Hanan, Emily J.; Barr, Kenneth J.; Zhu, Jiang; Paulvannan, Kumar; Yang, Wenjin; Romanowski, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section F: Structural Biology and Crystallization Communications</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">686-691, 686/1</span>CODEN:
                <span class="NLM_cas:coden">ACSFCL</span>;
        ISSN:<span class="NLM_cas:issn">1744-3091</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Polo-like kinase 1 (Plk1) is a member of the Polo-like kinase family of serine/threonine kinases involved in the regulation of cell-cycle progression and cytokinesis and is an attractive target for the development of anticancer therapeutics.  The catalytic domain of this enzyme shares significant primary amino-acid homol. and structural similarity with another mitotic kinase, Aurora A.  While screening an Aurora A library of ATP-competitive compds., a urea-contg. inhibitor with low affinity for mouse Aurora A but with submicromolar potency for human and zebrafish Plk1 (hPlk1 and zPlk1, resp.) was identified.  A crystal structure of the zebrafish Plk1 kinase domain-inhibitor complex reveals that the small mol. occupies the purine pocket and extends past the catalytic lysine into the adaptive region of the active site.  Anal. of the structures of this protein-inhibitor complex and of similar small mols. cocrystd. with other kinases facilitates understanding of the specificity of the inhibitor for Plk1 and documents for the first time that Plk1 can accommodate extended ATP-competitive compds. that project toward the adaptive pocket and help the enzyme order its activation segment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoNk4ABCR2TrVg90H21EOLACvtfcHk0lhiV06Vgn5O9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptlOqsrc%253D&md5=2e5a5d8c4bb288b0699b5397720cd35c</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS1744309108019623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1744309108019623%26sid%3Dliteratum%253Aachs%26aulast%3DElling%26aufirst%3DR.%2BA.%26aulast%3DFucini%26aufirst%3DR.%2BV.%26aulast%3DHanan%26aufirst%3DE.%2BJ.%26aulast%3DBarr%26aufirst%3DK.%2BJ.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DPaulvannan%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DRomanowski%26aufirst%3DM.%2BJ.%26atitle%3DStructures%2520of%2520the%2520wild-type%2520and%2520activated%2520catalytic%2520domains%2520of%2520Brachydanio%2520rerio%2520polo-like%2520kinase%25201%2520%2528Plk1%2529%253A%2520changes%2520in%2520the%2520active-site%2520conformation%2520and%2520interactions%2520with%2520ligands%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520F%26date%3D2008%26spage%3D686%26epage%3D691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Tong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claiborne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Credo, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, W. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwaltney, S. L.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judge, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N. H.</span><span> </span><span class="NLM_article-title">Discovery of 1,4-dihydroindeno[1,2-<i>c</i>]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2759</span><span class="NLM_x">–</span> <span class="NLM_lpage">2767</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1016%2Fj.bmc.2007.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=17287122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivVagt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=2759-2767&author=Y.+Tongauthor=A.+Claiborneauthor=K.+D.+Stewartauthor=C.+Parkauthor=P.+Kovarauthor=Z.+Chenauthor=R.+B.+Credoauthor=W.+Z.+Guauthor=S.+L.+Gwaltneyauthor=R.+A.+Judgeauthor=H.+Zhangauthor=S.+H.+Rosenbergauthor=H.+L.+Shamauthor=T.+J.+Sowinauthor=N.+H.+Lin&title=Discovery+of+1%2C4-dihydroindeno%5B1%2C2-c%5Dpyrazoles+as+a+novel+class+of+potent+and+selective+checkpoint+kinase+1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitors</span></div><div class="casAuthors">Tong, Yunsong; Claiborne, Akiyo; Stewart, Kent D.; Park, Chang; Kovar, Peter; Chen, Zehan; Credo, Robert B.; Gu, Wen-Zhen; Gwaltney, Stephen L.; Judge, Russell A.; Zhang, Haiying; Rosenberg, Saul H.; Sham, Hing L.; Sowin, Thomas J.; Lin, Nan-horng</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2759-2767</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A new class of checkpoint kinase 1 (CHK-1) inhibitors bearing a 1,4-dihydroindeno[1,2-c]pyrazole core was developed after initial hits from high throughput screening.  The efficient hit-to-lead process was facilitated by X-ray crystallog. and led to potent inhibitors (<10 nM) against CHK-1.  X-ray co-crystal structures of bound inhibitors demonstrated that two sub-series of this class of compds., exemplified by 21 and 41, exhibit distinctive hydrogen bonding patterns in the specificity pocket of the active site.  Two compds., 41 and 43, were capable of potentiating doxorubicin and camptothecin, both DNA-damaging agents, in cell proliferation assays (MTS and soft agar assays) and abrogating G2/M checkpoint in a mechanism-based FACS assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVp7DNSZaexbVg90H21EOLACvtfcHk0lipr9RCehE5SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivVagt7w%253D&md5=0966753ebf59128001db7601ca7d8cee</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DY.%26aulast%3DClaiborne%26aufirst%3DA.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DCredo%26aufirst%3DR.%2BB.%26aulast%3DGu%26aufirst%3DW.%2BZ.%26aulast%3DGwaltney%26aufirst%3DS.%2BL.%26aulast%3DJudge%26aufirst%3DR.%2BA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DSowin%26aufirst%3DT.%2BJ.%26aulast%3DLin%26aufirst%3DN.%2BH.%26atitle%3DDiscovery%2520of%25201%252C4-dihydroindeno%255B1%252C2-c%255Dpyrazoles%2520as%2520a%2520novel%2520class%2520of%2520potent%2520and%2520selective%2520checkpoint%2520kinase%25201%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D2759%26epage%3D2767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakespeare, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaramoorthi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keats, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wardwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snodgrass, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broudy, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalgarno, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clackson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, T. K.</span><span> </span><span class="NLM_article-title">Novel N9-arenethenyl purines as potent dual Src/Abl tyrosine kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4907</span><span class="NLM_x">–</span> <span class="NLM_lpage">4912</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4907-4912&author=Y.+Wangauthor=W.+C.+Shakespeareauthor=W.+S.+Huangauthor=R.+Sundaramoorthiauthor=S.+Lentiniauthor=S.+Dasauthor=S.+Liuauthor=G.+Bandaauthor=D.+Wenauthor=X.+Zhuauthor=Q.+Xuauthor=J.+Keatsauthor=F.+Wangauthor=S.+Wardwellauthor=Y.+Ningauthor=J.+T.+Snodgrassauthor=M.+I.+Broudyauthor=K.+Russianauthor=D.+Dalgarnoauthor=T.+Clacksonauthor=T.+K.+Sawyer&title=Novel+N9-arenethenyl+purines+as+potent+dual+Src%2FAbl+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26aulast%3DHuang%26aufirst%3DW.%2BS.%26aulast%3DSundaramoorthi%26aufirst%3DR.%26aulast%3DLentini%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DBanda%26aufirst%3DG.%26aulast%3DWen%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DKeats%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWardwell%26aufirst%3DS.%26aulast%3DNing%26aufirst%3DY.%26aulast%3DSnodgrass%26aufirst%3DJ.%2BT.%26aulast%3DBroudy%26aufirst%3DM.%2BI.%26aulast%3DRussian%26aufirst%3DK.%26aulast%3DDalgarno%26aufirst%3DD.%26aulast%3DClackson%26aufirst%3DT.%26aulast%3DSawyer%26aufirst%3DT.%2BK.%26atitle%3DNovel%2520N9-arenethenyl%2520purines%2520as%2520potent%2520dual%2520Src%252FAbl%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4907%26epage%3D4912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhamra, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bull, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopher, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hind, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranshaw, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skone, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickerstaff, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washington, M.</span><span> </span><span class="NLM_article-title"><i>N</i>-4-Pyrimidinyl-1<i>H</i>-indazol-4-amine inhibitors of Lck: indazoles as phenol isosteres with improved pharmacokinetics</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4363</span><span class="NLM_x">–</span> <span class="NLM_lpage">4368</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4363-4368&author=P.+Bamboroughauthor=R.+M.+Angellauthor=I.+Bhamraauthor=D.+Brownauthor=J.+Bullauthor=J.+A.+Christopherauthor=A.+W.+Cooperauthor=L.+H.+Fazalauthor=I.+Giordanoauthor=L.+Hindauthor=V.+K.+Patelauthor=L.+E.+Ranshawauthor=M.+J.+Simsauthor=P.+A.+Skoneauthor=K.+J.+Smithauthor=E.+Vickerstaffauthor=M.+Washington&title=N-4-Pyrimidinyl-1H-indazol-4-amine+inhibitors+of+Lck%3A+indazoles+as+phenol+isosteres+with+improved+pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DAngell%26aufirst%3DR.%2BM.%26aulast%3DBhamra%26aufirst%3DI.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBull%26aufirst%3DJ.%26aulast%3DChristopher%26aufirst%3DJ.%2BA.%26aulast%3DCooper%26aufirst%3DA.%2BW.%26aulast%3DFazal%26aufirst%3DL.%2BH.%26aulast%3DGiordano%26aufirst%3DI.%26aulast%3DHind%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DV.%2BK.%26aulast%3DRanshaw%26aufirst%3DL.%2BE.%26aulast%3DSims%26aufirst%3DM.%2BJ.%26aulast%3DSkone%26aufirst%3DP.%2BA.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DVickerstaff%26aufirst%3DE.%26aulast%3DWashington%26aufirst%3DM.%26atitle%3DN-4-Pyrimidinyl-1H-indazol-4-amine%2520inhibitors%2520of%2520Lck%253A%2520indazoles%2520as%2520phenol%2520isosteres%2520with%2520improved%2520pharmacokinetics%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4363%26epage%3D4368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Angell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angell, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longstaff, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smee, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somers, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, M.</span><span> </span><span class="NLM_article-title">Biphenyl amide p38 kinase inhibitors 2: optimisation and SAR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">324</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=324-328&author=R.+M.+Angellauthor=T.+D.+Angellauthor=P.+Bamboroughauthor=D.+Brownauthor=M.+Brownauthor=J.+B.+Bucktonauthor=S.+G.+Cockerillauthor=C.+D.+Edwardsauthor=K.+L.+Jonesauthor=T.+Longstaffauthor=P.+A.+Smeeauthor=K.+J.+Smithauthor=D.+O.+Somersauthor=A.+L.+Walkerauthor=M.+Willson&title=Biphenyl+amide+p38+kinase+inhibitors+2%3A+optimisation+and+SAR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAngell%26aufirst%3DR.%2BM.%26aulast%3DAngell%26aufirst%3DT.%2BD.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DBuckton%26aufirst%3DJ.%2BB.%26aulast%3DCockerill%26aufirst%3DS.%2BG.%26aulast%3DEdwards%26aufirst%3DC.%2BD.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DLongstaff%26aufirst%3DT.%26aulast%3DSmee%26aufirst%3DP.%2BA.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26aulast%3DWillson%26aufirst%3DM.%26atitle%3DBiphenyl%2520amide%2520p38%2520kinase%2520inhibitors%25202%253A%2520optimisation%2520and%2520SAR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D324%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Graham Robinett, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freemerman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skinner, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shewchuk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackey, K.</span><span> </span><span class="NLM_article-title">The discovery of substituted 4-(3-hydroxyanilino)-quinolines as potent RET kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5886</span><span class="NLM_x">–</span> <span class="NLM_lpage">5893</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5886-5893&author=R.+Graham+Robinettauthor=A.+J.+Freemermanauthor=M.+A.+Skinnerauthor=L.+Shewchukauthor=K.+Lackey&title=The+discovery+of+substituted+4-%283-hydroxyanilino%29-quinolines+as+potent+RET+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGraham%2BRobinett%26aufirst%3DR.%26aulast%3DFreemerman%26aufirst%3DA.%2BJ.%26aulast%3DSkinner%26aufirst%3DM.%2BA.%26aulast%3DShewchuk%26aufirst%3DL.%26aulast%3DLackey%26aufirst%3DK.%26atitle%3DThe%2520discovery%2520of%2520substituted%25204-%25283-hydroxyanilino%2529-quinolines%2520as%2520potent%2520RET%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5886%26epage%3D5893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Hynes, J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyckman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrobleski, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillooly, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanner, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonial, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pokross, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newitt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">Design, synthesis, and anti-inflammatory properties of orally active 4-(phenylamino)-pyrrolo[2,1-<i>f</i>][1,2,4]triazine p38alpha mitogen-activated protein kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7009414" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4-16&author=J.+Hynesauthor=A.+J.+Dyckmanauthor=S.+Linauthor=S.+T.+Wrobleskiauthor=H.+Wuauthor=K.+M.+Gilloolyauthor=S.+B.+Kannerauthor=H.+Lonialauthor=D.+Looauthor=K.+W.+McIntyreauthor=S.+Pittauthor=D.+R.+Shenauthor=D.+J.+Shusterauthor=X.+Yangauthor=R.+Zhangauthor=K.+Behniaauthor=H.+Zhangauthor=P.+H.+Maratheauthor=A.+M.+Doweykoauthor=J.+S.+Tokarskiauthor=J.+S.+Sackauthor=M.+Pokrossauthor=S.+E.+Kieferauthor=J.+A.+Newittauthor=J.+C.+Barrishauthor=J.+Doddauthor=G.+L.+Schievenauthor=K.+Leftheris&title=Design%2C+synthesis%2C+and+anti-inflammatory+properties+of+orally+active+4-%28phenylamino%29-pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazine+p38alpha+mitogen-activated+protein+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm7009414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009414%26sid%3Dliteratum%253Aachs%26aulast%3DHynes%26aufirst%3DJ.%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DWrobleski%26aufirst%3DS.%2BT.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DKanner%26aufirst%3DS.%2BB.%26aulast%3DLonial%26aufirst%3DH.%26aulast%3DLoo%26aufirst%3DD.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DBehnia%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMarathe%26aufirst%3DP.%2BH.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DPokross%26aufirst%3DM.%26aulast%3DKiefer%26aufirst%3DS.%2BE.%26aulast%3DNewitt%26aufirst%3DJ.%2BA.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DDodd%26aufirst%3DJ.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520anti-inflammatory%2520properties%2520of%2520orally%2520active%25204-%2528phenylamino%2529-pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazine%2520p38alpha%2520mitogen-activated%2520protein%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Deak, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMauro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodous, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span> </span><span class="NLM_article-title"><i>N</i>-(3-(Phenylcarbamoyl-arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: structure, synthesis and SAR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1172</span><span class="NLM_x">–</span> <span class="NLM_lpage">1176</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1172-1176&author=H.+L.+Deakauthor=J.+R.+Newcombauthor=J.+J.+Nunesauthor=C.+Boucherauthor=A.+C.+Chengauthor=E.+F.+DiMauroauthor=L.+F.+Epsteinauthor=P.+Gallantauthor=B.+L.+Hodousauthor=X.+Huangauthor=J.+H.+Leeauthor=V.+F.+Patelauthor=S.+Schneiderauthor=S.+M.+Turciauthor=X.+Zhu&title=N-%283-%28Phenylcarbamoyl-arylpyrimidine%29-5-carboxamides+as+potent+and+selective+inhibitors+of+Lck%3A+structure%2C+synthesis+and+SAR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeak%26aufirst%3DH.%2BL.%26aulast%3DNewcomb%26aufirst%3DJ.%2BR.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DEpstein%26aufirst%3DL.%2BF.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DHodous%26aufirst%3DB.%2BL.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DN-%25283-%2528Phenylcarbamoyl-arylpyrimidine%2529-5-carboxamides%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520Lck%253A%2520structure%252C%2520synthesis%2520and%2520SAR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1172%26epage%3D1176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Prien, O.; Schmees, N.; Eis, K.; Guenther, J.; Brohm, D.; Voehringer, V.; Li, V. M. J.; Beck, H.; Lobell, M.; Greschat, S.; Lang, D.</span><span> </span><span class="NLM_article-title">Novel Sulphoximide-Substituted Quinoline and Quinazoline Derivatives as Kinase Inhibitors</span>. PCT Int. Appl. WO 2009080200,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Bayer.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=O.+Prien&author=N.+Schmees&author=K.+Eis&author=J.+Guenther&author=D.+Brohm&author=V.+Voehringer&author=V.+M.+J.+Li&author=H.+Beck&author=M.+Lobell&author=S.+Greschat&author=D.+Lang&title=Novel+Sulphoximide-Substituted+Quinoline+and+Quinazoline+Derivatives+as+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPrien%26aufirst%3DO.%26atitle%3DNovel%2520Sulphoximide-Substituted%2520Quinoline%2520and%2520Quinazoline%2520Derivatives%2520as%2520Kinase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Hartung, I.; Bothe, U.; Kettschau, G.; Luecking, U.; Mengel, A.; Krueger, M.; Thierauch, K. H.; Lienau, P; Boemer, U.</span><span> </span><span class="NLM_article-title">Alkynylpyrimidines as Tie2 Kinase Inhibitors</span>. PCT Int. Appl. WO 2008155140,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Bayer.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=I.+Hartung&author=U.+Bothe&author=G.+Kettschau&author=U.+Luecking&author=A.+Mengel&author=M.+Krueger&author=K.+H.+Thierauch&author=P+Lienau&author=U.+Boemer&title=Alkynylpyrimidines+as+Tie2+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHartung%26aufirst%3DI.%26atitle%3DAlkynylpyrimidines%2520as%2520Tie2%2520Kinase%2520Inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span> <span class="citation_source-book">Abstracts of Papers</span>, 237th National Meeting of the American Chemical Society, Salt Lake City, UT, March 22−26,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span><span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>; MEDI 15.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Abstracts+of+Papers%2C+237th+National+Meeting+of+the+American+Chemical+Society%2C+Salt+Lake+City%2C+UT%2C+March+22%E2%88%9226%2C+2009%3B+American+Chemical+Society%3A+Washington%2C+DC%3B+MEDI+15."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DAbstracts%2520of%2520Papers%26date%3D2009%26pub%3DAmerican%2520Chemical%2520Society" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Tiansheng, W.; Ledeboer, M. W.; Duffy, J. P.; Pierce, A. C.; Zuccola, H. J.; Block, E.; Shlyakter, D.; Hogan, J. K.; Bennani, Y. L.</span><span> </span><span class="NLM_article-title">A novel chemotype of kinase inhibitors: discovery of 3,4-ring fused 7-azaindole and deazapurines as potent Jak2 inhibitors</span>.  <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span>, in press.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Tiansheng%2C+W.%3B+Ledeboer%2C+M.+W.%3B+Duffy%2C+J.+P.%3B+Pierce%2C+A.+C.%3B+Zuccola%2C+H.+J.%3B+Block%2C+E.%3B+Shlyakter%2C+D.%3B+Hogan%2C+J.+K.%3B+Bennani%2C+Y.+L.+A+novel+chemotype+of+kinase+inhibitors%3A+discovery+of+3%2C4-ring+fused+7-azaindole+and+deazapurines+as+potent+Jak2+inhibitors.+Bioorg.+Med.+Chem.+Lett.%2C+in+press."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTiansheng%26aufirst%3DW.%26atitle%3DA%2520novel%2520chemotype%2520of%2520kinase%2520inhibitors%253A%2520discovery%2520of%25203%252C4-ring%2520fused%25207-azaindole%2520and%2520deazapurines%2520as%2520potent%2520Jak2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Di Grandi, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopper, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunnick, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamantidis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zapf, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wojciechowicz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frommer, E.</span><span> </span><span class="NLM_article-title">Novel pyrazolopyrimidines as highly potent B-Raf inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6957</span><span class="NLM_x">–</span> <span class="NLM_lpage">6961</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6957-6961&author=M.+J.+Di+Grandiauthor=D.+M.+Bergerauthor=D.+W.+Hopperauthor=C.+Zhangauthor=M.+Dutiaauthor=A.+L.+Dunnickauthor=N.+Torresauthor=J.+I.+Levinauthor=G.+Diamantidisauthor=C.+W.+Zapfauthor=J.+D.+Bloomauthor=Y.+Huauthor=D.+Powellauthor=D.+Wojciechowiczauthor=K.+Collinsauthor=E.+Frommer&title=Novel+pyrazolopyrimidines+as+highly+potent+B-Raf+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BGrandi%26aufirst%3DM.%2BJ.%26aulast%3DBerger%26aufirst%3DD.%2BM.%26aulast%3DHopper%26aufirst%3DD.%2BW.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DDutia%26aufirst%3DM.%26aulast%3DDunnick%26aufirst%3DA.%2BL.%26aulast%3DTorres%26aufirst%3DN.%26aulast%3DLevin%26aufirst%3DJ.%2BI.%26aulast%3DDiamantidis%26aufirst%3DG.%26aulast%3DZapf%26aufirst%3DC.%2BW.%26aulast%3DBloom%26aufirst%3DJ.%2BD.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DPowell%26aufirst%3DD.%26aulast%3DWojciechowicz%26aufirst%3DD.%26aulast%3DCollins%26aufirst%3DK.%26aulast%3DFrommer%26aufirst%3DE.%26atitle%3DNovel%2520pyrazolopyrimidines%2520as%2520highly%2520potent%2520B-Raf%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6957%26epage%3D6961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Lafleur, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caflisch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevado, C.</span><span> </span><span class="NLM_article-title">Structure-based optimization of potent and selective inhibitors of the tyrosine kinase erythropoietin producing human hepatocellular carcinoma receptor B4 (EphB4)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6433</span><span class="NLM_x">–</span> <span class="NLM_lpage">6446</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9009444" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6433-6446&author=K.+Lafleurauthor=D.+Huangauthor=T.+Zhouauthor=A.+Caflischauthor=C.+Nevado&title=Structure-based+optimization+of+potent+and+selective+inhibitors+of+the+tyrosine+kinase+erythropoietin+producing+human+hepatocellular+carcinoma+receptor+B4+%28EphB4%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm9009444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9009444%26sid%3Dliteratum%253Aachs%26aulast%3DLafleur%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DCaflisch%26aufirst%3DA.%26aulast%3DNevado%26aufirst%3DC.%26atitle%3DStructure-based%2520optimization%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520the%2520tyrosine%2520kinase%2520erythropoietin%2520producing%2520human%2520hepatocellular%2520carcinoma%2520receptor%2520B4%2520%2528EphB4%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6433%26epage%3D6446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Vulpetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosotti, R.</span><span> </span><span class="NLM_article-title">Sequence and structural analysis of kinase ATP pocket residues</span> <span class="citation_source-journal">Farmaco</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">765</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1016%2Fj.farmac.2004.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=15474052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotlWms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2004&pages=759-765&author=A.+Vulpettiauthor=R.+Bosotti&title=Sequence+and+structural+analysis+of+kinase+ATP+pocket+residues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Sequence and structural analysis of kinase ATP pocket residues</span></div><div class="casAuthors">Vulpetti, Anna; Bosotti, Roberta</div><div class="citationInfo"><span class="NLM_cas:title">Farmaco</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">759-765</span>CODEN:
                <span class="NLM_cas:coden">FRMCE8</span>;
        ISSN:<span class="NLM_cas:issn">0014-827X</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">Protein kinases represent one of the largest known families of enzymes.  Most kinases bind ATP and most synthetic kinase inhibitors are ATP-competitive, which makes selectivity a potential problem.  However, despite the high sequence similarity in the ATP binding pocket, several groups including ours have been able to develop highly potent and selective ATP-competitive inhibitors.  To systematically aid the design of specific inhibitors in our protein kinase projects, we aligned all known three-dimensional structures and all known sequences of human protein kinases.  We identified a set of 38 residues that make up the ATP pocket and analyzed the variability among these residues.  The most variable residues in the ATP pocket are targeted to design specificity into inhibitors in our various kinase projects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKrQCe0MaGh7Vg90H21EOLACvtfcHk0lh8yRkYVza6gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotlWms7o%253D&md5=d710962f752fcd893880696e34bf35a1</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.farmac.2004.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.farmac.2004.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DBosotti%26aufirst%3DR.%26atitle%3DSequence%2520and%2520structural%2520analysis%2520of%2520kinase%2520ATP%2520pocket%2520residues%26jtitle%3DFarmaco%26date%3D2004%26volume%3D59%26spage%3D759%26epage%3D765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="note"><p class="first last">Residues were classified as small, medium, or large on the basis of their side chain number of atoms: (small) up to three atoms; (medium) four or five atoms; (large) more than five atoms.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Scapin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisnock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoGrasso, P. V.</span><span> </span><span class="NLM_article-title">The structure of JNK3 in complex with small molecule inhibitors. Structural basis for potency and selectivity</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">712</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1016%2FS1074-5521%2803%2900159-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=12954329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFSisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=705-712&issue=8&author=G.+Scapinauthor=S.+B.+Patelauthor=J.+Lisnockauthor=J.+W.+Beckerauthor=P.+V.+LoGrasso&title=The+structure+of+JNK3+in+complex+with+small+molecule+inhibitors.+Structural+basis+for+potency+and+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The Structure of JNK3 in Complex with Small Molecule Inhibitors. Structural Basis for Potency and Selectivity</span></div><div class="casAuthors">Scapin, Giovanna; Patel, Sangita B.; Lisnock, JeanMarie; Becker, Joseph W.; LoGrasso, Philip V.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">705-712</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The c-Jun terminal kinases (JNKs) are members of the mitogen-activated protein (MAP) kinase family and regulate signal transduction in response to environmental stress.  Activation of JNK3, a neuronal-specific isoform, has been assocd. with neurol. damage, and as such, JNK3 may represent an attractive target for the treatment of neurol. disorders.  The MAP kinases share between 50% and 80% sequence identity.  In order to obtain efficacious and safe compds., it is necessary to address the issues of potency and selectivity.  We report here four crystal structures of JNK3 in complex with three different classes of inhibitors.  These structures provide a clear picture of the interactions that each class of compd. made with the kinase.  Knowledge of the at. interactions involved in these diverse binding modes provides a platform for structure-guided modification of these compds., or the de novo design of novel inhibitors that could satisfy the need for potency and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG3bvVv5ERO7Vg90H21EOLACvtfcHk0linz-q9MydXkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFSisb0%253D&md5=354f2b571d3afc70e29faf67af1fac93</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2803%2900159-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252803%252900159-5%26sid%3Dliteratum%253Aachs%26aulast%3DScapin%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DLisnock%26aufirst%3DJ.%26aulast%3DBecker%26aufirst%3DJ.%2BW.%26aulast%3DLoGrasso%26aufirst%3DP.%2BV.%26atitle%3DThe%2520structure%2520of%2520JNK3%2520in%2520complex%2520with%2520small%2520molecule%2520inhibitors.%2520Structural%2520basis%2520for%2520potency%2520and%2520selectivity%26jtitle%3DChem.%2520Biol.%26date%3D2003%26volume%3D10%26issue%3D8%26spage%3D705%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Peifer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abadleh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischof, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schattel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knippschild, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, S.</span><span> </span><span class="NLM_article-title">3,4-Diaryl-isoxazoles and -imidazoles as potent dual inhibitors of p38.alpha. mitogen activated protein kinase and casein kinase 1δ</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7618</span><span class="NLM_x">–</span> <span class="NLM_lpage">7630</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9005127" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7618-7630&author=C.+Peiferauthor=M.+Abadlehauthor=J.+Bischofauthor=D.+Hauserauthor=V.+Schattelauthor=H.+Hirnerauthor=U.+Knippschildauthor=S.+Laufer&title=3%2C4-Diaryl-isoxazoles+and+-imidazoles+as+potent+dual+inhibitors+of+p38.alpha.+mitogen+activated+protein+kinase+and+casein+kinase+1%CE%B4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm9005127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9005127%26sid%3Dliteratum%253Aachs%26aulast%3DPeifer%26aufirst%3DC.%26aulast%3DAbadleh%26aufirst%3DM.%26aulast%3DBischof%26aufirst%3DJ.%26aulast%3DHauser%26aufirst%3DD.%26aulast%3DSchattel%26aufirst%3DV.%26aulast%3DHirner%26aufirst%3DH.%26aulast%3DKnippschild%26aufirst%3DU.%26aulast%3DLaufer%26aufirst%3DS.%26atitle%3D3%252C4-Diaryl-isoxazoles%2520and%2520-imidazoles%2520as%2520potent%2520dual%2520inhibitors%2520of%2520p38.alpha.%2520mitogen%2520activated%2520protein%2520kinase%2520and%2520casein%2520kinase%25201%25CE%25B4%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7618%26epage%3D7630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':[],'ref61':['cit61'],'ref62':['cit62']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 322 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Enrico Speri, Yuanyuan Qian, Jeshina Janardhanan, Cesar Masitas, Elena Lastochkin, Stefania De Benedetti, Man Wang, Valerie A. Schroeder, William R. Wolter, Allen G. Oliver, Jed F. Fisher, Shahriar Mobashery, <span class="NLM_string-name hlFld-ContribAuthor">Mayland Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–Activity Relationship for the Picolinamide Antibacterials that Selectively Target Clostridioides difficile. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (6)
                                     , 991-995. <a href="https://doi.org/10.1021/acsmedchemlett.1c00135" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.1c00135</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.1c00135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.1c00135%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%2525E2%252580%252593Activity%252BRelationship%252Bfor%252Bthe%252BPicolinamide%252BAntibacterials%252Bthat%252BSelectively%252BTarget%252BClostridioides%252Bdifficile%26aulast%3DSperi%26aufirst%3DEnrico%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D05032021%26date%3D03052021%26date%3D07052021%26volume%3D12%26issue%3D6%26spage%3D991%26epage%3D995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Richard A. Ward, Stephen Fawell, Nicolas Floc’h, Vikki Flemington, Darren McKerrecher, <span class="NLM_string-name hlFld-ContribAuthor">Paul D. Smith</span>. </span><span class="cited-content_cbyCitation_article-title">Challenges and Opportunities in Cancer Drug Resistance. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2021,</strong> <em>121 </em>
                                    (6)
                                     , 3297-3351. <a href="https://doi.org/10.1021/acs.chemrev.0c00383" title="DOI URL">https://doi.org/10.1021/acs.chemrev.0c00383</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.0c00383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.0c00383%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DChallenges%252Band%252BOpportunities%252Bin%252BCancer%252BDrug%252BResistance%26aulast%3DWard%26aufirst%3DRichard%2BA.%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D29042020%26date%3D21072020%26volume%3D121%26issue%3D6%26spage%3D3297%26epage%3D3351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lauren B. Arendse, Susan Wyllie, Kelly Chibale, <span class="NLM_string-name hlFld-ContribAuthor">Ian H. Gilbert</span>. </span><span class="cited-content_cbyCitation_article-title">Plasmodium Kinases as Potential Drug Targets for Malaria: Challenges and Opportunities. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2021,</strong> <em>7 </em>
                                    (3)
                                     , 518-534. <a href="https://doi.org/10.1021/acsinfecdis.0c00724" title="DOI URL">https://doi.org/10.1021/acsinfecdis.0c00724</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.0c00724&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.0c00724%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DPlasmodium%252BKinases%252Bas%252BPotential%252BDrug%252BTargets%252Bfor%252BMalaria%25253A%252BChallenges%252Band%252BOpportunities%26aulast%3DArendse%26aufirst%3DLauren%2BB.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D15102020%26date%3D16022021%26volume%3D7%26issue%3D3%26spage%3D518%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Elsie C. Yu, Joey L. Methot, Xavier Fradera, Charles A. Lesburg, Brian M. Lacey, Phieng Siliphaivanh, Ping Liu, Dustin M. Smith, Zangwei Xu, Jennifer A. Piesvaux, Shuhei Kawamura, Haiyan Xu, J. Richard Miller, Mark Bittinger, <span class="NLM_string-name hlFld-ContribAuthor">Alexander Pasternak</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Potent Reverse Indazole Inhibitors for HPK1. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (3)
                                     , 459-466. <a href="https://doi.org/10.1021/acsmedchemlett.0c00672" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00672</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00672%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252BPotent%252BReverse%252BIndazole%252BInhibitors%252Bfor%252BHPK1%26aulast%3DYu%26aufirst%3DElsie%2BC.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D21122020%26date%3D23022021%26date%3D01032021%26volume%3D12%26issue%3D3%26spage%3D459%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Martin Schröder, Alex N. Bullock, Oleg Fedorov, Franz Bracher, Apirat Chaikuad, <span class="NLM_string-name hlFld-ContribAuthor">Stefan Knapp</span>. </span><span class="cited-content_cbyCitation_article-title">DFG-1 Residue Controls Inhibitor Binding Mode and Affinity, Providing a Basis for Rational Design of Kinase Inhibitor Selectivity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (18)
                                     , 10224-10234. <a href="https://doi.org/10.1021/acs.jmedchem.0c00898" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00898</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00898&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00898%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDFG-1%252BResidue%252BControls%252BInhibitor%252BBinding%252BMode%252Band%252BAffinity%25252C%252BProviding%252Ba%252BBasis%252Bfor%252BRational%252BDesign%252Bof%252BKinase%252BInhibitor%252BSelectivity%26aulast%3DSchr%25C3%25B6der%26aufirst%3DMartin%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D27052020%26date%3D27082020%26date%3D12082020%26volume%3D63%26issue%3D18%26spage%3D10224%26epage%3D10234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Erik B. Faber, <span class="NLM_string-name hlFld-ContribAuthor">Gunda I. Georg</span>. </span><span class="cited-content_cbyCitation_article-title">DFG-1 Binding: A New Residue for Developing Selective Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (18)
                                     , 10221-10223. <a href="https://doi.org/10.1021/acs.jmedchem.0c01501" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01501</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01501%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDFG-1%252BBinding%25253A%252BA%252BNew%252BResidue%252Bfor%252BDeveloping%252BSelective%252BKinase%252BInhibitors%26aulast%3DFaber%26aufirst%3DErik%2BB.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D27082020%26date%3D11092020%26volume%3D63%26issue%3D18%26spage%3D10221%26epage%3D10223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Luca Pinzi, <span class="NLM_string-name hlFld-ContribAuthor">Giulio Rastelli</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Target Associations for Polypharmacology from Analysis of Crystallographic Ligands of the Protein Data Bank. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (1)
                                     , 372-390. <a href="https://doi.org/10.1021/acs.jcim.9b00821" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b00821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b00821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b00821%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DIdentification%252Bof%252BTarget%252BAssociations%252Bfor%252BPolypharmacology%252Bfrom%252BAnalysis%252Bof%252BCrystallographic%252BLigands%252Bof%252Bthe%252BProtein%252BData%252BBank%26aulast%3DPinzi%26aufirst%3DLuca%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D20092019%26date%3D19122019%26date%3D04122019%26volume%3D60%26issue%3D1%26spage%3D372%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rama K. Mishra, Kristine K. Deibler, Matthew R. Clutter, Purav P. Vagadia, Matthew O’Connor, Gary E. Schiltz, Raymond Bergan, <span class="NLM_string-name hlFld-ContribAuthor">Karl A. Scheidt</span>. </span><span class="cited-content_cbyCitation_article-title">Modeling MEK4 Kinase Inhibitors through Perturbed Electrostatic Potential Charges. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (10)
                                     , 4460-4466. <a href="https://doi.org/10.1021/acs.jcim.9b00490" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b00490</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b00490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b00490%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DModeling%252BMEK4%252BKinase%252BInhibitors%252Bthrough%252BPerturbed%252BElectrostatic%252BPotential%252BCharges%26aulast%3DMishra%26aufirst%3DRama%2BK.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D12062019%26date%3D14102019%26date%3D30092019%26volume%3D59%26issue%3D10%26spage%3D4460%26epage%3D4466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jianwen A. Feng, Patrick Lee, Moulay Hicham Alaoui, Kathy Barrett, Georgette Castanedo, Robert Godemann, Paul McEwan, Xiaolu Wang, Ping Wu, Yamin Zhang, Seth F. Harris, <span class="NLM_string-name hlFld-ContribAuthor">Steven T. Staben</span>. </span><span class="cited-content_cbyCitation_article-title">Structure Based Design of Potent Selective Inhibitors of Protein Kinase D1 (PKD1). </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (9)
                                     , 1260-1265. <a href="https://doi.org/10.1021/acsmedchemlett.8b00658" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00658</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00658%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%252BBased%252BDesign%252Bof%252BPotent%252BSelective%252BInhibitors%252Bof%252BProtein%252BKinase%252BD1%252B%252528PKD1%252529%26aulast%3DFeng%26aufirst%3DJianwen%2BA.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D31122018%26date%3D24072019%26date%3D12082019%26date%3D24072019%26volume%3D10%26issue%3D9%26spage%3D1260%26epage%3D1265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kelly
L. Damm-Ganamet, Nidhi Arora, Stephane Becart, James P. Edwards, Alec D. Lebsack, Heather M. McAllister, Marina I. Nelen, Navin L. Rao, Lori Westover, John J. M. Wiener, <span class="NLM_string-name hlFld-ContribAuthor">Taraneh Mirzadegan</span>. </span><span class="cited-content_cbyCitation_article-title">Accelerating Lead Identification by High Throughput Virtual Screening: Prospective Case Studies from the Pharmaceutical Industry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (5)
                                     , 2046-2062. <a href="https://doi.org/10.1021/acs.jcim.8b00941" title="DOI URL">https://doi.org/10.1021/acs.jcim.8b00941</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.8b00941&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.8b00941%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DAccelerating%252BLead%252BIdentification%252Bby%252BHigh%252BThroughput%252BVirtual%252BScreening%25253A%252BProspective%252BCase%252BStudies%252Bfrom%252Bthe%252BPharmaceutical%252BIndustry%26aulast%3DDamm-Ganamet%26aufirst%3DKelly%2BL.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D20122018%26date%3D13032019%26date%3D28022019%26volume%3D59%26issue%3D5%26spage%3D2046%26epage%3D2062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Avisek Bhattacharya, Anindita Paul, Dipanjan Chakrabarti, <span class="NLM_string-name hlFld-ContribAuthor">Maitrayee DasGupta</span>. </span><span class="cited-content_cbyCitation_article-title">Gatekeeper–Activation Loop Cross-Talk Determines Distinct Autoactivation States of Symbiosis Receptor Kinase. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2019,</strong> <em>58 </em>
                                    (19)
                                     , 2419-2431. <a href="https://doi.org/10.1021/acs.biochem.9b00071" title="DOI URL">https://doi.org/10.1021/acs.biochem.9b00071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.9b00071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.9b00071%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DGatekeeper%2525E2%252580%252593Activation%252BLoop%252BCross-Talk%252BDetermines%252BDistinct%252BAutoactivation%252BStates%252Bof%252BSymbiosis%252BReceptor%252BKinase%26aulast%3DBhattacharya%26aufirst%3DAvisek%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D24012019%26date%3D14042019%26date%3D02052019%26date%3D25042019%26volume%3D58%26issue%3D19%26spage%3D2419%26epage%3D2431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mikhail O. Konev, T. Andrew McTeague, <span class="NLM_string-name hlFld-ContribAuthor">Jeffrey W. Johannes</span>. </span><span class="cited-content_cbyCitation_article-title">Nickel-Catalyzed Photoredox-Mediated Cross-Coupling of Aryl Electrophiles and Aryl Azides. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2018,</strong> <em>8 </em>
                                    (10)
                                     , 9120-9124. <a href="https://doi.org/10.1021/acscatal.8b02954" title="DOI URL">https://doi.org/10.1021/acscatal.8b02954</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.8b02954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.8b02954%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DNickel-Catalyzed%252BPhotoredox-Mediated%252BCross-Coupling%252Bof%252BAryl%252BElectrophiles%252Band%252BAryl%252BAzides%26aulast%3DKonev%26aufirst%3DMikhail%2BO.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D26072018%26date%3D28082018%26date%3D04092018%26date%3D30082018%26volume%3D8%26issue%3D10%26spage%3D9120%26epage%3D9124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Diego
González Cabrera, André Horatscheck, Colin R. Wilson, Greg Basarab, Charles J. Eyermann, <span class="NLM_string-name hlFld-ContribAuthor">Kelly Chibale</span>. </span><span class="cited-content_cbyCitation_article-title">Plasmodial Kinase Inhibitors: License to Cure?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (18)
                                     , 8061-8077. <a href="https://doi.org/10.1021/acs.jmedchem.8b00329" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00329</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00329%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPlasmodial%252BKinase%252BInhibitors%25253A%252BLicense%252Bto%252BCure%25253F%26aulast%3DCabrera%26aufirst%3DDiego%2BGonz%25C3%25A1lez%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D28022018%26date%3D04062018%26date%3D17052018%26volume%3D61%26issue%3D18%26spage%3D8061%26epage%3D8077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nicole Blaquiere, Georgette M. Castanedo, Jason D. Burch, Leonid M. Berezhkovskiy, Hans Brightbill, Suzanne Brown, Connie Chan, Po-Chang Chiang, James J. Crawford, Teresa Dong, Peter Fan, Jianwen Feng, Nico Ghilardi, Robert Godemann, Emily Gogol, Alice Grabbe, Alison J. Hole, Baihua Hu, Sarah G. Hymowitz, Moulay Hicham Alaoui Ismaili, Hoa Le, Patrick Lee, Wyne Lee, Xingyu Lin, Ning Liu, Paul A. McEwan, Brent McKenzie, Hernani L. Silvestre, Eric Suto, Swathi Sujatha-Bhaskar, Guosheng Wu, Lawren C. Wu, Yamin Zhang, Zoe Zhong, <span class="NLM_string-name hlFld-ContribAuthor">Steven T. Staben</span>. </span><span class="cited-content_cbyCitation_article-title">Scaffold-Hopping Approach To Discover Potent, Selective, and Efficacious Inhibitors of NF-κB Inducing Kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (15)
                                     , 6801-6813. <a href="https://doi.org/10.1021/acs.jmedchem.8b00678" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00678</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00678%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DScaffold-Hopping%252BApproach%252BTo%252BDiscover%252BPotent%25252C%252BSelective%25252C%252Band%252BEfficacious%252BInhibitors%252Bof%252BNF-%2525CE%2525BAB%252BInducing%252BKinase%26aulast%3DBlaquiere%26aufirst%3DNicole%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D29042018%26date%3D24072018%26date%3D25062018%26volume%3D61%26issue%3D15%26spage%3D6801%26epage%3D6813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Noé Sturm, Annachiara Tinivella, <span class="NLM_string-name hlFld-ContribAuthor">Giulio Rastelli</span>. </span><span class="cited-content_cbyCitation_article-title">Exploration and Comparison of the Geometrical and Physicochemical Properties of an αC Allosteric Pocket in the Structural Kinome. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2018,</strong> <em>58 </em>
                                    (5)
                                     , 1094-1103. <a href="https://doi.org/10.1021/acs.jcim.7b00735" title="DOI URL">https://doi.org/10.1021/acs.jcim.7b00735</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.7b00735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.7b00735%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DExploration%252Band%252BComparison%252Bof%252Bthe%252BGeometrical%252Band%252BPhysicochemical%252BProperties%252Bof%252Ban%252B%2525CE%2525B1C%252BAllosteric%252BPocket%252Bin%252Bthe%252BStructural%252BKinome%26aulast%3DSturm%26aufirst%3DNo%25C3%25A9%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D22122017%26date%3D04052018%26date%3D26042018%26volume%3D58%26issue%3D5%26spage%3D1094%26epage%3D1103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jean-Philippe Métivier, Bertrand Cuissart, Ronan Bureau, <span class="NLM_string-name hlFld-ContribAuthor">Alban Lepailleur</span>. </span><span class="cited-content_cbyCitation_article-title">The Pharmacophore Network: A Computational Method for Exploring Structure–Activity Relationships from a Large Chemical Data Set. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (8)
                                     , 3551-3564. <a href="https://doi.org/10.1021/acs.jmedchem.7b01890" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01890</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01890%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BPharmacophore%252BNetwork%25253A%252BA%252BComputational%252BMethod%252Bfor%252BExploring%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Bfrom%252Ba%252BLarge%252BChemical%252BData%252BSet%26aulast%3DM%25C3%25A9tivier%26aufirst%3DJean-Philippe%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D21122017%26date%3D18042018%26date%3D12042018%26volume%3D61%26issue%3D8%26spage%3D3551%26epage%3D3564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peichen  Pan</span>, <span class="hlFld-ContribAuthor ">Huidong  Yu</span>, <span class="hlFld-ContribAuthor ">Qinglan  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaotian  Kong</span>, <span class="hlFld-ContribAuthor ">Hu  Chen</span>, <span class="hlFld-ContribAuthor ">Jiean  Chen</span>, <span class="hlFld-ContribAuthor ">Qi  Liu</span>, <span class="hlFld-ContribAuthor ">Dan  Li</span>, <span class="hlFld-ContribAuthor ">Yu  Kang</span>, <span class="hlFld-ContribAuthor ">Huiyong  Sun</span>, <span class="hlFld-ContribAuthor ">Wenfang  Zhou</span>, <span class="hlFld-ContribAuthor ">Sheng  Tian</span>, <span class="hlFld-ContribAuthor ">Sunliang  Cui</span>, <span class="hlFld-ContribAuthor ">Feng  Zhu</span>, <span class="hlFld-ContribAuthor ">Youyong  Li</span>, <span class="hlFld-ContribAuthor ">Yong  Huang</span>, and <span class="hlFld-ContribAuthor ">Tingjun  Hou</span>  . </span><span class="cited-content_cbyCitation_article-title">Combating Drug-Resistant Mutants of Anaplastic Lymphoma Kinase with Potent and Selective Type-I1/2 Inhibitors by Stabilizing Unique DFG-Shifted Loop Conformation. </span><span class="cited-content_cbyCitation_journal-name">ACS Central Science</span><span> <strong>2017,</strong> <em>3 </em>
                                    (11)
                                     , 1208-1220. <a href="https://doi.org/10.1021/acscentsci.7b00419" title="DOI URL">https://doi.org/10.1021/acscentsci.7b00419</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscentsci.7b00419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscentsci.7b00419%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Central%2520Science%26atitle%3DCombating%252BDrug-Resistant%252BMutants%252Bof%252BAnaplastic%252BLymphoma%252BKinase%252Bwith%252BPotent%252Band%252BSelective%252BType-I1%25252F2%252BInhibitors%252Bby%252BStabilizing%252BUnique%252BDFG-Shifted%252BLoop%252BConformation%26aulast%3DPan%26aufirst%3DPeichen%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D09092017%26date%3D03112017%26date%3D22112017%26volume%3D3%26issue%3D11%26spage%3D1208%26epage%3D1220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanli  Wang</span>, <span class="hlFld-ContribAuthor ">Yuze  Sun</span>, <span class="hlFld-ContribAuthor ">Ran  Cao</span>, <span class="hlFld-ContribAuthor ">Dan  Liu</span>, <span class="hlFld-ContribAuthor ">Yuting  Xie</span>, <span class="hlFld-ContribAuthor ">Li  Li</span>, <span class="hlFld-ContribAuthor ">Xiangbing  Qi</span>, and <span class="hlFld-ContribAuthor ">Niu  Huang</span>  . </span><span class="cited-content_cbyCitation_article-title">In Silico Identification of a Novel Hinge-Binding Scaffold for Kinase Inhibitor Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (20)
                                     , 8552-8564. <a href="https://doi.org/10.1021/acs.jmedchem.7b01075" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01075%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIn%252BSilico%252BIdentification%252Bof%252Ba%252BNovel%252BHinge-Binding%252BScaffold%252Bfor%252BKinase%252BInhibitor%252BDiscovery%26aulast%3DWang%26aufirst%3DYanli%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D28072017%26date%3D16102017%26date%3D26102017%26date%3D25092017%26volume%3D60%26issue%3D20%26spage%3D8552%26epage%3D8564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Niklas M.  Walter</span>, <span class="hlFld-ContribAuthor ">Heike K.  Wentsch</span>, <span class="hlFld-ContribAuthor ">Mike  Bührmann</span>, <span class="hlFld-ContribAuthor ">Silke M.  Bauer</span>, <span class="hlFld-ContribAuthor ">Eva  Döring</span>, <span class="hlFld-ContribAuthor ">Svenja  Mayer-Wrangowski</span>, <span class="hlFld-ContribAuthor ">Adrian  Sievers-Engler</span>, <span class="hlFld-ContribAuthor ">Nicole  Willemsen-Seegers</span>, <span class="hlFld-ContribAuthor ">Guido  Zaman</span>, <span class="hlFld-ContribAuthor ">Rogier  Buijsman</span>, <span class="hlFld-ContribAuthor ">Michael  Lämmerhofer</span>, <span class="hlFld-ContribAuthor ">Daniel  Rauh</span>, and <span class="hlFld-ContribAuthor ">Stefan A.  Laufer</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Novel Type I1/2 p38α MAP Kinase Inhibitors with Excellent Selectivity, High Potency, and Prolonged Target Residence Time by Interfering with the R-Spine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (19)
                                     , 8027-8054. <a href="https://doi.org/10.1021/acs.jmedchem.7b00745" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00745</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00745%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252BType%252BI1%25252F2%252Bp38%2525CE%2525B1%252BMAP%252BKinase%252BInhibitors%252Bwith%252BExcellent%252BSelectivity%25252C%252BHigh%252BPotency%25252C%252Band%252BProlonged%252BTarget%252BResidence%252BTime%252Bby%252BInterfering%252Bwith%252Bthe%252BR-Spine%26aulast%3DWalter%26aufirst%3DNiklas%2BM.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D19052017%26date%3D07092017%26date%3D12102017%26date%3D23082017%26volume%3D60%26issue%3D19%26spage%3D8027%26epage%3D8054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zoë A.  Henley</span>, <span class="hlFld-ContribAuthor ">Benjamin D.  Bax</span>, <span class="hlFld-ContribAuthor ">Laura M.  Inglesby</span>, <span class="hlFld-ContribAuthor ">Aurélie  Champigny</span>, <span class="hlFld-ContribAuthor ">Simon  Gaines</span>, <span class="hlFld-ContribAuthor ">Paul  Faulder</span>, <span class="hlFld-ContribAuthor ">Joelle  Le</span>, <span class="hlFld-ContribAuthor ">Daniel A.  Thomas</span>, <span class="hlFld-ContribAuthor ">Yoshiaki  Washio</span>, and <span class="hlFld-ContribAuthor ">Ian R.  Baldwin</span>  . </span><span class="cited-content_cbyCitation_article-title">From PIM1 to PI3Kδ via GSK3β: Target Hopping through the Kinome. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (10)
                                     , 1093-1098. <a href="https://doi.org/10.1021/acsmedchemlett.7b00296" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00296</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00296%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DFrom%252BPIM1%252Bto%252BPI3K%2525CE%2525B4%252Bvia%252BGSK3%2525CE%2525B2%25253A%252BTarget%252BHopping%252Bthrough%252Bthe%252BKinome%26aulast%3DHenley%26aufirst%3DZo%25C3%25AB%2BA.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D20072017%26date%3D05092017%26date%3D07092017%26date%3D12102017%26volume%3D8%26issue%3D10%26spage%3D1093%26epage%3D1098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giuseppina  La Sala</span>, <span class="hlFld-ContribAuthor ">Sergio  Decherchi</span>, <span class="hlFld-ContribAuthor ">Marco  De Vivo</span>, and <span class="hlFld-ContribAuthor ">Walter  Rocchia</span>  . </span><span class="cited-content_cbyCitation_article-title">Allosteric Communication Networks in Proteins Revealed through Pocket Crosstalk Analysis. </span><span class="cited-content_cbyCitation_journal-name">ACS Central Science</span><span> <strong>2017,</strong> <em>3 </em>
                                    (9)
                                     , 949-960. <a href="https://doi.org/10.1021/acscentsci.7b00211" title="DOI URL">https://doi.org/10.1021/acscentsci.7b00211</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscentsci.7b00211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscentsci.7b00211%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Central%2520Science%26atitle%3DAllosteric%252BCommunication%252BNetworks%252Bin%252BProteins%252BRevealed%252Bthrough%252BPocket%252BCrosstalk%252BAnalysis%26aulast%3DLa%2BSala%26aufirst%3DGiuseppina%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D18052017%26date%3D10082017%26date%3D27092017%26volume%3D3%26issue%3D9%26spage%3D949%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Chen</span>, <span class="hlFld-ContribAuthor ">John  Giraldes</span>, <span class="hlFld-ContribAuthor ">Elizabeth R.  Sprague</span>, <span class="hlFld-ContribAuthor ">Subarna  Shakya</span>, <span class="hlFld-ContribAuthor ">Zhuoliang  Chen</span>, <span class="hlFld-ContribAuthor ">Yaping  Wang</span>, <span class="hlFld-ContribAuthor ">Carol  Joud</span>, <span class="hlFld-ContribAuthor ">Simon  Mathieu</span>, <span class="hlFld-ContribAuthor ">Christine Hiu-Tung  Chen</span>, <span class="hlFld-ContribAuthor ">Christopher  Straub</span>, <span class="hlFld-ContribAuthor ">Jose  Duca</span>, <span class="hlFld-ContribAuthor ">Kristen  Hurov</span>, <span class="hlFld-ContribAuthor ">Yanqiu  Yuan</span>, <span class="hlFld-ContribAuthor ">Wenlin  Shao</span>, and <span class="hlFld-ContribAuthor ">B. Barry  Touré</span>  . </span><span class="cited-content_cbyCitation_article-title">“Addition” and “Subtraction”: Selectivity Design for Type II Maternal Embryonic Leucine Zipper Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (5)
                                     , 2155-2161. <a href="https://doi.org/10.1021/acs.jmedchem.7b00033" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00033%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D%2525E2%252580%25259CAddition%2525E2%252580%25259D%252Band%252B%2525E2%252580%25259CSubtraction%2525E2%252580%25259D%25253A%252BSelectivity%252BDesign%252Bfor%252BType%252BII%252BMaternal%252BEmbryonic%252BLeucine%252BZipper%252BKinase%252BInhibitors%26aulast%3DChen%26aufirst%3DXin%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D09012017%26date%3D24022017%26date%3D09032017%26date%3D10022017%26volume%3D60%26issue%3D5%26spage%3D2155%26epage%3D2161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Georgette M.  Castanedo</span>, <span class="hlFld-ContribAuthor ">Nicole  Blaquiere</span>, <span class="hlFld-ContribAuthor ">Maureen  Beresini</span>, <span class="hlFld-ContribAuthor ">Brandon  Bravo</span>, <span class="hlFld-ContribAuthor ">Hans  Brightbill</span>, <span class="hlFld-ContribAuthor ">Jacob  Chen</span>, <span class="hlFld-ContribAuthor ">Hai-Feng  Cui</span>, <span class="hlFld-ContribAuthor ">Charles  Eigenbrot</span>, <span class="hlFld-ContribAuthor ">Christine  Everett</span>, <span class="hlFld-ContribAuthor ">Jianwen  Feng</span>, <span class="hlFld-ContribAuthor ">Robert  Godemann</span>, <span class="hlFld-ContribAuthor ">Emily  Gogol</span>, <span class="hlFld-ContribAuthor ">Sarah  Hymowitz</span>, <span class="hlFld-ContribAuthor ">Adam  Johnson</span>, <span class="hlFld-ContribAuthor ">Nobuhiko  Kayagaki</span>, <span class="hlFld-ContribAuthor ">Pawan Bir  Kohli</span>, <span class="hlFld-ContribAuthor ">Kathleen  Knüppel</span>, <span class="hlFld-ContribAuthor ">Joachim  Kraemer</span>, <span class="hlFld-ContribAuthor ">Susan  Krüger</span>, <span class="hlFld-ContribAuthor ">Pui  Loke</span>, <span class="hlFld-ContribAuthor ">Paul  McEwan</span>, <span class="hlFld-ContribAuthor ">Christian  Montalbetti</span>, <span class="hlFld-ContribAuthor ">David A.  Roberts</span>, <span class="hlFld-ContribAuthor ">Myron  Smith</span>, <span class="hlFld-ContribAuthor ">Stefan  Steinbacher</span>, <span class="hlFld-ContribAuthor ">Swathi  Sujatha-Bhaskar</span>, <span class="hlFld-ContribAuthor ">Ryan  Takahashi</span>, <span class="hlFld-ContribAuthor ">Xiaolu  Wang</span>, <span class="hlFld-ContribAuthor ">Lawren C.  Wu</span>, <span class="hlFld-ContribAuthor ">Yamin  Zhang</span>, and <span class="hlFld-ContribAuthor ">Steven T.  Staben</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Tricyclic NF-κB Inducing Kinase (NIK) Inhibitors That Have High Selectivity over Phosphoinositide-3-kinase (PI3K). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (2)
                                     , 627-640. <a href="https://doi.org/10.1021/acs.jmedchem.6b01363" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01363</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01363&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01363%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252BTricyclic%252BNF-%2525CE%2525BAB%252BInducing%252BKinase%252B%252528NIK%252529%252BInhibitors%252BThat%252BHave%252BHigh%252BSelectivity%252Bover%252BPhosphoinositide-3-kinase%252B%252528PI3K%252529%26aulast%3DCastanedo%26aufirst%3DGeorgette%2BM.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D23092016%26date%3D12012017%26date%3D26012017%26date%3D22122016%26volume%3D60%26issue%3D2%26spage%3D627%26epage%3D640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Jones</span>, <span class="hlFld-ContribAuthor ">R. Ian  Storer</span>, <span class="hlFld-ContribAuthor ">Yogesh A.  Sabnis</span>, <span class="hlFld-ContribAuthor ">Florian M.  Wakenhut</span>, <span class="hlFld-ContribAuthor ">Gavin A.  Whitlock</span>, <span class="hlFld-ContribAuthor ">Katherine S.  England</span>, <span class="hlFld-ContribAuthor ">Takasuke  Mukaiyama</span>, <span class="hlFld-ContribAuthor ">Christoph M.  Dehnhardt</span>, <span class="hlFld-ContribAuthor ">Jotham W.  Coe</span>, <span class="hlFld-ContribAuthor ">Steve W.  Kortum</span>, <span class="hlFld-ContribAuthor ">Jill E.  Chrencik</span>, <span class="hlFld-ContribAuthor ">David G.  Brown</span>, <span class="hlFld-ContribAuthor ">Rhys M.  Jones</span>, <span class="hlFld-ContribAuthor ">John R.  Murphy</span>, <span class="hlFld-ContribAuthor ">Thean  Yeoh</span>, <span class="hlFld-ContribAuthor ">Paul  Morgan</span>, and <span class="hlFld-ContribAuthor ">Iain  Kilty</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (2)
                                     , 767-786. <a href="https://doi.org/10.1021/acs.jmedchem.6b01634" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01634</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01634%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252Ba%252BPan-Janus%252BKinase%252BInhibitor%252BClinical%252BCandidate%252B%252528PF-06263276%252529%252BSuitable%252Bfor%252BInhaled%252Band%252BTopical%252BDelivery%252Bfor%252Bthe%252BTreatment%252Bof%252BInflammatory%252BDiseases%252Bof%252Bthe%252BLungs%252Band%252BSkin%26aulast%3DJones%26aufirst%3DPeter%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D08112016%26date%3D04012017%26date%3D26012017%26date%3D16122016%26volume%3D60%26issue%3D2%26spage%3D767%26epage%3D786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicolas  Bosc</span>, <span class="hlFld-ContribAuthor ">Berthold  Wroblowski</span>, <span class="hlFld-ContribAuthor ">Christophe  Meyer</span>, and <span class="hlFld-ContribAuthor ">Pascal  Bonnet</span>  . </span><span class="cited-content_cbyCitation_article-title">Prediction of Protein Kinase–Ligand Interactions through 2.5D Kinochemometrics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (1)
                                     , 93-101. <a href="https://doi.org/10.1021/acs.jcim.6b00520" title="DOI URL">https://doi.org/10.1021/acs.jcim.6b00520</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.6b00520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.6b00520%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DPrediction%252Bof%252BProtein%252BKinase%2525E2%252580%252593Ligand%252BInteractions%252Bthrough%252B2.5D%252BKinochemometrics%26aulast%3DBosc%26aufirst%3DNicolas%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D31082016%26date%3D03012017%26date%3D23012017%26date%3D16122016%26volume%3D57%26issue%3D1%26spage%3D93%26epage%3D101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>  . </span><span class="cited-content_cbyCitation_article-title">Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (22)
                                     , 10030-10066. <a href="https://doi.org/10.1021/acs.jmedchem.6b00618" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00618%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BBrain%252BCancer%26aulast%3DHeffron%26aufirst%3DTimothy%2BP.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D21042016%26date%3D03082016%26date%3D23112016%26date%3D14072016%26volume%3D59%26issue%3D22%26spage%3D10030%26epage%3D10066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Carlino</span> and <span class="hlFld-ContribAuthor ">Giulio  Rastelli</span>  . </span><span class="cited-content_cbyCitation_article-title">Dual Kinase-Bromodomain Inhibitors in Anticancer Drug Discovery: A Structural and Pharmacological Perspective. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (20)
                                     , 9305-9320. <a href="https://doi.org/10.1021/acs.jmedchem.6b00438" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00438</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00438%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual%252BKinase-Bromodomain%252BInhibitors%252Bin%252BAnticancer%252BDrug%252BDiscovery%25253A%252BA%252BStructural%252Band%252BPharmacological%252BPerspective%26aulast%3DCarlino%26aufirst%3DLuca%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D24032016%26date%3D07092016%26date%3D27102016%26date%3D25082016%26volume%3D59%26issue%3D20%26spage%3D9305%26epage%3D9320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Serge  Christmann-Franck</span>, <span class="hlFld-ContribAuthor ">Gerard J. P.  van Westen</span>, <span class="hlFld-ContribAuthor ">George  Papadatos</span>, <span class="hlFld-ContribAuthor ">Fanny  Beltran Escudie</span>, <span class="hlFld-ContribAuthor ">Alexander  Roberts</span>, <span class="hlFld-ContribAuthor ">John P.  Overington</span>, and <span class="hlFld-ContribAuthor ">Daniel  Domine</span>  . </span><span class="cited-content_cbyCitation_article-title">Unprecedently Large-Scale Kinase Inhibitor Set Enabling the Accurate Prediction of Compound–Kinase Activities: A Way toward Selective Promiscuity by Design?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2016,</strong> <em>56 </em>
                                    (9)
                                     , 1654-1675. <a href="https://doi.org/10.1021/acs.jcim.6b00122" title="DOI URL">https://doi.org/10.1021/acs.jcim.6b00122</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.6b00122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.6b00122%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DUnprecedently%252BLarge-Scale%252BKinase%252BInhibitor%252BSet%252BEnabling%252Bthe%252BAccurate%252BPrediction%252Bof%252BCompound%2525E2%252580%252593Kinase%252BActivities%25253A%252BA%252BWay%252Btoward%252BSelective%252BPromiscuity%252Bby%252BDesign%25253F%26aulast%3DChristmann-Franck%26aufirst%3DSerge%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D03032016%26date%3D11082016%26date%3D26092016%26date%3D02082016%26volume%3D56%26issue%3D9%26spage%3D1654%26epage%3D1675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frank E.  Kwarcinski</span>, <span class="hlFld-ContribAuthor ">Kristoffer R.  Brandvold</span>, <span class="hlFld-ContribAuthor ">Sameer  Phadke</span>, <span class="hlFld-ContribAuthor ">Omar M.  Beleh</span>, <span class="hlFld-ContribAuthor ">Taylor K.  Johnson</span>, <span class="hlFld-ContribAuthor ">Jennifer L.  Meagher</span>, <span class="hlFld-ContribAuthor ">Markus A.  Seeliger</span>, <span class="hlFld-ContribAuthor ">Jeanne A.  Stuckey</span>, and <span class="hlFld-ContribAuthor ">Matthew B.  Soellner</span>  . </span><span class="cited-content_cbyCitation_article-title">Conformation-Selective Analogues of Dasatinib Reveal Insight into Kinase Inhibitor Binding and Selectivity. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2016,</strong> <em>11 </em>
                                    (5)
                                     , 1296-1304. <a href="https://doi.org/10.1021/acschembio.5b01018" title="DOI URL">https://doi.org/10.1021/acschembio.5b01018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.5b01018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.5b01018%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DConformation-Selective%252BAnalogues%252Bof%252BDasatinib%252BReveal%252BInsight%252Binto%252BKinase%252BInhibitor%252BBinding%252Band%252BSelectivity%26aulast%3DKwarcinski%26aufirst%3DFrank%2BE.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D10122015%26date%3D19022016%26date%3D01032016%26date%3D20052016%26date%3D19022016%26volume%3D11%26issue%3D5%26spage%3D1296%26epage%3D1304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiyong  Park</span>, <span class="hlFld-ContribAuthor ">Joseph J.  McDonald</span>, <span class="hlFld-ContribAuthor ">Russell C.  Petter</span>, and <span class="hlFld-ContribAuthor ">K. N.  Houk</span>  . </span><span class="cited-content_cbyCitation_article-title">Molecular Dynamics Analysis of Binding of Kinase Inhibitors to WT EGFR and the T790M Mutant. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2016,</strong> <em>12 </em>
                                    (4)
                                     , 2066-2078. <a href="https://doi.org/10.1021/acs.jctc.5b01221" title="DOI URL">https://doi.org/10.1021/acs.jctc.5b01221</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jctc.5b01221&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jctc.5b01221%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DMolecular%252BDynamics%252BAnalysis%252Bof%252BBinding%252Bof%252BKinase%252BInhibitors%252Bto%252BWT%252BEGFR%252Band%252Bthe%252BT790M%252BMutant%26aulast%3DPark%26aufirst%3DJiyong%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D24122015%26date%3D04042016%26date%3D12042016%26date%3D24032016%26volume%3D12%26issue%3D4%26spage%3D2066%26epage%3D2078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leila T.  Alexander</span>, <span class="hlFld-ContribAuthor ">Henrik  Möbitz</span>, <span class="hlFld-ContribAuthor ">Peter  Drueckes</span>, <span class="hlFld-ContribAuthor ">Pavel  Savitsky</span>, <span class="hlFld-ContribAuthor ">Oleg  Fedorov</span>, <span class="hlFld-ContribAuthor ">Jonathan M.  Elkins</span>, <span class="hlFld-ContribAuthor ">Charlotte M.  Deane</span>, <span class="hlFld-ContribAuthor ">Sandra W.  Cowan-Jacob</span>, and <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>  . </span><span class="cited-content_cbyCitation_article-title">Type II Inhibitors Targeting CDK2. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2015,</strong> <em>10 </em>
                                    (9)
                                     , 2116-2125. <a href="https://doi.org/10.1021/acschembio.5b00398" title="DOI URL">https://doi.org/10.1021/acschembio.5b00398</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.5b00398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.5b00398%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DType%252BII%252BInhibitors%252BTargeting%252BCDK2%26aulast%3DAlexander%26aufirst%3DLeila%2BT.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D26052015%26date%3D09072015%26date%3D20072015%26date%3D18092015%26date%3D09072015%26volume%3D10%26issue%3D9%26spage%3D2116%26epage%3D2125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christal D.  Sohl</span>, <span class="hlFld-ContribAuthor ">Molly R.  Ryan</span>, <span class="hlFld-ContribAuthor ">BeiBei  Luo</span>, <span class="hlFld-ContribAuthor ">Kathleen M.  Frey</span>, and <span class="hlFld-ContribAuthor ">Karen S.  Anderson</span>  . </span><span class="cited-content_cbyCitation_article-title">Illuminating the Molecular Mechanisms of Tyrosine Kinase Inhibitor Resistance for the FGFR1 Gatekeeper Mutation: The Achilles’ Heel of Targeted Therapy. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2015,</strong> <em>10 </em>
                                    (5)
                                     , 1319-1329. <a href="https://doi.org/10.1021/acschembio.5b00014" title="DOI URL">https://doi.org/10.1021/acschembio.5b00014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.5b00014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.5b00014%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DIlluminating%252Bthe%252BMolecular%252BMechanisms%252Bof%252BTyrosine%252BKinase%252BInhibitor%252BResistance%252Bfor%252Bthe%252BFGFR1%252BGatekeeper%252BMutation%25253A%252BThe%252BAchilles%2525E2%252580%252599%252BHeel%252Bof%252BTargeted%252BTherapy%26aulast%3DSohl%26aufirst%3DChristal%2BD.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D08012015%26date%3D16022015%26date%3D24022015%26date%3D15052015%26date%3D16022015%26volume%3D10%26issue%3D5%26spage%3D1319%26epage%3D1329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ha-Soon  Choi</span>, <span class="hlFld-ContribAuthor ">Paul V.  Rucker</span>, <span class="hlFld-ContribAuthor ">Zhicheng  Wang</span>, <span class="hlFld-ContribAuthor ">Yi  Fan</span>, <span class="hlFld-ContribAuthor ">Pamela  Albaugh</span>, <span class="hlFld-ContribAuthor ">Greg  Chopiuk</span>, <span class="hlFld-ContribAuthor ">Francois  Gessier</span>, <span class="hlFld-ContribAuthor ">Fangxian  Sun</span>, <span class="hlFld-ContribAuthor ">Francisco  Adrian</span>, <span class="hlFld-ContribAuthor ">Guoxun  Liu</span>, <span class="hlFld-ContribAuthor ">Tami  Hood</span>, <span class="hlFld-ContribAuthor ">Nanxin  Li</span>, <span class="hlFld-ContribAuthor ">Yong  Jia</span>, <span class="hlFld-ContribAuthor ">Jianwei  Che</span>, <span class="hlFld-ContribAuthor ">Susan  McCormack</span>, <span class="hlFld-ContribAuthor ">Allen  Li</span>, <span class="hlFld-ContribAuthor ">Jie  Li</span>, <span class="hlFld-ContribAuthor ">Auzon  Steffy</span>, <span class="hlFld-ContribAuthor ">AnneMarie  Culazzo</span>, <span class="hlFld-ContribAuthor ">Celine  Tompkins</span>, <span class="hlFld-ContribAuthor ">Van  Phung</span>, <span class="hlFld-ContribAuthor ">Andreas  Kreusch</span>, <span class="hlFld-ContribAuthor ">Min  Lu</span>, <span class="hlFld-ContribAuthor ">Bin  Hu</span>, <span class="hlFld-ContribAuthor ">Apurva  Chaudhary</span>, <span class="hlFld-ContribAuthor ">Mahavir  Prashad</span>, <span class="hlFld-ContribAuthor ">Tove  Tuntland</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>, <span class="hlFld-ContribAuthor ">Jennifer  Harris</span>, <span class="hlFld-ContribAuthor ">H. Martin  Seidel</span>, <span class="hlFld-ContribAuthor ">Jon  Loren</span>, and <span class="hlFld-ContribAuthor ">Valentina  Molteni</span>  . </span><span class="cited-content_cbyCitation_article-title">(R)-2-Phenylpyrrolidine Substituted Imidazopyridazines: A New Class of Potent and Selective Pan-TRK Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (5)
                                     , 562-567. <a href="https://doi.org/10.1021/acsmedchemlett.5b00050" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00050%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D%252528R%252529-2-Phenylpyrrolidine%252BSubstituted%252BImidazopyridazines%25253A%252BA%252BNew%252BClass%252Bof%252BPotent%252Band%252BSelective%252BPan-TRK%252BInhibitors%26aulast%3DChoi%26aufirst%3DHa-Soon%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D30012015%26date%3D16032015%26date%3D19032015%26date%3D14052015%26date%3D16032015%26volume%3D6%26issue%3D5%26spage%3D562%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emily A.  Peterson</span>, <span class="hlFld-ContribAuthor ">Yohannes  Teffera</span>, <span class="hlFld-ContribAuthor ">Brian K.  Albrecht</span>, <span class="hlFld-ContribAuthor ">David  Bauer</span>, <span class="hlFld-ContribAuthor ">Steven F.  Bellon</span>, <span class="hlFld-ContribAuthor ">Alessandro  Boezio</span>, <span class="hlFld-ContribAuthor ">Christiane  Boezio</span>, <span class="hlFld-ContribAuthor ">Martin A.  Broome</span>, <span class="hlFld-ContribAuthor ">Deborah  Choquette</span>, <span class="hlFld-ContribAuthor ">Katrina W.  Copeland</span>, <span class="hlFld-ContribAuthor ">Isabelle  Dussault</span>, <span class="hlFld-ContribAuthor ">Richard  Lewis</span>, <span class="hlFld-ContribAuthor ">Min-Hwa Jasmine  Lin</span>, <span class="hlFld-ContribAuthor ">Julia  Lohman</span>, <span class="hlFld-ContribAuthor ">Jingzhou  Liu</span>, <span class="hlFld-ContribAuthor ">Michele  Potashman</span>, <span class="hlFld-ContribAuthor ">Karen  Rex</span>, <span class="hlFld-ContribAuthor ">Roman  Shimanovich</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Karina R.  Vaida</span>, and <span class="hlFld-ContribAuthor ">Jean-Christophe  Harmange</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent and Selective 8-Fluorotriazolopyridine c-Met Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (5)
                                     , 2417-2430. <a href="https://doi.org/10.1021/jm501913a" title="DOI URL">https://doi.org/10.1021/jm501913a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501913a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501913a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%252Band%252BSelective%252B8-Fluorotriazolopyridine%252Bc-Met%252BInhibitors%26aulast%3DPeterson%26aufirst%3DEmily%2BA.%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D10122014%26date%3D03032015%26date%3D12032015%26date%3D20022015%26volume%3D58%26issue%3D5%26spage%3D2417%26epage%3D2430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Obdulia  Rabal</span>, <span class="hlFld-ContribAuthor ">Fares Ibrahim  Amr</span>, and <span class="hlFld-ContribAuthor ">Julen  Oyarzabal</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Scaffold Fingerprint (SFP): Applications in Scaffold Hopping and Scaffold-Based Selection of Diverse Compounds. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2015,</strong> <em>55 </em>
                                    (1)
                                     , 1-18. <a href="https://doi.org/10.1021/ci500542e" title="DOI URL">https://doi.org/10.1021/ci500542e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci500542e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci500542e%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DNovel%252BScaffold%252BFingerprint%252B%252528SFP%252529%25253A%252BApplications%252Bin%252BScaffold%252BHopping%252Band%252BScaffold-Based%252BSelection%252Bof%252BDiverse%252BCompounds%26aulast%3DRabal%26aufirst%3DObdulia%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D31072014%26date%3D13012015%26date%3D26012015%26date%3D05012015%26volume%3D55%26issue%3D1%26spage%3D1%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Tong</span> and <span class="hlFld-ContribAuthor ">Markus A.  Seeliger</span>  . </span><span class="cited-content_cbyCitation_article-title">Targeting Conformational Plasticity of Protein Kinases. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2015,</strong> <em>10 </em>
                                    (1)
                                     , 190-200. <a href="https://doi.org/10.1021/cb500870a" title="DOI URL">https://doi.org/10.1021/cb500870a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb500870a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb500870a%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DTargeting%252BConformational%252BPlasticity%252Bof%252BProtein%252BKinases%26aulast%3DTong%26aufirst%3DMichael%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D24102014%26date%3D08122014%26date%3D19122014%26date%3D16012015%26date%3D08122014%26volume%3D10%26issue%3D1%26spage%3D190%26epage%3D200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srinivasaraghavan  Kannan</span>, <span class="hlFld-ContribAuthor ">Anders  Poulsen</span>, <span class="hlFld-ContribAuthor ">Hai Yan  Yang</span>, <span class="hlFld-ContribAuthor ">Melvyn  Ho</span>, <span class="hlFld-ContribAuthor ">Shi Hua  Ang</span>, <span class="hlFld-ContribAuthor ">Tan Sum Wai  Eldwin</span>, <span class="hlFld-ContribAuthor ">Duraiswamy Athisayamani  Jeyaraj</span>, <span class="hlFld-ContribAuthor ">Lohitha Rao  Chennamaneni</span>, <span class="hlFld-ContribAuthor ">Boping  Liu</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Hill</span>, <span class="hlFld-ContribAuthor ">Chandra S.  Verma</span>, and <span class="hlFld-ContribAuthor ">Kassoum  Nacro</span>  . </span><span class="cited-content_cbyCitation_article-title">Probing the Binding Mechanism of Mnk Inhibitors by Docking and Molecular Dynamics Simulations. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2015,</strong> <em>54 </em>
                                    (1)
                                     , 32-46. <a href="https://doi.org/10.1021/bi501261j" title="DOI URL">https://doi.org/10.1021/bi501261j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bi501261j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbi501261j%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DProbing%252Bthe%252BBinding%252BMechanism%252Bof%252BMnk%252BInhibitors%252Bby%252BDocking%252Band%252BMolecular%252BDynamics%252BSimulations%26aulast%3DKannan%26aufirst%3DSrinivasaraghavan%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D07102014%26date%3D26112014%26date%3D05122014%26date%3D13012015%26date%3D28112014%26volume%3D54%26issue%3D1%26spage%3D32%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-Christophe  Carry</span>, <span class="hlFld-ContribAuthor ">François  Clerc</span>, <span class="hlFld-ContribAuthor ">Hervé  Minoux</span>, <span class="hlFld-ContribAuthor ">Laurent  Schio</span>, <span class="hlFld-ContribAuthor ">Jacques  Mauger</span>, <span class="hlFld-ContribAuthor ">Anil  Nair</span>, <span class="hlFld-ContribAuthor ">Eric  Parmantier</span>, <span class="hlFld-ContribAuthor ">Ronan  Le Moigne</span>, <span class="hlFld-ContribAuthor ">Cécile  Delorme</span>, <span class="hlFld-ContribAuthor ">Jean-Paul  Nicolas</span>, <span class="hlFld-ContribAuthor ">Alain  Krick</span>, <span class="hlFld-ContribAuthor ">Pierre-Yves  Abécassis</span>, <span class="hlFld-ContribAuthor ">Véronique  Crocq-Stuerga</span>, <span class="hlFld-ContribAuthor ">Stéphanie  Pouzieux</span>, <span class="hlFld-ContribAuthor ">Laure  Delarbre</span>, <span class="hlFld-ContribAuthor ">Sébastien  Maignan</span>, <span class="hlFld-ContribAuthor ">Thomas  Bertrand</span>, <span class="hlFld-ContribAuthor ">Kirsten  Bjergarde</span>, <span class="hlFld-ContribAuthor ">Nina  Ma</span>, <span class="hlFld-ContribAuthor ">Sylvette  Lachaud</span>, <span class="hlFld-ContribAuthor ">Houlfa  Guizani</span>, <span class="hlFld-ContribAuthor ">Rémi  Lebel</span>, <span class="hlFld-ContribAuthor ">Gilles  Doerflinger</span>, <span class="hlFld-ContribAuthor ">Sylvie  Monget</span>, <span class="hlFld-ContribAuthor ">Sébastien  Perron</span>, <span class="hlFld-ContribAuthor ">Francis  Gasse</span>, <span class="hlFld-ContribAuthor ">Odile  Angouillant-Boniface</span>, <span class="hlFld-ContribAuthor ">Bruno  Filoche-Rommé</span>, <span class="hlFld-ContribAuthor ">Michel  Murer</span>, <span class="hlFld-ContribAuthor ">Sylvie  Gontier</span>, <span class="hlFld-ContribAuthor ">Céline  Prévost</span>, <span class="hlFld-ContribAuthor ">Marie-Line  Monteiro</span>, and <span class="hlFld-ContribAuthor ">Cécile  Combeau</span>  . </span><span class="cited-content_cbyCitation_article-title">SAR156497, an Exquisitely Selective Inhibitor of Aurora Kinases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 362-375. <a href="https://doi.org/10.1021/jm501326k" title="DOI URL">https://doi.org/10.1021/jm501326k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501326k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501326k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSAR156497%25252C%252Ban%252BExquisitely%252BSelective%252BInhibitor%252Bof%252BAurora%252BKinases%26aulast%3DCarry%26aufirst%3DJean-Christophe%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D29082014%26date%3D24112014%26date%3D08012015%26date%3D04112014%26volume%3D58%26issue%3D1%26spage%3D362%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joachim  Rudolph</span>, <span class="hlFld-ContribAuthor ">James J.  Crawford</span>, <span class="hlFld-ContribAuthor ">Klaus P.  Hoeflich</span>, and <span class="hlFld-ContribAuthor ">Weiru  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">Inhibitors of p21-Activated Kinases (PAKs). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 111-129. <a href="https://doi.org/10.1021/jm501613q" title="DOI URL">https://doi.org/10.1021/jm501613q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501613q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501613q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInhibitors%252Bof%252Bp21-Activated%252BKinases%252B%252528PAKs%252529%26aulast%3DRudolph%26aufirst%3DJoachim%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D18102014%26date%3D03122014%26date%3D08012015%26date%3D21112014%26volume%3D58%26issue%3D1%26spage%3D111%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Dong</span>, <span class="hlFld-ContribAuthor ">Hongtao  Zhao</span>, <span class="hlFld-ContribAuthor ">Ting  Zhou</span>, <span class="hlFld-ContribAuthor ">Dimitrios  Spiliotopoulos</span>, <span class="hlFld-ContribAuthor ">Chitra  Rajendran</span>, <span class="hlFld-ContribAuthor ">Xiao-Dan  Li</span>, <span class="hlFld-ContribAuthor ">Danzhi  Huang</span>, and <span class="hlFld-ContribAuthor ">Amedeo  Caflisch</span>  . </span><span class="cited-content_cbyCitation_article-title">Structural Analysis of the Binding of Type I, I1/2, and II Inhibitors to Eph Tyrosine Kinases. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (1)
                                     , 79-83. <a href="https://doi.org/10.1021/ml500355x" title="DOI URL">https://doi.org/10.1021/ml500355x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml500355x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml500355x%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructural%252BAnalysis%252Bof%252Bthe%252BBinding%252Bof%252BType%252BI%25252C%252BI1%25252F2%25252C%252Band%252BII%252BInhibitors%252Bto%252BEph%252BTyrosine%252BKinases%26aulast%3DDong%26aufirst%3DJing%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D01092014%26date%3D29092014%26date%3D03102014%26date%3D08012015%26date%3D29092014%26volume%3D6%26issue%3D1%26spage%3D79%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kiyoshi  Okamoto</span>, <span class="hlFld-ContribAuthor ">Megumi  Ikemori-Kawada</span>, <span class="hlFld-ContribAuthor ">Anja  Jestel</span>, <span class="hlFld-ContribAuthor ">Konstanze  von König</span>, <span class="hlFld-ContribAuthor ">Yasuhiro  Funahashi</span>, <span class="hlFld-ContribAuthor ">Tomohiro  Matsushima</span>, <span class="hlFld-ContribAuthor ">Akihiko  Tsuruoka</span>, <span class="hlFld-ContribAuthor ">Atsushi  Inoue</span>, and <span class="hlFld-ContribAuthor ">Junji  Matsui</span>  . </span><span class="cited-content_cbyCitation_article-title">Distinct Binding Mode of Multikinase Inhibitor Lenvatinib Revealed by Biochemical Characterization. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (1)
                                     , 89-94. <a href="https://doi.org/10.1021/ml500394m" title="DOI URL">https://doi.org/10.1021/ml500394m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml500394m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml500394m%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDistinct%252BBinding%252BMode%252Bof%252BMultikinase%252BInhibitor%252BLenvatinib%252BRevealed%252Bby%252BBiochemical%252BCharacterization%26aulast%3DOkamoto%26aufirst%3DKiyoshi%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D29092014%26date%3D17112014%26date%3D20112014%26date%3D08012015%26date%3D17112014%26volume%3D6%26issue%3D1%26spage%3D89%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Unzue</span>, <span class="hlFld-ContribAuthor ">Jing  Dong</span>, <span class="hlFld-ContribAuthor ">Karine  Lafleur</span>, <span class="hlFld-ContribAuthor ">Hongtao  Zhao</span>, <span class="hlFld-ContribAuthor ">Emilie  Frugier</span>, <span class="hlFld-ContribAuthor ">Amedeo  Caflisch</span>, and <span class="hlFld-ContribAuthor ">Cristina  Nevado</span>  . </span><span class="cited-content_cbyCitation_article-title">Pyrrolo[3,2-b]quinoxaline Derivatives as Types I1/2 and II Eph Tyrosine Kinase Inhibitors: Structure-Based Design, Synthesis, and in Vivo Validation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (15)
                                     , 6834-6844. <a href="https://doi.org/10.1021/jm5009242" title="DOI URL">https://doi.org/10.1021/jm5009242</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5009242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5009242%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyrrolo%25255B3%25252C2-b%25255Dquinoxaline%252BDerivatives%252Bas%252BTypes%252BI1%25252F2%252Band%252BII%252BEph%252BTyrosine%252BKinase%252BInhibitors%25253A%252BStructure-Based%252BDesign%25252C%252BSynthesis%25252C%252Band%252Bin%252BVivo%252BValidation%26aulast%3DUnzue%26aufirst%3DAndrea%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D18062014%26date%3D30072014%26date%3D14082014%26volume%3D57%26issue%3D15%26spage%3D6834%26epage%3D6844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shawn J.  Stachel</span>, <span class="hlFld-ContribAuthor ">John M.  Sanders</span>, <span class="hlFld-ContribAuthor ">Darrell A.  Henze</span>, <span class="hlFld-ContribAuthor ">Mike T.  Rudd</span>, <span class="hlFld-ContribAuthor ">Hua-Poo  Su</span>, <span class="hlFld-ContribAuthor ">Yiwei  Li</span>, <span class="hlFld-ContribAuthor ">Kausik K.  Nanda</span>, <span class="hlFld-ContribAuthor ">Melissa S.  Egbertson</span>, <span class="hlFld-ContribAuthor ">Peter J.  Manley</span>, <span class="hlFld-ContribAuthor ">Kristen L. G.  Jones</span>, <span class="hlFld-ContribAuthor ">Edward J.  Brnardic</span>, <span class="hlFld-ContribAuthor ">Ahren  Green</span>, <span class="hlFld-ContribAuthor ">Jay A.  Grobler</span>, <span class="hlFld-ContribAuthor ">Barbara  Hanney</span>, <span class="hlFld-ContribAuthor ">Michael  Leitl</span>, <span class="hlFld-ContribAuthor ">Ming-Tain  Lai</span>, <span class="hlFld-ContribAuthor ">Vandna  Munshi</span>, <span class="hlFld-ContribAuthor ">Dennis  Murphy</span>, <span class="hlFld-ContribAuthor ">Keith  Rickert</span>, <span class="hlFld-ContribAuthor ">Daniel  Riley</span>, <span class="hlFld-ContribAuthor ">Alicja  Krasowska-Zoladek</span>, <span class="hlFld-ContribAuthor ">Christopher  Daley</span>, <span class="hlFld-ContribAuthor ">Paul  Zuck</span>, <span class="hlFld-ContribAuthor ">Stephanie A.  Kane</span>, and <span class="hlFld-ContribAuthor ">Mark T.  Bilodeau</span>  . </span><span class="cited-content_cbyCitation_article-title">Maximizing Diversity from a Kinase Screen: Identification of Novel and Selective pan-Trk Inhibitors for Chronic Pain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (13)
                                     , 5800-5816. <a href="https://doi.org/10.1021/jm5006429" title="DOI URL">https://doi.org/10.1021/jm5006429</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5006429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5006429%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMaximizing%252BDiversity%252Bfrom%252Ba%252BKinase%252BScreen%25253A%252BIdentification%252Bof%252BNovel%252Band%252BSelective%252Bpan-Trk%252BInhibitors%252Bfor%252BChronic%252BPain%26aulast%3DStachel%26aufirst%3DShawn%2BJ.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D01052014%26date%3D19062014%26date%3D10072014%26date%3D10062014%26volume%3D57%26issue%3D13%26spage%3D5800%26epage%3D5816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng  Zhao</span>, <span class="hlFld-ContribAuthor ">Hong  Wu</span>, <span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Yi  Liu</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Qingsong  Liu</span>, and <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>  . </span><span class="cited-content_cbyCitation_article-title">Exploration of Type II Binding Mode: A Privileged Approach for Kinase Inhibitor Focused Drug Discovery?. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2014,</strong> <em>9 </em>
                                    (6)
                                     , 1230-1241. <a href="https://doi.org/10.1021/cb500129t" title="DOI URL">https://doi.org/10.1021/cb500129t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb500129t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb500129t%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DExploration%252Bof%252BType%252BII%252BBinding%252BMode%25253A%252BA%252BPrivileged%252BApproach%252Bfor%252BKinase%252BInhibitor%252BFocused%252BDrug%252BDiscovery%25253F%26aulast%3DZhao%26aufirst%3DZheng%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D19022014%26date%3D14042014%26date%3D29042014%26date%3D20062014%26date%3D14042014%26volume%3D9%26issue%3D6%26spage%3D1230%26epage%3D1241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giovanni  Marzaro</span>, <span class="hlFld-ContribAuthor ">Antonio  Coluccia</span>, <span class="hlFld-ContribAuthor ">Alessandro  Ferrarese</span>, <span class="hlFld-ContribAuthor ">Paola  Brun</span>, <span class="hlFld-ContribAuthor ">Ignazio  Castagliuolo</span>, <span class="hlFld-ContribAuthor ">Maria Teresa  Conconi</span>, <span class="hlFld-ContribAuthor ">Giuseppe  La Regina</span>, <span class="hlFld-ContribAuthor ">Ruoli  Bai</span>, <span class="hlFld-ContribAuthor ">Romano  Silvestri</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, and <span class="hlFld-ContribAuthor ">Adriana  Chilin</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Biarylaminoquinazolines as Novel Tubulin Polymerization Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (11)
                                     , 4598-4605. <a href="https://doi.org/10.1021/jm500034j" title="DOI URL">https://doi.org/10.1021/jm500034j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500034j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500034j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BBiarylaminoquinazolines%252Bas%252BNovel%252BTubulin%252BPolymerization%252BInhibitors%26aulast%3DMarzaro%26aufirst%3DGiovanni%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D08012014%26date%3D14052014%26date%3D12062014%26date%3D06052014%26volume%3D57%26issue%3D11%26spage%3D4598%26epage%3D4605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhihong  Li</span>, <span class="hlFld-ContribAuthor ">Xianghong  Wang</span>, <span class="hlFld-ContribAuthor ">John  Eksterowicz</span>, <span class="hlFld-ContribAuthor ">Michael W.  Gribble, Jr.</span>, <span class="hlFld-ContribAuthor ">Grace Q.  Alba</span>, <span class="hlFld-ContribAuthor ">Merrill  Ayres</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Carlson</span>, <span class="hlFld-ContribAuthor ">Ada  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaoqi  Chen</span>, <span class="hlFld-ContribAuthor ">Robert  Cho</span>, <span class="hlFld-ContribAuthor ">Richard V.  Connors</span>, <span class="hlFld-ContribAuthor ">Michael  DeGraffenreid</span>, <span class="hlFld-ContribAuthor ">Jeffrey T.  Deignan</span>, <span class="hlFld-ContribAuthor ">Jason  Duquette</span>, <span class="hlFld-ContribAuthor ">Pingchen  Fan</span>, <span class="hlFld-ContribAuthor ">Benjamin  Fisher</span>, <span class="hlFld-ContribAuthor ">Jiasheng  Fu</span>, <span class="hlFld-ContribAuthor ">Justin N.  Huard</span>, <span class="hlFld-ContribAuthor ">Jacob  Kaizerman</span>, <span class="hlFld-ContribAuthor ">Kathleen S.  Keegan</span>, <span class="hlFld-ContribAuthor ">Cong  Li</span>, <span class="hlFld-ContribAuthor ">Kexue  Li</span>, <span class="hlFld-ContribAuthor ">Yunxiao  Li</span>, <span class="hlFld-ContribAuthor ">Lingming  Liang</span>, <span class="hlFld-ContribAuthor ">Wen  Liu</span>, <span class="hlFld-ContribAuthor ">Sarah E.  Lively</span>, <span class="hlFld-ContribAuthor ">Mei-Chu  Lo</span>, <span class="hlFld-ContribAuthor ">Ji  Ma</span>, <span class="hlFld-ContribAuthor ">Dustin L.  McMinn</span>, <span class="hlFld-ContribAuthor ">Jeffrey T.  Mihalic</span>, <span class="hlFld-ContribAuthor ">Kriti  Modi</span>, <span class="hlFld-ContribAuthor ">Rachel  Ngo</span>, <span class="hlFld-ContribAuthor ">Kanaka  Pattabiraman</span>, <span class="hlFld-ContribAuthor ">Derek E.  Piper</span>, <span class="hlFld-ContribAuthor ">Christophe  Queva</span>, <span class="hlFld-ContribAuthor ">Mark L.  Ragains</span>, <span class="hlFld-ContribAuthor ">Julia  Suchomel</span>, <span class="hlFld-ContribAuthor ">Steve  Thibault</span>, <span class="hlFld-ContribAuthor ">Nigel  Walker</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Wang</span>, <span class="hlFld-ContribAuthor ">Zhulun  Wang</span>, <span class="hlFld-ContribAuthor ">Malgorzata  Wanska</span>, <span class="hlFld-ContribAuthor ">Paul M.  Wehn</span>, <span class="hlFld-ContribAuthor ">Margaret F.  Weidner</span>, <span class="hlFld-ContribAuthor ">Alex J.  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaoning  Zhao</span>, <span class="hlFld-ContribAuthor ">Alexander  Kamb</span>, <span class="hlFld-ContribAuthor ">Dineli  Wickramasinghe</span>, <span class="hlFld-ContribAuthor ">Kang  Dai</span>, <span class="hlFld-ContribAuthor ">Lawrence R.  McGee</span>, and <span class="hlFld-ContribAuthor ">Julio C.  Medina</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of AMG 925, a FLT3 and CDK4 Dual Kinase Inhibitor with Preferential Affinity for the Activated State of FLT3. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (8)
                                     , 3430-3449. <a href="https://doi.org/10.1021/jm500118j" title="DOI URL">https://doi.org/10.1021/jm500118j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500118j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500118j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BAMG%252B925%25252C%252Ba%252BFLT3%252Band%252BCDK4%252BDual%252BKinase%252BInhibitor%252Bwith%252BPreferential%252BAffinity%252Bfor%252Bthe%252BActivated%252BState%252Bof%252BFLT3%26aulast%3DLi%26aufirst%3DZhihong%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D22012014%26date%3D02042014%26date%3D24042014%26date%3D18032014%26volume%3D57%26issue%3D8%26spage%3D3430%26epage%3D3449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael R.  Jones</span>, <span class="hlFld-ContribAuthor ">Cong  Liu</span>, and <span class="hlFld-ContribAuthor ">Angela K.  Wilson</span>  . </span><span class="cited-content_cbyCitation_article-title">Molecular Dynamics Studies of the Protein–Protein Interactions in Inhibitor of κB Kinase-β. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2014,</strong> <em>54 </em>
                                    (2)
                                     , 562-572. <a href="https://doi.org/10.1021/ci400720n" title="DOI URL">https://doi.org/10.1021/ci400720n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci400720n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci400720n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DMolecular%252BDynamics%252BStudies%252Bof%252Bthe%252BProtein%2525E2%252580%252593Protein%252BInteractions%252Bin%252BInhibitor%252Bof%252B%2525CE%2525BAB%252BKinase-%2525CE%2525B2%26aulast%3DJones%26aufirst%3DMichael%2BR.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D06122013%26date%3D11022014%26date%3D24022014%26date%3D19012014%26volume%3D54%26issue%3D2%26spage%3D562%26epage%3D572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven T.  Staben</span>, <span class="hlFld-ContribAuthor ">Jianwen A.  Feng</span>, <span class="hlFld-ContribAuthor ">Karen  Lyle</span>, <span class="hlFld-ContribAuthor ">Marcia  Belvin</span>, <span class="hlFld-ContribAuthor ">Jason  Boggs</span>, <span class="hlFld-ContribAuthor ">Jason D.  Burch</span>, <span class="hlFld-ContribAuthor ">Ching-ching  Chua</span>, <span class="hlFld-ContribAuthor ">Haifeng  Cui</span>, <span class="hlFld-ContribAuthor ">Antonio G.  DiPasquale</span>, <span class="hlFld-ContribAuthor ">Lori S.  Friedman</span>, <span class="hlFld-ContribAuthor ">Christopher  Heise</span>, <span class="hlFld-ContribAuthor ">Hartmut  Koeppen</span>, <span class="hlFld-ContribAuthor ">Adrian  Kotey</span>, <span class="hlFld-ContribAuthor ">Robert  Mintzer</span>, <span class="hlFld-ContribAuthor ">Angela  Oh</span>, <span class="hlFld-ContribAuthor ">David Allen  Roberts</span>, <span class="hlFld-ContribAuthor ">Lionel  Rouge</span>, <span class="hlFld-ContribAuthor ">Joachim  Rudolph</span>, <span class="hlFld-ContribAuthor ">Christine  Tam</span>, <span class="hlFld-ContribAuthor ">Weiru  Wang</span>, <span class="hlFld-ContribAuthor ">Yisong  Xiao</span>, <span class="hlFld-ContribAuthor ">Amy  Young</span>, <span class="hlFld-ContribAuthor ">Yamin  Zhang</span>, and <span class="hlFld-ContribAuthor ">Klaus P.  Hoeflich</span>  . </span><span class="cited-content_cbyCitation_article-title">Back Pocket Flexibility Provides Group II p21-Activated Kinase  (PAK) Selectivity for Type I 1/2 Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (3)
                                     , 1033-1045. <a href="https://doi.org/10.1021/jm401768t" title="DOI URL">https://doi.org/10.1021/jm401768t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401768t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401768t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBack%252BPocket%252BFlexibility%252BProvides%252BGroup%252BII%252Bp21-Activated%252BKinase%252B%252528PAK%252529%252BSelectivity%252Bfor%252BType%252BI%252B1%25252F2%252BKinase%252BInhibitors%26aulast%3DStaben%26aufirst%3DSteven%2BT.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D15112013%26date%3D04022014%26date%3D13022014%26date%3D16012014%26volume%3D57%26issue%3D3%26spage%3D1033%26epage%3D1045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oscar P. J.  van Linden</span>, <span class="hlFld-ContribAuthor ">Albert J.  Kooistra</span>, <span class="hlFld-ContribAuthor ">Rob  Leurs</span>, <span class="hlFld-ContribAuthor ">Iwan J. P.  de Esch</span>, and <span class="hlFld-ContribAuthor ">Chris  de Graaf</span>  . </span><span class="cited-content_cbyCitation_article-title">KLIFS: A Knowledge-Based Structural Database To Navigate Kinase–Ligand Interaction Space. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (2)
                                     , 249-277. <a href="https://doi.org/10.1021/jm400378w" title="DOI URL">https://doi.org/10.1021/jm400378w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400378w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400378w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DKLIFS%25253A%252BA%252BKnowledge-Based%252BStructural%252BDatabase%252BTo%252BNavigate%252BKinase%2525E2%252580%252593Ligand%252BInteraction%252BSpace%26aulast%3Dvan%2BLinden%26aufirst%3DOscar%2BP.%2BJ.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D14032013%26date%3D20092013%26date%3D23012014%26date%3D13082013%26volume%3D57%26issue%3D2%26spage%3D249%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vigneshwari  Subramanian</span>, <span class="hlFld-ContribAuthor ">Peteris  Prusis</span>, <span class="hlFld-ContribAuthor ">Lars-Olof  Pietilä</span>, <span class="hlFld-ContribAuthor ">Henri  Xhaard</span>, and <span class="hlFld-ContribAuthor ">Gerd  Wohlfahrt</span>  . </span><span class="cited-content_cbyCitation_article-title">Visually Interpretable Models of Kinase Selectivity Related Features Derived from Field-Based Proteochemometrics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2013,</strong> <em>53 </em>
                                    (11)
                                     , 3021-3030. <a href="https://doi.org/10.1021/ci400369z" title="DOI URL">https://doi.org/10.1021/ci400369z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci400369z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci400369z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DVisually%252BInterpretable%252BModels%252Bof%252BKinase%252BSelectivity%252BRelated%252BFeatures%252BDerived%252Bfrom%252BField-Based%252BProteochemometrics%26aulast%3DSubramanian%26aufirst%3DVigneshwari%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D27062013%26date%3D25102013%26date%3D25112013%26date%3D12102013%26volume%3D53%26issue%3D11%26spage%3D3021%26epage%3D3030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ken-ichi  Kusakabe</span>, <span class="hlFld-ContribAuthor ">Nobuyuki  Ide</span>, <span class="hlFld-ContribAuthor ">Yataro  Daigo</span>, <span class="hlFld-ContribAuthor ">Yuki  Tachibana</span>, <span class="hlFld-ContribAuthor ">Takeshi,  Itoh</span>, <span class="hlFld-ContribAuthor ">Takahiko  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Hashizume</span>, <span class="hlFld-ContribAuthor ">Yoshio  Hato</span>, <span class="hlFld-ContribAuthor ">Kenichi  Higashino</span>, <span class="hlFld-ContribAuthor ">Yousuke  Okano</span>, <span class="hlFld-ContribAuthor ">Yuji  Sato</span>, <span class="hlFld-ContribAuthor ">Makiko  Inoue</span>, <span class="hlFld-ContribAuthor ">Motofumi  Iguchi</span>, <span class="hlFld-ContribAuthor ">Takayuki  Kanazawa</span>, <span class="hlFld-ContribAuthor ">Yukichi  Ishioka</span>, <span class="hlFld-ContribAuthor ">Keiji  Dohi</span>, <span class="hlFld-ContribAuthor ">Yasuto  Kido</span>, <span class="hlFld-ContribAuthor ">Shingo  Sakamoto</span>, <span class="hlFld-ContribAuthor ">Kazuya  Yasuo</span>, <span class="hlFld-ContribAuthor ">Masahiro  Maeda</span>, <span class="hlFld-ContribAuthor ">Masayo  Higaki</span>, <span class="hlFld-ContribAuthor ">Kazuo  Ueda</span>, <span class="hlFld-ContribAuthor ">Hidenori  Yoshizawa</span>, <span class="hlFld-ContribAuthor ">Yoshiyasu  Baba</span>, <span class="hlFld-ContribAuthor ">Takeshi  Shiota</span>, <span class="hlFld-ContribAuthor ">Hitoshi  Murai</span>, and <span class="hlFld-ContribAuthor ">Yusuke  Nakamura</span>  . </span><span class="cited-content_cbyCitation_article-title">Indazole-Based Potent and Cell-Active Mps1 Kinase Inhibitors: Rational Design from Pan-Kinase Inhibitor Anthrapyrazolone (SP600125). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (11)
                                     , 4343-4356. <a href="https://doi.org/10.1021/jm4000215" title="DOI URL">https://doi.org/10.1021/jm4000215</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4000215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4000215%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIndazole-Based%252BPotent%252Band%252BCell-Active%252BMps1%252BKinase%252BInhibitors%25253A%252BRational%252BDesign%252Bfrom%252BPan-Kinase%252BInhibitor%252BAnthrapyrazolone%252B%252528SP600125%252529%26aulast%3DKusakabe%26aufirst%3DKen-ichi%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D04012013%26date%3D24052013%26date%3D13062013%26date%3D01052013%26volume%3D56%26issue%3D11%26spage%3D4343%26epage%3D4356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-Hui  Peng</span>, <span class="hlFld-ContribAuthor ">Hui-Yi  Shiao</span>, <span class="hlFld-ContribAuthor ">Chih-Hsiang  Tu</span>, <span class="hlFld-ContribAuthor ">Pang-Min  Liu</span>, <span class="hlFld-ContribAuthor ">John Tsu-An  Hsu</span>, <span class="hlFld-ContribAuthor ">Prashanth Kumar  Amancha</span>, <span class="hlFld-ContribAuthor ">Jian-Sung  Wu</span>, <span class="hlFld-ContribAuthor ">Mohane Selvaraj  Coumar</span>, <span class="hlFld-ContribAuthor ">Chun-Hwa  Chen</span>, <span class="hlFld-ContribAuthor ">Sing-Yi  Wang</span>, <span class="hlFld-ContribAuthor ">Wen-Hsing  Lin</span>, <span class="hlFld-ContribAuthor ">Hsu-Yi  Sun</span>, <span class="hlFld-ContribAuthor ">Yu-Sheng  Chao</span>, <span class="hlFld-ContribAuthor ">Ping-Chiang  Lyu</span>, <span class="hlFld-ContribAuthor ">Hsing-Pang  Hsieh</span>, and <span class="hlFld-ContribAuthor ">Su-Ying  Wu</span>  . </span><span class="cited-content_cbyCitation_article-title">Protein Kinase Inhibitor Design by Targeting the Asp-Phe-Gly (DFG) Motif: The Role of the DFG Motif in the Design of Epidermal Growth Factor Receptor Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (10)
                                     , 3889-3903. <a href="https://doi.org/10.1021/jm400072p" title="DOI URL">https://doi.org/10.1021/jm400072p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400072p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400072p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProtein%252BKinase%252BInhibitor%252BDesign%252Bby%252BTargeting%252Bthe%252BAsp-Phe-Gly%252B%252528DFG%252529%252BMotif%25253A%252BThe%252BRole%252Bof%252Bthe%252BDFG%252BMotif%252Bin%252Bthe%252BDesign%252Bof%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BInhibitors%26aulast%3DPeng%26aufirst%3DYi-Hui%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D15012013%26date%3D10052013%26date%3D23052013%26date%3D23042013%26volume%3D56%26issue%3D10%26spage%3D3889%26epage%3D3903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James  Solowiej</span>, <span class="hlFld-ContribAuthor ">Jeffrey H.  Chen</span>, <span class="hlFld-ContribAuthor ">Helen Y.  Zou</span>, <span class="hlFld-ContribAuthor ">Stephan K.  Grant</span>, and <span class="hlFld-ContribAuthor ">Brion W.  Murray</span>  . </span><span class="cited-content_cbyCitation_article-title">Substrate-Specific Conformational Regulation of the Receptor Tyrosine Kinase VEGFR2 Catalytic Domain. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2013,</strong> <em>8 </em>
                                    (5)
                                     , 978-986. <a href="https://doi.org/10.1021/cb400040z" title="DOI URL">https://doi.org/10.1021/cb400040z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb400040z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb400040z%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DSubstrate-Specific%252BConformational%252BRegulation%252Bof%252Bthe%252BReceptor%252BTyrosine%252BKinase%252BVEGFR2%252BCatalytic%252BDomain%26aulast%3DSolowiej%26aufirst%3DJames%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D17012013%26date%3D26022013%26date%3D06032013%26date%3D17052013%26date%3D26022013%26volume%3D8%26issue%3D5%26spage%3D978%26epage%3D986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alan B.  Northrup</span>, <span class="hlFld-ContribAuthor ">Matthew H.  Katcher</span>, <span class="hlFld-ContribAuthor ">Michael D.  Altman</span>, <span class="hlFld-ContribAuthor ">Melissa  Chenard</span>, <span class="hlFld-ContribAuthor ">Matthew H.  Daniels</span>, <span class="hlFld-ContribAuthor ">Sujal V.  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Danielle  Falcone</span>, <span class="hlFld-ContribAuthor ">David J.  Guerin</span>, <span class="hlFld-ContribAuthor ">Harold  Hatch</span>, <span class="hlFld-ContribAuthor ">Chaomin  Li</span>, <span class="hlFld-ContribAuthor ">Wei  Lu</span>, <span class="hlFld-ContribAuthor ">Bart  Lutterbach</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Allison</span>, <span class="hlFld-ContribAuthor ">Sangita B.  Patel</span>, <span class="hlFld-ContribAuthor ">John F.  Reilly</span>, <span class="hlFld-ContribAuthor ">Michael  Reutershan</span>, <span class="hlFld-ContribAuthor ">Keith W.  Rickert</span>, <span class="hlFld-ContribAuthor ">Craig  Rosenstein</span>, <span class="hlFld-ContribAuthor ">Stephen M.  Soisson</span>, <span class="hlFld-ContribAuthor ">Alexander A.  Szewczak</span>, <span class="hlFld-ContribAuthor ">Deborah  Walker</span>, <span class="hlFld-ContribAuthor ">Kevin  Wilson</span>, <span class="hlFld-ContribAuthor ">Jonathan R.  Young</span>, <span class="hlFld-ContribAuthor ">Bo-Sheng  Pan</span>, and <span class="hlFld-ContribAuthor ">Christopher J.  Dinsmore</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 1-[3-(1-Methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): A Specific c-Met/Ron Dual Kinase Inhibitor with Preferential Affinity for the Activated State of c-Met. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (6)
                                     , 2294-2310. <a href="https://doi.org/10.1021/jm301619u" title="DOI URL">https://doi.org/10.1021/jm301619u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301619u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301619u%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B1-%25255B3-%2525281-Methyl-1H-pyrazol-4-yl%252529-5-oxo-5H-benzo%25255B4%25252C5%25255Dcyclohepta%25255B1%25252C2-b%25255Dpyridin-7-yl%25255D-N-%252528pyridin-2-ylmethyl%252529methanesulfonamide%252B%252528MK-8033%252529%25253A%252BA%252BSpecific%252Bc-Met%25252FRon%252BDual%252BKinase%252BInhibitor%252Bwith%252BPreferential%252BAffinity%252Bfor%252Bthe%252BActivated%252BState%252Bof%252Bc-Met%26aulast%3DNorthrup%26aufirst%3DAlan%2BB.%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D02112012%26date%3D18032013%26date%3D28032013%26date%3D04022013%26volume%3D56%26issue%3D6%26spage%3D2294%26epage%3D2310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daisuke  Takaya</span>, <span class="hlFld-ContribAuthor ">Tomohiro  Sato</span>, <span class="hlFld-ContribAuthor ">Hitomi  Yuki</span>, <span class="hlFld-ContribAuthor ">Shunta  Sasaki</span>, <span class="hlFld-ContribAuthor ">Akiko  Tanaka</span>, <span class="hlFld-ContribAuthor ">Shigeyuki  Yokoyama</span>, and <span class="hlFld-ContribAuthor ">Teruki  Honma</span>  . </span><span class="cited-content_cbyCitation_article-title">Prediction of Ligand-Induced Structural Polymorphism of Receptor Interaction Sites Using Machine Learning. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2013,</strong> <em>53 </em>
                                    (3)
                                     , 704-716. <a href="https://doi.org/10.1021/ci300458g" title="DOI URL">https://doi.org/10.1021/ci300458g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci300458g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci300458g%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DPrediction%252Bof%252BLigand-Induced%252BStructural%252BPolymorphism%252Bof%252BReceptor%252BInteraction%252BSites%252BUsing%252BMachine%252BLearning%26aulast%3DTakaya%26aufirst%3DDaisuke%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D26092012%26date%3D15022013%26date%3D25032013%26date%3D25012013%26volume%3D53%26issue%3D3%26spage%3D704%26epage%3D716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephan C.  Schürer</span> and <span class="hlFld-ContribAuthor ">Steven M.  Muskal</span>  . </span><span class="cited-content_cbyCitation_article-title">Kinome-wide Activity Modeling from Diverse Public High-Quality Data Sets. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2013,</strong> <em>53 </em>
                                    (1)
                                     , 27-38. <a href="https://doi.org/10.1021/ci300403k" title="DOI URL">https://doi.org/10.1021/ci300403k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci300403k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci300403k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DKinome-wide%252BActivity%252BModeling%252Bfrom%252BDiverse%252BPublic%252BHigh-Quality%252BData%252BSets%26aulast%3DSch%25C3%25BCrer%26aufirst%3DStephan%2BC.%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D24082012%26date%3D09012013%26date%3D28012013%26date%3D21122012%26volume%3D53%26issue%3D1%26spage%3D27%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karine  Lafleur</span>, <span class="hlFld-ContribAuthor ">Jing  Dong</span>, <span class="hlFld-ContribAuthor ">Danzhi  Huang</span>, <span class="hlFld-ContribAuthor ">Amedeo  Caflisch</span>, and <span class="hlFld-ContribAuthor ">Cristina  Nevado</span>  . </span><span class="cited-content_cbyCitation_article-title">Optimization of Inhibitors of the Tyrosine Kinase EphB4. 2. Cellular Potency Improvement and Binding Mode Validation by X-ray Crystallography. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (1)
                                     , 84-96. <a href="https://doi.org/10.1021/jm301187e" title="DOI URL">https://doi.org/10.1021/jm301187e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301187e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301187e%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252BInhibitors%252Bof%252Bthe%252BTyrosine%252BKinase%252BEphB4.%252B2.%252BCellular%252BPotency%252BImprovement%252Band%252BBinding%252BMode%252BValidation%252Bby%252BX-ray%252BCrystallography%26aulast%3DLafleur%26aufirst%3DKarine%26date%3D2013%26date%3D2012%26date%3D2012%26date%3D12082012%26date%3D19122012%26date%3D10012013%26volume%3D56%26issue%3D1%26spage%3D84%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dušica  Vidović</span>, <span class="hlFld-ContribAuthor ">Steven M.  Muskal</span>, and <span class="hlFld-ContribAuthor ">Stephan C.  Schürer</span>  . </span><span class="cited-content_cbyCitation_article-title">Novel Kinase Inhibitors by Reshuffling Ligand Functionalities Across the Human Kinome. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2012,</strong> <em>52 </em>
                                    (12)
                                     , 3107-3115. <a href="https://doi.org/10.1021/ci3003842" title="DOI URL">https://doi.org/10.1021/ci3003842</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci3003842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci3003842%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DNovel%252BKinase%252BInhibitors%252Bby%252BReshuffling%252BLigand%252BFunctionalities%252BAcross%252Bthe%252BHuman%252BKinome%26aulast%3DVidovi%25C4%2587%26aufirst%3DDu%25C5%25A1ica%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D16082012%26date%3D20112012%26date%3D21122012%26date%3D05112012%26volume%3D52%26issue%3D12%26spage%3D3107%26epage%3D3115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pratistha  Ranjitkar</span>, <span class="hlFld-ContribAuthor ">B. Gayani K.  Perera</span>, <span class="hlFld-ContribAuthor ">Daniel L.  Swaney</span>, <span class="hlFld-ContribAuthor ">Sanjay B.  Hari</span>, <span class="hlFld-ContribAuthor ">Eric T.  Larson</span>, <span class="hlFld-ContribAuthor ">Ratika  Krishnamurty</span>, <span class="hlFld-ContribAuthor ">Ethan A.  Merritt</span>, <span class="hlFld-ContribAuthor ">Judit  Villén</span>, and <span class="hlFld-ContribAuthor ">Dustin J.  Maly</span>  . </span><span class="cited-content_cbyCitation_article-title">Affinity-Based Probes Based on Type II Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2012,</strong> <em>134 </em>
                                    (46)
                                     , 19017-19025. <a href="https://doi.org/10.1021/ja306035v" title="DOI URL">https://doi.org/10.1021/ja306035v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja306035v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja306035v%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DAffinity-Based%252BProbes%252BBased%252Bon%252BType%252BII%252BKinase%252BInhibitors%26aulast%3DRanjitkar%26aufirst%3DPratistha%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D20062012%26date%3D06112012%26date%3D21112012%26date%3D22102012%26volume%3D134%26issue%3D46%26spage%3D19017%26epage%3D19025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongtao  Zhao</span>, <span class="hlFld-ContribAuthor ">Jing  Dong</span>, <span class="hlFld-ContribAuthor ">Karine  Lafleur</span>, <span class="hlFld-ContribAuthor ">Cristina  Nevado</span>, and <span class="hlFld-ContribAuthor ">Amedeo  Caflisch</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Novel Chemotype of Tyrosine Kinase Inhibitors by Fragment-Based Docking and Molecular Dynamics. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>3 </em>
                                    (10)
                                     , 834-838. <a href="https://doi.org/10.1021/ml3001984" title="DOI URL">https://doi.org/10.1021/ml3001984</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml3001984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml3001984%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BNovel%252BChemotype%252Bof%252BTyrosine%252BKinase%252BInhibitors%252Bby%252BFragment-Based%252BDocking%252Band%252BMolecular%252BDynamics%26aulast%3DZhao%26aufirst%3DHongtao%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D16072012%26date%3D23082012%26date%3D29082012%26date%3D11102012%26date%3D23082012%26volume%3D3%26issue%3D10%26spage%3D834%26epage%3D838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaolun  Wang</span> and <span class="hlFld-ContribAuthor ">Joseph  Kim</span>  . </span><span class="cited-content_cbyCitation_article-title">Conformation-Specific Effects of Raf Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (17)
                                     , 7332-7341. <a href="https://doi.org/10.1021/jm300613w" title="DOI URL">https://doi.org/10.1021/jm300613w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300613w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300613w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DConformation-Specific%252BEffects%252Bof%252BRaf%252BKinase%252BInhibitors%26aulast%3DWang%26aufirst%3DXiaolun%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D03052012%26date%3D03082012%26date%3D13092012%26date%3D18072012%26volume%3D55%26issue%3D17%26spage%3D7332%26epage%3D7341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Megumi  Ikemori-Kawada</span>, <span class="hlFld-ContribAuthor ">Atsushi  Inoue</span>, <span class="hlFld-ContribAuthor ">Masaki  Goto</span>, <span class="hlFld-ContribAuthor ">Yuan John  Wang</span>, and <span class="hlFld-ContribAuthor ">Yoshiyuki  Kawakami</span>  . </span><span class="cited-content_cbyCitation_article-title">Docking Simulation Study and Kinase Selectivity of f152A1 and Its Analogs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2012,</strong> <em>52 </em>
                                    (8)
                                     , 2059-2068. <a href="https://doi.org/10.1021/ci300135g" title="DOI URL">https://doi.org/10.1021/ci300135g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci300135g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci300135g%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DDocking%252BSimulation%252BStudy%252Band%252BKinase%252BSelectivity%252Bof%252Bf152A1%252Band%252BIts%252BAnalogs%26aulast%3DIkemori-Kawada%26aufirst%3DMegumi%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D13032012%26date%3D09082012%26date%3D27082012%26date%3D25072012%26volume%3D52%26issue%3D8%26spage%3D2059%26epage%3D2068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ken-ichi  Kusakabe</span>, <span class="hlFld-ContribAuthor ">Nobuyuki  Ide</span>, <span class="hlFld-ContribAuthor ">Yataro  Daigo</span>, <span class="hlFld-ContribAuthor ">Takeshi  Itoh</span>, <span class="hlFld-ContribAuthor ">Kenichi  Higashino</span>, <span class="hlFld-ContribAuthor ">Yousuke  Okano</span>, <span class="hlFld-ContribAuthor ">Genta  Tadano</span>, <span class="hlFld-ContribAuthor ">Yuki  Tachibana</span>, <span class="hlFld-ContribAuthor ">Yuji  Sato</span>, <span class="hlFld-ContribAuthor ">Makiko  Inoue</span>, <span class="hlFld-ContribAuthor ">Tooru  Wada</span>, <span class="hlFld-ContribAuthor ">Motofumi  Iguchi</span>, <span class="hlFld-ContribAuthor ">Takayuki  Kanazawa</span>, <span class="hlFld-ContribAuthor ">Yukichi  Ishioka</span>, <span class="hlFld-ContribAuthor ">Keiji  Dohi</span>, <span class="hlFld-ContribAuthor ">Sachie  Tagashira</span>, <span class="hlFld-ContribAuthor ">Yasuto  Kido</span>, <span class="hlFld-ContribAuthor ">Shingo  Sakamoto</span>, <span class="hlFld-ContribAuthor ">Kazuya  Yasuo</span>, <span class="hlFld-ContribAuthor ">Masahiro  Maeda</span>, <span class="hlFld-ContribAuthor ">Takahiko  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Masayo  Higaki</span>, <span class="hlFld-ContribAuthor ">Takeshi  Endoh</span>, <span class="hlFld-ContribAuthor ">Kazuo  Ueda</span>, <span class="hlFld-ContribAuthor ">Takeshi  Shiota</span>, <span class="hlFld-ContribAuthor ">Hitoshi  Murai</span>, and <span class="hlFld-ContribAuthor ">Yusuke  Nakamura</span>  . </span><span class="cited-content_cbyCitation_article-title">Diaminopyridine-Based Potent and Selective Mps1 Kinase Inhibitors Binding to an Unusual Flipped-Peptide Conformation. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>3 </em>
                                    (7)
                                     , 560-564. <a href="https://doi.org/10.1021/ml3000879" title="DOI URL">https://doi.org/10.1021/ml3000879</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml3000879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml3000879%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiaminopyridine-Based%252BPotent%252Band%252BSelective%252BMps1%252BKinase%252BInhibitors%252BBinding%252Bto%252Ban%252BUnusual%252BFlipped-Peptide%252BConformation%26aulast%3DKusakabe%26aufirst%3DKen-ichi%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D07042012%26date%3D06062012%26date%3D07062012%26date%3D12072012%26date%3D06062012%26volume%3D3%26issue%3D7%26spage%3D560%26epage%3D564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richard A.  Norman</span>, <span class="hlFld-ContribAuthor ">Anne-Kathrin  Schott</span>, <span class="hlFld-ContribAuthor ">David M.  Andrews</span>, <span class="hlFld-ContribAuthor ">Jason  Breed</span>, <span class="hlFld-ContribAuthor ">Kevin M.  Foote</span>, <span class="hlFld-ContribAuthor ">Andrew P.  Garner</span>, <span class="hlFld-ContribAuthor ">Derek  Ogg</span>, <span class="hlFld-ContribAuthor ">Jonathon P.  Orme</span>, <span class="hlFld-ContribAuthor ">Jennifer H.  Pink</span>, <span class="hlFld-ContribAuthor ">Karen  Roberts</span>, <span class="hlFld-ContribAuthor ">David A.  Rudge</span>, <span class="hlFld-ContribAuthor ">Andrew P.  Thomas</span>, and <span class="hlFld-ContribAuthor ">Andrew G.  Leach</span>  . </span><span class="cited-content_cbyCitation_article-title">Protein–Ligand Crystal Structures Can Guide the Design of Selective Inhibitors of the FGFR Tyrosine Kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (11)
                                     , 5003-5012. <a href="https://doi.org/10.1021/jm3004043" title="DOI URL">https://doi.org/10.1021/jm3004043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3004043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3004043%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProtein%2525E2%252580%252593Ligand%252BCrystal%252BStructures%252BCan%252BGuide%252Bthe%252BDesign%252Bof%252BSelective%252BInhibitors%252Bof%252Bthe%252BFGFR%252BTyrosine%252BKinase%26aulast%3DNorman%26aufirst%3DRichard%2BA.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D15112011%26date%3D21052012%26date%3D14062012%26volume%3D55%26issue%3D11%26spage%3D5003%26epage%3D5012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Obdulia  Rabal</span> and <span class="hlFld-ContribAuthor ">Julen  Oyarzabal</span>  . </span><span class="cited-content_cbyCitation_article-title">Using Novel Descriptor Accounting for Ligand–Receptor Interactions To Define and Visually Explore Biologically Relevant Chemical Space. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2012,</strong> <em>52 </em>
                                    (5)
                                     , 1086-1102. <a href="https://doi.org/10.1021/ci200627v" title="DOI URL">https://doi.org/10.1021/ci200627v</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci200627v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci200627v%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DUsing%252BNovel%252BDescriptor%252BAccounting%252Bfor%252BLigand%2525E2%252580%252593Receptor%252BInteractions%252BTo%252BDefine%252Band%252BVisually%252BExplore%252BBiologically%252BRelevant%252BChemical%252BSpace%26aulast%3DRabal%26aufirst%3DObdulia%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D29122011%26date%3D19042012%26date%3D25052012%26date%3D08042012%26volume%3D52%26issue%3D5%26spage%3D1086%26epage%3D1102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matteo  Chioccioli</span>, <span class="hlFld-ContribAuthor ">Simone  Marsili</span>, <span class="hlFld-ContribAuthor ">Claudia  Bonaccini</span>, <span class="hlFld-ContribAuthor ">Piero  Procacci</span>, and <span class="hlFld-ContribAuthor ">Paola  Gratteri</span>  . </span><span class="cited-content_cbyCitation_article-title">Insights into the Conformational Switching Mechanism of the Human Vascular Endothelial Growth Factor Receptor Type 2 Kinase Domain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2012,</strong> <em>52 </em>
                                    (2)
                                     , 483-491. <a href="https://doi.org/10.1021/ci200513a" title="DOI URL">https://doi.org/10.1021/ci200513a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci200513a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci200513a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DInsights%252Binto%252Bthe%252BConformational%252BSwitching%252BMechanism%252Bof%252Bthe%252BHuman%252BVascular%252BEndothelial%252BGrowth%252BFactor%252BReceptor%252BType%252B2%252BKinase%252BDomain%26aulast%3DChioccioli%26aufirst%3DMatteo%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D26102011%26date%3D23012012%26date%3D27022012%26date%3D10012012%26volume%3D52%26issue%3D2%26spage%3D483%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marian C.  Bryan</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Elizabeth M.  Doherty</span>, <span class="hlFld-ContribAuthor ">James R.  Falsey</span>, <span class="hlFld-ContribAuthor ">Alan C.  Cheng</span>, <span class="hlFld-ContribAuthor ">Renee  Emkey</span>, <span class="hlFld-ContribAuthor ">Rachael L.  Brake</span>, and <span class="hlFld-ContribAuthor ">Richard T.  Lewis</span>  . </span><span class="cited-content_cbyCitation_article-title">Rapid Development of Piperidine Carboxamides as Potent and Selective Anaplastic Lymphoma Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (4)
                                     , 1698-1705. <a href="https://doi.org/10.1021/jm201565s" title="DOI URL">https://doi.org/10.1021/jm201565s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201565s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201565s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRapid%252BDevelopment%252Bof%252BPiperidine%252BCarboxamides%252Bas%252BPotent%252Band%252BSelective%252BAnaplastic%252BLymphoma%252BKinase%252BInhibitors%26aulast%3DBryan%26aufirst%3DMarian%2BC.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D21112011%26date%3D09022012%26date%3D23022012%26date%3D20012012%26volume%3D55%26issue%3D4%26spage%3D1698%26epage%3D1705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian  Delvare</span>, <span class="hlFld-ContribAuthor ">Craig S.  Harris</span>, <span class="hlFld-ContribAuthor ">Laurent  Hennequin</span>, <span class="hlFld-ContribAuthor ">Patrice  Koza</span>, <span class="hlFld-ContribAuthor ">Christine  Lambert-van der Brempt</span>, <span class="hlFld-ContribAuthor ">Jacques  Pelleter</span>, and <span class="hlFld-ContribAuthor ">Olivier  Willerval</span>  . </span><span class="cited-content_cbyCitation_article-title">Efficient Three-Step One-Pot Synthesis of a Novel 2,3,5-Substituted Pyrazine Library. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2011,</strong> <em>13 </em>
                                    (5)
                                     , 449-452. <a href="https://doi.org/10.1021/co200062n" title="DOI URL">https://doi.org/10.1021/co200062n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/co200062n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fco200062n%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DEfficient%252BThree-Step%252BOne-Pot%252BSynthesis%252Bof%252Ba%252BNovel%252B2%25252C3%25252C5-Substituted%252BPyrazine%252BLibrary%26aulast%3DDelvare%26aufirst%3DChristian%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D03042011%26date%3D06062011%26date%3D01072011%26date%3D12092011%26date%3D07062011%26volume%3D13%26issue%3D5%26spage%3D449%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephane  Betzi</span>, <span class="hlFld-ContribAuthor ">Riazul  Alam</span>, <span class="hlFld-ContribAuthor ">Mathew  Martin</span>, <span class="hlFld-ContribAuthor ">Donna J.  Lubbers</span>, <span class="hlFld-ContribAuthor ">Huijong  Han</span>, <span class="hlFld-ContribAuthor ">Sudhakar R.  Jakkaraj</span>, <span class="hlFld-ContribAuthor ">Gunda I.  Georg</span>, and <span class="hlFld-ContribAuthor ">Ernst  Schönbrunn</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potential Allosteric Ligand Binding Site in CDK2. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2011,</strong> <em>6 </em>
                                    (5)
                                     , 492-501. <a href="https://doi.org/10.1021/cb100410m" title="DOI URL">https://doi.org/10.1021/cb100410m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb100410m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb100410m%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DDiscovery%252Bof%252Ba%252BPotential%252BAllosteric%252BLigand%252BBinding%252BSite%252Bin%252BCDK2%26aulast%3DBetzi%26aufirst%3DStephane%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D15122010%26date%3D03022011%26date%3D22022011%26date%3D20052011%26date%3D03022011%26volume%3D6%26issue%3D5%26spage%3D492%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emeline  Leproult</span>, <span class="hlFld-ContribAuthor ">Sofia  Barluenga</span>, <span class="hlFld-ContribAuthor ">Dino  Moras</span>, <span class="hlFld-ContribAuthor ">Jean-Marie  Wurtz</span>, and <span class="hlFld-ContribAuthor ">Nicolas  Winssinger</span>  . </span><span class="cited-content_cbyCitation_article-title">Cysteine Mapping in Conformationally Distinct Kinase Nucleotide Binding Sites: Application to the Design of Selective Covalent Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (5)
                                     , 1347-1355. <a href="https://doi.org/10.1021/jm101396q" title="DOI URL">https://doi.org/10.1021/jm101396q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm101396q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm101396q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCysteine%252BMapping%252Bin%252BConformationally%252BDistinct%252BKinase%252BNucleotide%252BBinding%252BSites%25253A%252BApplication%252Bto%252Bthe%252BDesign%252Bof%252BSelective%252BCovalent%252BInhibitors%26aulast%3DLeproult%26aufirst%3DEmeline%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D28102010%26date%3D15022011%26date%3D10032011%26volume%3D54%26issue%3D5%26spage%3D1347%26epage%3D1355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Preethi  Badrinarayan</span> and <span class="hlFld-ContribAuthor ">G. Narahari  Sastry</span>. </span><span class="cited-content_cbyCitation_article-title">Sequence, Structure, and Active Site Analyses of p38 MAP Kinase: Exploiting DFG-out Conformation as a Strategy to Design New Type II Leads. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2011,</strong> <em>51 </em>
                                    (1)
                                     , 115-129. <a href="https://doi.org/10.1021/ci100340w" title="DOI URL">https://doi.org/10.1021/ci100340w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci100340w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci100340w%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DSequence%25252C%252BStructure%25252C%252Band%252BActive%252BSite%252BAnalyses%252Bof%252Bp38%252BMAP%252BKinase%25253A%252BExploiting%252BDFG-out%252BConformation%252Bas%252Ba%252BStrategy%252Bto%252BDesign%252BNew%252BType%252BII%252BLeads%26aulast%3DBadrinarayan%26aufirst%3DPreethi%26date%3D2011%26date%3D2010%26date%3D2010%26date%3D1%252009%25202010%26date%3D08122010%26date%3D24012011%26volume%3D51%26issue%3D1%26spage%3D115%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Runzhi  Wu</span>, <span class="hlFld-ContribAuthor ">Eric D.  Smidansky</span>, <span class="hlFld-ContribAuthor ">Hyung Suk  Oh</span>, <span class="hlFld-ContribAuthor ">Ratree  Takhampunya</span>, <span class="hlFld-ContribAuthor ">Radhakrishnan  Padmanabhan</span>, <span class="hlFld-ContribAuthor ">Craig E.  Cameron</span>, and <span class="hlFld-ContribAuthor ">Blake R.  Peterson</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of a 6-Methyl-7-deaza Analogue of Adenosine That Potently Inhibits Replication of Polio and Dengue Viruses. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (22)
                                     , 7958-7966. <a href="https://doi.org/10.1021/jm100593s" title="DOI URL">https://doi.org/10.1021/jm100593s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100593s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100593s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252Ba%252B6-Methyl-7-deaza%252BAnalogue%252Bof%252BAdenosine%252BThat%252BPotently%252BInhibits%252BReplication%252Bof%252BPolio%252Band%252BDengue%252BViruses%26aulast%3DWu%26aufirst%3DRunzhi%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D18052010%26date%3D22102010%26date%3D25112010%26volume%3D53%26issue%3D22%26spage%3D7958%26epage%3D7966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel K.  Whelligan</span>, <span class="hlFld-ContribAuthor ">Savade  Solanki</span>, <span class="hlFld-ContribAuthor ">Dawn  Taylor</span>, <span class="hlFld-ContribAuthor ">Douglas W.  Thomson</span>, <span class="hlFld-ContribAuthor ">Kwai-Ming J.  Cheung</span>, <span class="hlFld-ContribAuthor ">Kathy  Boxall</span>, <span class="hlFld-ContribAuthor ">Corine  Mas-Droux</span>, <span class="hlFld-ContribAuthor ">Caterina  Barillari</span>, <span class="hlFld-ContribAuthor ">Samantha  Burns</span>, <span class="hlFld-ContribAuthor ">Charles G.  Grummitt</span>, <span class="hlFld-ContribAuthor ">Ian  Collins</span>, <span class="hlFld-ContribAuthor ">Rob L. M.  van Montfort</span>, <span class="hlFld-ContribAuthor ">G. Wynne  Aherne</span>, <span class="hlFld-ContribAuthor ">Richard  Bayliss</span>, and <span class="hlFld-ContribAuthor ">Swen  Hoelder</span>  . </span><span class="cited-content_cbyCitation_article-title">Aminopyrazine Inhibitors Binding to an Unusual Inactive Conformation of the Mitotic Kinase Nek2: SAR and Structural Characterization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (21)
                                     , 7682-7698. <a href="https://doi.org/10.1021/jm1008727" title="DOI URL">https://doi.org/10.1021/jm1008727</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm1008727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm1008727%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAminopyrazine%252BInhibitors%252BBinding%252Bto%252Ban%252BUnusual%252BInactive%252BConformation%252Bof%252Bthe%252BMitotic%252BKinase%252BNek2%25253A%252BSAR%252Band%252BStructural%252BCharacterization%26aulast%3DWhelligan%26aufirst%3DDaniel%2BK.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D13072010%26date%3D11102010%26date%3D11112010%26volume%3D53%26issue%3D21%26spage%3D7682%26epage%3D7698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Govindan  Subramanian</span> and <span class="hlFld-ContribAuthor ">Manish  Sud</span>  . </span><span class="cited-content_cbyCitation_article-title">Computational Modeling of Kinase Inhibitor Selectivity. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>1 </em>
                                    (8)
                                     , 395-399. <a href="https://doi.org/10.1021/ml1001097" title="DOI URL">https://doi.org/10.1021/ml1001097</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml1001097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml1001097%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DComputational%252BModeling%252Bof%252BKinase%252BInhibitor%252BSelectivity%26aulast%3DSubramanian%26aufirst%3DGovindan%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D11052010%26date%3D26072010%26date%3D28072010%26date%3D11112010%26volume%3D1%26issue%3D8%26spage%3D395%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victor J.  Cee</span>, <span class="hlFld-ContribAuthor ">Laurie B.  Schenkel</span>, <span class="hlFld-ContribAuthor ">Brian L.  Hodous</span>, <span class="hlFld-ContribAuthor ">Holly L.  Deak</span>, <span class="hlFld-ContribAuthor ">Hanh N.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Philip R.  Olivieri</span>, <span class="hlFld-ContribAuthor ">Karina  Romero</span>, <span class="hlFld-ContribAuthor ">Annette  Bak</span>, <span class="hlFld-ContribAuthor ">Xuhai  Be</span>, <span class="hlFld-ContribAuthor ">Steve  Bellon</span>, <span class="hlFld-ContribAuthor ">Tammy L.  Bush</span>, <span class="hlFld-ContribAuthor ">Alan C.  Cheng</span>, <span class="hlFld-ContribAuthor ">Grace  Chung</span>, <span class="hlFld-ContribAuthor ">Steve  Coats</span>, <span class="hlFld-ContribAuthor ">Patrick M.  Eden</span>, <span class="hlFld-ContribAuthor ">Kelly  Hanestad</span>, <span class="hlFld-ContribAuthor ">Paul L.  Gallant</span>, <span class="hlFld-ContribAuthor ">Yan  Gu</span>, <span class="hlFld-ContribAuthor ">Xin  Huang</span>, <span class="hlFld-ContribAuthor ">Richard L.  Kendall</span>, <span class="hlFld-ContribAuthor ">Min-Hwa Jasmine  Lin</span>, <span class="hlFld-ContribAuthor ">Michael J.  Morrison</span>, <span class="hlFld-ContribAuthor ">Vinod F.  Patel</span>, <span class="hlFld-ContribAuthor ">Robert  Radinsky</span>, <span class="hlFld-ContribAuthor ">Paul E.  Rose</span>, <span class="hlFld-ContribAuthor ">Sandra  Ross</span>, <span class="hlFld-ContribAuthor ">Ji-Rong  Sun</span>, <span class="hlFld-ContribAuthor ">Jin  Tang</span>, <span class="hlFld-ContribAuthor ">Huilin  Zhao</span>, <span class="hlFld-ContribAuthor ">Marc  Payton</span> and <span class="hlFld-ContribAuthor ">Stephanie D.  Geuns-Meyer</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent, Selective, and Orally Bioavailable Pyridinyl-Pyrimidine Phthalazine Aurora Kinase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (17)
                                     , 6368-6377. <a href="https://doi.org/10.1021/jm100394y" title="DOI URL">https://doi.org/10.1021/jm100394y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100394y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100394y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BBioavailable%252BPyridinyl-Pyrimidine%252BPhthalazine%252BAurora%252BKinase%252BInhibitor%26aulast%3DCee%26aufirst%3DVictor%2BJ.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D29032010%26date%3D04082010%26date%3D09092010%26volume%3D53%26issue%3D17%26spage%3D6368%26epage%3D6377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Wu</span>, <span class="hlFld-ContribAuthor ">Hui-Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Liping  Pettus</span>, <span class="hlFld-ContribAuthor ">Ryan P.  Wurz</span>, <span class="hlFld-ContribAuthor ">Elizabeth M.  Doherty</span>, <span class="hlFld-ContribAuthor ">Bradley  Henkle</span>, <span class="hlFld-ContribAuthor ">Helen J.  McBride</span>, <span class="hlFld-ContribAuthor ">Christiaan J. M.  Saris</span>, <span class="hlFld-ContribAuthor ">Lu Min  Wong</span>, <span class="hlFld-ContribAuthor ">Matthew H.  Plant</span>, <span class="hlFld-ContribAuthor ">Lisa  Sherman</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Lee</span>, <span class="hlFld-ContribAuthor ">Faye  Hsieh</span> and <span class="hlFld-ContribAuthor ">Andrew S.  Tasker</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Pyridazinopyridinones as Potent and Selective p38 Mitogen-Activated Protein Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>53 </em>
                                    (17)
                                     , 6398-6411. <a href="https://doi.org/10.1021/jm100567y" title="DOI URL">https://doi.org/10.1021/jm100567y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm100567y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm100567y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPyridazinopyridinones%252Bas%252BPotent%252Band%252BSelective%252Bp38%252BMitogen-Activated%252BProtein%252BKinase%252BInhibitors%26aulast%3DWu%26aufirst%3DBin%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D10052010%26date%3D16082010%26date%3D09092010%26volume%3D53%26issue%3D17%26spage%3D6398%26epage%3D6411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Yu</span>, <span class="hlFld-ContribAuthor ">Jayaram R.  Tagat</span>, <span class="hlFld-ContribAuthor ">Angela D.  Kerekes</span>, <span class="hlFld-ContribAuthor ">Ronald J.  Doll</span>, <span class="hlFld-ContribAuthor ">Yonglian  Zhang</span>, <span class="hlFld-ContribAuthor ">Yushi  Xiao</span>, <span class="hlFld-ContribAuthor ">Sara  Esposite</span>, <span class="hlFld-ContribAuthor ">David B.  Belanger</span>, <span class="hlFld-ContribAuthor ">Patrick J.  Curran</span>, <span class="hlFld-ContribAuthor ">Amit K.  Mandal</span>, <span class="hlFld-ContribAuthor ">M. Arshad  Siddiqui</span>, <span class="hlFld-ContribAuthor ">Neng-Yang  Shih</span>, <span class="hlFld-ContribAuthor ">Andrea D.  Basso</span>, <span class="hlFld-ContribAuthor ">Ming  Liu</span>, <span class="hlFld-ContribAuthor ">Kimberly  Gray</span>, <span class="hlFld-ContribAuthor ">Seema  Tevar</span>, <span class="hlFld-ContribAuthor ">Jennifer  Jones</span>, <span class="hlFld-ContribAuthor ">Suining  Lee</span>, <span class="hlFld-ContribAuthor ">Lianzhu  Liang</span>, <span class="hlFld-ContribAuthor ">Samad  Ponery</span>, <span class="hlFld-ContribAuthor ">Elizabeth B.  Smith</span>, <span class="hlFld-ContribAuthor ">Alan  Hruza</span>, <span class="hlFld-ContribAuthor ">Johannes  Voigt</span>, <span class="hlFld-ContribAuthor ">Lata  Ramanathan</span>, <span class="hlFld-ContribAuthor ">Winifred  Prosise</span> and <span class="hlFld-ContribAuthor ">Mengwei  Hu</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent, Injectable Inhibitor of Aurora Kinases Based on the Imidazo-[1,2-a]-Pyrazine Core. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>1 </em>
                                    (5)
                                     , 214-218. <a href="https://doi.org/10.1021/ml100063w" title="DOI URL">https://doi.org/10.1021/ml100063w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml100063w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml100063w%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%25252C%252BInjectable%252BInhibitor%252Bof%252BAurora%252BKinases%252BBased%252Bon%252Bthe%252BImidazo-%25255B1%25252C2-a%25255D-Pyrazine%252BCore%26aulast%3DYu%26aufirst%3DTao%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D31032010%26date%3D14052010%26date%3D07062010%26date%3D12082010%26volume%3D1%26issue%3D5%26spage%3D214%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Zhong  Chen</span>, <span class="hlFld-ContribAuthor ">Qiu–Yang  Huang</span>, <span class="hlFld-ContribAuthor ">Xiu-Yan  Yu</span>, <span class="hlFld-ContribAuthor ">Chen  Dai</span>, <span class="hlFld-ContribAuthor ">Yan  Shen</span>, <span class="hlFld-ContribAuthor ">Zhi-Hua  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Insights into the structural requirements of PKCζ inhibitors as potential anti-arthritis agents based on 3D-QSAR, homology modeling and docking approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1246 </em>, 131148. <a href="https://doi.org/10.1016/j.molstruc.2021.131148" title="DOI URL">https://doi.org/10.1016/j.molstruc.2021.131148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2021.131148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2021.131148%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DInsights%252Binto%252Bthe%252Bstructural%252Brequirements%252Bof%252BPKC%2525CE%2525B6%252Binhibitors%252Bas%252Bpotential%252Banti-arthritis%252Bagents%252Bbased%252Bon%252B3D-QSAR%25252C%252Bhomology%252Bmodeling%252Band%252Bdocking%252Bapproach%26aulast%3DChen%26aufirst%3DXiao-Zhong%26date%3D2021%26volume%3D1246%26spage%3D131148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ni Made Pitri  Susanti</span>, <span class="hlFld-ContribAuthor ">Daryono Hadi  Tjahjono</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclin-Dependent Kinase 4 and 6 Inhibitors in Cell Cycle Dysregulation for Breast Cancer Treatment. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (15)
                                     , 4462. <a href="https://doi.org/10.3390/molecules26154462" title="DOI URL">https://doi.org/10.3390/molecules26154462</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26154462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26154462%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DCyclin-Dependent%252BKinase%252B4%252Band%252B6%252BInhibitors%252Bin%252BCell%252BCycle%252BDysregulation%252Bfor%252BBreast%252BCancer%252BTreatment%26aulast%3DSusanti%26aufirst%3DNi%2BMade%2BPitri%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D15%26spage%3D4462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Roskoski</span>. </span><span class="cited-content_cbyCitation_article-title">Hydrophobic and polar interactions of FDA-approved small molecule protein kinase inhibitors with their target enzymes. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2021,</strong> <em>169 </em>, 105660. <a href="https://doi.org/10.1016/j.phrs.2021.105660" title="DOI URL">https://doi.org/10.1016/j.phrs.2021.105660</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2021.105660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2021.105660%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DHydrophobic%252Band%252Bpolar%252Binteractions%252Bof%252BFDA-approved%252Bsmall%252Bmolecule%252Bprotein%252Bkinase%252Binhibitors%252Bwith%252Btheir%252Btarget%252Benzymes%26aulast%3DRoskoski%26aufirst%3DRobert%26date%3D2021%26volume%3D169%26spage%3D105660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francisco Carlos  da Silva</span>, <span class="hlFld-ContribAuthor ">Alessandra Hübner  de Souza</span>, <span class="hlFld-ContribAuthor ">Bruna Kempfer  Bassoli</span>, <span class="hlFld-ContribAuthor ">Gleiciane Alves  Prates</span>, <span class="hlFld-ContribAuthor ">Cíntia  Daudt</span>, <span class="hlFld-ContribAuthor ">Dionatas Ulises de Oliveira  Meneguetti</span>, <span class="hlFld-ContribAuthor ">Áurea Pandolfo  Corrêa</span>, <span class="hlFld-ContribAuthor ">Iasmine Berbigier  de Oliveira</span>, <span class="hlFld-ContribAuthor ">Sandro de Vargas  Schons</span>, <span class="hlFld-ContribAuthor ">Maria Fernanda Pessano  Fialho</span>, <span class="hlFld-ContribAuthor ">Dione Silva  Correa</span>, <span class="hlFld-ContribAuthor ">Jaqueline Nascimento  Picada</span>, <span class="hlFld-ContribAuthor ">Alexandre de Barros Falcão  Ferraz</span>. </span><span class="cited-content_cbyCitation_article-title">Myrciaria dubia
              Juice (camu-camu) Exhibits Analgesic and Antiedematogenic Activities in Mice. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Food</span><span> <strong>2021,</strong> <em>24 </em>
                                    (6)
                                     , 626-634. <a href="https://doi.org/10.1089/jmf.2020.0094" title="DOI URL">https://doi.org/10.1089/jmf.2020.0094</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/jmf.2020.0094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fjmf.2020.0094%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Food%26atitle%3DMyrciaria%252Bdubia%252BJuice%252B%252528camu-camu%252529%252BExhibits%252BAnalgesic%252Band%252BAntiedematogenic%252BActivities%252Bin%252BMice%26aulast%3Dda%2BSilva%26aufirst%3DFrancisco%2BCarlos%26date%3D2021%26volume%3D24%26issue%3D6%26spage%3D626%26epage%3D634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrés Felipe  Vásquez</span>, <span class="hlFld-ContribAuthor ">Andrés Fernando  González Barrios</span>. </span><span class="cited-content_cbyCitation_article-title">Classical MD and metadynamics simulations on back-pocket binders of CDK2 and VEGFR2: a guidepost to design novel small-molecule dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>6 </em>, 1-12. <a href="https://doi.org/10.1080/07391102.2021.1922311" title="DOI URL">https://doi.org/10.1080/07391102.2021.1922311</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1922311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1922311%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DClassical%252BMD%252Band%252Bmetadynamics%252Bsimulations%252Bon%252Bback-pocket%252Bbinders%252Bof%252BCDK2%252Band%252BVEGFR2%25253A%252Ba%252Bguidepost%252Bto%252Bdesign%252Bnovel%252Bsmall-molecule%252Bdual%252Binhibitors%26aulast%3DV%25C3%25A1squez%26aufirst%3DAndr%25C3%25A9s%2BFelipe%26date%3D2021%26date%3D2021%26volume%3D6%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingyu  Zhu</span>, <span class="hlFld-ContribAuthor ">Kan  Li</span>, <span class="hlFld-ContribAuthor ">Li  Yu</span>, <span class="hlFld-ContribAuthor ">Yun  Chen</span>, <span class="hlFld-ContribAuthor ">Yanfei  Cai</span>, <span class="hlFld-ContribAuthor ">Jian  Jin</span>, <span class="hlFld-ContribAuthor ">Tingjun  Hou</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting phosphatidylinositol 3‐kinase gamma (PI3Kγ): Discovery and development of its selective inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2021,</strong> <em>41 </em>
                                    (3)
                                     , 1599-1621. <a href="https://doi.org/10.1002/med.21770" title="DOI URL">https://doi.org/10.1002/med.21770</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21770%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DTargeting%252Bphosphatidylinositol%252B3%2525E2%252580%252590kinase%252Bgamma%252B%252528PI3K%2525CE%2525B3%252529%25253A%252BDiscovery%252Band%252Bdevelopment%252Bof%252Bits%252Bselective%252Binhibitors%26aulast%3DZhu%26aufirst%3DJingyu%26date%3D2021%26date%3D2020%26volume%3D41%26issue%3D3%26spage%3D1599%26epage%3D1621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Débora Bublitz  Anton</span>, <span class="hlFld-ContribAuthor ">Rodrigo Gay  Ducati</span>, <span class="hlFld-ContribAuthor ">Luís Fernando Saraiva Macedo  Timmers</span>, <span class="hlFld-ContribAuthor ">Stefan  Laufer</span>, <span class="hlFld-ContribAuthor ">Márcia Inês  Goettert</span>. </span><span class="cited-content_cbyCitation_article-title">A Special View of What Was Almost Forgotten: p38δ MAPK. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (9)
                                     , 2077. <a href="https://doi.org/10.3390/cancers13092077" title="DOI URL">https://doi.org/10.3390/cancers13092077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13092077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13092077%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DA%252BSpecial%252BView%252Bof%252BWhat%252BWas%252BAlmost%252BForgotten%25253A%252Bp38%2525CE%2525B4%252BMAPK%26aulast%3DAnton%26aufirst%3DD%25C3%25A9bora%2BBublitz%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D9%26spage%3D2077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert M.  Borzilleri</span>, <span class="hlFld-ContribAuthor ">Amy C.  Hart</span>, <span class="hlFld-ContribAuthor ">Ryan  Moslin</span>, <span class="hlFld-ContribAuthor ">John S.  Tokarski</span>, <span class="hlFld-ContribAuthor ">Stephen T.  Wrobleski</span>. </span><span class="cited-content_cbyCitation_article-title">JAK
              Family Inhibitors for Autoimmune Diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-86. <a href="https://doi.org/10.1002/0471266949.bmc279" title="DOI URL">https://doi.org/10.1002/0471266949.bmc279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc279%26sid%3Dliteratum%253Aachs%26atitle%3DJAK%252BFamily%252BInhibitors%252Bfor%252BAutoimmune%252BDiseases%26aulast%3DBorzilleri%26aufirst%3DRobert%2BM.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D86%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingfeng  Yu</span>, <span class="hlFld-ContribAuthor ">Solomon  Tadesse</span>, <span class="hlFld-ContribAuthor ">Shudong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">US FDA‐Approved Small‐Molecule Kinase Inhibitors for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-65. <a href="https://doi.org/10.1002/0471266949.bmc214.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc214.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc214.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc214.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DUS%252BFDA%2525E2%252580%252590Approved%252BSmall%2525E2%252580%252590Molecule%252BKinase%252BInhibitors%252Bfor%252BCancer%252BTherapy%26aulast%3DYu%26aufirst%3DMingfeng%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D65%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdallah E.  Abdallah</span>, <span class="hlFld-ContribAuthor ">Sally I.  Eissa</span>, <span class="hlFld-ContribAuthor ">Maged Mohammed Saleh  Al Ward</span>, <span class="hlFld-ContribAuthor ">Reda R.  Mabrouk</span>, <span class="hlFld-ContribAuthor ">Ahmed B.M.  Mehany</span>, <span class="hlFld-ContribAuthor ">Mohamed Ayman  El-Zahabi</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and molecular modeling of new quinazolin-4(3H)-one based VEGFR-2 kinase inhibitors for potential anticancer evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>109 </em>, 104695. <a href="https://doi.org/10.1016/j.bioorg.2021.104695" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104695</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104695%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bmolecular%252Bmodeling%252Bof%252Bnew%252Bquinazolin-4%2525283H%252529-one%252Bbased%252BVEGFR-2%252Bkinase%252Binhibitors%252Bfor%252Bpotential%252Banticancer%252Bevaluation%26aulast%3DAbdallah%26aufirst%3DAbdallah%2BE.%26date%3D2021%26volume%3D109%26spage%3D104695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prateek  Pathak</span>, <span class="hlFld-ContribAuthor ">Hrvoje  Rimac</span>, <span class="hlFld-ContribAuthor ">Maria  Grishina</span>, <span class="hlFld-ContribAuthor ">Amita  Verma</span>, <span class="hlFld-ContribAuthor ">Vladimir  Potemkin</span>. </span><span class="cited-content_cbyCitation_article-title">Hybrid Quinazoline 1,3,5‐Triazines as Epidermal Growth Factor Receptor (EGFR) Inhibitors with Anticancer Activity: Design, Synthesis, and Computational Study. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (5)
                                     , 822-838. <a href="https://doi.org/10.1002/cmdc.202000646" title="DOI URL">https://doi.org/10.1002/cmdc.202000646</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000646%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DHybrid%252BQuinazoline%252B1%25252C3%25252C5%2525E2%252580%252590Triazines%252Bas%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252B%252528EGFR%252529%252BInhibitors%252Bwith%252BAnticancer%252BActivity%25253A%252BDesign%25252C%252BSynthesis%25252C%252Band%252BComputational%252BStudy%26aulast%3DPathak%26aufirst%3DPrateek%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D5%26spage%3D822%26epage%3D838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Roskoski</span>. </span><span class="cited-content_cbyCitation_article-title">Orally effective FDA-approved protein kinase targeted covalent inhibitors (TCIs). </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2021,</strong> <em>165 </em>, 105422. <a href="https://doi.org/10.1016/j.phrs.2021.105422" title="DOI URL">https://doi.org/10.1016/j.phrs.2021.105422</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2021.105422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2021.105422%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DOrally%252Beffective%252BFDA-approved%252Bprotein%252Bkinase%252Btargeted%252Bcovalent%252Binhibitors%252B%252528TCIs%252529%26aulast%3DRoskoski%26aufirst%3DRobert%26date%3D2021%26volume%3D165%26spage%3D105422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Roskoski</span>. </span><span class="cited-content_cbyCitation_article-title">Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2021,</strong> <em>165 </em>, 105463. <a href="https://doi.org/10.1016/j.phrs.2021.105463" title="DOI URL">https://doi.org/10.1016/j.phrs.2021.105463</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2021.105463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2021.105463%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DProperties%252Bof%252BFDA-approved%252Bsmall%252Bmolecule%252Bprotein%252Bkinase%252Binhibitors%25253A%252BA%252B2021%252Bupdate%26aulast%3DRoskoski%26aufirst%3DRobert%26date%3D2021%26volume%3D165%26spage%3D105463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Zhu</span>, <span class="hlFld-ContribAuthor ">Saad  Alqahtani</span>, <span class="hlFld-ContribAuthor ">Xiche  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Aromatic Rings as Molecular Determinants for the Molecular Recognition of Protein Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (6)
                                     , 1776. <a href="https://doi.org/10.3390/molecules26061776" title="DOI URL">https://doi.org/10.3390/molecules26061776</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26061776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26061776%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAromatic%252BRings%252Bas%252BMolecular%252BDeterminants%252Bfor%252Bthe%252BMolecular%252BRecognition%252Bof%252BProtein%252BKinase%252BInhibitors%26aulast%3DZhu%26aufirst%3DYan%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D6%26spage%3D1776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yeasmin Akter  Munni</span>, <span class="hlFld-ContribAuthor ">Md. Chayan  Ali</span>, <span class="hlFld-ContribAuthor ">Nusrat Jahan  Selsi</span>, <span class="hlFld-ContribAuthor ">Marium  Sultana</span>, <span class="hlFld-ContribAuthor ">Md.  Hossen</span>, <span class="hlFld-ContribAuthor ">Tanjiba Harun  Bipasha</span>, <span class="hlFld-ContribAuthor ">Mahbubur  Rahman</span>, <span class="hlFld-ContribAuthor ">Md Nazim  Uddin</span>, <span class="hlFld-ContribAuthor ">S.M. Zahid  Hosen</span>, <span class="hlFld-ContribAuthor ">Raju  Dash</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular simulation studies to reveal the binding mechanisms of shikonin derivatives inhibiting VEGFR-2 kinase. </span><span class="cited-content_cbyCitation_journal-name">Computational Biology and Chemistry</span><span> <strong>2021,</strong> <em>90 </em>, 107414. <a href="https://doi.org/10.1016/j.compbiolchem.2020.107414" title="DOI URL">https://doi.org/10.1016/j.compbiolchem.2020.107414</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiolchem.2020.107414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiolchem.2020.107414%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520Biology%2520and%2520Chemistry%26atitle%3DMolecular%252Bsimulation%252Bstudies%252Bto%252Breveal%252Bthe%252Bbinding%252Bmechanisms%252Bof%252Bshikonin%252Bderivatives%252Binhibiting%252BVEGFR-2%252Bkinase%26aulast%3DMunni%26aufirst%3DYeasmin%2BAkter%26date%3D2021%26volume%3D90%26spage%3D107414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Farrhat F.  Mohammed</span>, <span class="hlFld-ContribAuthor ">Mohamad  Hagar</span>, <span class="hlFld-ContribAuthor ">Shazia  Parveen</span>, <span class="hlFld-ContribAuthor ">Rua B.  Alnoman</span>, <span class="hlFld-ContribAuthor ">Hoda A.  Ahmed</span>, <span class="hlFld-ContribAuthor ">El Sayed H. El  Ashry</span>, <span class="hlFld-ContribAuthor ">Hanaa A.  Rasheed</span>. </span><span class="cited-content_cbyCitation_article-title">2-(Alkylthio)-3-(Naphthalen-1-yl)Quinazolin-4(3
              H
              )-Ones: Ultrasonic Synthesis, DFT and Molecular Docking Aspects. </span><span class="cited-content_cbyCitation_journal-name">Polycyclic Aromatic Compounds</span><span> <strong>2021,</strong> <em>25 </em>, 1-15. <a href="https://doi.org/10.1080/10406638.2021.1878245" title="DOI URL">https://doi.org/10.1080/10406638.2021.1878245</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10406638.2021.1878245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10406638.2021.1878245%26sid%3Dliteratum%253Aachs%26jtitle%3DPolycyclic%2520Aromatic%2520Compounds%26atitle%3D2-%252528Alkylthio%252529-3-%252528Naphthalen-1-yl%252529Quinazolin-4%2525283%252BH%252B%252529-Ones%25253A%252BUltrasonic%252BSynthesis%25252C%252BDFT%252Band%252BMolecular%252BDocking%252BAspects%26aulast%3DMohammed%26aufirst%3DFarrhat%2BF.%26date%3D2021%26date%3D2021%26volume%3D25%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siddharth J.  Modi</span>, <span class="hlFld-ContribAuthor ">Vithal M.  Kulkarni</span>. </span><span class="cited-content_cbyCitation_article-title">Exploration of structural requirements for the inhibition of VEGFR-2 tyrosine kinase: Binding site analysis of type II, ‘DFG-out’ inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>1 </em>, 1-16. <a href="https://doi.org/10.1080/07391102.2021.1872417" title="DOI URL">https://doi.org/10.1080/07391102.2021.1872417</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2021.1872417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2021.1872417%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DExploration%252Bof%252Bstructural%252Brequirements%252Bfor%252Bthe%252Binhibition%252Bof%252BVEGFR-2%252Btyrosine%252Bkinase%25253A%252BBinding%252Bsite%252Banalysis%252Bof%252Btype%252BII%25252C%252B%2525E2%252580%252598DFG-out%2525E2%252580%252599%252Binhibitors%26aulast%3DModi%26aufirst%3DSiddharth%2BJ.%26date%3D2021%26date%3D2021%26volume%3D1%26spage%3D1%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Mologni</span>. </span><span class="cited-content_cbyCitation_article-title">Resistance mechanisms to ALK TKIs in tumors other than lung cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 101-121. <a href="https://doi.org/10.1016/B978-0-12-821774-0.00005-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-821774-0.00005-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-821774-0.00005-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-821774-0.00005-X%26sid%3Dliteratum%253Aachs%26atitle%3DResistance%252Bmechanisms%252Bto%252BALK%252BTKIs%252Bin%252Btumors%252Bother%252Bthan%252Blung%252Bcancer%26aulast%3DMologni%26aufirst%3DLuca%26date%3D2021%26spage%3D101%26epage%3D121%26pub%3DElsevier%26atitle%3DTherapeutic%252BStrategies%252Bto%252BOvercome%252BALK%252BResistance%252Bin%252BCancer%26date%3D2021%26volume%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Teodora  Djikic</span>, <span class="hlFld-ContribAuthor ">Zarko  Gagic</span>, <span class="hlFld-ContribAuthor ">Katarina  Nikolic</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Discovery of Kinase Inhibitors Using Docking Studies. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 337-365. <a href="https://doi.org/10.1016/B978-0-12-822312-3.00009-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-822312-3.00009-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-822312-3.00009-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-822312-3.00009-6%26sid%3Dliteratum%253Aachs%26atitle%3DDesign%252Band%252BDiscovery%252Bof%252BKinase%252BInhibitors%252BUsing%252BDocking%252BStudies%26aulast%3DDjikic%26aufirst%3DTeodora%26date%3D2021%26spage%3D337%26epage%3D365%26pub%3DElsevier%26atitle%3DMolecular%252BDocking%252Bfor%252BComputer-Aided%252BDrug%252BDesign%26date%3D2021%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingyu  Li</span>, <span class="hlFld-ContribAuthor ">Ashfaq Ur  Rehman</span>, <span class="hlFld-ContribAuthor ">Yaqin  Liu</span>, <span class="hlFld-ContribAuthor ">Kai  Chen</span>, <span class="hlFld-ContribAuthor ">Shaoyong  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Dual roles of ATP-binding site in protein kinases: Orthosteric inhibition and allosteric regulation. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 87-119. <a href="https://doi.org/10.1016/bs.apcsb.2020.09.005" title="DOI URL">https://doi.org/10.1016/bs.apcsb.2020.09.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.apcsb.2020.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.apcsb.2020.09.005%26sid%3Dliteratum%253Aachs%26atitle%3DDual%252Broles%252Bof%252BATP-binding%252Bsite%252Bin%252Bprotein%252Bkinases%25253A%252BOrthosteric%252Binhibition%252Band%252Ballosteric%252Bregulation%26aulast%3DLi%26aufirst%3DMingyu%26date%3D2021%26spage%3D87%26epage%3D119%26pub%3DElsevier%26atitle%3DProtein%252BKinases%252Bin%252BDrug%252BDiscovery%26date%3D2021%26volume%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joyce Villa Verde Bastos  Borba</span>, <span class="hlFld-ContribAuthor ">Arthur Carvalho  Silva</span>, <span class="hlFld-ContribAuthor ">Marilia Nunes Nascimento  Lima</span>, <span class="hlFld-ContribAuthor ">Sabrina Silva  Mendonca</span>, <span class="hlFld-ContribAuthor ">Nicholas  Furnham</span>, <span class="hlFld-ContribAuthor ">Fabio Trindade Maranhão  Costa</span>, <span class="hlFld-ContribAuthor ">Carolina Horta  Andrade</span>. </span><span class="cited-content_cbyCitation_article-title">Chemogenomics and bioinformatics approaches for prioritizing kinases as drug targets for neglected tropical diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 187-223. <a href="https://doi.org/10.1016/bs.apcsb.2020.10.006" title="DOI URL">https://doi.org/10.1016/bs.apcsb.2020.10.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.apcsb.2020.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.apcsb.2020.10.006%26sid%3Dliteratum%253Aachs%26atitle%3DChemogenomics%252Band%252Bbioinformatics%252Bapproaches%252Bfor%252Bprioritizing%252Bkinases%252Bas%252Bdrug%252Btargets%252Bfor%252Bneglected%252Btropical%252Bdiseases%26aulast%3DBorba%26aufirst%3DJoyce%2BVilla%2BVerde%2BBastos%26date%3D2021%26spage%3D187%26epage%3D223%26pub%3DElsevier%26atitle%3DProtein%252BKinases%252Bin%252BDrug%252BDiscovery%26date%3D2021%26volume%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alejandro  Morales-Bayuelo</span>, <span class="hlFld-ContribAuthor ">Jesús  Sánchez-Márquez</span>. </span><span class="cited-content_cbyCitation_article-title">New insights about the serine/threonine protein kinase substrates from Mycobacterium tuberculosis using molecular docking, quantum similarity analysis and DFT calculations. </span><span class="cited-content_cbyCitation_journal-name">F1000Research</span><span> <strong>2021,</strong> <em>10 </em>, 66. <a href="https://doi.org/10.12688/f1000research.28078.1" title="DOI URL">https://doi.org/10.12688/f1000research.28078.1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.12688/f1000research.28078.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.12688%2Ff1000research.28078.1%26sid%3Dliteratum%253Aachs%26jtitle%3DF1000Research%26atitle%3DNew%252Binsights%252Babout%252Bthe%252Bserine%25252Fthreonine%252Bprotein%252Bkinase%252Bsubstrates%252Bfrom%252BMycobacterium%252Btuberculosis%252Busing%252Bmolecular%252Bdocking%25252C%252Bquantum%252Bsimilarity%252Banalysis%252Band%252BDFT%252Bcalculations%26aulast%3DMorales-Bayuelo%26aufirst%3DAlejandro%26date%3D2021%26date%3D2021%26volume%3D10%26spage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dario  Doller</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulation. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-820472-6.00057-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-820472-6.00057-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-820472-6.00057-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-820472-6.00057-8%26sid%3Dliteratum%253Aachs%26atitle%3DAllosteric%252BModulation%26aulast%3DDoller%26aufirst%3DDario%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BBiomedical%252BSciences%26date%3D2021%26volume%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm901443h&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-7%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm901443h%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=322&amp;pagesCount=4&amp;pageNumber=2" title="Load more citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load more citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/medium/jm-2009-01443h_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Kinase inhibitors currently on the market.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901443h&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/medium/jm-2009-01443h_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) ATP binding site regions and ATP interactions with the hinge residues. Hydrogen bonds are represented by orange dashed lines. (B) Type I kinase inhibitor pharmacophore representing the potential hydrogen bonds with the hinge region. (C) Type II kinase inhibitor pharmacophore representing interactions with the hinge region and the allosteric site present in the DFG “out” conformation. (D) Type I<sup>1</sup>/<sub>2</sub> pharmacophore representing the potential interactions at the hinge and in the back cavity. Hydrogen bond donors are represented by circles labeled D, hydrogen bond acceptors by circles labeled A. The larger circles labeled HYD indicate the moieties, hydrophobic in nature, that occupy the adenine ring region (green) and the allosteric site (orange).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901443h&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/medium/jm-2009-01443h_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of the hydrophobic back pockets of a kinase proteins with a large (CDK2) and a small (bRAF) gatekeeper residue. (A) Molecular surface of ATP binding cavity in the ATP-CDK2 complex (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1b39">1b39</a>). The large gatekeeper residue Phe 80 limits the dimensions of the back pocket. (B) Molecular surface of the ATP binding cavity in the SB590885-bRAF complex (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2fb8">2fb8</a>). The small gatekeeper residue Thr 529 allows a large back pocket. To facilitate comparison, the SB590885 ligand was removed and replaced by the ATP molecule after superimposition of the two structures. For clarity, only the gatekeeper residue and the hinge region of the protein are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901443h&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/medium/jm-2009-01443h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Chemical structure of the p38 inhibitor <b>9</b> and its mode of binding in the ATP binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901443h&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/medium/jm-2009-01443h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Chemical structure of the Src inhibitor <b>10</b> and its mode of binding in the ATP binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901443h&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/medium/jm-2009-01443h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Chemical structure of the KDR inhibitors <b>11</b> and <b>12</b> and their mode of binding in the ATP binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901443h&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/medium/jm-2009-01443h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Chemical structure of the Sunesis PLK1 inhibitor <b>13</b> and its mode of binding in the ATP binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901443h&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/medium/jm-2009-01443h_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Chemical structure of the CHK1 inhibitor <b>14</b> and its mode of binding in the ATP binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901443h&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/medium/jm-2009-01443h_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Additional structures of type I<sup>1</sup>/<sub>2</sub> kinase inhibitors. All compounds target kinases with a small/medium gatekeeper residue. The region interacting with back cavity portion of the type I<sup>1</sup>/<sub>2</sub> pharmacophore is indicated in blue. In parentheses is the kinase target for which the compound has been developed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-7/jm901443h/production/images/large/jm-2009-01443h_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm901443h&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i20">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54402" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54402" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 62 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_contrib-group">Mannig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whyte, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudarsanam, S.</span><span> </span><span class="NLM_article-title">The protein kinase complement of the human genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1912</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1912-1934&author=G.+Mannigauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sudarsanam&title=The+protein+kinase+complement+of+the+human+genome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMannig%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSudarsanam%26aufirst%3DS.%26atitle%3DThe%2520protein%2520kinase%2520complement%2520of%2520the%2520human%2520genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1912%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Hanks, S. K.</span><span> </span><span class="NLM_article-title">Genomic analysis of the eukaryotic protein kinase superfamily: a perspective</span> <span class="citation_source-journal">GenomeBiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=111&author=S.+K.+Hanks&title=Genomic+analysis+of+the+eukaryotic+protein+kinase+superfamily%3A+a+perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanks%26aufirst%3DS.%2BK.%26atitle%3DGenomic%2520analysis%2520of%2520the%2520eukaryotic%2520protein%2520kinase%2520superfamily%253A%2520a%2520perspective%26jtitle%3DGenomeBiology%26date%3D2003%26volume%3D4%26spage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Johnson, N. L.</span><span> </span><span class="NLM_article-title">Protein Kinase Inhibitors: Contributions from Structure to Clinical Compounds</span>.  <span class="citation_source-book">Quarterly Reviews of Biophysics</span>; <span class="NLM_publisher-name">Cambridge University Press</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1</span>− <span class="NLM_lpage">40</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=1-40&author=N.+L.+Johnson&title=Quarterly+Reviews+of+Biophysics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DN.%2BL.%26atitle%3DProtein%2520Kinase%2520Inhibitors%253A%2520Contributions%2520from%2520Structure%2520to%2520Clinical%2520Compounds%26btitle%3DQuarterly%2520Reviews%2520of%2520Biophysics%26pub%3DCambridge%2520University%2520Press%26date%3D2009%26spage%3D1%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Targeting cancer with small molecule kinase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1038%2Fnrc2559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=19104514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1yg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=28-39&author=J.+Zhangauthor=P.+L.+Yangauthor=N.+S.+Gray&title=Targeting+cancer+with+small+molecule+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer with small molecule kinase inhibitors</span></div><div class="casAuthors">Zhang, Jianming; Yang, Priscilla L.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiol. constraints on growth and survival.  To date, 11 kinase inhibitors have received US Food and Drug Administration approval as cancer treatments, and there are considerable efforts to develop selective small mol. inhibitors for a host of other kinases that are implicated in cancer and other diseases.  Herein we discuss the current challenges in the field, such as designing selective inhibitors and developing strategies to overcome resistance mutations.  This Review provides a broad overview of some of the approaches currently used to discover and characterize new kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriSM3BN_uEz7Vg90H21EOLACvtfcHk0ljmEMBhPXtG6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1yg&md5=35bc38f414cd21eef5e61ce181b580fb</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrc2559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2559%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DP.%2BL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520cancer%2520with%2520small%2520molecule%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D28%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Smith, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, C. A.</span><span> </span><span class="NLM_article-title">Kinase activity of mutant LRRK2 mediates neuronal toxicity</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1231</span><span class="NLM_x">–</span> <span class="NLM_lpage">1233</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1038%2Fnn1776" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=16980962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVSgu7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=1231-1233&author=W.+W.+Smithauthor=Z.+Peiauthor=H.+Jiangauthor=V.+L.+Dawsonauthor=T.+M.+Dawsonauthor=C.+A.+Ross&title=Kinase+activity+of+mutant+LRRK2+mediates+neuronal+toxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase activity of mutant LRRK2 mediates neuronal toxicity</span></div><div class="casAuthors">Smith, Wanli W.; Pei, Zhong; Jiang, Haibing; Dawson, Valina L.; Dawson, Ted M.; Ross, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1231-1233</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mutations in the leucine-rich repeat kinase-2 (LRRK2) gene cause autosomal-dominant Parkinson disease and some cases of sporadic Parkinson disease.  Here we found that LRRK2 kinase activity was regulated by GTP via the intrinsic GTPase Roc domain, and alterations of LRRK2 protein that reduced kinase activity of mutant LRRK2 correspondingly reduced neuronal toxicity.  These data elucidate the pathogenesis of LRRK2-linked Parkinson disease, potentially illuminate mechanisms of sporadic Parkinson disease and suggest therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqS61-FFqaSfLVg90H21EOLACvtfcHk0ljmEMBhPXtG6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVSgu7fJ&md5=353c92fdf5be0efb00e23b6d0b8141d6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnn1776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn1776%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DPei%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DDawson%26aufirst%3DV.%2BL.%26aulast%3DDawson%26aufirst%3DT.%2BM.%26aulast%3DRoss%26aufirst%3DC.%2BA.%26atitle%3DKinase%2520activity%2520of%2520mutant%2520LRRK2%2520mediates%2520neuronal%2520toxicity%26jtitle%3DNat.%2520Neurosci.%26date%3D2006%26volume%3D9%26spage%3D1231%26epage%3D1233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Whartenby, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabresi, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCadden, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kardian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosse, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardoll, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, D.</span><span> </span><span class="NLM_article-title">Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">16741</span><span class="NLM_x">–</span> <span class="NLM_lpage">16746</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=16741-16746&author=K.+A.+Whartenbyauthor=P.+A.+Calabresiauthor=E.+McCaddenauthor=B.+Nguyenauthor=D.+Kardianauthor=T.+Wangauthor=C.+Mosseauthor=D.+M.+Pardollauthor=D.+Small&title=Inhibition+of+FLT3+signaling+targets+DCs+to+ameliorate+autoimmune+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWhartenby%26aufirst%3DK.%2BA.%26aulast%3DCalabresi%26aufirst%3DP.%2BA.%26aulast%3DMcCadden%26aufirst%3DE.%26aulast%3DNguyen%26aufirst%3DB.%26aulast%3DKardian%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DMosse%26aufirst%3DC.%26aulast%3DPardoll%26aufirst%3DD.%2BM.%26aulast%3DSmall%26aufirst%3DD.%26atitle%3DInhibition%2520of%2520FLT3%2520signaling%2520targets%2520DCs%2520to%2520ameliorate%2520autoimmune%2520disease%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D16741%26epage%3D16746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Solinas, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilcu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neels, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandyopadhyay, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naugler, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grivennikov, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynshaw-Boris, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scadeng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olefsky, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karin, M.</span><span> </span><span class="NLM_article-title">JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">386</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1016%2Fj.cmet.2007.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=17983584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlemsr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=386-397&author=G.+Solinasauthor=C.+Vilcuauthor=J.+G.+Neelsauthor=G.+K.+Bandyopadhyayauthor=J.+L.+Luoauthor=W.+Nauglerauthor=S.+Grivennikovauthor=A.+Wynshaw-Borisauthor=M.+Scadengauthor=J.+M.+Olefskyauthor=M.+Karin&title=JNK1+in+hematopoietically+derived+cells+contributes+to+diet-induced+inflammation+and+insulin+resistance+without+affecting+obesity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity</span></div><div class="casAuthors">Solinas, Giovanni; Vilcu, Cristian; Neels, Jaap G.; Bandyopadhyay, Gautam K.; Luo, Jun-Li; Naugler, Willscott; Grivennikov, Sergei; Wynshaw-Boris, Anthony; Scadeng, Miriam; Olefsky, Jerrold M.; Karin, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">386-397</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Obesity-induced insulin resistance is a major factor in the etiol. of type 2 diabetes, and Jun kinases (JNKs) are key neg. regulators of insulin sensitivity in the obese state.  Activation of JNKs (mainly JNK1) in insulin target cells results in phosphorylation of insulin receptor substrates (IRSs) at serine and threonine residues that inhibit insulin signaling.  JNK1 activation is also required for accumulation of visceral fat.  Here the authors used reciprocal adoptive transfer expts. to det. whether JNK1 in myeloid cells, such as macrophages, also contributes to insulin resistance and central adiposity.  The authors' results show that deletion of Jnk1 in the nonhematopoietic compartment protects mice from high-fat diet (HFD)-induced insulin resistance, in part through decreased adiposity.  By contrast, Jnk1 removal from hematopoietic cells has no effect on adiposity but confers protection against HFD-induced insulin resistance by decreasing obesity-induced inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzkPr_p6vAZLVg90H21EOLACvtfcHk0liiWns1cv5yhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlemsr%252FL&md5=d700af389f61db82aa6e6837617394ef</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2007.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2007.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DSolinas%26aufirst%3DG.%26aulast%3DVilcu%26aufirst%3DC.%26aulast%3DNeels%26aufirst%3DJ.%2BG.%26aulast%3DBandyopadhyay%26aufirst%3DG.%2BK.%26aulast%3DLuo%26aufirst%3DJ.%2BL.%26aulast%3DNaugler%26aufirst%3DW.%26aulast%3DGrivennikov%26aufirst%3DS.%26aulast%3DWynshaw-Boris%26aufirst%3DA.%26aulast%3DScadeng%26aufirst%3DM.%26aulast%3DOlefsky%26aufirst%3DJ.%2BM.%26aulast%3DKarin%26aufirst%3DM.%26atitle%3DJNK1%2520in%2520hematopoietically%2520derived%2520cells%2520contributes%2520to%2520diet-induced%2520inflammation%2520and%2520insulin%2520resistance%2520without%2520affecting%2520obesity%26jtitle%3DCell%2520Metab.%26date%3D2007%26volume%3D6%26spage%3D386%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Johnson, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D.</span><span> </span><span class="NLM_article-title">The eleventh Datta lecture. The structural basis for substrate recognition and control by protein kinases</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">430</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=1998&pages=1-11&author=L.+N.+Johnsonauthor=E.+D.+Loweauthor=M.+E.+Nobleauthor=D.+Owen&title=The+eleventh+Datta+lecture.+The+structural+basis+for+substrate+recognition+and+control+by+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DL.%2BN.%26aulast%3DLowe%26aufirst%3DE.%2BD.%26aulast%3DNoble%26aufirst%3DM.%2BE.%26aulast%3DOwen%26aufirst%3DD.%26atitle%3DThe%2520eleventh%2520Datta%2520lecture.%2520The%2520structural%2520basis%2520for%2520substrate%2520recognition%2520and%2520control%2520by%2520protein%2520kinases%26jtitle%3DFEBS%2520Lett.%26date%3D1998%26volume%3D430%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Huse, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span> </span><span class="NLM_article-title">The conformational plasticity of protein kinases</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1016%2FS0092-8674%2802%2900741-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=12015977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvV2lsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=275-282&author=M.+Huseauthor=J.+Kuriyan&title=The+conformational+plasticity+of+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The conformational plasticity of protein kinases</span></div><div class="casAuthors">Huse, Morgan; Kuriyan, John</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">275-282</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review with 48 refs.  Protein kinases operate in a large no. of distinct signaling pathways, where the tight regulation of their catalytic activity is crucial to the development and maintenance of eukaryotic organisms.  The catalytic domains of different kinases adopt strikingly similar structures when they are active.  By contrast, crystal structures of inactive kinases have revealed a marked plasticity in the kinase domain that allows the adoption of distinct conformations in response to interactions with specific regulatory domains or proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJrn7F3h4ej7Vg90H21EOLACvtfcHk0liiWns1cv5yhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvV2lsLw%253D&md5=cd56edae94ad239f2ce7a5d6c8930cbb</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2802%2900741-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252802%252900741-9%26sid%3Dliteratum%253Aachs%26aulast%3DHuse%26aufirst%3DM.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DThe%2520conformational%2520plasticity%2520of%2520protein%2520kinases%26jtitle%3DCell%26date%3D2002%26volume%3D109%26spage%3D275%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Schindler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornmann, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicena, P</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarkson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span> </span><span class="NLM_article-title">Structural mechanism for STI-571 inhibition of abelson tyrosine kinase</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">1938</span><span class="NLM_x">–</span> <span class="NLM_lpage">1942</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1126%2Fscience.289.5486.1938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=10988075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD3cXms1altLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2000&pages=1938-1942&author=T.+Schindlerauthor=W.+Bornmannauthor=P+Pellicenaauthor=W.+T.+Millerauthor=B.+Clarksonauthor=J.+Kuriyan&title=Structural+mechanism+for+STI-571+inhibition+of+abelson+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase</span></div><div class="casAuthors">Schindler, Thomas; Bornmann, William; Pellicena, Patricia; Miller, W. Todd; Clarkson, Bayard; Kuriyan, John</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">5486</span>),
    <span class="NLM_cas:pages">1938-1942</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The inadvertent activation of the Abelson tyrosine kinase (Abl) causes chronic myelogenous leukemia (CML).  A small-mol. inhibitor of Abl (STI-571) is effective in the treatment of CML.  We report the crystal structure of the catalytic domain of Abl, complexed to a variant of STI-571.  Crit. to the binding of STI-571 is the adoption by the kinase of an inactive conformation, in which a centrally located "activation loop" is not phosphorylated.  The conformation of this loop is distinct from that in active protein kinases, as well as in the inactive form of the closely related Src kinases.  These results suggest that compds. that exploit the distinctive inactivation mechanisms of individual protein kinases can achieve both high affinity and high specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9eAZqIQ1aebVg90H21EOLACvtfcHk0lhfoxNkMT0LJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXms1altLc%253D&md5=56bb233f010f099d0073020ac6b9db59</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1126%2Fscience.289.5486.1938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.289.5486.1938%26sid%3Dliteratum%253Aachs%26aulast%3DSchindler%26aufirst%3DT.%26aulast%3DBornmann%26aufirst%3DW.%26aulast%3DPellicena%26aufirst%3DP%26aulast%3DMiller%26aufirst%3DW.%2BT.%26aulast%3DClarkson%26aufirst%3DB.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DStructural%2520mechanism%2520for%2520STI-571%2520inhibition%2520of%2520abelson%2520tyrosine%2520kinase%26jtitle%3DScience%26date%3D2000%26volume%3D289%26spage%3D1938%26epage%3D1942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Bikker, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooijmans, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span> </span><span class="NLM_article-title">Kinase domain mutations in cancer: implications for small molecule drug design strategies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1493</span><span class="NLM_x">–</span> <span class="NLM_lpage">1509</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8010542" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisVCisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1493-1509&author=J.+A.+Bikkerauthor=N.+Brooijmansauthor=A.+Wisserauthor=T.+S.+Mansour&title=Kinase+domain+mutations+in+cancer%3A+implications+for+small+molecule+drug+design+strategies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase Domain Mutations in Cancer: Implications for Small Molecule Drug Design Strategies</span></div><div class="casAuthors">Bikker, Jack A.; Brooijmans, Natasja; Wissner, Allan; Mansour, Tarek S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1493-1509</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review will provide a brief overview of kinase structure and function as it pertains to drug discovery, describe the location and importance of clin. mutations, and review the emerging understanding of their impact based on sequence homol., protein crystal complexes, and biochem./biophys. information.  Underlying this discussion is our appreciation that the current clin. arsenal of small mol. kinase inhibitors only contains the first weapons to be deployed in a long war against drug resistance mutations occurring in multiple kinases that target multiple cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBBjVt8P6JI7Vg90H21EOLACvtfcHk0lhfoxNkMT0LJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisVCisr0%253D&md5=fa09d8a6e553ccd1bb1f093176ecb366</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm8010542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8010542%26sid%3Dliteratum%253Aachs%26aulast%3DBikker%26aufirst%3DJ.%2BA.%26aulast%3DBrooijmans%26aufirst%3DN.%26aulast%3DWisser%26aufirst%3DA.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26atitle%3DKinase%2520domain%2520mutations%2520in%2520cancer%253A%2520implications%2520for%2520small%2520molecule%2520drug%2520design%2520strategies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1493%26epage%3D1509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Jänne, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settleman, J.</span><span> </span><span class="NLM_article-title">Factors underlying sensitivity of cancers to small-molecule kinase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">709</span><span class="NLM_x">–</span> <span class="NLM_lpage">723</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=709-723&issue=9&author=P.+A.+J%C3%A4nneauthor=N.+Grayauthor=J.+Settleman&title=Factors+underlying+sensitivity+of+cancers+to+small-molecule+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJ%25C3%25A4nne%26aufirst%3DP.%2BA.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DSettleman%26aufirst%3DJ.%26atitle%3DFactors%2520underlying%2520sensitivity%2520of%2520cancers%2520to%2520small-molecule%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26issue%3D9%26spage%3D709%26epage%3D723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Fernandez, A.</span><span> </span><span class="NLM_article-title">Is there a case for selectively promiscuous anticancer drugs?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">5</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=1-5&author=A.+Fernandez&title=Is+there+a+case+for+selectively+promiscuous+anticancer+drugs%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez%26aufirst%3DA.%26atitle%3DIs%2520there%2520a%2520case%2520for%2520selectively%2520promiscuous%2520anticancer%2520drugs%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2009%26volume%3D14%26spage%3D1%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Petrelli, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, S.</span><span> </span><span class="NLM_article-title">From single- to multi-target drugs in cancer therapy: when aspecificity becomes an advantage</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">422</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.2174%2F092986708783503212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=18288997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVyisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=422-432&author=A+Petrelliauthor=S.+Giordano&title=From+single-+to+multi-target+drugs+in+cancer+therapy%3A+when+aspecificity+becomes+an+advantage"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">From single- to multi-target drugs in cancer therapy: when a specificity becomes an advantage</span></div><div class="casAuthors">Petrelli, A.; Giordano, S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">422-432</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Targeted therapies by means of compds. that inhibit a specific target mol. represent a new perspective in the treatment of cancer.  In contrast to conventional chemotherapy which acts on all dividing cells generating toxic effects and damage of normal tissues, targeted drugs allow to hit, in a more specific manner, subpopulations of cells directly involved in tumor progression.  Mols. controlling cell proliferation and death, such as Tyrosine Kinase Receptors (RTKs) for growth factors, are among the best targets for this type of therapeutic approach.  Two classes of compds. targeting RTKs are currently used in clin. practice: monoclonal antibodies and tyrosine kinase inhibitors.  The era of targeted therapy began with the approval of Trastuzumab, a monoclonal antibody against HER2, for treatment of metastatic breast cancer, and Imatinib, a small tyrosine kinase inhibitor targeting BCR-Abl, in Chronic Myeloid Leukemia.  Despite the initial enthusiasm for the efficacy of these treatments, clinicians had to face soon the problem of relapse, as almost invariably cancer patients developed drug resistance, often due to the activation of alternative RTKs pathways.  In this view, the rationale at the basis of targeting drugs is radically shifting.  In the past, the main effort was aimed at developing highly specific inhibitors acting on single RTKs.  Now, there is a general agreement that mols. interfering simultaneously with multiple RTKs might be more effective than single target agents.  With the recent approval by FDA of Sorafenib and Sunitinib - targeting VEGFR, PDGFR, FLT-3 and c-Kit - a different scenario has been emerging, where a new generation of anti-cancer drugs, able to inhibit more than one pathway, would probably play a major role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8AXb2ROTStLVg90H21EOLACvtfcHk0lhfoxNkMT0LJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVyisL0%253D&md5=d90df6a670921b6fad58caa46db01fa5</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.2174%2F092986708783503212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708783503212%26sid%3Dliteratum%253Aachs%26aulast%3DPetrelli%26aufirst%3DA%26aulast%3DGiordano%26aufirst%3DS.%26atitle%3DFrom%2520single-%2520to%2520multi-target%2520drugs%2520in%2520cancer%2520therapy%253A%2520when%2520aspecificity%2520becomes%2520an%2520advantage%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26spage%3D422%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Smyth, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span> </span><span class="NLM_article-title">Measuring and interpreting the selectivity of protein kinase inhibitors</span> <span class="citation_source-journal">J. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">151</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1007%2Fs12154-009-0023-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A280%3ADC%252BD1MrkslGqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=131-151&issue=3&author=L.+A.+Smythauthor=I.+Collins&title=Measuring+and+interpreting+the+selectivity+of+protein+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Measuring and interpreting the selectivity of protein kinase inhibitors</span></div><div class="casAuthors">Smyth Lynette A; Collins Ian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of chemical biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">131-51</span>
        ISSN:<span class="NLM_cas:issn">1864-6158</span>.
    </div><div class="casAbstract">Protein kinase inhibitors are a well-established class of clinically useful drugs, particularly for the treatment of cancer.  Achieving inhibitor selectivity for particular protein kinases often remains a significant challenge in the development of new small molecules as drugs or as tools for chemical biology research.  This review summarises the methodologies available for measuring kinase inhibitor selectivity, both in vitro and in cells.  The interpretation of kinase inhibitor selectivity data is discussed, particularly with reference to the structural biology of the protein targets.  Measurement and prediction of kinase inhibitor selectivity will be important for the development of new multi-targeted kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQzU9rA5WZcz9FxYDaSSP8XfW6udTcc2eZbvEi-odretrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrkslGqtA%253D%253D&md5=f78ff1202a949a71ffd65e804298c37f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1007%2Fs12154-009-0023-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12154-009-0023-9%26sid%3Dliteratum%253Aachs%26aulast%3DSmyth%26aufirst%3DL.%2BA.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DMeasuring%2520and%2520interpreting%2520the%2520selectivity%2520of%2520protein%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D2%26issue%3D3%26spage%3D131%26epage%3D151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Morphy, R.</span><span> </span><span class="NLM_article-title">Selectively nonselective kinase inhibition: striking the right balance</span>.  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1021/jm901132v</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm901132v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=R.+Morphy&title=Selectively+nonselective+kinase+inhibition%3A+striking+the+right+balance&doi=10.1021%2Fjm901132v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm901132v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901132v%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26atitle%3DSelectively%2520nonselective%2520kinase%2520inhibition%253A%2520striking%2520the%2520right%2520balance%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26doi%3D10.1021%2Fjm901132v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Cowan-Jacob, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Möbitz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span> </span><span class="NLM_article-title">Structural biology contributions to tyrosine kinase drug discovery</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">280</span><span class="NLM_x">–</span> <span class="NLM_lpage">287</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1016%2Fj.ceb.2009.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=19208462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVCksr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=280-287&issue=2&author=S.+W.+Cowan-Jacobauthor=H.+M%C3%B6bitzauthor=D.+Fabbro&title=Structural+biology+contributions+to+tyrosine+kinase+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Structural biology contributions to tyrosine kinase drug discovery</span></div><div class="casAuthors">Cowan-Jacob, Sandra W.; Moebitz, Henrik; Fabbro, Doriano</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">280-287</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Successful kinase inhibitor drug discovery relies heavily on the structural knowledge of the interaction of inhibitors with the target.  Structural biol. of kinases and in particular of tyrosine kinases has given detailed insights into the intrinsic flexibility of the catalytic domain and has provided a rational basis for obtaining selective inhibitors.  Important progress was made recently, both in academia and in the pharmaceutical industry, with respect to solving structures of inactive, multidomain or protein-protein complexes of kinases, which helps our understanding of the dynamics of regulation of kinase activity.  This leads to a better understanding of how mutations lead to activation of kinases and resistance, in addn. to providing opportunities for novel modes of targeting kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo09-Hgo00-bLVg90H21EOLACvtfcHk0liePFk5lV8WiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVCksr8%253D&md5=125e7217308850813cde9dce356bf1a4</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2009.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2009.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DCowan-Jacob%26aufirst%3DS.%2BW.%26aulast%3DM%25C3%25B6bitz%26aufirst%3DH.%26aulast%3DFabbro%26aufirst%3DD.%26atitle%3DStructural%2520biology%2520contributions%2520to%2520tyrosine%2520kinase%2520drug%2520discovery%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2009%26volume%3D21%26issue%3D2%26spage%3D280%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Azam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeliger, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daley, G. Q.</span><span> </span><span class="NLM_article-title">Activation of tyrosine kinases by mutation of the gatekeeper threonine</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1109</span><span class="NLM_x">–</span> <span class="NLM_lpage">1118</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1038%2Fnsmb.1486" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=18794843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Sisb%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=1109-1118&issue=10&author=M.+Azamauthor=M.+A.+Seeligerauthor=N.+S.+Grayauthor=J.+Kuriyanauthor=G.+Q.+Daley&title=Activation+of+tyrosine+kinases+by+mutation+of+the+gatekeeper+threonine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of tyrosine kinases by mutation of the gatekeeper threonine</span></div><div class="casAuthors">Azam, Mohammad; Seeliger, Markus A.; Gray, Nathanael S.; Kuriyan, John; Daley, George Q.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural & Molecular Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1109-1118</span>CODEN:
                <span class="NLM_cas:coden">NSMBCU</span>;
        ISSN:<span class="NLM_cas:issn">1545-9993</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Protein kinases targeted by small-mol. inhibitors develop resistance through mutation of the 'gatekeeper' threonine residue of the active site.  Here we show that the gatekeeper mutation in the cellular forms of c-ABL, c-SRC, platelet-derived growth factor receptor-α and -β, and epidermal growth factor receptor activates the kinase and promotes malignant transformation of BaF3 cells.  Structural anal. reveals that a network of hydrophobic interactions - the hydrophobic spine - characteristic of the active kinase conformation is stabilized by the gatekeeper substitution.  Substitution of glycine for the residues constituting the spine disrupts the hydrophobic connectivity and inactivates the kinase.  Furthermore, a small-mol. inhibitor (compd. 14) that maximizes complementarity with the dismantled spine inhibits the gatekeeper mutation of BCR-ABL-T315I.  These results demonstrate that mutation of the gatekeeper threonine is a common mechanism of activation for tyrosine kinases and provide structural insights to guide the development of next-generation inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEoZTY5SkbALVg90H21EOLACvtfcHk0liePFk5lV8WiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Sisb%252FM&md5=4afc4e5a0850a4510ced3fa5fbda97fa</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnsmb.1486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsmb.1486%26sid%3Dliteratum%253Aachs%26aulast%3DAzam%26aufirst%3DM.%26aulast%3DSeeliger%26aufirst%3DM.%2BA.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DKuriyan%26aufirst%3DJ.%26aulast%3DDaley%26aufirst%3DG.%2BQ.%26atitle%3DActivation%2520of%2520tyrosine%2520kinases%2520by%2520mutation%2520of%2520the%2520gatekeeper%2520threonine%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2008%26volume%3D15%26issue%3D10%26spage%3D1109%26epage%3D1118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Kornev, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haste, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ten Eyck, L. F.</span><span> </span><span class="NLM_article-title">Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">17783</span><span class="NLM_x">–</span> <span class="NLM_lpage">17788</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1073%2Fpnas.0607656103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=17095602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1KnurfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=17783-17788&author=A.+P.+Kornevauthor=N.+M.+Hasteauthor=S.+S.+Taylorauthor=L.+F.+Ten+Eyck&title=Surface+comparison+of+active+and+inactive+protein+kinases+identifies+a+conserved+activation+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism</span></div><div class="casAuthors">Kornev, Alexandr P.; Haste, Nina M.; Taylor, Susan S.; Ten Eyck, Lynn F.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">17783-17788</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The surface comparison of different serine-threonine and tyrosine kinases reveals a set of 30 residues whose spatial positions are highly conserved.  The comparison between active and inactive conformations identified the residues whose positions are the most sensitive to activation.  Based on these results, we propose a model of protein kinase activation.  This model explains how the presence of a phosphate group in the activation loop dets. the position of the catalytically important aspartate in the Asp-Phe-Gly (DFG) motif.  According to the model, the most important feature of the activation is a "spine" formation that is dynamically assembled in all active kinases.  The spine is comprised of four hydrophobic residues that we detected in a set of 23 eukaryotic and prokaryotic kinases.  It spans the mol. and plays a coordinating role in activated kinases.  The spine is disordered in the inactive kinases and can explain how stabilization of the whole mol. is achieved upon phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwv4ByA5owH7Vg90H21EOLACvtfcHk0lituwVVmsNkpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1KnurfJ&md5=f474acffd8b17d8352ac9f6fc9bbbf8f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0607656103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0607656103%26sid%3Dliteratum%253Aachs%26aulast%3DKornev%26aufirst%3DA.%2BP.%26aulast%3DHaste%26aufirst%3DN.%2BM.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26aulast%3DTen%2BEyck%26aufirst%3DL.%2BF.%26atitle%3DSurface%2520comparison%2520of%2520active%2520and%2520inactive%2520protein%2520kinases%2520identifies%2520a%2520conserved%2520activation%2520mechanism%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D17783%26epage%3D17788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Kornev, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ten Eyck, L. F.</span><span> </span><span class="NLM_article-title">A helix scaffold for the assembly of active protein kinases</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">14377</span><span class="NLM_x">–</span> <span class="NLM_lpage">14382</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=14377-14382&author=A.+P.+Kornevauthor=S.+S.+Taylorauthor=L.+F.+Ten+Eyck&title=A+helix+scaffold+for+the+assembly+of+active+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKornev%26aufirst%3DA.%2BP.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26aulast%3DTen%2BEyck%26aufirst%3DL.%2BF.%26atitle%3DA%2520helix%2520scaffold%2520for%2520the%2520assembly%2520of%2520active%2520protein%2520kinases%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D14377%26epage%3D14382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Rational design of inhibitors that bind to inactive kinase conformations</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1038%2Fnchembio799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=16783341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFGjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=358-364&issue=7&author=Y.+Liuauthor=N.+S.+Gray&title=Rational+design+of+inhibitors+that+bind+to+inactive+kinase+conformations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of inhibitors that bind to inactive kinase conformations</span></div><div class="casAuthors">Liu, Yi; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">358-364</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The majority of kinase inhibitors, known as type I inhibitors that have been developed so far target the ATP binding site of the kinase in its active conformation, in which the activation loop is phosphorylated.  Recently, crystal structures of inhibitors such as imatinib, BIRB796, and sorafenib (BAY43-9006), known as type II inhibitors, have revealed a new binding mode that exploits an addnl. binding site immediately adjacent to the region occupied by ATP.  This pocket is made accessible by an activation-loop rearrangement that is characteristic of kinases in an inactive conformation.  The examn. of binding features of known type II inhibitors is discussed and a pharmacophore model currently used in the design of a new generation of structurally diverse type II inhibitors is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxahsMPlhgDbVg90H21EOLACvtfcHk0lituwVVmsNkpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFGjs7g%253D&md5=4a9347a44a2cf4a412c9741fdcc5696b</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnchembio799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio799%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DRational%2520design%2520of%2520inhibitors%2520that%2520bind%2520to%2520inactive%2520kinase%2520conformations%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26issue%3D7%26spage%3D358%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Backes, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zech, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebl, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, G.</span><span> </span><span class="NLM_article-title">Small-molecule inhibitors binding to protein kinases. Part I: exceptions from the traditional pharmacophore approach of type I inhibition</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1409</span><span class="NLM_x">–</span> <span class="NLM_lpage">1425</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1409-1425&issue=12&author=A.+C.+Backesauthor=B.+Zechauthor=B.+Felberauthor=B.+Kleblauthor=G.+M%C3%BCller&title=Small-molecule+inhibitors+binding+to+protein+kinases.+Part+I%3A+exceptions+from+the+traditional+pharmacophore+approach+of+type+I+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBackes%26aufirst%3DA.%2BC.%26aulast%3DZech%26aufirst%3DB.%26aulast%3DFelber%26aufirst%3DB.%26aulast%3DKlebl%26aufirst%3DB.%26aulast%3DM%25C3%25BCller%26aufirst%3DG.%26atitle%3DSmall-molecule%2520inhibitors%2520binding%2520to%2520protein%2520kinases.%2520Part%2520I%253A%2520exceptions%2520from%2520the%2520traditional%2520pharmacophore%2520approach%2520of%2520type%2520I%2520inhibition%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2008%26volume%3D3%26issue%3D12%26spage%3D1409%26epage%3D1425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Sun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirazian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuj, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuda, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nematalla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sistla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luu, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, C.</span><span> </span><span class="NLM_article-title">Discovery of 5-[5-fluoro-2-oxo-1,2- dihydroindol-(3<i>Z</i>)-ylidenemethyl]-2,4-dimethyl-1<i>H</i>-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1116</span><span class="NLM_x">–</span> <span class="NLM_lpage">1119</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0204183" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1116-1119&author=L.+Sunauthor=C.+Liangauthor=S.+Shirazianauthor=Y.+Zhouauthor=T.+Millerauthor=J.+Cujauthor=J.+Y.+Fukudaauthor=J.+Y.+Chuauthor=A.+Nematallaauthor=X.+Wangauthor=H.+Chenauthor=A.+Sistlaauthor=T.+C.+Luuauthor=F.+Tangauthor=J.+Weiauthor=C.+Tang&title=Discovery+of+5-%5B5-fluoro-2-oxo-1%2C2-+dihydroindol-%283Z%29-ylidenemethyl%5D-2%2C4-dimethyl-1H-pyrrole-3-carboxylic+acid+%282-diethylaminoethyl%29amide%2C+a+novel+tyrosine+kinase+inhibitor+targeting+vascular+endothelial+and+platelet-derived+growth+factor+receptor+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm0204183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0204183%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DShirazian%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DCuj%26aufirst%3DJ.%26aulast%3DFukuda%26aufirst%3DJ.%2BY.%26aulast%3DChu%26aufirst%3DJ.%2BY.%26aulast%3DNematalla%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DSistla%26aufirst%3DA.%26aulast%3DLuu%26aufirst%3DT.%2BC.%26aulast%3DTang%26aufirst%3DF.%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DC.%26atitle%3DDiscovery%2520of%25205-%255B5-fluoro-2-oxo-1%252C2-%2520dihydroindol-%25283Z%2529-ylidenemethyl%255D-2%252C4-dimethyl-1H-pyrrole-3-carboxylic%2520acid%2520%25282-diethylaminoethyl%2529amide%252C%2520a%2520novel%2520tyrosine%2520kinase%2520inhibitor%2520targeting%2520vascular%2520endothelial%2520and%2520platelet-derived%2520growth%2520factor%2520receptor%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1116%26epage%3D1119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Karaman, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraoni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pallares, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">A quantitative analysis of kinase inhibitor selectivity</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1038%2Fnbt1358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=18183025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=127-132&author=M.+W.+Karamanauthor=S.+Herrgardauthor=D.+K.+Treiberauthor=P.+Gallantauthor=C.+E.+Atteridgeauthor=B.+T.+Campbellauthor=K.+W.+Chanauthor=P.+Ciceriauthor=M.+I.+Davisauthor=P.+T.+Edeenauthor=R.+Faraoniauthor=M.+Floydauthor=J.+P.+Huntauthor=D.+J.+Lockhartauthor=Z.+V.+Milanovauthor=M.+J.+Morrisonauthor=G.+Pallaresauthor=H.+K.+Patelauthor=S.+Pritchardauthor=L.+M.+Wodickaauthor=P.+P.+Zarrinkar&title=A+quantitative+analysis+of+kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A quantitative analysis of kinase inhibitor selectivity</span></div><div class="casAuthors">Karaman, Mazen W.; Herrgard, Sanna; Treiber, Daniel K.; Gallant, Paul; Atteridge, Corey E.; Campbell, Brian T.; Chan, Katrina W.; Ciceri, Pietro; Davis, Mindy I.; Edeen, Philip T.; Faraoni, Raffaella; Floyd, Mark; Hunt, Jeremy P.; Lockhart, Daniel J.; Milanov, Zdravko V.; Morrison, Michael J.; Pallares, Gabriel; Patel, Hitesh K.; Pritchard, Stephanie; Wodicka, Lisa M.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">127-132</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets.  The biol. consequences of multikinase activity are poorly defined, and an important step toward understanding the relationship between selectivity, efficacy and safety is the exploration of how inhibitors interact with the human kinome.  The authors present interaction maps for 38 kinase inhibitors across a panel of 317 kinases representing >50% of the predicted human protein kinome.  The data constitute the most comprehensive study of kinase inhibitor selectivity to date and reveal a wide diversity of interaction patterns.  To enable a global anal. of the results, the authors introduce the concept of a selectivity score as a general tool to quantify and differentiate the obsd. interaction patterns.  The authors further investigate the impact of panel size and find that small assay panels do not provide a robust measure of selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiArJSq2_lPrVg90H21EOLACvtfcHk0li2jmqsWKPGCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFGlsQ%253D%253D&md5=346265d412853ced636ad4128ed8a76f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnbt1358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1358%26sid%3Dliteratum%253Aachs%26aulast%3DKaraman%26aufirst%3DM.%2BW.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DCampbell%26aufirst%3DB.%2BT.%26aulast%3DChan%26aufirst%3DK.%2BW.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DM.%2BI.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFaraoni%26aufirst%3DR.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DHunt%26aufirst%3DJ.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DPallares%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DPritchard%26aufirst%3DS.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DA%2520quantitative%2520analysis%2520of%2520kinase%2520inhibitor%2520selectivity%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D127%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><div class="note"><p class="first last">An important feature of sunitinib is that its promiscuous profile is due to the indolinone scaffold ability to bind both DFG “in” and DFG “out” states of the protein, interacting via hydrogen bond with the hinge region and displaying hydrophobic contacts like a type I inhibitor. </p></div><span class="NLM_contrib-group">Gajiwala, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiNitto, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">English, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greig, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacques, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunney, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molina, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quenzer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmett, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demetri, J. D.</span><span> </span><span class="NLM_article-title">KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">1542</span><span class="NLM_x">–</span> <span class="NLM_lpage">1547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1073%2Fpnas.0812413106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=19164557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVOms78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=1542-1547&author=K.+S.+Gajiwalaauthor=J.+C.+Wuauthor=J.+Christensenauthor=G.+D.+Deshmukhauthor=W.+Diehlauthor=J.+P.+DiNittoauthor=J.+M.+Englishauthor=J.+M.+Greigauthor=Y.+A.+Heauthor=S.+L.+Jacquesauthor=E.+A.+Lunneyauthor=M.+McTigueauthor=D.+Molinaauthor=T.+Quenzerauthor=P.+A.+Wellsauthor=X.+Yuauthor=Y.+Zhangauthor=A.+Zouauthor=M.+R.+Emmettauthor=A.+G.+Marshallauthor=H.+M.+Zhangauthor=J.+D.+Demetri&title=KIT+kinase+mutants+show+unique+mechanisms+of+drug+resistance+to+imatinib+and+sunitinib+in+gastrointestinal+stromal+tumor+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients</span></div><div class="casAuthors">Gajiwala, Ketan S.; Wu, Joe C.; Christensen, James; Deshmukh, Gayatri D.; Diehl, Wade; DiNitto, Jonathan P.; English, Jessie M.; Greig, Michael J.; He, You-Ai; Jacques, Suzanne L.; Lunney, Elizabeth A.; McTigue, Michele; Molina, Dave; Quenzer, Terri; Wells, Peter A.; Yu, Xiu; Zhang, Yan; Zou, Aihua; Emmett, Mark R.; Marshall, Alan G.; Zhang, Hui-Min; Demetri, George D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1542-1547</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Most gastrointestinal stromal tumors (GISTs) exhibit aberrant activation of the receptor tyrosine kinase (RTK) KIT.  The efficacy of the inhibitors imatinib mesylate and sunitinib malate in GIST patients has been linked to their inhibition of these mutant KIT proteins.  However, patients on imatinib can acquire secondary KIT mutations that render the protein insensitive to the inhibitor.  Sunitinib has shown efficacy against certain imatinib-resistant mutants, although a subset that resides in the activation loop, including D816H/V, remains resistant.  Biochem. and structural studies were undertaken to det. the mol. basis of sunitinib resistance.  Our results show that sunitinib targets the autoinhibited conformation of WT KIT and that the D816H mutant undergoes a shift in conformational equil. toward the active state.  These findings provide a structural and enzymol. explanation for the resistance profile obsd. with the KIT inhibitors.  Prospectively, they have implications for understanding oncogenic kinase mutants and for circumventing drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkwFxa-p-iWbVg90H21EOLACvtfcHk0li2jmqsWKPGCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVOms78%253D&md5=dd226c914c6f9a258426c0f4984a5258</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0812413106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0812413106%26sid%3Dliteratum%253Aachs%26aulast%3DGajiwala%26aufirst%3DK.%2BS.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DDeshmukh%26aufirst%3DG.%2BD.%26aulast%3DDiehl%26aufirst%3DW.%26aulast%3DDiNitto%26aufirst%3DJ.%2BP.%26aulast%3DEnglish%26aufirst%3DJ.%2BM.%26aulast%3DGreig%26aufirst%3DJ.%2BM.%26aulast%3DHe%26aufirst%3DY.%2BA.%26aulast%3DJacques%26aufirst%3DS.%2BL.%26aulast%3DLunney%26aufirst%3DE.%2BA.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DMolina%26aufirst%3DD.%26aulast%3DQuenzer%26aufirst%3DT.%26aulast%3DWells%26aufirst%3DP.%2BA.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZou%26aufirst%3DA.%26aulast%3DEmmett%26aufirst%3DM.%2BR.%26aulast%3DMarshall%26aufirst%3DA.%2BG.%26aulast%3DZhang%26aufirst%3DH.%2BM.%26aulast%3DDemetri%26aufirst%3DJ.%2BD.%26atitle%3DKIT%2520kinase%2520mutants%2520show%2520unique%2520mechanisms%2520of%2520drug%2520resistance%2520to%2520imatinib%2520and%2520sunitinib%2520in%2520gastrointestinal%2520stromal%2520tumor%2520patients%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D1542%26epage%3D1547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Features of selective kinase inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">637</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1016%2Fj.chembiol.2005.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=15975507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=621-637&author=Z.+A.+Knightauthor=K.+M.+Shokat&title=Features+of+selective+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Features of Selective Kinase Inhibitors</span></div><div class="casAuthors">Knight, Zachary A.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">621-637</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Summary: Small-mol. inhibitors of protein and lipid kinases have emerged as indispensable tools for studying signal transduction.  Despite the widespread use of these reagents, there is little consensus about the biochem. criteria that define their potency and selectivity in cells.  We discuss some of the features that det. the cellular activity of kinase inhibitors and propose a framework for interpreting inhibitor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJWhVxtSrCLVg90H21EOLACvtfcHk0lgrL8mgk88bzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlsFGhtrc%253D&md5=ce5b3505a0326b04479172ec05573152</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2005.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2005.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DFeatures%2520of%2520selective%2520kinase%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2005%26volume%3D12%26spage%3D621%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Sequist, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, T. J.</span><span> </span><span class="NLM_article-title">EGFR tyrosine kinase inhibitors in lung cancer: an evolving story</span> <span class="citation_source-journal">Annu. Rev. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">429</span><span class="NLM_x">–</span> <span class="NLM_lpage">442</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2008&pages=429-442&author=L.+V.+Sequistauthor=T.+J.+Lynch&title=EGFR+tyrosine+kinase+inhibitors+in+lung+cancer%3A+an+evolving+story"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSequist%26aufirst%3DL.%2BV.%26aulast%3DLynch%26aufirst%3DT.%2BJ.%26atitle%3DEGFR%2520tyrosine%2520kinase%2520inhibitors%2520in%2520lung%2520cancer%253A%2520an%2520evolving%2520story%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2008%26volume%3D59%26spage%3D429%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Lynch, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sordella, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurubhagavatula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okimoto, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brannigan, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haserlat, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Supko, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haluska, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiani, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settleman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haber, D. A.</span><span> </span><span class="NLM_article-title">Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">2129</span><span class="NLM_x">–</span> <span class="NLM_lpage">2139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1056%2FNEJMoa040938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=15118073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktF2js7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2004&pages=2129-2139&issue=21&author=T.+J.+Lynchauthor=D.+W.+Bellauthor=R.+Sordellaauthor=S.+Gurubhagavatulaauthor=R.+A.+Okimotoauthor=B.+W.+Branniganauthor=P.+L.+Harrisauthor=S.+M.+Haserlatauthor=J.+G.+Supkoauthor=F.+G.+Haluskaauthor=D.+N.+Louisauthor=D.+C.+Christianiauthor=J.+Settlemanauthor=D.+A.+Haber&title=Activating+mutations+in+the+epidermal+growth+factor+receptor+underlying+responsiveness+of+non-small-cell+lung+cancer+to+gefitinib"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib</span></div><div class="casAuthors">Lynch, Thomas J.; Bell, Daphne W.; Sordella, Raffaella; Gurubhagavatula, Sarada; Okimoto, Ross A.; Brannigan, Brian W.; Harris, Patricia L.; Haserlat, Sara M.; Supko, Jeffrey G.; Haluska, Frank G.; Louis, David N.; Christiani, David C.; Settleman, Jeff; Haber, Daniel A.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2129-2139</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Most patients with non-small-cell lung cancer have no response to the tyrosine kinase inhibitor gefitinib, which targets the epidermal growth factor receptor (EGFR).  However, about 10% of patients have a rapid and often dramatic clin. response.  The mol. mechanisms underlying sensitivity to gefitinib are unknown.  We searched for mutations in the EGFR gene in primary tumors from patients with non-small-cell lung cancer who had a response to gefitinib, those who did not have a response, and those who had not been exposed to gefitinib.  The functional consequences of identified mutations were evaluated after the mutant proteins were expressed in cultured cells.  Somatic mutations were identified in the tyrosine kinase domain of the EGFR gene in eight of nine patients with gefitinib-responsive lung cancer, as compared with none of the seven patients with no response (P < 0.001).  Mutations were either small, in-frame deletions or amino acid substitutions clustered around the ATP-binding pocket of the tyrosine kinase domain.  Similar mutations were detected in tumors from 2 of 25 patients with primary non-small-cell lung cancer who had not been exposed to gefitinib (8%).  All mutations were heterozygous, and identical mutations were obsd. in multiple patients, suggesting an additive specific gain of function.  In vitro, EGFR mutants demonstrated enhanced tyrosine kinase activity in response to epidermal growth factor and increased sensitivity to inhibition by gefitinib.  A subgroup of patients with non-small-cell lung cancer have specific mutations in the EGFR gene, which correlate with clin. responsiveness to the tyrosine kinase inhibitor gefitinib.  These mutations lead to increased growth factor signaling and confer susceptibility to the inhibitor.  Screening for such mutations in lung cancers may identify patients who will have a response to gefitinib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXwWGeAQrNTLVg90H21EOLACvtfcHk0lgrL8mgk88bzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktF2js7c%253D&md5=fad70aa0f32ad4105ad6f3db98135bf9</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa040938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa040938%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DT.%2BJ.%26aulast%3DBell%26aufirst%3DD.%2BW.%26aulast%3DSordella%26aufirst%3DR.%26aulast%3DGurubhagavatula%26aufirst%3DS.%26aulast%3DOkimoto%26aufirst%3DR.%2BA.%26aulast%3DBrannigan%26aufirst%3DB.%2BW.%26aulast%3DHarris%26aufirst%3DP.%2BL.%26aulast%3DHaserlat%26aufirst%3DS.%2BM.%26aulast%3DSupko%26aufirst%3DJ.%2BG.%26aulast%3DHaluska%26aufirst%3DF.%2BG.%26aulast%3DLouis%26aufirst%3DD.%2BN.%26aulast%3DChristiani%26aufirst%3DD.%2BC.%26aulast%3DSettleman%26aufirst%3DJ.%26aulast%3DHaber%26aufirst%3DD.%2BA.%26atitle%3DActivating%2520mutations%2520in%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520underlying%2520responsiveness%2520of%2520non-small-cell%2520lung%2520cancer%2520to%2520gefitinib%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D350%26issue%3D21%26spage%3D2129%26epage%3D2139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Paez, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jänne, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greulich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggon, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naoki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span> </span><span class="NLM_article-title">EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">1497</span><span class="NLM_x">–</span> <span class="NLM_lpage">1500</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1126%2Fscience.1099314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=15118125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVGmsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2004&pages=1497-1500&author=J.+G.+Paezauthor=P.+A.+J%C3%A4nneauthor=J.+C.+Leeauthor=S.+Tracyauthor=H.+Greulichauthor=S.+Gabrielauthor=P.+Hermanauthor=F.+J.+Kayeauthor=N.+Lindemanauthor=T.+J.+Boggonauthor=K.+Naokiauthor=H.+Sasakiauthor=Y.+Fujiiauthor=M.+J.+Eckauthor=W.+R.+Sellersauthor=B.+E.+Johnsonauthor=M.+Meyerson&title=EGFR+mutations+in+lung+cancer%3A+correlation+with+clinical+response+to+gefitinib+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy</span></div><div class="casAuthors">Paez, J. Guillermo; Jaenne, Pasi A.; Lee, Jeffrey C.; Tracy, Sean; Greulich, Heidi; Gabriel, Stacey; Herman, Paula; Kaye, Frederic J.; Lindeman, Neal; Boggon, Titus J.; Naoki, Katsuhiko; Sasaki, Hidefumi; Fujii, Yoshitaka; Eck, Michael J.; Sellers, William R.; Johnson, Bruce E.; Meyerson, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">5676</span>),
    <span class="NLM_cas:pages">1497-1500</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Receptor tyrosine kinase genes were sequenced in non-small cell lung cancer (NSCLC) and matched normal tissue.  Somatic mutations of the epidermal growth factor receptor gene EGFR were found in 15 of 58 unselected tumors from Japan and 1 of 61 from the United States.  Treatment with the EGFR kinase inhibitor gefitinib (Iressa) causes tumor regression in some patients with NSCLC, more frequently in Japan.  EGFR mutations were found in addnl. lung cancer samples from U.S. patients who responded to gefitinib therapy and in a lung adenocarcinoma cell line that was hypersensitive to growth inhibition by gefitinib, but not in gefitinib-insensitive tumors or cell lines.  These results suggest that EGFR mutations may predict sensitivity to gefitinib.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGxLJH5f3Kb7Vg90H21EOLACvtfcHk0lhDkiwRSdC-qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVGmsbs%253D&md5=6df1b11bf9b3c284fbe000e34c61ebac</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1126%2Fscience.1099314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1099314%26sid%3Dliteratum%253Aachs%26aulast%3DPaez%26aufirst%3DJ.%2BG.%26aulast%3DJ%25C3%25A4nne%26aufirst%3DP.%2BA.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DTracy%26aufirst%3DS.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DGabriel%26aufirst%3DS.%26aulast%3DHerman%26aufirst%3DP.%26aulast%3DKaye%26aufirst%3DF.%2BJ.%26aulast%3DLindeman%26aufirst%3DN.%26aulast%3DBoggon%26aufirst%3DT.%2BJ.%26aulast%3DNaoki%26aufirst%3DK.%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DFujii%26aufirst%3DY.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DJohnson%26aufirst%3DB.%2BE.%26aulast%3DMeyerson%26aufirst%3DM.%26atitle%3DEGFR%2520mutations%2520in%2520lung%2520cancer%253A%2520correlation%2520with%2520clinical%2520response%2520to%2520gefitinib%2520therapy%26jtitle%3DScience%26date%3D2004%26volume%3D304%26spage%3D1497%26epage%3D1500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Alton, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunney, E. A.</span><span> </span><span class="NLM_article-title">Targeting the inactivated conformations of protein kinases for small molecule drug discovery</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">595</span><span class="NLM_x">–</span> <span class="NLM_lpage">605</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=595-605&issue=6&author=G.+R.+Altonauthor=E.+A.+Lunney&title=Targeting+the+inactivated+conformations+of+protein+kinases+for+small+molecule+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlton%26aufirst%3DG.%2BR.%26aulast%3DLunney%26aufirst%3DE.%2BA.%26atitle%3DTargeting%2520the%2520inactivated%2520conformations%2520of%2520protein%2520kinases%2520for%2520small%2520molecule%2520drug%2520discovery%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2008%26volume%3D3%26issue%3D6%26spage%3D595%26epage%3D605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Backes, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zech, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebl, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, G.</span><span> </span><span class="NLM_article-title">Small-molecule inhibitors binding to protein kinase. Part II: the novel pharmacophore approach of type II and type III inhibition</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1427</span><span class="NLM_x">–</span> <span class="NLM_lpage">1449</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=1427-1449&issue=12&author=A.+C.+Backesauthor=B.+Zechauthor=B.+Felberauthor=B.+Kleblauthor=G.+M%C3%BCller&title=Small-molecule+inhibitors+binding+to+protein+kinase.+Part+II%3A+the+novel+pharmacophore+approach+of+type+II+and+type+III+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBackes%26aufirst%3DA.%2BC.%26aulast%3DZech%26aufirst%3DB.%26aulast%3DFelber%26aufirst%3DB.%26aulast%3DKlebl%26aufirst%3DB.%26aulast%3DM%25C3%25BCller%26aufirst%3DG.%26atitle%3DSmall-molecule%2520inhibitors%2520binding%2520to%2520protein%2520kinase.%2520Part%2520II%253A%2520the%2520novel%2520pharmacophore%2520approach%2520of%2520type%2520II%2520and%2520type%2520III%2520inhibition%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2008%26volume%3D3%26issue%3D12%26spage%3D1427%26epage%3D1449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Chène, P.</span><span> </span><span class="NLM_article-title">Challenges in design of biochemical assays for the identification of small molecules to target multiple conformations of protein kinases</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">522</span><span class="NLM_x">–</span> <span class="NLM_lpage">529</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=522-529&author=P.+Ch%C3%A8ne&title=Challenges+in+design+of+biochemical+assays+for+the+identification+of+small+molecules+to+target+multiple+conformations+of+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCh%25C3%25A8ne%26aufirst%3DP.%26atitle%3DChallenges%2520in%2520design%2520of%2520biochemical%2520assays%2520for%2520the%2520identification%2520of%2520small%2520molecules%2520to%2520target%2520multiple%2520conformations%2520of%2520protein%2520kinases%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2008%26volume%3D13%26spage%3D522%26epage%3D529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Regan, J.</span><span> </span><span class="NLM_article-title">The kinetics of binding to p38 MAP kinase by analogues of BIRB 796</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3101</span><span class="NLM_x">–</span> <span class="NLM_lpage">3104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1016%2FS0960-894X%2803%2900656-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=12941343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1Gmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3101-3104&author=J.+Regan&title=The+kinetics+of+binding+to+p38+MAP+kinase+by+analogues+of+BIRB+796"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The kinetics of binding to p38 MAP kinase of analogues of BIRB 796</span></div><div class="casAuthors">Regan, John; Pargellis, Christopher A.; Cirillo, Pier F.; Gilmore, Thomas; Hickey, Eugene R.; Peet, Gregory W.; Proto, Alfred; Swinamer, Alan; Moss, Neil</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3101-3104</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">BIRB 796, a member of the N-pyrazole-N'-naphthyl urea class of p38 MAPK inhibitors, binds to the kinase with both slow assocn. and dissocn. rates.  Prior to binding, the kinase undergoes a reorganization of the activation loop exposing a crit. binding domain.  We demonstrate that, independent of the loop movement, assocn. rates are governed by low energy conformations of the inhibitor and polar functionality on the tolyl ring.  As anticipated, the dissocn. rates of the inhibitors from the kinase are slowed by lipophilic and hydrogen bond interactions.  The value of structure-kinetic relationships (SKR) in drug design is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr1jPKElIlvrVg90H21EOLACvtfcHk0lixLZXzGhlTMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1Gmt7s%253D&md5=1ca2cb661cf037790ec1b0b43a105cf3</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900656-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900656-5%26sid%3Dliteratum%253Aachs%26aulast%3DRegan%26aufirst%3DJ.%26atitle%3DThe%2520kinetics%2520of%2520binding%2520to%2520p38%2520MAP%2520kinase%2520by%2520analogues%2520of%2520BIRB%2520796%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D3101%26epage%3D3104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Pargellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchill, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grob, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, J.</span><span> </span><span class="NLM_article-title">Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1038%2Fnsb770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Kisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=268-272&author=C.+Pargellisauthor=L.+Tongauthor=L.+Churchillauthor=P.+F.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=P.+M.+Grobauthor=E.+R.+Hickeyauthor=N.+Mossauthor=S.+Pavauthor=J.+Regan&title=Inhibition+of+p38+MAP+kinase+by+utilizing+a+novel+allosteric+binding+site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site</span></div><div class="casAuthors">Pargellis, Christopher; Tong, Liang; Churchill, Laurie; Cirillo, Pier F.; Gilmore, Thomas; Graham, Anne G.; Grob, Peter M.; Hickey, Eugene R.; Moss, Neil; Pav, Susan; Regan, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">268-272</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">The p38 MAP kinase plays a crucial role in regulating the prodn. of proinflammatory cytokines, such as tumor necrosis factor and interleukin-1.  Blocking this kinase may offer an effective therapy for treating many inflammatory diseases.  Here we report a new allosteric binding site for a diaryl urea class of highly potent and selective inhibitors against human p38 MAP kinase.  The formation of this binding site requires a large conformational change not obsd. previously for any of the protein Ser/Thr kinases.  This change is in the highly conserved Asp-Phe-Gly motif within the active site of the kinase.  Soln. studies demonstrate that this class of compds. has slow binding kinetics, consistent with the requirement for conformational change.  Improving interactions in this allosteric pocket, as well as establishing binding interactions in the ATP pocket, enhanced the affinity of the inhibitors by 12,000-fold.  One of the most potent compds. in this series, BIRB 796, has picomolar affinity for the kinase and low nanomolar inhibitory activity in cell culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT8_QT7_pbYrVg90H21EOLACvtfcHk0lixLZXzGhlTMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Kisbk%253D&md5=68850ecdbe08df4285ba38cfa2c93ea4</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fnsb770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb770%26sid%3Dliteratum%253Aachs%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DChurchill%26aufirst%3DL.%26aulast%3DCirillo%26aufirst%3DP.%2BF.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DGrob%26aufirst%3DP.%2BM.%26aulast%3DHickey%26aufirst%3DE.%2BR.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DRegan%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520p38%2520MAP%2520kinase%2520by%2520utilizing%2520a%2520novel%2520allosteric%2520binding%2520site%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D268%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harmange, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polverino, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borg, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bready, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choquette, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMelfi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doerr, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harriman, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neervannan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potashman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roveto, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schrag, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starnes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teffera, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanon, R.</span><span> </span><span class="NLM_article-title">Evaluation of a series of naphthamides as potent, orally active vascular endothelial growth factor receptor-2 tyrosine kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1668</span><span class="NLM_x">–</span> <span class="NLM_lpage">1680</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701098w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1668-1680&author=M.+M.+Weissauthor=J.+C.+Harmangeauthor=A.+J.+Polverinoauthor=D.+Bauerauthor=L.+Berryauthor=V.+Berryauthor=G.+Borgauthor=J.+Breadyauthor=D.+Chenauthor=D.+Choquetteauthor=A.+Coxonauthor=T.+DeMelfiauthor=N.+Doerrauthor=J.+Estradaauthor=J.+Flynnauthor=R.+F.+Graceffaauthor=S.+P.+Harrimanauthor=S.+Kaufmanauthor=D.+S.+Laauthor=A.+Longauthor=S.+Neervannanauthor=V.+F.+Patelauthor=M.+Potashmanauthor=K.+Regalauthor=P.+M.+Rovetoauthor=M.+L.+Schragauthor=C.+Starnesauthor=A.+Taskerauthor=Y.+Tefferaauthor=D.+A.+Whittingtonauthor=R.+Zanon&title=Evaluation+of+a+series+of+naphthamides+as+potent%2C+orally+active+vascular+endothelial+growth+factor+receptor-2+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm701098w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701098w%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DHarmange%26aufirst%3DJ.%2BC.%26aulast%3DPolverino%26aufirst%3DA.%2BJ.%26aulast%3DBauer%26aufirst%3DD.%26aulast%3DBerry%26aufirst%3DL.%26aulast%3DBerry%26aufirst%3DV.%26aulast%3DBorg%26aufirst%3DG.%26aulast%3DBready%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DChoquette%26aufirst%3DD.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DDeMelfi%26aufirst%3DT.%26aulast%3DDoerr%26aufirst%3DN.%26aulast%3DEstrada%26aufirst%3DJ.%26aulast%3DFlynn%26aufirst%3DJ.%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DHarriman%26aufirst%3DS.%2BP.%26aulast%3DKaufman%26aufirst%3DS.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLong%26aufirst%3DA.%26aulast%3DNeervannan%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DPotashman%26aufirst%3DM.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DRoveto%26aufirst%3DP.%2BM.%26aulast%3DSchrag%26aufirst%3DM.%2BL.%26aulast%3DStarnes%26aufirst%3DC.%26aulast%3DTasker%26aufirst%3DA.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DZanon%26aufirst%3DR.%26atitle%3DEvaluation%2520of%2520a%2520series%2520of%2520naphthamides%2520as%2520potent%252C%2520orally%2520active%2520vascular%2520endothelial%2520growth%2520factor%2520receptor-2%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1668%26epage%3D1680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Shah, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagar, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorre, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquette, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyers, C. L.</span><span> </span><span class="NLM_article-title">Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">125</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=117-125&issue=2&author=N.+P.+Shahauthor=J.+M.+Nicollauthor=B.+Nagarauthor=M.+E.+Gorreauthor=R.+L.+Paquetteauthor=J.+Kuriyanauthor=C.+L.+Sawyers&title=Multiple+BCR-ABL+kinase+domain+mutations+confer+polyclonal+resistance+to+the+tyrosine+kinase+inhibitor+imatinib+%28STI571%29+in+chronic+phase+and+blast+crisis+chronic+myeloid+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DN.%2BP.%26aulast%3DNicoll%26aufirst%3DJ.%2BM.%26aulast%3DNagar%26aufirst%3DB.%26aulast%3DGorre%26aufirst%3DM.%2BE.%26aulast%3DPaquette%26aufirst%3DR.%2BL.%26aulast%3DKuriyan%26aufirst%3DJ.%26aulast%3DSawyers%26aufirst%3DC.%2BL.%26atitle%3DMultiple%2520BCR-ABL%2520kinase%2520domain%2520mutations%2520confer%2520polyclonal%2520resistance%2520to%2520the%2520tyrosine%2520kinase%2520inhibitor%2520imatinib%2520%2528STI571%2529%2520in%2520chronic%2520phase%2520and%2520blast%2520crisis%2520chronic%2520myeloid%2520leukemia%26jtitle%3DCancer%2520Cell%26date%3D2002%26volume%3D2%26issue%3D2%26spage%3D117%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Cuenda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouse, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doza, Y. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallagher, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span> </span><span class="NLM_article-title">SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">364</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=1995&pages=229-233&issue=2&author=A.+Cuendaauthor=J.+Rouseauthor=Y.+N.+Dozaauthor=R.+Meierauthor=P.+Cohenauthor=T.+F.+Gallagherauthor=P.+R.+Youngauthor=J.+C.+Lee&title=SB+203580+is+a+specific+inhibitor+of+a+MAP+kinase+homologue+which+is+stimulated+by+cellular+stresses+and+interleukin-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCuenda%26aufirst%3DA.%26aulast%3DRouse%26aufirst%3DJ.%26aulast%3DDoza%26aufirst%3DY.%2BN.%26aulast%3DMeier%26aufirst%3DR.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DGallagher%26aufirst%3DT.%2BF.%26aulast%3DYoung%26aufirst%3DP.%2BR.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26atitle%3DSB%2520203580%2520is%2520a%2520specific%2520inhibitor%2520of%2520a%2520MAP%2520kinase%2520homologue%2520which%2520is%2520stimulated%2520by%2520cellular%2520stresses%2520and%2520interleukin-1%26jtitle%3DFEBS%2520Lett.%26date%3D1995%26volume%3D364%26issue%3D2%26spage%3D229%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cywin, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C. A.</span><span> </span><span class="NLM_article-title">A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket</span> <span class="citation_source-journal">Nat. Struct. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">316</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1038%2Fnsb0497-311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADyaK2sXitl2murc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1997&pages=311-316&author=L.+Tongauthor=S.+Pavauthor=D.+M.+Whiteauthor=S+Rogersauthor=K.+M.+Craneauthor=C.+L.+Cywinauthor=M.+L.+Brownauthor=C.+A.+Pargellis&title=A+highly+specific+inhibitor+of+human+p38+MAP+kinase+binds+in+the+ATP+pocket"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket</span></div><div class="casAuthors">Tong, Liang; Pav, Susan; White, Della M.; Rogers, Sheri; Crane, Kathy M.; Cywin, Charles L.; Brown, Maryanne L.; Pargellis, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-316</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Co.</span>)
        </div><div class="casAbstract">The crystal structure of human p38 mitogen-activated protein (MAP) kinase in complex with a potent and highly specific pyridinyl-imidazole inhibitor was detd. at 2.0 Å resoln.  The structure of the kinase, which is in its unphosphorylated state, is similar to that of the closely-related ERK2.  The inhibitor mol. is bound in the ATP pocket.  A hydrogen bond is made between the pyridyl nitrogen of the inhibitor and the main chain amido nitrogen of residue 109, analogous to the interaction from the N1 atom of ATP.  The crystal structure provides possible explanations for the specificity of this class of inhibitors.  Other protein kinase inhibitors may achieve their specificity through a similar mechanism.  The structure also reveals a possible second binding site for this inhibitor, with currently unknown function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNChzA5qquarVg90H21EOLACvtfcHk0lh5GVXRJr4nqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXitl2murc%253D&md5=3d5f157fdfa876b74dc3881857bc67b3</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnsb0497-311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb0497-311%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DL.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DD.%2BM.%26aulast%3DRogers%26aufirst%3DS%26aulast%3DCrane%26aufirst%3DK.%2BM.%26aulast%3DCywin%26aufirst%3DC.%2BL.%26aulast%3DBrown%26aufirst%3DM.%2BL.%26aulast%3DPargellis%26aufirst%3DC.%2BA.%26atitle%3DA%2520highly%2520specific%2520inhibitor%2520of%2520human%2520p38%2520MAP%2520kinase%2520binds%2520in%2520the%2520ATP%2520pocket%26jtitle%3DNat.%2520Struct.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D4%26spage%3D311%26epage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><div class="note"><p class="first last">Lapatinib is an EGFR inhibitor. Structural evidence (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1xkk">1xkk</a>) shows that it binds to an inactive form of the kinase. However, in this particular case, the kinase inactivity is not the consequence of a DFG “out” state but instead the result of a misplaced αC-helix (probably a ligand induced effect) that leads to the disruption of the salt bridge between the conserved Lys-Glu residues which is essential for catalytic activity. </p></div><span class="NLM_contrib-group">Lackey, K. E.</span><span> </span><span class="NLM_article-title">Lessons from the drug discovery of lapatinib, a dual ErbB1/2 tyrosine kinase inhibitor</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">460</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.2174%2F156802606776743156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=16719802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtV2juro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=435-460&author=K.+E.+Lackey&title=Lessons+from+the+drug+discovery+of+lapatinib%2C+a+dual+ErbB1%2F2+tyrosine+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons from the drug discovery of Lapatinib, a dual ErbB1/2 tyrosine Kinase inhibitor</span></div><div class="casAuthors">Lackey, Karen E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">435-460</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein Kinases offer many opportunities for drug intervention points since phosphorylation is the most common post-translational modification.  Phosphorylation regulates activity, location, degrdn., and conformation and the aberrant activity is implicated in many diseases, including cancer, inflammation, cardiovascular, and central nervous system diseases.  The focus of this review will be on the generation of highly effective signaling inhibitors targeting members of the erbB family of receptor tyrosine kinases, EGFR and ErbB-2, also known as transmembrane Type 1 receptor tyrosine kinases of the HER family of receptors.  Ligand binding to the receptor causes a conformational change which activates the tyrosine kinase domain leading to autophosphorylation.  This autophosphorylation activates the RAS/mitogen-activated protein (MAP) kinase and phosphoinositol-3-kinase (PI3K) pathways leading to a myriad of signaling and cellular activities.  Type 1 receptors are overexpressed in a variety of cancers and generally correlate with poor prognosis.  For this reason, scientists at GlaxoSmithKline and many others in the scientific community target the ATP binding site of the intracellular portion of the protein to block the aberrant signaling event.  This review intends to cover the lessons learned in the discovery of Lapatinib (GW572016, GW2016) by pulling together the various different publications that have been generated in distinct disciplines on aspects of the drug discovery program.  Data analyses and correlation of assay data to help with the design of drug-like mols. are included and demonstrate a break from the traditional focus on abs. potency as a guiding factor in lead compd. selection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnKhQE45WWsbVg90H21EOLACvtfcHk0lirAb7LE1DeGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtV2juro%253D&md5=5bb70c03abc1fb8c301cac0f5f713fbe</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.2174%2F156802606776743156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606776743156%26sid%3Dliteratum%253Aachs%26aulast%3DLackey%26aufirst%3DK.%2BE.%26atitle%3DLessons%2520from%2520the%2520drug%2520discovery%2520of%2520lapatinib%252C%2520a%2520dual%2520ErbB1%252F2%2520tyrosine%2520kinase%2520inhibitor%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D435%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Dalgarno, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stehle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schelling, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Schravendijk, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keats, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ram, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacNeil, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, C.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakespeare, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaramoorthi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohacek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigele, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, T.</span><span> </span><span class="NLM_article-title">Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1111%2Fj.1747-0285.2005.00316.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=16492148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVSjt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=46-57&author=D.+Dalgarnoauthor=T.+Stehleauthor=S.+Narulaauthor=P.+Schellingauthor=M.+R.+van+Schravendijkauthor=S.+Adamsauthor=L.+Andradeauthor=J.+Keatsauthor=M.+Ramauthor=L.+Jinauthor=T.+Grossmanauthor=I.+MacNeilauthor=C.+Metcalfauthor=W.+Shakespeareauthor=Y.+Wangauthor=T.+Keenanauthor=R.+Sundaramoorthiauthor=R.+Bohacekauthor=M.+Weigeleauthor=T.+Sawyer&title=Structural+basis+of+Src+tyrosine+kinase+inhibition+with+a+new+class+of+potent+and+selective+trisubstituted+purine-based+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds</span></div><div class="casAuthors">Dalgarno, David; Stehle, Thilo; Narula, Surinder; Schelling, Pierre; van Schravendijk, Marie Rose; Adams, Susan; Andrade, Lawrence; Keats, Jeff; Ram, Mary; Jin, Lei; Grossman, Trudy; MacNeil, Ian; Metcalf, Chester, III; Shakespeare, William; Wang, Yihan; Keenan, Terry; Sundaramoorthi, Raji; Bohacek, Regine; Weigele, Manfred; Sawyer, Tomi</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-57</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The tyrosine kinase pp60src (Src) is the prototypical member of a family of proteins that participate in a broad array of cellular signal transduction processes, including cell growth, differentiation, survival, adhesion, and migration.  Abnormal Src family kinase (SFK) signaling has been linked to several disease states, including osteoporosis and cancer metastases.  Src has thus emerged as a mol. target for the discovery of small-mol. inhibitors that regulate Src kinase activity by binding to the ATP pocket within the catalytic domain.  Here, we present crystal structures of the kinase domain of Src in complex with two purine-based inhibitors: AP23451, a small-mol. inhibitor designed to inhibit Src-dependent bone resorption, and AP23464, a small-mol. inhibitor designed to inhibit the Src-dependent metastatic spread of cancer.  In each case, a trisubstituted purine template core was elaborated using structure-based drug design to yield a potent Src kinase inhibitor.  These structures represent early examples of high affinity purine-based Src family kinase-inhibitor complexes, and they provide a detailed view of the specific protein-ligand interactions that lead to potent inhibition of Src.  In particular, the 3-hydroxyphenethyl N9 substituent of AP23464 forms unique interactions with the protein that are crit. to the picomolar affinity of this compd. for Src.  The comparison of these new structures with two relevant kinase-inhibitor complexes provides a structural basis for the obsd. kinase inhibitory selectivity.  Further comparisons reveal a concerted induced-fit movement between the N- and C-terminal lobes of the kinase that correlates with the affinity of the ligand.  Binding of the most potent inhibitor, AP23464, results in the largest induced-fit movement, which can be directly linked to interactions of the hydrophenethyl N9 substituent with a region at the interface between the two lobes.  A less pronounced induced-fit movement is also obsd. in the Src-AP23451 complex.  These new structures illustrate how the combination of structural, computational, and medicinal chem. can be used to rationalize the process of developing high affinity, selective tyrosine kinase inhibitors as potential therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqAcWZyLy8JrVg90H21EOLACvtfcHk0lirAb7LE1DeGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVSjt7Y%253D&md5=5a89de976e29e65aec0553c84e2e0b92</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2005.00316.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2005.00316.x%26sid%3Dliteratum%253Aachs%26aulast%3DDalgarno%26aufirst%3DD.%26aulast%3DStehle%26aufirst%3DT.%26aulast%3DNarula%26aufirst%3DS.%26aulast%3DSchelling%26aufirst%3DP.%26aulast%3Dvan%2BSchravendijk%26aufirst%3DM.%2BR.%26aulast%3DAdams%26aufirst%3DS.%26aulast%3DAndrade%26aufirst%3DL.%26aulast%3DKeats%26aufirst%3DJ.%26aulast%3DRam%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DGrossman%26aufirst%3DT.%26aulast%3DMacNeil%26aufirst%3DI.%26aulast%3DMetcalf%26aufirst%3DC.%26aulast%3DShakespeare%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DKeenan%26aufirst%3DT.%26aulast%3DSundaramoorthi%26aufirst%3DR.%26aulast%3DBohacek%26aufirst%3DR.%26aulast%3DWeigele%26aufirst%3DM.%26aulast%3DSawyer%26aufirst%3DT.%26atitle%3DStructural%2520basis%2520of%2520Src%2520tyrosine%2520kinase%2520inhibition%2520with%2520a%2520new%2520class%2520of%2520potent%2520and%2520selective%2520trisubstituted%2520purine-based%2520compounds%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2006%26volume%3D67%26spage%3D46%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Mauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guba, W.</span><span> </span><span class="NLM_article-title">Recent developments in de novo design and scaffold hopping</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=18428090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXls1Wkuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=365-374&author=H.+Mauserauthor=W.+Guba&title=Recent+developments+in+de+novo+design+and+scaffold+hopping"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in de novo design and scaffold hopping</span></div><div class="casAuthors">Mauser, Harald; Guba, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">365-374</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  This review covers the developments in the fields of de novo ligand design and scaffold hopping since 2006.  De novo ligand design was introduced in 1991 as a purely structure-based method to suggest ligands for synthesis and was later augmented by ligand-based approaches.  Both structure-based and ligand-based methods identify pharmacophores, as well as shape constraints, and subsequently match these with complementary features embedded into small-mol. topologies.  Recently, significant attention has been paid to de novo ligand design in combination with biophys. fragment screening and x-ray structure elucidation.  Scaffold hopping has evolved from a niche application of de novo design into a rapidly expanding suite of different software tools, which are used extensively in the pharmaceutical industry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3SAbJ0iQ7W7Vg90H21EOLACvtfcHk0ljZV1j8C6Mw-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXls1Wkuro%253D&md5=d09183320c2739c1aef769f4d16b606e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DGuba%26aufirst%3DW.%26atitle%3DRecent%2520developments%2520in%2520de%2520novo%2520design%2520and%2520scaffold%2520hopping%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2008%26volume%3D11%26spage%3D365%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Azam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nardi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakespeare, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, C. A.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohacek, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaramoorthi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sliz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veach, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornmann, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarkson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalgarno, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daley, G. Q.</span><span> </span><span class="NLM_article-title">Activity of dual SRC-ABL inhibitors highlights the role of BCR/ABL kinase dynamics in drug resistance</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">9244</span><span class="NLM_x">–</span> <span class="NLM_lpage">9249</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=9244-9249&author=M.+Azamauthor=V.+Nardiauthor=W.+C.+Shakespeareauthor=C.+A.+Metcalfauthor=R.+S.+Bohacekauthor=Y.+Wangauthor=R.+Sundaramoorthiauthor=P.+Slizauthor=D.+R.+Veachauthor=W.+G.+Bornmannauthor=B.+Clarksonauthor=D.+C.+Dalgarnoauthor=T.+K.+Sawyerauthor=G.+Q.+Daley&title=Activity+of+dual+SRC-ABL+inhibitors+highlights+the+role+of+BCR%2FABL+kinase+dynamics+in+drug+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAzam%26aufirst%3DM.%26aulast%3DNardi%26aufirst%3DV.%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26aulast%3DMetcalf%26aufirst%3DC.%2BA.%26aulast%3DBohacek%26aufirst%3DR.%2BS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSundaramoorthi%26aufirst%3DR.%26aulast%3DSliz%26aufirst%3DP.%26aulast%3DVeach%26aufirst%3DD.%2BR.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DClarkson%26aufirst%3DB.%26aulast%3DDalgarno%26aufirst%3DD.%2BC.%26aulast%3DSawyer%26aufirst%3DT.%2BK.%26aulast%3DDaley%26aufirst%3DG.%2BQ.%26atitle%3DActivity%2520of%2520dual%2520SRC-ABL%2520inhibitors%2520highlights%2520the%2520role%2520of%2520BCR%252FABL%2520kinase%2520dynamics%2520in%2520drug%2520resistance%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D9244%26epage%3D9249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Angell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angell, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bambourough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamford, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flack, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laine, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longstaff, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludbrook, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smee, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somers, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span> </span><span class="NLM_article-title">Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4433</span><span class="NLM_x">–</span> <span class="NLM_lpage">4437</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4433-4437&author=R.+M.+Angellauthor=T.+D.+Angellauthor=P.+Bambouroughauthor=M.+J.+Bamfordauthor=C.+Chungauthor=S.+G.+Cockerillauthor=S.+S.+Flackauthor=K.+L.+Jonesauthor=D.+I.+Laineauthor=T.+Longstaffauthor=S.+Ludbrookauthor=R.+Pearsonauthor=K.+J.+Smithauthor=P.+A.+Smeeauthor=D.+O.+Somersauthor=A.+L.+Walker&title=Biphenyl+amide+p38+kinase+inhibitors+4%3A+DFG-in+and+DFG-out+binding+modes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAngell%26aufirst%3DR.%2BM.%26aulast%3DAngell%26aufirst%3DT.%2BD.%26aulast%3DBambourough%26aufirst%3DP.%26aulast%3DBamford%26aufirst%3DM.%2BJ.%26aulast%3DChung%26aufirst%3DC.%26aulast%3DCockerill%26aufirst%3DS.%2BG.%26aulast%3DFlack%26aufirst%3DS.%2BS.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DLaine%26aufirst%3DD.%2BI.%26aulast%3DLongstaff%26aufirst%3DT.%26aulast%3DLudbrook%26aufirst%3DS.%26aulast%3DPearson%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DSmee%26aufirst%3DP.%2BA.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26atitle%3DBiphenyl%2520amide%2520p38%2520kinase%2520inhibitors%25204%253A%2520DFG-in%2520and%2520DFG-out%2520binding%2520modes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4433%26epage%3D4437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Deak, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMauro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodous, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span> </span><span class="NLM_article-title"><i>N</i>-(3-(Phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: structure, synthesis and SAR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1172</span><span class="NLM_x">–</span> <span class="NLM_lpage">1176</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1172-1176&author=H.+L.+Deakauthor=J.+R.+Newcombauthor=J.+J.+Nunesauthor=C.+Boucherauthor=A.+C.+Chengauthor=E.+F.+DiMauroauthor=L.+F.+Epsteinauthor=P.+Gallantauthor=B.+L.+Hodousauthor=X.+Huangauthor=J.+H.+Leeauthor=V.+F.+Patelauthor=S.+Schneiderauthor=S.+M.+Turciauthor=X.+Zhu&title=N-%283-%28Phenylcarbamoyl%29arylpyrimidine%29-5-carboxamides+as+potent+and+selective+inhibitors+of+Lck%3A+structure%2C+synthesis+and+SAR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeak%26aufirst%3DH.%2BL.%26aulast%3DNewcomb%26aufirst%3DJ.%2BR.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DEpstein%26aufirst%3DL.%2BF.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DHodous%26aufirst%3DB.%2BL.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DN-%25283-%2528Phenylcarbamoyl%2529arylpyrimidine%2529-5-carboxamides%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520Lck%253A%2520structure%252C%2520synthesis%2520and%2520SAR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1172%26epage%3D1176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Elling, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fucini, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanan, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barr, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulvannan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romanowski, M. J.</span><span> </span><span class="NLM_article-title">Structures of the wild-type and activated catalytic domains of <i>Brachydanio rerio</i> polo-like kinase 1 (Plk1): changes in the active-site conformation and interactions with ligands</span> <span class="citation_source-journal">Acta Crystallogr., Sect. F</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">686</span><span class="NLM_x">–</span> <span class="NLM_lpage">691</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1107%2FS1744309108019623" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=18678933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptlOqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=686-691&author=R.+A.+Ellingauthor=R.+V.+Fuciniauthor=E.+J.+Hananauthor=K.+J.+Barrauthor=J.+Zhuauthor=K.+Paulvannanauthor=W.+Yangauthor=M.+J.+Romanowski&title=Structures+of+the+wild-type+and+activated+catalytic+domains+of+Brachydanio+rerio+polo-like+kinase+1+%28Plk1%29%3A+changes+in+the+active-site+conformation+and+interactions+with+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the Brachydanio rerio Polo-like kinase 1 (Plk1) catalytic domain in complex with an extended inhibitor targeting the adaptive pocket of the enzyme</span></div><div class="casAuthors">Elling, Robert A.; Fucini, Raymond V.; Hanan, Emily J.; Barr, Kenneth J.; Zhu, Jiang; Paulvannan, Kumar; Yang, Wenjin; Romanowski, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section F: Structural Biology and Crystallization Communications</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">686-691, 686/1</span>CODEN:
                <span class="NLM_cas:coden">ACSFCL</span>;
        ISSN:<span class="NLM_cas:issn">1744-3091</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Polo-like kinase 1 (Plk1) is a member of the Polo-like kinase family of serine/threonine kinases involved in the regulation of cell-cycle progression and cytokinesis and is an attractive target for the development of anticancer therapeutics.  The catalytic domain of this enzyme shares significant primary amino-acid homol. and structural similarity with another mitotic kinase, Aurora A.  While screening an Aurora A library of ATP-competitive compds., a urea-contg. inhibitor with low affinity for mouse Aurora A but with submicromolar potency for human and zebrafish Plk1 (hPlk1 and zPlk1, resp.) was identified.  A crystal structure of the zebrafish Plk1 kinase domain-inhibitor complex reveals that the small mol. occupies the purine pocket and extends past the catalytic lysine into the adaptive region of the active site.  Anal. of the structures of this protein-inhibitor complex and of similar small mols. cocrystd. with other kinases facilitates understanding of the specificity of the inhibitor for Plk1 and documents for the first time that Plk1 can accommodate extended ATP-competitive compds. that project toward the adaptive pocket and help the enzyme order its activation segment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoNk4ABCR2TrVg90H21EOLACvtfcHk0lgdbtBa3NhkqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptlOqsrc%253D&md5=2e5a5d8c4bb288b0699b5397720cd35c</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS1744309108019623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1744309108019623%26sid%3Dliteratum%253Aachs%26aulast%3DElling%26aufirst%3DR.%2BA.%26aulast%3DFucini%26aufirst%3DR.%2BV.%26aulast%3DHanan%26aufirst%3DE.%2BJ.%26aulast%3DBarr%26aufirst%3DK.%2BJ.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DPaulvannan%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DRomanowski%26aufirst%3DM.%2BJ.%26atitle%3DStructures%2520of%2520the%2520wild-type%2520and%2520activated%2520catalytic%2520domains%2520of%2520Brachydanio%2520rerio%2520polo-like%2520kinase%25201%2520%2528Plk1%2529%253A%2520changes%2520in%2520the%2520active-site%2520conformation%2520and%2520interactions%2520with%2520ligands%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520F%26date%3D2008%26spage%3D686%26epage%3D691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Tong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claiborne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Credo, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, W. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwaltney, S. L.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judge, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N. H.</span><span> </span><span class="NLM_article-title">Discovery of 1,4-dihydroindeno[1,2-<i>c</i>]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2759</span><span class="NLM_x">–</span> <span class="NLM_lpage">2767</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1016%2Fj.bmc.2007.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=17287122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivVagt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=2759-2767&author=Y.+Tongauthor=A.+Claiborneauthor=K.+D.+Stewartauthor=C.+Parkauthor=P.+Kovarauthor=Z.+Chenauthor=R.+B.+Credoauthor=W.+Z.+Guauthor=S.+L.+Gwaltneyauthor=R.+A.+Judgeauthor=H.+Zhangauthor=S.+H.+Rosenbergauthor=H.+L.+Shamauthor=T.+J.+Sowinauthor=N.+H.+Lin&title=Discovery+of+1%2C4-dihydroindeno%5B1%2C2-c%5Dpyrazoles+as+a+novel+class+of+potent+and+selective+checkpoint+kinase+1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitors</span></div><div class="casAuthors">Tong, Yunsong; Claiborne, Akiyo; Stewart, Kent D.; Park, Chang; Kovar, Peter; Chen, Zehan; Credo, Robert B.; Gu, Wen-Zhen; Gwaltney, Stephen L.; Judge, Russell A.; Zhang, Haiying; Rosenberg, Saul H.; Sham, Hing L.; Sowin, Thomas J.; Lin, Nan-horng</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2759-2767</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A new class of checkpoint kinase 1 (CHK-1) inhibitors bearing a 1,4-dihydroindeno[1,2-c]pyrazole core was developed after initial hits from high throughput screening.  The efficient hit-to-lead process was facilitated by X-ray crystallog. and led to potent inhibitors (<10 nM) against CHK-1.  X-ray co-crystal structures of bound inhibitors demonstrated that two sub-series of this class of compds., exemplified by 21 and 41, exhibit distinctive hydrogen bonding patterns in the specificity pocket of the active site.  Two compds., 41 and 43, were capable of potentiating doxorubicin and camptothecin, both DNA-damaging agents, in cell proliferation assays (MTS and soft agar assays) and abrogating G2/M checkpoint in a mechanism-based FACS assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVp7DNSZaexbVg90H21EOLACvtfcHk0ljroBbLGBxa6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivVagt7w%253D&md5=0966753ebf59128001db7601ca7d8cee</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DY.%26aulast%3DClaiborne%26aufirst%3DA.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DCredo%26aufirst%3DR.%2BB.%26aulast%3DGu%26aufirst%3DW.%2BZ.%26aulast%3DGwaltney%26aufirst%3DS.%2BL.%26aulast%3DJudge%26aufirst%3DR.%2BA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DSowin%26aufirst%3DT.%2BJ.%26aulast%3DLin%26aufirst%3DN.%2BH.%26atitle%3DDiscovery%2520of%25201%252C4-dihydroindeno%255B1%252C2-c%255Dpyrazoles%2520as%2520a%2520novel%2520class%2520of%2520potent%2520and%2520selective%2520checkpoint%2520kinase%25201%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D2759%26epage%3D2767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakespeare, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaramoorthi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banda, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keats, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wardwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snodgrass, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broudy, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russian, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalgarno, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clackson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, T. K.</span><span> </span><span class="NLM_article-title">Novel N9-arenethenyl purines as potent dual Src/Abl tyrosine kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4907</span><span class="NLM_x">–</span> <span class="NLM_lpage">4912</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4907-4912&author=Y.+Wangauthor=W.+C.+Shakespeareauthor=W.+S.+Huangauthor=R.+Sundaramoorthiauthor=S.+Lentiniauthor=S.+Dasauthor=S.+Liuauthor=G.+Bandaauthor=D.+Wenauthor=X.+Zhuauthor=Q.+Xuauthor=J.+Keatsauthor=F.+Wangauthor=S.+Wardwellauthor=Y.+Ningauthor=J.+T.+Snodgrassauthor=M.+I.+Broudyauthor=K.+Russianauthor=D.+Dalgarnoauthor=T.+Clacksonauthor=T.+K.+Sawyer&title=Novel+N9-arenethenyl+purines+as+potent+dual+Src%2FAbl+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26aulast%3DHuang%26aufirst%3DW.%2BS.%26aulast%3DSundaramoorthi%26aufirst%3DR.%26aulast%3DLentini%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DBanda%26aufirst%3DG.%26aulast%3DWen%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DKeats%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWardwell%26aufirst%3DS.%26aulast%3DNing%26aufirst%3DY.%26aulast%3DSnodgrass%26aufirst%3DJ.%2BT.%26aulast%3DBroudy%26aufirst%3DM.%2BI.%26aulast%3DRussian%26aufirst%3DK.%26aulast%3DDalgarno%26aufirst%3DD.%26aulast%3DClackson%26aufirst%3DT.%26aulast%3DSawyer%26aufirst%3DT.%2BK.%26atitle%3DNovel%2520N9-arenethenyl%2520purines%2520as%2520potent%2520dual%2520Src%252FAbl%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4907%26epage%3D4912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhamra, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bull, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopher, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hind, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranshaw, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skone, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickerstaff, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washington, M.</span><span> </span><span class="NLM_article-title"><i>N</i>-4-Pyrimidinyl-1<i>H</i>-indazol-4-amine inhibitors of Lck: indazoles as phenol isosteres with improved pharmacokinetics</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4363</span><span class="NLM_x">–</span> <span class="NLM_lpage">4368</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4363-4368&author=P.+Bamboroughauthor=R.+M.+Angellauthor=I.+Bhamraauthor=D.+Brownauthor=J.+Bullauthor=J.+A.+Christopherauthor=A.+W.+Cooperauthor=L.+H.+Fazalauthor=I.+Giordanoauthor=L.+Hindauthor=V.+K.+Patelauthor=L.+E.+Ranshawauthor=M.+J.+Simsauthor=P.+A.+Skoneauthor=K.+J.+Smithauthor=E.+Vickerstaffauthor=M.+Washington&title=N-4-Pyrimidinyl-1H-indazol-4-amine+inhibitors+of+Lck%3A+indazoles+as+phenol+isosteres+with+improved+pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DAngell%26aufirst%3DR.%2BM.%26aulast%3DBhamra%26aufirst%3DI.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBull%26aufirst%3DJ.%26aulast%3DChristopher%26aufirst%3DJ.%2BA.%26aulast%3DCooper%26aufirst%3DA.%2BW.%26aulast%3DFazal%26aufirst%3DL.%2BH.%26aulast%3DGiordano%26aufirst%3DI.%26aulast%3DHind%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DV.%2BK.%26aulast%3DRanshaw%26aufirst%3DL.%2BE.%26aulast%3DSims%26aufirst%3DM.%2BJ.%26aulast%3DSkone%26aufirst%3DP.%2BA.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DVickerstaff%26aufirst%3DE.%26aulast%3DWashington%26aufirst%3DM.%26atitle%3DN-4-Pyrimidinyl-1H-indazol-4-amine%2520inhibitors%2520of%2520Lck%253A%2520indazoles%2520as%2520phenol%2520isosteres%2520with%2520improved%2520pharmacokinetics%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4363%26epage%3D4368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Angell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angell, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockerill, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longstaff, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smee, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somers, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willson, M.</span><span> </span><span class="NLM_article-title">Biphenyl amide p38 kinase inhibitors 2: optimisation and SAR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">324</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=324-328&author=R.+M.+Angellauthor=T.+D.+Angellauthor=P.+Bamboroughauthor=D.+Brownauthor=M.+Brownauthor=J.+B.+Bucktonauthor=S.+G.+Cockerillauthor=C.+D.+Edwardsauthor=K.+L.+Jonesauthor=T.+Longstaffauthor=P.+A.+Smeeauthor=K.+J.+Smithauthor=D.+O.+Somersauthor=A.+L.+Walkerauthor=M.+Willson&title=Biphenyl+amide+p38+kinase+inhibitors+2%3A+optimisation+and+SAR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAngell%26aufirst%3DR.%2BM.%26aulast%3DAngell%26aufirst%3DT.%2BD.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DBuckton%26aufirst%3DJ.%2BB.%26aulast%3DCockerill%26aufirst%3DS.%2BG.%26aulast%3DEdwards%26aufirst%3DC.%2BD.%26aulast%3DJones%26aufirst%3DK.%2BL.%26aulast%3DLongstaff%26aufirst%3DT.%26aulast%3DSmee%26aufirst%3DP.%2BA.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26aulast%3DWalker%26aufirst%3DA.%2BL.%26aulast%3DWillson%26aufirst%3DM.%26atitle%3DBiphenyl%2520amide%2520p38%2520kinase%2520inhibitors%25202%253A%2520optimisation%2520and%2520SAR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D324%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Graham Robinett, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freemerman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skinner, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shewchuk, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lackey, K.</span><span> </span><span class="NLM_article-title">The discovery of substituted 4-(3-hydroxyanilino)-quinolines as potent RET kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5886</span><span class="NLM_x">–</span> <span class="NLM_lpage">5893</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5886-5893&author=R.+Graham+Robinettauthor=A.+J.+Freemermanauthor=M.+A.+Skinnerauthor=L.+Shewchukauthor=K.+Lackey&title=The+discovery+of+substituted+4-%283-hydroxyanilino%29-quinolines+as+potent+RET+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGraham%2BRobinett%26aufirst%3DR.%26aulast%3DFreemerman%26aufirst%3DA.%2BJ.%26aulast%3DSkinner%26aufirst%3DM.%2BA.%26aulast%3DShewchuk%26aufirst%3DL.%26aulast%3DLackey%26aufirst%3DK.%26atitle%3DThe%2520discovery%2520of%2520substituted%25204-%25283-hydroxyanilino%2529-quinolines%2520as%2520potent%2520RET%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5886%26epage%3D5893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Hynes, J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyckman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrobleski, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillooly, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanner, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lonial, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marathe, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sack, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pokross, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newitt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">Design, synthesis, and anti-inflammatory properties of orally active 4-(phenylamino)-pyrrolo[2,1-<i>f</i>][1,2,4]triazine p38alpha mitogen-activated protein kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7009414" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4-16&author=J.+Hynesauthor=A.+J.+Dyckmanauthor=S.+Linauthor=S.+T.+Wrobleskiauthor=H.+Wuauthor=K.+M.+Gilloolyauthor=S.+B.+Kannerauthor=H.+Lonialauthor=D.+Looauthor=K.+W.+McIntyreauthor=S.+Pittauthor=D.+R.+Shenauthor=D.+J.+Shusterauthor=X.+Yangauthor=R.+Zhangauthor=K.+Behniaauthor=H.+Zhangauthor=P.+H.+Maratheauthor=A.+M.+Doweykoauthor=J.+S.+Tokarskiauthor=J.+S.+Sackauthor=M.+Pokrossauthor=S.+E.+Kieferauthor=J.+A.+Newittauthor=J.+C.+Barrishauthor=J.+Doddauthor=G.+L.+Schievenauthor=K.+Leftheris&title=Design%2C+synthesis%2C+and+anti-inflammatory+properties+of+orally+active+4-%28phenylamino%29-pyrrolo%5B2%2C1-f%5D%5B1%2C2%2C4%5Dtriazine+p38alpha+mitogen-activated+protein+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm7009414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009414%26sid%3Dliteratum%253Aachs%26aulast%3DHynes%26aufirst%3DJ.%26aulast%3DDyckman%26aufirst%3DA.%2BJ.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DWrobleski%26aufirst%3DS.%2BT.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DKanner%26aufirst%3DS.%2BB.%26aulast%3DLonial%26aufirst%3DH.%26aulast%3DLoo%26aufirst%3DD.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DBehnia%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMarathe%26aufirst%3DP.%2BH.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DSack%26aufirst%3DJ.%2BS.%26aulast%3DPokross%26aufirst%3DM.%26aulast%3DKiefer%26aufirst%3DS.%2BE.%26aulast%3DNewitt%26aufirst%3DJ.%2BA.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DDodd%26aufirst%3DJ.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520anti-inflammatory%2520properties%2520of%2520orally%2520active%25204-%2528phenylamino%2529-pyrrolo%255B2%252C1-f%255D%255B1%252C2%252C4%255Dtriazine%2520p38alpha%2520mitogen-activated%2520protein%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Deak, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMauro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodous, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span> </span><span class="NLM_article-title"><i>N</i>-(3-(Phenylcarbamoyl-arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: structure, synthesis and SAR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1172</span><span class="NLM_x">–</span> <span class="NLM_lpage">1176</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1172-1176&author=H.+L.+Deakauthor=J.+R.+Newcombauthor=J.+J.+Nunesauthor=C.+Boucherauthor=A.+C.+Chengauthor=E.+F.+DiMauroauthor=L.+F.+Epsteinauthor=P.+Gallantauthor=B.+L.+Hodousauthor=X.+Huangauthor=J.+H.+Leeauthor=V.+F.+Patelauthor=S.+Schneiderauthor=S.+M.+Turciauthor=X.+Zhu&title=N-%283-%28Phenylcarbamoyl-arylpyrimidine%29-5-carboxamides+as+potent+and+selective+inhibitors+of+Lck%3A+structure%2C+synthesis+and+SAR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeak%26aufirst%3DH.%2BL.%26aulast%3DNewcomb%26aufirst%3DJ.%2BR.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DA.%2BC.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DEpstein%26aufirst%3DL.%2BF.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DHodous%26aufirst%3DB.%2BL.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DN-%25283-%2528Phenylcarbamoyl-arylpyrimidine%2529-5-carboxamides%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520Lck%253A%2520structure%252C%2520synthesis%2520and%2520SAR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1172%26epage%3D1176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Prien, O.; Schmees, N.; Eis, K.; Guenther, J.; Brohm, D.; Voehringer, V.; Li, V. M. J.; Beck, H.; Lobell, M.; Greschat, S.; Lang, D.</span><span> </span><span class="NLM_article-title">Novel Sulphoximide-Substituted Quinoline and Quinazoline Derivatives as Kinase Inhibitors</span>. PCT Int. Appl. WO 2009080200,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>Bayer.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=O.+Prien&author=N.+Schmees&author=K.+Eis&author=J.+Guenther&author=D.+Brohm&author=V.+Voehringer&author=V.+M.+J.+Li&author=H.+Beck&author=M.+Lobell&author=S.+Greschat&author=D.+Lang&title=Novel+Sulphoximide-Substituted+Quinoline+and+Quinazoline+Derivatives+as+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPrien%26aufirst%3DO.%26atitle%3DNovel%2520Sulphoximide-Substituted%2520Quinoline%2520and%2520Quinazoline%2520Derivatives%2520as%2520Kinase%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Hartung, I.; Bothe, U.; Kettschau, G.; Luecking, U.; Mengel, A.; Krueger, M.; Thierauch, K. H.; Lienau, P; Boemer, U.</span><span> </span><span class="NLM_article-title">Alkynylpyrimidines as Tie2 Kinase Inhibitors</span>. PCT Int. Appl. WO 2008155140,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">; </span>Bayer.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=I.+Hartung&author=U.+Bothe&author=G.+Kettschau&author=U.+Luecking&author=A.+Mengel&author=M.+Krueger&author=K.+H.+Thierauch&author=P+Lienau&author=U.+Boemer&title=Alkynylpyrimidines+as+Tie2+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHartung%26aufirst%3DI.%26atitle%3DAlkynylpyrimidines%2520as%2520Tie2%2520Kinase%2520Inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span> <span class="citation_source-book">Abstracts of Papers</span>, 237th National Meeting of the American Chemical Society, Salt Lake City, UT, March 22−26,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span><span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Washington, DC</span>; MEDI 15.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Abstracts+of+Papers%2C+237th+National+Meeting+of+the+American+Chemical+Society%2C+Salt+Lake+City%2C+UT%2C+March+22%E2%88%9226%2C+2009%3B+American+Chemical+Society%3A+Washington%2C+DC%3B+MEDI+15."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DAbstracts%2520of%2520Papers%26date%3D2009%26pub%3DAmerican%2520Chemical%2520Society" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Tiansheng, W.; Ledeboer, M. W.; Duffy, J. P.; Pierce, A. C.; Zuccola, H. J.; Block, E.; Shlyakter, D.; Hogan, J. K.; Bennani, Y. L.</span><span> </span><span class="NLM_article-title">A novel chemotype of kinase inhibitors: discovery of 3,4-ring fused 7-azaindole and deazapurines as potent Jak2 inhibitors</span>.  <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span>, in press.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Tiansheng%2C+W.%3B+Ledeboer%2C+M.+W.%3B+Duffy%2C+J.+P.%3B+Pierce%2C+A.+C.%3B+Zuccola%2C+H.+J.%3B+Block%2C+E.%3B+Shlyakter%2C+D.%3B+Hogan%2C+J.+K.%3B+Bennani%2C+Y.+L.+A+novel+chemotype+of+kinase+inhibitors%3A+discovery+of+3%2C4-ring+fused+7-azaindole+and+deazapurines+as+potent+Jak2+inhibitors.+Bioorg.+Med.+Chem.+Lett.%2C+in+press."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTiansheng%26aufirst%3DW.%26atitle%3DA%2520novel%2520chemotype%2520of%2520kinase%2520inhibitors%253A%2520discovery%2520of%25203%252C4-ring%2520fused%25207-azaindole%2520and%2520deazapurines%2520as%2520potent%2520Jak2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Di Grandi, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopper, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunnick, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torres, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamantidis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zapf, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wojciechowicz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frommer, E.</span><span> </span><span class="NLM_article-title">Novel pyrazolopyrimidines as highly potent B-Raf inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6957</span><span class="NLM_x">–</span> <span class="NLM_lpage">6961</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6957-6961&author=M.+J.+Di+Grandiauthor=D.+M.+Bergerauthor=D.+W.+Hopperauthor=C.+Zhangauthor=M.+Dutiaauthor=A.+L.+Dunnickauthor=N.+Torresauthor=J.+I.+Levinauthor=G.+Diamantidisauthor=C.+W.+Zapfauthor=J.+D.+Bloomauthor=Y.+Huauthor=D.+Powellauthor=D.+Wojciechowiczauthor=K.+Collinsauthor=E.+Frommer&title=Novel+pyrazolopyrimidines+as+highly+potent+B-Raf+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BGrandi%26aufirst%3DM.%2BJ.%26aulast%3DBerger%26aufirst%3DD.%2BM.%26aulast%3DHopper%26aufirst%3DD.%2BW.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DDutia%26aufirst%3DM.%26aulast%3DDunnick%26aufirst%3DA.%2BL.%26aulast%3DTorres%26aufirst%3DN.%26aulast%3DLevin%26aufirst%3DJ.%2BI.%26aulast%3DDiamantidis%26aufirst%3DG.%26aulast%3DZapf%26aufirst%3DC.%2BW.%26aulast%3DBloom%26aufirst%3DJ.%2BD.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DPowell%26aufirst%3DD.%26aulast%3DWojciechowicz%26aufirst%3DD.%26aulast%3DCollins%26aufirst%3DK.%26aulast%3DFrommer%26aufirst%3DE.%26atitle%3DNovel%2520pyrazolopyrimidines%2520as%2520highly%2520potent%2520B-Raf%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6957%26epage%3D6961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Lafleur, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caflisch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevado, C.</span><span> </span><span class="NLM_article-title">Structure-based optimization of potent and selective inhibitors of the tyrosine kinase erythropoietin producing human hepatocellular carcinoma receptor B4 (EphB4)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6433</span><span class="NLM_x">–</span> <span class="NLM_lpage">6446</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9009444" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6433-6446&author=K.+Lafleurauthor=D.+Huangauthor=T.+Zhouauthor=A.+Caflischauthor=C.+Nevado&title=Structure-based+optimization+of+potent+and+selective+inhibitors+of+the+tyrosine+kinase+erythropoietin+producing+human+hepatocellular+carcinoma+receptor+B4+%28EphB4%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm9009444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9009444%26sid%3Dliteratum%253Aachs%26aulast%3DLafleur%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DCaflisch%26aufirst%3DA.%26aulast%3DNevado%26aufirst%3DC.%26atitle%3DStructure-based%2520optimization%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520the%2520tyrosine%2520kinase%2520erythropoietin%2520producing%2520human%2520hepatocellular%2520carcinoma%2520receptor%2520B4%2520%2528EphB4%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6433%26epage%3D6446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Vulpetti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosotti, R.</span><span> </span><span class="NLM_article-title">Sequence and structural analysis of kinase ATP pocket residues</span> <span class="citation_source-journal">Farmaco</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">759</span><span class="NLM_x">–</span> <span class="NLM_lpage">765</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1016%2Fj.farmac.2004.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=15474052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotlWms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2004&pages=759-765&author=A.+Vulpettiauthor=R.+Bosotti&title=Sequence+and+structural+analysis+of+kinase+ATP+pocket+residues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Sequence and structural analysis of kinase ATP pocket residues</span></div><div class="casAuthors">Vulpetti, Anna; Bosotti, Roberta</div><div class="citationInfo"><span class="NLM_cas:title">Farmaco</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">759-765</span>CODEN:
                <span class="NLM_cas:coden">FRMCE8</span>;
        ISSN:<span class="NLM_cas:issn">0014-827X</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">Protein kinases represent one of the largest known families of enzymes.  Most kinases bind ATP and most synthetic kinase inhibitors are ATP-competitive, which makes selectivity a potential problem.  However, despite the high sequence similarity in the ATP binding pocket, several groups including ours have been able to develop highly potent and selective ATP-competitive inhibitors.  To systematically aid the design of specific inhibitors in our protein kinase projects, we aligned all known three-dimensional structures and all known sequences of human protein kinases.  We identified a set of 38 residues that make up the ATP pocket and analyzed the variability among these residues.  The most variable residues in the ATP pocket are targeted to design specificity into inhibitors in our various kinase projects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKrQCe0MaGh7Vg90H21EOLACvtfcHk0lgfrKzAV4wBig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotlWms7o%253D&md5=d710962f752fcd893880696e34bf35a1</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2Fj.farmac.2004.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.farmac.2004.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DVulpetti%26aufirst%3DA.%26aulast%3DBosotti%26aufirst%3DR.%26atitle%3DSequence%2520and%2520structural%2520analysis%2520of%2520kinase%2520ATP%2520pocket%2520residues%26jtitle%3DFarmaco%26date%3D2004%26volume%3D59%26spage%3D759%26epage%3D765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="note"><p class="first last">Residues were classified as small, medium, or large on the basis of their side chain number of atoms: (small) up to three atoms; (medium) four or five atoms; (large) more than five atoms.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Scapin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisnock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoGrasso, P. V.</span><span> </span><span class="NLM_article-title">The structure of JNK3 in complex with small molecule inhibitors. Structural basis for potency and selectivity</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">712</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm901443h&amp;key=10.1016%2FS1074-5521%2803%2900159-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm901443h&amp;key=12954329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm901443h&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFSisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=705-712&issue=8&author=G.+Scapinauthor=S.+B.+Patelauthor=J.+Lisnockauthor=J.+W.+Beckerauthor=P.+V.+LoGrasso&title=The+structure+of+JNK3+in+complex+with+small+molecule+inhibitors.+Structural+basis+for+potency+and+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The Structure of JNK3 in Complex with Small Molecule Inhibitors. Structural Basis for Potency and Selectivity</span></div><div class="casAuthors">Scapin, Giovanna; Patel, Sangita B.; Lisnock, JeanMarie; Becker, Joseph W.; LoGrasso, Philip V.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">705-712</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The c-Jun terminal kinases (JNKs) are members of the mitogen-activated protein (MAP) kinase family and regulate signal transduction in response to environmental stress.  Activation of JNK3, a neuronal-specific isoform, has been assocd. with neurol. damage, and as such, JNK3 may represent an attractive target for the treatment of neurol. disorders.  The MAP kinases share between 50% and 80% sequence identity.  In order to obtain efficacious and safe compds., it is necessary to address the issues of potency and selectivity.  We report here four crystal structures of JNK3 in complex with three different classes of inhibitors.  These structures provide a clear picture of the interactions that each class of compd. made with the kinase.  Knowledge of the at. interactions involved in these diverse binding modes provides a platform for structure-guided modification of these compds., or the de novo design of novel inhibitors that could satisfy the need for potency and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG3bvVv5ERO7Vg90H21EOLACvtfcHk0ljwyFfJ9yIwJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFSisb0%253D&md5=354f2b571d3afc70e29faf67af1fac93</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2803%2900159-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252803%252900159-5%26sid%3Dliteratum%253Aachs%26aulast%3DScapin%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DLisnock%26aufirst%3DJ.%26aulast%3DBecker%26aufirst%3DJ.%2BW.%26aulast%3DLoGrasso%26aufirst%3DP.%2BV.%26atitle%3DThe%2520structure%2520of%2520JNK3%2520in%2520complex%2520with%2520small%2520molecule%2520inhibitors.%2520Structural%2520basis%2520for%2520potency%2520and%2520selectivity%26jtitle%3DChem.%2520Biol.%26date%3D2003%26volume%3D10%26issue%3D8%26spage%3D705%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Peifer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abadleh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischof, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schattel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knippschild, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufer, S.</span><span> </span><span class="NLM_article-title">3,4-Diaryl-isoxazoles and -imidazoles as potent dual inhibitors of p38.alpha. mitogen activated protein kinase and casein kinase 1δ</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7618</span><span class="NLM_x">–</span> <span class="NLM_lpage">7630</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9005127" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7618-7630&author=C.+Peiferauthor=M.+Abadlehauthor=J.+Bischofauthor=D.+Hauserauthor=V.+Schattelauthor=H.+Hirnerauthor=U.+Knippschildauthor=S.+Laufer&title=3%2C4-Diaryl-isoxazoles+and+-imidazoles+as+potent+dual+inhibitors+of+p38.alpha.+mitogen+activated+protein+kinase+and+casein+kinase+1%CE%B4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Fjm9005127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9005127%26sid%3Dliteratum%253Aachs%26aulast%3DPeifer%26aufirst%3DC.%26aulast%3DAbadleh%26aufirst%3DM.%26aulast%3DBischof%26aufirst%3DJ.%26aulast%3DHauser%26aufirst%3DD.%26aulast%3DSchattel%26aufirst%3DV.%26aulast%3DHirner%26aufirst%3DH.%26aulast%3DKnippschild%26aufirst%3DU.%26aulast%3DLaufer%26aufirst%3DS.%26atitle%3D3%252C4-Diaryl-isoxazoles%2520and%2520-imidazoles%2520as%2520potent%2520dual%2520inhibitors%2520of%2520p38.alpha.%2520mitogen%2520activated%2520protein%2520kinase%2520and%2520casein%2520kinase%25201%25CE%25B4%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7618%26epage%3D7630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1xkk" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1xkk','PDB','1xkk'); return false;">PDB: 1xkk</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3g0e" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3g0e','PDB','3g0e'); return false;">PDB: 3g0e</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1b39" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1b39','PDB','1b39'); return false;">PDB: 1b39</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2fb8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2fb8','PDB','2fb8'); return false;">PDB: 2fb8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2bdj" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2bdj','PDB','2bdj'); return false;">PDB: 2bdj</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3b8q" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3b8q','PDB','3b8q'); return false;">PDB: 3b8q</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3db6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3db6','PDB','3db6'); return false;">PDB: 3db6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2e9n" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2e9n','PDB','2e9n'); return false;">PDB: 2e9n</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm901443h&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-7%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm901443h%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm901443h" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67995766d8b123b0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
